data_5ghb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5ghb _Structure_validation_residue.Date_analyzed 2017-06-02 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 53.0 p-80 . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -114.82 169.5 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.473 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.7 m-80 -97.76 141.37 30.85 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.67 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.538 HD13 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -132.38 162.42 31.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.111 0.481 . . . . 0.0 110.421 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.97 148.24 48.39 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.065 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 32' ' ' PHE . 80.8 t -126.97 115.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.377 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.82 126.7 37.01 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.86 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.42 ' HA3' ' HH ' ' A' ' 47' ' ' TYR . . . -91.38 164.87 29.68 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -68.41 -14.24 62.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.444 0.64 . . . . 0.0 110.916 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.8 -12.43 58.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.346 0.593 . . . . 0.0 110.525 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.39 48.79 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.83 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -105.43 152.3 23.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.41 137.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 15.0 p -105.41 141.59 20.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.855 0.359 . . . . 0.0 110.262 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -110.23 127.33 54.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.424 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -149.35 168.36 23.58 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.419 0.628 . . . . 0.0 111.883 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -116.52 134.97 54.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -140.48 147.08 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.044 0.45 . . . . 0.0 110.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 24.9 mtmt -82.47 157.93 23.42 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.754 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 15.4 mmm-85 -63.66 -39.74 95.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.995 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -92.76 8.27 40.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.704 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.4 m -91.6 128.3 47.02 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.702 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.47 145.62 77.47 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.822 2.348 . . . . 0.0 113.085 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.599 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.9 mp -60.09 -14.05 14.84 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.611 0.765 . . . . 0.0 112.087 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.444 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.6 m . . . . . 0 C--O 1.242 0.692 0 CA-C-O 121.246 0.545 . . . . 0.0 110.569 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.3 tt . . . . . 0 C--O 1.238 0.461 0 CA-C-O 120.959 0.409 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 1.9 mpt? -58.02 -42.39 85.2 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.01 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -68.66 -42.2 78.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.299 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.68 -52.86 62.41 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.42 ' HH ' ' HA3' ' A' ' 24' ' ' GLY . 51.8 t80 -61.19 -40.44 93.95 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.171 0.51 . . . . 0.0 110.887 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -40.82 91.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.92 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.02 -39.5 75.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.897 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 32.2 mmt180 -68.54 -52.85 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -22.14 59.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.981 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.13 57.35 3.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 0.0 111.96 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.6 175.6 10.47 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.691 -0.3 . . . . 0.0 110.332 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 m -96.78 128.38 43.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.825 0.345 . . . . 0.0 111.416 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.8 ptp -63.46 -26.24 68.63 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.233 0.539 . . . . 0.0 111.071 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -75.81 -11.43 59.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.203 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -105.23 7.04 33.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.332 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.428 HG21 ' HG2' ' A' ' 88' ' ' GLN . 27.0 pt -136.15 170.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.342 0.591 . . . . 0.0 111.629 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -140.8 148.78 41.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.147 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.3 m-85 -116.49 130.9 57.01 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.201 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.574 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.3 OUTLIER -132.36 142.67 49.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 0.0 110.045 177.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.404 ' HB2' HG13 ' A' ' 84' ' ' ILE . 87.2 t80 -136.74 134.3 36.99 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.255 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.32 31.7 21.19 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.044 0.449 . . . . 0.0 111.874 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.93 -14.85 59.34 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.356 -1.402 . . . . 0.0 113.251 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -117.33 148.16 42.05 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 121.974 -0.721 . . . . 0.0 112.165 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.04 147.96 21.42 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 123.392 2.728 . . . . 0.0 112.863 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.06 138.01 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.266 0.555 . . . . 0.0 111.284 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.81 158.14 15.68 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.61 -21.14 37.49 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.236 0.614 . . . . 0.0 111.956 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.3 p -79.29 -3.15 44.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.136 0.493 . . . . 0.0 111.539 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.519 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.6 m-20 -98.47 162.81 12.96 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.0 -0.437 . . . . 0.0 110.978 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.5 p -117.03 156.88 47.81 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.74 -11.05 30.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.278 1.985 . . . . 0.0 111.773 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -94.61 -19.29 20.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 110.454 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -63.61 -35.95 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 0.0 110.294 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.07 1.14 17.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.921 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 51.53 62.38 2.74 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.52 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.538 ' SD ' HD13 ' A' ' 20' ' ' LEU . 8.7 ptp -77.69 165.81 23.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 110.42 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.03 161.97 16.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.348 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.26 136.9 42.68 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.022 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 72.03 16.7 5.32 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.979 0.911 . . . . 0.0 111.484 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.72 175.85 5.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.468 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.439 ' C ' HD13 ' A' ' 84' ' ' ILE . 1.6 m -132.44 150.51 52.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.321 0.582 . . . . 0.0 111.721 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.439 HD13 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -120.96 139.04 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.574 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 11.3 m-20 -88.99 134.03 34.12 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.011 0.434 . . . . 0.0 110.596 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.07 137.84 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 121.63 0.729 . . . . 0.0 111.019 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -137.8 146.35 43.43 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.377 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HG2' HG21 ' A' ' 58' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.314 -0.937 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 . . . . . 0 N--CA 1.429 -1.494 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -122.09 169.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.383 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' HD23 ' A' ' 20' ' ' LEU . 28.1 m-80 -99.65 144.35 28.83 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.8 mm? -132.4 160.53 36.1 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.102 0.477 . . . . 0.0 110.172 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.5 mtpt -132.5 147.86 52.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.911 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 32' ' ' PHE . 75.5 t -125.78 118.28 51.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.092 0.472 . . . . 0.0 110.177 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.09 118.28 30.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.056 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.26 155.47 34.44 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.431 ' CG ' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -63.06 -13.78 40.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.29 0.567 . . . . 0.0 111.371 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.05 -11.69 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.76 41.41 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.947 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 t -110.2 162.18 14.85 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.18 141.12 28.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.194 0.521 . . . . 0.0 111.126 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 50' ' ' ARG . 12.1 p -109.65 142.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.999 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -113.12 124.14 51.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.274 0.559 . . . . 0.0 109.775 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 16.8 p90 -145.29 167.97 21.56 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -114.95 136.79 52.72 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.59 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.405 ' CG2' HD22 ' A' ' 20' ' ' LEU . 15.9 tt -143.81 148.96 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.032 0.444 . . . . 0.0 110.368 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.4 mtmt -83.97 158.69 21.44 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.793 -0.567 . . . . 0.0 110.973 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.438 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 27.6 mmm-85 -64.24 -40.75 96.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -91.17 8.84 33.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.294 0.569 . . . . 0.0 110.995 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 14.7 m -94.31 130.97 32.3 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.0 149.93 77.55 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.974 2.449 . . . . 0.0 113.586 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 71' ' ' ASP . 7.0 mp -61.44 -12.17 13.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.096 0.958 . . . . 0.0 112.873 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 p . . . . . 0 C--N 1.326 -0.456 0 CA-C-O 120.962 0.411 . . . . 0.0 111.049 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.4 tt . . . . . 0 C--O 1.236 0.358 0 CA-C-O 121.394 0.616 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.64 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.9 mtt -60.41 -48.0 83.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HE3' ' HE2' ' A' ' 55' ' ' MET . 3.9 tppp? -61.53 -42.28 98.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.8 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.608 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.38 -52.89 62.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.757 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.28 -41.0 96.21 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.135 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 75.5 m -65.39 -34.89 79.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.079 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -70.31 -34.89 73.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.2 mmp_? -73.77 -46.68 44.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.353 0.596 . . . . 0.0 111.084 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.5 -21.35 42.03 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.056 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.56 57.74 3.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.579 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.58 175.29 10.98 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 122.552 -0.381 . . . . 0.0 110.878 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 26.4 m -97.23 131.37 44.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.012 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.467 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 6.5 ptp -66.28 -26.84 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.217 0.532 . . . . 0.0 110.988 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -76.04 -13.75 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.431 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 22.2 mm-40 -101.26 2.38 39.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.504 0.669 . . . . 0.0 110.443 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.464 HD12 ' SG ' ' A' ' 48' ' ' CYS . 35.0 pt -135.09 176.24 9.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -146.95 154.43 41.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.834 0.35 . . . . 0.0 111.008 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.5 m-85 -119.03 132.44 56.05 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.092 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.561 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.1 ppt_? -134.63 141.5 46.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 111.098 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -141.39 139.83 33.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.575 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t70 57.99 27.97 15.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 111.305 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.12 -3.54 70.94 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.192 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -118.43 140.98 28.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 122.182 -0.599 . . . . 0.0 111.347 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.08 147.33 38.09 Favored 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 122.67 2.247 . . . . 0.0 112.261 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.22 139.0 51.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 110.594 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.8 165.82 11.6 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.979 0.419 . . . . 0.0 111.202 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.2 pt-20 -61.87 -17.13 55.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.194 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.4 p -82.98 -4.28 58.12 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.933 0.397 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.514 ' O ' HD11 ' A' ' 40' ' ' LEU . 46.5 m-20 -88.75 156.71 18.82 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -117.66 150.74 47.42 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 122.427 0.291 . . . . 0.0 110.222 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.24 -13.04 37.67 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.366 2.044 . . . . 0.0 112.234 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 36' ' ' ARG . . . -94.76 -13.74 25.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 110.817 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -72.2 -35.86 69.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.332 0.587 . . . . 0.0 110.176 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.89 1.0 22.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.69 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 53.01 61.34 3.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.321 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.1 ptp -80.24 166.45 21.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.415 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -91.94 167.62 11.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.065 0.459 . . . . 0.0 110.983 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.98 139.67 36.92 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.328 0.585 . . . . 0.0 110.091 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 71.6 15.27 6.06 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.487 1.115 . . . . 0.0 111.341 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.74 176.7 2.87 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -134.84 150.32 50.47 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.546 -0.721 . . . . 0.0 111.731 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 142.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.561 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 29.5 t70 -90.88 136.53 33.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.11 0.481 . . . . 0.0 110.869 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.75 134.06 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.948 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.76 137.47 49.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.813 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.431 ' HG3' ' CG ' ' A' ' 25' ' ' GLN . 2.2 mt-30 . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 0.0 111.1 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.667 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 . . . . . 0 N--CA 1.429 -1.479 0 CA-C-O 121.077 0.465 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 pt -123.2 170.17 13.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.987 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' O ' HD21 ' A' ' 20' ' ' LEU . 19.3 m-80 -93.89 142.09 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.653 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.581 HD12 ' SD ' ' A' ' 78' ' ' MET . 1.6 mm? -133.24 163.47 29.23 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.288 0.566 . . . . 0.0 110.87 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.4 mtpt -134.82 146.07 48.95 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.905 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.43 HG22 ' CE1' ' A' ' 32' ' ' PHE . 91.2 t -127.29 114.06 34.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.19 0.519 . . . . 0.0 110.132 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.84 130.32 37.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.414 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.421 ' HA3' ' HH ' ' A' ' 47' ' ' TYR . . . -95.93 161.82 22.82 Favored Glycine 0 N--CA 1.42 -2.417 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.959 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.402 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -65.02 -11.76 42.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.562 0.696 . . . . 0.0 110.897 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.87 -15.0 58.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.254 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.17 6.51 56.77 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.0 t -101.24 153.9 19.22 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.57 136.43 46.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.309 0.576 . . . . 0.0 111.507 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 11.6 p -105.19 140.07 24.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.391 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -110.97 124.95 53.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CE1' HG22 ' A' ' 22' ' ' VAL . 8.4 p90 -149.56 169.85 19.99 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.135 0.493 . . . . 0.0 111.452 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -113.61 143.27 44.85 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.985 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 14.7 tt -148.75 143.34 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.119 0.485 . . . . 0.0 110.359 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.667 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 25.7 mtmt -79.45 155.36 28.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.374 0.607 . . . . 0.0 111.772 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.0 mmm-85 -64.95 -36.49 84.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.641 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.19 4.91 53.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.337 0.589 . . . . 0.0 110.753 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 20.6 m -93.57 129.49 38.32 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.23 151.46 85.35 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.891 2.394 . . . . 0.0 112.856 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.461 ' CD2' HD12 ' A' ' 43' ' ' LEU . 81.2 mt -65.38 -11.87 46.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.55 0.74 . . . . 0.0 111.919 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.238 0.466 0 CA-C-O 121.117 0.484 . . . . 0.0 111.098 178.546 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 40' ' ' LEU . 4.0 tt . . . . . 0 C--O 1.235 0.341 0 CA-C-O 121.011 0.434 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.699 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 37.8 mtt -61.75 -39.69 92.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.168 0.508 . . . . 0.0 110.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.56 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.9 tppp? -70.16 -40.91 74.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.694 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.52 68.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 110.912 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.421 ' HH ' ' HA3' ' A' ' 24' ' ' GLY . 42.9 t80 -63.69 -37.05 85.91 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.061 0.458 . . . . 0.0 110.822 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -34.55 78.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.138 0.494 . . . . 0.0 110.812 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.0 mm-40 -72.59 -42.14 64.87 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.272 0.558 . . . . 0.0 110.62 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HG3' HG23 ' A' ' 30' ' ' VAL . 22.9 mmm-85 -62.99 -52.6 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.452 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -21.41 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.884 0.373 . . . . 0.0 111.927 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.02 2.82 90.65 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.925 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.54 175.95 8.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 0.0 111.208 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 m -97.42 127.02 43.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.698 0.285 . . . . 0.0 110.574 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.6 ptp -60.81 -25.24 66.43 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.093 0.473 . . . . 0.0 111.985 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -78.78 -11.36 59.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.242 0.544 . . . . 0.0 111.129 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -101.22 5.67 42.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.0 110.63 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.47 HG21 ' HG2' ' A' ' 88' ' ' GLN . 31.2 pt -135.22 177.23 7.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.118 0.485 . . . . 0.0 111.065 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -147.42 147.18 29.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 14.0 m-85 -113.87 128.06 56.25 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.21 0.529 . . . . 0.0 111.237 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 1.1 ppt_? -132.04 136.64 47.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.395 0.617 . . . . 0.0 110.735 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -135.79 134.77 39.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.538 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.39 28.5 18.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.216 0.531 . . . . 0.0 110.654 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.76 -4.52 64.86 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 119.645 -1.264 . . . . 0.0 113.198 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -115.99 136.81 23.01 Favored Pre-proline 0 C--N 1.322 -0.607 0 O-C-N 121.905 -0.762 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.27 142.91 30.96 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.704 2.269 . . . . 0.0 112.104 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 133.3 68.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.564 0.697 . . . . 0.0 111.365 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 149.47 21.44 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.335 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.0 pp20? -58.27 -20.0 38.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.432 HG21 ' OE2' ' A' ' 69' ' ' GLU . 40.9 p -76.26 -13.11 60.17 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.376 0.608 . . . . 0.0 111.164 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.79 166.79 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -118.13 158.4 46.38 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.07 -5.64 14.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.578 2.186 . . . . 0.0 112.074 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.04 -13.73 24.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.16 0.505 . . . . 0.0 110.525 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -68.6 -35.93 78.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.429 0.633 . . . . 0.0 110.549 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.434 HD23 ' HE2' ' A' ' 78' ' ' MET . 0.0 OUTLIER -111.16 1.47 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.482 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 52.6 60.05 4.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.581 ' SD ' HD12 ' A' ' 20' ' ' LEU . 7.6 ptp -74.97 163.02 28.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -87.89 159.97 18.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.47 131.48 44.81 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 14.3 mt-10 72.88 20.67 3.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 124.288 1.035 . . . . 0.0 111.593 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.75 179.42 3.13 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 m -135.13 150.43 50.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.509 -0.745 . . . . 0.0 111.887 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.1 mp -118.63 148.81 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.557 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 6.8 t70 -97.97 128.59 44.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.788 0.328 . . . . 0.0 110.334 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.11 135.0 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.576 0.703 . . . . 0.0 110.846 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.454 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -136.85 145.08 44.0 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.64 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.47 ' HG2' HG21 ' A' ' 58' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.313 -1.002 0 CA-C-O 121.126 0.488 . . . . 0.0 110.06 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 . . . . . 0 N--CA 1.43 -1.452 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.79 169.61 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.349 0.595 . . . . 0.0 111.095 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.463 ' O ' HD22 ' A' ' 20' ' ' LEU . 22.2 m-80 -99.95 145.81 27.41 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.568 HD12 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -132.63 162.39 31.46 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.323 0.582 . . . . 0.0 110.823 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 57.5 mtpt -133.55 147.98 51.61 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.989 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.7 t -128.74 117.96 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.09 0.472 . . . . 0.0 110.265 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.94 124.93 35.15 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.889 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.31 159.52 27.44 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.7 pp0? -63.32 -14.68 52.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.496 0.665 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.23 -19.25 62.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.55 6.19 50.6 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -107.39 163.66 12.86 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.0 143.39 31.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.488 HG22 ' HG3' ' A' ' 50' ' ' ARG . 6.1 p -112.36 145.28 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.172 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -112.77 131.05 55.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.299 0.571 . . . . 0.0 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 10.8 p90 -152.08 169.12 23.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.219 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -111.95 143.72 42.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.036 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.431 ' CG2' HD21 ' A' ' 20' ' ' LEU . 16.5 tt -150.54 149.23 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.063 0.459 . . . . 0.0 110.333 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.3 mtmt -87.23 158.03 19.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.73 -0.606 . . . . 0.0 110.74 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.9 mmm-85 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -90.48 7.75 37.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.119 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.3 m -93.7 129.98 36.48 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.37 150.22 87.35 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.904 2.402 . . . . 0.0 112.984 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.449 ' CD2' HD11 ' A' ' 43' ' ' LEU . 87.4 mt -65.26 -11.97 46.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.862 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p . . . . . 0 C--O 1.235 0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 111.142 178.817 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt . . . . . 0 C--O 1.238 0.487 0 CA-C-O 121.186 0.517 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.643 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 29.9 mtt -61.31 -40.88 95.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 17.8 tppt? -70.37 -38.33 74.72 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.967 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.09 -50.99 71.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.957 0.408 . . . . 0.0 110.566 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.41 -33.61 76.25 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.985 0.421 . . . . 0.0 110.532 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -38.13 89.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.247 0.546 . . . . 0.0 110.547 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 68.2 mm-40 -73.12 -34.64 66.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.071 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 30' ' ' VAL . 11.5 mmt180 -68.1 -49.54 60.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.011 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -22.38 28.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.81 58.31 3.06 Favored Glycine 0 C--N 1.321 -0.301 0 C-N-CA 119.673 -1.251 . . . . 0.0 111.696 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.52 174.07 11.74 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 122.564 -0.374 . . . . 0.0 110.286 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.9 m -100.05 129.23 46.08 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.86 0.362 . . . . 0.0 110.897 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.1 ptp -64.85 -25.52 67.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.414 ' HG3' ' HG2' ' A' ' 57' ' ' GLN . 12.7 ptt180 -75.81 -11.62 60.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.199 0.523 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 56' ' ' ARG . 19.3 mm-40 -104.53 2.62 31.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.407 HG23 ' HG2' ' A' ' 88' ' ' GLN . 37.7 pt -134.0 172.97 15.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.043 0.449 . . . . 0.0 110.636 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -142.24 149.89 40.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.778 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.3 m-85 -114.53 132.8 56.19 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.318 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.6 ppt_? -135.82 140.03 43.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.328 0.585 . . . . 0.0 111.076 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -138.2 137.7 37.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.822 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.85 34.06 21.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.78 -4.55 74.03 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.735 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -120.95 141.49 32.76 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.992 -0.711 . . . . 0.0 111.684 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.51 148.08 32.9 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 111.711 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.82 136.19 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.063 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.25 157.65 16.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -59.74 -22.07 61.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.4 p -74.5 -15.17 60.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.998 0.428 . . . . 0.0 111.229 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.36 165.45 13.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.6 p -117.33 158.76 43.93 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -67.35 -7.46 19.13 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.432 2.088 . . . . 0.0 111.83 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.91 -19.49 20.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.534 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -60.91 -40.01 91.54 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.63 0.729 . . . . 0.0 110.39 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.81 0.35 25.98 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.767 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.5 62.21 2.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' HD12 ' A' ' 20' ' ' LEU . 10.0 ptp -79.8 167.12 21.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.007 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -92.85 167.02 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.286 0.565 . . . . 0.0 110.914 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -75.92 139.74 41.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.134 0.492 . . . . 0.0 110.119 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 68.21 19.56 9.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.755 0.822 . . . . 0.0 111.137 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -72.06 179.76 3.14 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.798 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.431 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.6 m -135.04 150.07 50.23 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 121.602 -0.687 . . . . 0.0 111.618 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.431 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.98 144.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.571 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 28.8 t70 -92.2 139.69 30.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 120.812 0.339 . . . . 0.0 110.685 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.73 139.34 50.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.677 0.751 . . . . 0.0 110.956 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -137.43 146.04 43.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.946 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.426 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 1.3 mt-30 . . . . . 0 C--N 1.319 -0.761 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 38.4 p-80 . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 120.84 0.352 . . . . 0.0 111.763 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.34 170.81 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.577 0.704 . . . . 0.0 112.466 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.448 ' O ' HD23 ' A' ' 20' ' ' LEU . 25.4 m-80 -96.42 139.64 32.23 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.643 HD13 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -128.87 161.38 29.96 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' THR . 60.1 mtpt -136.73 146.91 46.38 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.169 0.509 . . . . 0.0 110.247 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -128.22 117.25 45.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.201 0.524 . . . . 0.0 110.639 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.58 118.23 28.09 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.46 160.84 33.4 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.169 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -9.14 38.74 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.681 0.753 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -74.72 -15.73 60.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.62 6.94 57.12 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.472 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 t -110.01 167.33 10.26 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.61 140.14 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.458 HG22 ' HG3' ' A' ' 50' ' ' ARG . 9.5 p -103.98 140.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.003 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -113.84 123.51 49.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.43 0.633 . . . . 0.0 109.651 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 8.8 p90 -147.12 169.04 20.12 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.231 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 33.5 mtmm -115.28 144.6 43.49 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 111.462 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.7 tt -148.25 146.07 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.023 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.539 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 29.4 mtmt -81.05 155.31 26.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 18.6 mmm-85 -60.79 -40.19 91.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.094 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -92.91 10.15 32.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.6 m -95.6 130.21 32.54 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.396 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 150.24 83.48 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.765 2.31 . . . . 0.0 112.97 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 43' ' ' LEU . 88.5 mt -62.11 -12.18 18.09 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 123.456 0.702 . . . . 0.0 111.799 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.956 178.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 2.3 tt . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.23 0.538 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.536 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 25.8 mtt -63.27 -39.29 94.17 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.651 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.66 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 4.1 tppp? -67.96 -44.51 76.56 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.246 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.648 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -53.97 -53.15 56.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.386 . . . . 0.0 111.016 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CE2' HG12 ' A' ' 86' ' ' VAL . 46.9 t80 -60.55 -41.58 94.82 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -41.55 81.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.288 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.66 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 22.6 mt-10 -71.7 -42.52 67.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.307 0.575 . . . . 0.0 111.211 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.1 mmt85 -65.09 -50.66 65.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.247 0.546 . . . . 0.0 111.321 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.6 -14.7 59.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.431 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.18 57.19 8.78 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.519 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -146.68 176.13 10.08 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -99.57 128.3 45.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.424 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.405 ' HE1' ' HE3' ' A' ' 45' ' ' LYS . 4.0 ptp -63.12 -19.95 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.111 0.481 . . . . 0.0 111.789 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -83.07 -15.11 52.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.244 0.545 . . . . 0.0 111.011 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -100.04 5.13 45.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.454 0.645 . . . . 0.0 110.47 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.442 HG22 ' HG2' ' A' ' 88' ' ' GLN . 34.2 pt -135.32 171.9 16.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.733 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 21.5 mmm180 -141.99 148.45 38.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.775 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.536 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.7 m-85 -113.68 130.33 56.43 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.726 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.575 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.48 131.86 38.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.092 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -126.56 136.48 52.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.287 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.88 32.56 22.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.285 0.564 . . . . 0.0 111.013 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.35 -3.4 58.88 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.565 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -119.33 135.05 23.77 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 121.847 -0.796 . . . . 0.0 111.215 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.37 150.6 76.13 Favored 'Trans proline' 0 C--N 1.326 -0.619 0 C-N-CA 122.702 2.268 . . . . 0.0 111.831 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.32 142.93 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.805 0.812 . . . . 0.0 111.34 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.22 153.81 17.6 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.105 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.8 pt-20 -63.95 -17.28 63.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.164 0.507 . . . . 0.0 111.731 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.6 p -81.56 -5.97 58.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.26 158.7 15.61 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.154 -0.341 . . . . 0.0 110.365 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' ' 75' ' ' GLN . 20.0 p -118.16 151.41 49.14 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.54 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' MET . 27.6 Cg_endo -63.07 -13.76 37.37 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.428 2.085 . . . . 0.0 112.55 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.07 -21.31 18.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.106 0.479 . . . . 0.0 110.964 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.537 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 6.1 tt0 -66.0 -33.74 76.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.866 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.32 -1.72 24.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.343 0.592 . . . . 0.0 110.5 177.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.47 58.41 4.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.426 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.643 ' SD ' HD13 ' A' ' 20' ' ' LEU . 11.2 ptp -77.49 172.29 13.58 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.878 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.9 tp10 -92.18 156.54 17.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.17 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.88 141.6 49.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.234 0.54 . . . . 0.0 110.839 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 69.08 18.88 8.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.111 0.965 . . . . 0.0 111.04 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -70.47 175.78 4.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.19 150.5 52.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.46 0.647 . . . . 0.0 111.923 -176.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.69 145.52 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -92.43 135.88 33.67 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.975 0.417 . . . . 0.0 110.607 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 47' ' ' TYR . 2.8 t -120.62 135.58 60.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.781 0.801 . . . . 0.0 111.132 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -135.79 145.2 46.27 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.424 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.442 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.2 mt-30 . . . . . 0 C--N 1.318 -0.784 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.824 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.487 HG22 ' OD1' ' A' ' 80' ' ' ASP . 32.4 pt -130.08 169.1 21.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.34 0.591 . . . . 0.0 111.414 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.2 140.49 32.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.48 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.504 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.2 mm? -128.97 164.34 23.38 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.087 0.47 . . . . 0.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 83' ' ' THR . 62.6 mtpt -133.57 147.19 51.52 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.027 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.452 HG22 ' CE1' ' A' ' 32' ' ' PHE . 71.5 t -125.0 116.39 47.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 120.968 0.413 . . . . 0.0 109.892 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.39 122.62 35.02 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.753 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.3 160.06 34.37 Favored Glycine 0 N--CA 1.424 -2.158 0 C-N-CA 120.439 -0.886 . . . . 0.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -15.16 60.51 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.128 0.49 . . . . 0.0 111.832 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.559 0.695 . . . . 0.0 110.025 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.86 5.52 50.57 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.67 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -95.76 162.75 13.47 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.24 136.74 22.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.479 0.657 . . . . 0.0 111.297 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.3 t -107.65 138.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.933 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.84 128.18 55.16 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CE1' HG22 ' A' ' 22' ' ' VAL . 13.7 p90 -147.91 168.35 22.46 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.274 0.559 . . . . 0.0 111.538 -174.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 37.5 mtmt -112.19 135.54 52.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.619 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -144.43 144.15 22.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.19 0.519 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.459 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 24.3 mtmm -82.18 156.79 24.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.484 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 12.4 mmm-85 -64.14 -34.64 78.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.371 0.605 . . . . 0.0 110.547 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -95.21 6.65 48.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.288 0.566 . . . . 0.0 110.914 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 8.3 m -92.2 129.76 40.27 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.048 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.0 147.16 73.35 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 123.141 2.561 . . . . 0.0 113.595 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.8 mp -61.55 -12.27 14.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.285 1.034 . . . . 0.0 112.99 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.2 p . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 121.046 0.45 . . . . 0.0 110.805 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 7.2 tt . . . . . 0 C--O 1.236 0.347 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.671 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 mtt -58.85 -42.61 89.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -67.94 -43.35 79.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.009 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.44 -49.89 73.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.128 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.66 -39.22 93.31 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.194 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -39.17 93.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 110.502 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -68.37 -36.73 79.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.187 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 50' ' ' ARG . 10.7 mmp_? -70.12 -45.55 66.64 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -21.56 39.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.864 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.22 4.5 89.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.368 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.64 177.21 6.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.934 0.397 . . . . 0.0 110.99 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.448 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 37.7 m -93.97 126.45 39.19 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.263 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -62.51 -28.7 70.02 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -76.55 -9.84 58.95 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.457 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 25.0 mm-40 -101.09 4.54 42.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.157 0.503 . . . . 0.0 111.373 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.617 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 23.0 pt -133.17 168.5 24.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.246 0.546 . . . . 0.0 110.786 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.617 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 54.8 mmt-85 -133.78 153.09 51.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.339 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.671 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 13.5 m-85 -119.17 131.03 55.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.315 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.579 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.1 ppt_? -136.56 143.94 43.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.251 0.548 . . . . 0.0 111.316 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.701 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 74.8 t80 -139.39 130.98 27.2 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER 53.87 32.22 14.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.52 -33.08 1.38 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.623 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' A' ' 62' ' ' PHE . 7.5 pt20 -70.06 119.82 74.13 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.688 0.756 . . . . 0.0 111.736 -177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.08 144.51 57.88 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.658 2.238 . . . . 0.0 110.724 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.8 133.01 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.354 0.597 . . . . 0.0 110.668 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.94 159.11 15.91 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.456 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.4 pt-20 -58.8 -21.84 57.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.322 0.582 . . . . 0.0 111.79 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.9 p -84.97 0.26 51.96 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.575 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' HD13 ' A' ' 40' ' ' LEU . 66.9 m-20 -96.07 161.76 13.83 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.885 -0.51 . . . . 0.0 110.325 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.3 p -119.38 153.53 53.71 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.954 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.24 -12.0 33.71 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.722 2.281 . . . . 0.0 112.863 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -95.05 -17.08 22.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.37 0.605 . . . . 0.0 110.937 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -67.94 -32.88 73.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.561 . . . . 0.0 110.771 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.2 3.09 19.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.045 0.45 . . . . 0.0 110.957 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 50.22 57.85 6.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.721 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.504 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -72.81 168.98 17.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.432 . . . . 0.0 110.88 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.5 tp10 -87.97 143.84 26.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.042 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.487 ' OD1' HG22 ' A' ' 18' ' ' ILE . 3.4 m-20 -59.02 138.68 57.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.86 0.362 . . . . 0.0 110.352 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.65 25.55 8.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 112.042 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -77.73 -174.28 3.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 110.964 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.443 ' C ' HD11 ' A' ' 84' ' ' ILE . 2.8 m -136.23 150.97 49.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.443 HD11 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.66 140.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.8 t70 -89.01 138.03 31.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.256 0.55 . . . . 0.0 110.9 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 136.21 57.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.314 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.449 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 3.8 p90 -146.77 158.95 44.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.095 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.489 ' HG2' HG22 ' A' ' 58' ' ' ILE . 87.6 mt-30 . . . . . 0 C--N 1.317 -0.828 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.9 p-80 . . . . . 0 N--CA 1.417 -2.085 0 CA-C-O 121.225 0.536 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 pt -106.08 169.73 2.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.674 0.749 . . . . 0.0 111.621 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.519 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.4 m-80 -99.71 148.68 24.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.055 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.524 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -136.94 162.77 32.37 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.393 0.616 . . . . 0.0 111.087 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.2 mtpt -136.73 148.18 47.14 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.183 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.0 t -129.25 117.97 44.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.434 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.02 122.1 33.4 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.694 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.07 162.91 30.15 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.453 ' CG ' ' HG3' ' A' ' 88' ' ' GLN . 5.4 pp0? -69.18 -12.09 61.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.743 0.782 . . . . 0.0 109.851 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.33 -21.43 60.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.801 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.12 10.82 41.27 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 t -109.77 158.47 18.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.19 134.22 52.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.383 0.611 . . . . 0.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 7.5 p -100.67 139.66 21.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.528 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -154.97 169.57 23.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.074 0.464 . . . . 0.0 111.377 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -118.22 138.3 52.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.652 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.471 ' CG2' HD21 ' A' ' 20' ' ' LEU . 14.0 tt -143.35 148.0 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 26.8 mtmt -84.44 157.7 21.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.247 0.546 . . . . 0.0 110.994 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -68.55 -34.46 75.87 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.323 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -95.2 6.49 48.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.587 0.708 . . . . 0.0 110.668 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.7 m -94.54 131.98 29.77 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.205 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.1 151.1 86.78 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.571 2.181 . . . . 0.0 112.265 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD2' HD12 ' A' ' 43' ' ' LEU . 67.2 mt -65.57 -13.7 59.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.746 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 2.4 p . . . . . 0 C--O 1.235 0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.45 HD12 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.239 0.506 0 CA-C-O 120.839 0.352 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -60.15 -37.89 81.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.341 0.591 . . . . 0.0 110.502 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.4 tppp? -69.41 -42.25 75.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.45 -50.24 70.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.29 0.567 . . . . 0.0 110.723 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.31 -39.65 94.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.15 0.5 . . . . 0.0 110.902 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -34.15 77.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm-40 -71.64 -40.84 69.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.675 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' HG3' ' CG2' ' A' ' 30' ' ' VAL . 10.5 mmm180 -68.97 -43.75 74.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.099 0.476 . . . . 0.0 111.657 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.95 -16.65 40.28 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.979 0.418 . . . . 0.0 111.714 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.03 2.93 80.01 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.919 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -83.46 176.46 9.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.075 0.465 . . . . 0.0 111.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.0 m -94.21 130.57 40.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.4 ptp -66.54 -22.01 66.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.063 0.459 . . . . 0.0 111.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -80.05 -8.25 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.269 0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -104.66 7.96 35.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.969 0.414 . . . . 0.0 111.711 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' A' ' 88' ' ' GLN . 22.2 pt -136.53 171.82 16.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.394 0.616 . . . . 0.0 111.364 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 16.6 mmm180 -140.64 145.79 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.573 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.66 130.47 56.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.6 ppt_? -133.1 138.24 46.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.351 0.596 . . . . 0.0 110.986 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -138.48 140.36 39.17 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.551 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.12 26.05 16.0 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.09 0.472 . . . . 0.0 111.297 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.31 -6.8 70.47 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.856 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.56 142.61 31.82 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.073 -0.663 . . . . 0.0 111.411 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.94 148.9 36.2 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 122.431 2.087 . . . . 0.0 111.435 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.96 135.29 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.428 0.633 . . . . 0.0 111.545 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.48 154.65 17.32 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.46 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.4 pt-20 -60.67 -21.28 62.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.054 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -76.46 -12.49 60.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 111.271 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.2 166.43 11.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 p -115.9 158.57 41.95 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.99 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 78' ' ' MET . 39.1 Cg_endo -67.79 -3.23 10.0 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.71 2.273 . . . . 0.0 112.124 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.43 -21.3 19.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.0 110.547 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -62.29 -39.49 93.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.378 0.609 . . . . 0.0 110.92 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.12 1.42 28.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.174 0.511 . . . . 0.0 111.221 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 3.5 mm-40 51.88 62.62 2.61 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.7 ptp -76.33 165.22 25.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.05 0.452 . . . . 0.0 110.366 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.82 165.83 11.92 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.1 131.56 44.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 69.67 21.13 6.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.555 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -67.89 176.63 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 1.3 m -132.81 148.67 52.31 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.577 -0.702 . . . . 0.0 111.427 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.05 142.14 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.576 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 36.1 t70 -89.52 134.08 34.28 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.101 0.477 . . . . 0.0 110.531 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.17 137.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.789 0.804 . . . . 0.0 110.75 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.8 p90 -135.07 144.59 47.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.37 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.471 ' HG2' HG21 ' A' ' 58' ' ' ILE . 1.4 mt-30 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.447 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 46.9 p-80 . . . . . 0 N--CA 1.443 -0.803 0 CA-C-O 120.759 0.314 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 pt -108.05 169.87 2.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.502 0.668 . . . . 0.0 112.232 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' O ' HD22 ' A' ' 20' ' ' LEU . 15.6 m-80 -97.34 142.47 29.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.464 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -133.17 163.9 28.24 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.382 0.611 . . . . 0.0 110.887 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.8 mtpt -138.64 148.6 44.26 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.628 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 32' ' ' PHE . 92.7 t -127.88 117.25 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.094 0.473 . . . . 0.0 110.497 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.36 123.19 35.5 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.292 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.88 163.01 26.69 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -19.42 63.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.706 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.1 -6.14 49.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.261 0.553 . . . . 0.0 110.98 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.17 64.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.838 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 t -103.88 158.4 16.43 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.94 136.04 45.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.253 0.549 . . . . 0.0 111.191 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 11.4 p -106.54 141.79 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 122.188 -0.32 . . . . 0.0 110.217 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -111.88 129.87 56.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.229 0.538 . . . . 0.0 109.968 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.437 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 11.7 p90 -154.09 169.95 22.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.585 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -115.56 143.27 45.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.651 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.428 ' CG2' HD21 ' A' ' 20' ' ' LEU . 13.6 tt -148.9 148.53 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.231 0.539 . . . . 0.0 110.398 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.0 mtmt -84.15 158.05 21.48 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.01 0.433 . . . . 0.0 110.782 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 23.8 mmm-85 -69.13 -34.04 74.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.517 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.45 5.13 52.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.58 . . . . 0.0 110.913 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.1 m -93.46 131.26 32.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.778 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.69 149.57 90.53 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.923 2.415 . . . . 0.0 112.784 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.449 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.7 mt -65.13 -12.14 47.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.906 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 177.42 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.392 0.615 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.736 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 38.5 mtt -61.57 -49.65 75.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.353 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.0 tppp? -59.66 -44.31 93.6 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.18 -50.79 68.46 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.773 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -62.78 -41.01 99.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.186 0.517 . . . . 0.0 110.813 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 58' ' ' ILE . 79.2 m -65.52 -34.64 78.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.399 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 18.9 mm-40 -68.89 -37.13 78.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.22 0.533 . . . . 0.0 110.99 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 mmt180 -69.63 -44.33 70.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.34 -21.74 33.06 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.295 0.569 . . . . 0.0 110.67 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.71 88.79 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.532 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.69 176.0 7.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.288 0.566 . . . . 0.0 111.815 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.7 m -96.9 134.62 40.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.542 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.6 ptp -68.18 -19.74 64.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.096 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -83.42 -8.05 59.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.167 0.508 . . . . 0.0 111.059 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -106.65 9.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.001 0.429 . . . . 0.0 110.811 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.556 HD13 ' SG ' ' A' ' 48' ' ' CYS . 19.6 pt -137.29 173.41 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.614 0.721 . . . . 0.0 111.856 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 21.3 mmm180 -140.27 146.9 39.18 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.071 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.736 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.6 m-85 -113.75 128.15 56.3 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.386 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.56 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.5 OUTLIER -128.63 145.41 51.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.003 0.43 . . . . 0.0 110.211 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -140.96 131.44 25.32 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.039 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 t0 58.33 29.38 18.05 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.893 0.378 . . . . 0.0 111.684 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.9 69.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.089 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -114.03 134.79 22.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.054 -0.674 . . . . 0.0 111.116 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.65 149.33 33.98 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.848 2.365 . . . . 0.0 112.376 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.87 137.52 52.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.9 161.28 13.82 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.216 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.592 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.4 pt-20 -62.22 -20.91 64.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.093 0.473 . . . . 0.0 112.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -76.33 -6.89 53.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.251 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.419 ' OD1' ' HG2' ' A' ' 75' ' ' GLN . 1.7 m-20 -103.22 166.85 10.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.136 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -116.84 159.89 38.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 78' ' ' MET . 35.3 Cg_endo -66.52 -8.71 21.72 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.506 2.137 . . . . 0.0 111.912 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -94.99 -13.09 25.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.303 0.573 . . . . 0.0 110.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.419 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 2.3 tp-100 -68.26 -35.49 77.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.511 0.672 . . . . 0.0 110.16 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.449 HD22 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -110.52 1.19 18.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.366 -179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 54.16 61.73 2.91 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.382 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.553 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.8 ptp -77.18 164.39 25.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 110.734 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 38.1 tt0 -95.09 161.58 14.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.128 -175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.54 134.56 53.62 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.061 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 70.05 19.67 6.74 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.836 0.855 . . . . 0.0 111.555 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t0 -71.49 176.14 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.429 . . . . 0.0 110.111 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.463 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.5 m -131.32 150.26 52.22 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.22 0.534 . . . . 0.0 111.246 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.463 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.19 136.69 58.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.56 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 19.4 m-20 -89.83 138.07 31.8 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.041 0.448 . . . . 0.0 110.833 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -122.7 139.56 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.98 151.28 45.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 91.4 mt-30 . . . . . 0 CA--C 1.512 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.998 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 45.8 p-80 . . . . . 0 N--CA 1.437 -1.119 0 CA-C-O 120.886 0.374 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.44 170.51 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.369 0.604 . . . . 0.0 111.332 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.425 ' O ' HD21 ' A' ' 20' ' ' LEU . 23.6 m-80 -96.77 142.32 28.93 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.586 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -130.49 162.31 29.49 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.987 0.422 . . . . 0.0 109.889 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.2 mtpt -136.3 145.52 45.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.102 0.477 . . . . 0.0 110.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.408 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.6 t -125.56 116.67 47.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.156 0.503 . . . . 0.0 109.961 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.9 122.55 35.38 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.53 159.61 32.18 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -64.13 -11.9 34.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.166 0.508 . . . . 0.0 111.775 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -80.36 -15.51 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.356 0.598 . . . . 0.0 110.072 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 4.99 48.29 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.072 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 t -99.61 160.05 14.58 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.25 136.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.468 0.651 . . . . 0.0 111.496 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 50' ' ' ARG . 7.4 p -102.28 142.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -113.64 125.04 53.71 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.409 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 12.2 p90 -146.42 167.98 22.28 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.533 -174.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 40.8 mtmt -114.99 134.16 55.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 111.255 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.0 tt -144.71 150.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.106 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.563 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.8 mtmt -81.03 163.89 22.89 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.863 -0.523 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.43 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 22.4 mmm-85 -70.74 -40.24 72.84 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 110.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -91.8 5.97 47.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.568 0.699 . . . . 0.0 110.517 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.8 m -90.98 130.4 40.6 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.14 149.01 92.68 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.049 2.499 . . . . 0.0 113.233 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 43' ' ' LEU . 83.7 mt -64.05 -12.59 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.406 0.683 . . . . 0.0 111.994 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.239 0.519 0 CA-C-O 120.86 0.362 . . . . 0.0 110.991 179.532 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.429 HD13 ' CD2' ' A' ' 40' ' ' LEU . 2.4 tt . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.32 0.581 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.596 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 28.1 mtt -60.04 -47.28 86.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.369 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.0 tppt? -63.08 -41.87 99.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.752 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.73 74.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.958 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.67 -39.8 95.06 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.157 0.503 . . . . 0.0 110.71 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' HD12 ' A' ' 58' ' ' ILE . 70.7 m -67.68 -34.87 77.77 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 16.2 mm-40 -70.72 -33.99 71.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.2 0.524 . . . . 0.0 110.505 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HG3' HG23 ' A' ' 30' ' ' VAL . 15.9 mmt180 -65.45 -49.01 70.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.302 0.572 . . . . 0.0 110.511 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.63 -20.76 35.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.674 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.83 14.25 79.95 Favored Glycine 0 C--N 1.321 -0.269 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.371 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.99 178.54 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.451 0.643 . . . . 0.0 112.25 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.0 m -100.36 129.57 46.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.759 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.501 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.7 ptp -63.13 -24.04 67.71 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.119 0.485 . . . . 0.0 112.087 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -78.91 -12.48 60.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.351 0.596 . . . . 0.0 111.142 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -99.33 -0.29 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.146 0.498 . . . . 0.0 110.999 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.525 HD12 ' SG ' ' A' ' 48' ' ' CYS . 29.2 pt -132.77 169.9 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.229 0.537 . . . . 0.0 111.567 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 17.7 mmm180 -138.83 146.88 41.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.988 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.596 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.1 m-85 -112.72 130.73 55.96 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.825 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -130.71 145.22 51.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 0.0 110.66 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -146.51 135.79 22.77 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 60.88 28.04 17.83 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.427 0.632 . . . . 0.0 110.743 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.18 -1.2 70.94 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.445 -1.359 . . . . 0.0 113.51 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -118.53 139.84 27.5 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 117.527 0.664 . . . . 0.0 110.853 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.81 145.66 36.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.341 2.028 . . . . 0.0 111.577 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.7 137.58 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-O 121.543 0.687 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.53 154.25 17.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.544 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.575 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.2 pt-20 -61.7 -18.04 58.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.522 . . . . 0.0 112.325 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -79.51 -15.65 57.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.021 0.439 . . . . 0.0 111.278 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.39 164.07 15.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.942 0.401 . . . . 0.0 111.345 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -118.04 155.18 51.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.221 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.45 -11.35 29.97 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.754 2.303 . . . . 0.0 112.243 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 36' ' ' ARG . . . -94.93 -14.81 24.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.896 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -69.31 -38.79 78.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.438 0.637 . . . . 0.0 110.168 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.437 HD11 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -104.92 1.28 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.432 0.634 . . . . 0.0 110.15 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 50.85 60.83 3.59 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.784 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.586 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -77.0 163.6 26.55 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.5 tp10 -92.96 161.83 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.453 . . . . 0.0 110.814 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.36 138.65 51.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.286 0.565 . . . . 0.0 111.215 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 73.03 19.45 3.69 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.413 1.085 . . . . 0.0 110.9 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -72.82 175.35 6.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.731 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.463 ' C ' HD11 ' A' ' 84' ' ' ILE . 1.2 m -133.33 147.26 51.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.578 0.704 . . . . 0.0 111.506 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.463 HD11 ' C ' ' A' ' 83' ' ' THR . 2.5 mp -121.4 137.87 53.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.562 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 13.4 m-20 -88.73 136.38 33.03 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.1 0.476 . . . . 0.0 111.022 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -120.88 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-O 121.465 0.65 . . . . 0.0 110.609 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -137.94 147.15 44.06 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.305 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 121.191 0.52 . . . . 0.0 109.9 -175.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 10.6 p-80 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 120.989 0.423 . . . . 0.0 111.852 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 pt -129.66 169.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.353 -0.842 . . . . 0.0 112.125 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.563 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.3 m-80 -103.87 144.49 31.44 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.215 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.568 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -135.23 160.69 37.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.336 0.589 . . . . 0.0 110.936 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.2 mtpt -135.93 148.32 48.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 96.9 t -125.38 119.32 55.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.244 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.75 119.9 35.06 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.338 0.59 . . . . 0.0 110.222 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.84 157.98 32.96 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -64.43 -16.41 62.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.276 0.56 . . . . 0.0 111.369 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.98 -10.95 58.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 0.0 110.916 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.59 30.41 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.31 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -105.43 155.6 18.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.3 p -141.01 134.11 31.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.384 0.611 . . . . 0.0 110.958 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 85.9 t -107.24 138.45 33.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.99 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -110.11 131.75 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.422 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 7.1 p90 -155.9 170.07 22.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.305 0.574 . . . . 0.0 111.887 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -116.45 138.38 51.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.744 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.5 tt -143.52 150.52 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.103 0.477 . . . . 0.0 110.069 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 25.8 mtmm -86.47 158.39 19.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.404 ' NH2' ' HA ' ' A' ' 74' ' ' ALA . 24.0 mmm-85 -63.25 -38.29 90.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.647 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -95.47 9.41 40.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.027 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.9 m -93.95 128.34 41.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.378 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.0 149.42 89.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.685 2.256 . . . . 0.0 112.925 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.43 ' CD2' HD12 ' A' ' 43' ' ' LEU . 83.8 mt -63.91 -11.71 30.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.971 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.41 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 21.9 p . . . . . 0 C--O 1.236 0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt . . . . . 0 C--O 1.237 0.431 0 CA-C-O 121.135 0.493 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.608 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 34.0 mtt -62.32 -46.57 88.15 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.227 0.537 . . . . 0.0 110.648 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.692 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 17.6 tppt? -64.99 -41.44 95.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.793 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.39 -50.96 71.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.796 0.332 . . . . 0.0 110.655 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.17 -42.34 99.37 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.362 0.601 . . . . 0.0 110.262 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.692 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.09 -40.17 88.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.958 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 7.8 mt-10 -73.38 -33.51 65.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.866 0.365 . . . . 0.0 111.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 7.1 mmp_? -65.44 -47.71 75.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.314 0.578 . . . . 0.0 110.417 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.12 46.16 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.124 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.79 2.6 78.37 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.975 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.86 176.27 7.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.459 0.647 . . . . 0.0 112.47 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.4 m -97.52 136.68 37.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.651 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 6.5 ptp -68.09 -26.64 65.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.158 0.504 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -75.17 -10.28 59.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.407 0.623 . . . . 0.0 110.665 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -102.66 5.67 39.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.231 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.432 HG23 ' HG2' ' A' ' 88' ' ' GLN . 28.6 pt -138.8 176.66 6.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.118 0.485 . . . . 0.0 110.983 -177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -146.94 148.03 31.34 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.631 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.608 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.6 m-85 -114.55 132.33 56.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.789 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.54 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -131.0 142.58 50.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.46 0.648 . . . . 0.0 111.028 177.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -146.55 140.1 25.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t70 64.44 25.35 13.32 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.068 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.41 -0.39 64.34 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 119.819 -1.181 . . . . 0.0 113.161 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -120.79 143.3 36.27 Favored Pre-proline 0 N--CA 1.445 -0.695 0 O-C-N 122.134 -0.627 . . . . 0.0 110.808 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.62 148.7 47.87 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 122.233 1.956 . . . . 0.0 111.716 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.29 137.09 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-O 121.334 0.588 . . . . 0.0 110.648 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.19 156.24 16.96 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.574 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -60.66 -20.15 60.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.183 0.516 . . . . 0.0 112.062 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -79.54 -10.95 59.89 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.22 162.73 14.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.679 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -118.45 158.63 46.43 Favored Pre-proline 0 C--N 1.307 -1.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.16 -6.04 13.77 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.649 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.404 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . . . -95.42 -14.07 24.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.557 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -68.06 -37.02 80.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.444 0.64 . . . . 0.0 110.102 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.444 HD22 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -111.75 1.72 16.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.546 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 53.11 60.36 3.82 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' HD13 ' A' ' 20' ' ' LEU . 9.9 ptp -78.72 167.37 21.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.855 0.36 . . . . 0.0 110.534 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 80' ' ' ASP . 43.1 tt0 -93.29 165.64 12.7 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.095 0.474 . . . . 0.0 110.568 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 3.9 p-10 -77.25 137.87 39.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.063 0.459 . . . . 0.0 110.036 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.13 16.72 4.21 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.356 1.062 . . . . 0.0 111.317 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.07 176.43 3.81 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.6 m -136.41 151.04 49.09 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 121.805 -0.56 . . . . 0.0 111.004 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 61' ' ' ARG . 2.8 mp -120.81 144.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.5 t0 -88.87 130.96 35.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.146 0.498 . . . . 0.0 110.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.48 134.89 60.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.653 0.739 . . . . 0.0 111.046 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -135.65 145.96 47.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.432 ' HG2' HG23 ' A' ' 58' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.317 -0.809 0 CA-C-O 121.085 0.469 . . . . 0.0 110.659 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 21.5 p-80 . . . . . 0 N--CA 1.429 -1.518 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.7 pt -104.22 168.8 2.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-O 121.662 0.744 . . . . 0.0 112.217 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.43 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.9 m-80 -101.47 144.93 29.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.948 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -132.28 161.78 32.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.233 0.539 . . . . 0.0 110.459 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.0 mtpt -135.76 147.64 48.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.759 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.3 t -127.48 113.91 33.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 121.082 0.468 . . . . 0.0 110.294 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.07 123.02 34.21 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.778 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.01 163.75 29.47 Favored Glycine 0 N--CA 1.418 -2.545 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -12.08 59.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.574 0.702 . . . . 0.0 111.28 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.41 -13.15 58.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.734 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.73 9.3 56.5 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.764 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -103.28 155.39 18.49 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.32 130.71 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.635 0.731 . . . . 0.0 111.377 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 94.2 t -101.81 135.85 36.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.325 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -108.44 128.82 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -151.42 169.7 21.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.216 0.531 . . . . 0.0 111.528 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -115.46 138.21 51.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.842 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tt -145.54 149.31 16.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.467 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 30.5 mtmt -83.62 159.86 21.5 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 25.3 mmm-85 -69.46 -36.03 76.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.165 0.507 . . . . 0.0 110.594 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.99 5.95 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.272 0.558 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.2 m -91.29 131.57 36.23 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.321 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.45 147.89 93.0 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 70.9 mt -64.54 -13.44 52.67 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.408 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.238 0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 111.7 179.733 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.447 HD11 ' CD2' ' A' ' 40' ' ' LEU . 3.9 tt . . . . . 0 C--O 1.238 0.496 0 CA-C-O 120.822 0.344 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -60.56 -39.45 87.99 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.513 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 tppp? -68.72 -43.11 76.66 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.2 -51.15 65.33 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.78 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -64.68 -39.9 94.47 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.18 83.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 5.9 mm-40 -72.23 -35.36 68.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.273 0.558 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 27.6 mmm180 -69.43 -45.55 68.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.392 0.615 . . . . 0.0 111.402 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -21.74 33.54 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.676 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.09 89.78 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.908 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.79 178.04 7.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.912 0.386 . . . . 0.0 111.502 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.8 m -96.87 124.67 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.17 -27.77 64.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -79.05 -9.47 59.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.218 0.532 . . . . 0.0 111.622 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.48 2.11 35.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.556 0.693 . . . . 0.0 110.617 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.456 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.9 pt -130.78 170.68 19.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.235 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 16.2 mmm180 -140.51 147.27 39.29 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.252 0.549 . . . . 0.0 111.253 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.26 129.16 56.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.112 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.2 ppt_? -132.86 136.38 46.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 111.468 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -136.23 137.31 40.68 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 60.89 29.8 19.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.324 0.583 . . . . 0.0 111.134 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.51 67.99 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.197 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.03 139.78 31.02 Favored Pre-proline 0 C--N 1.323 -0.576 0 O-C-N 122.175 -0.603 . . . . 0.0 111.251 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 151.28 44.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.413 2.075 . . . . 0.0 111.851 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.88 136.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.353 0.597 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.71 154.51 17.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.508 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -59.11 -20.6 54.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.395 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.5 p -80.29 -10.37 59.75 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.304 0.573 . . . . 0.0 111.399 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.78 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 p -113.31 155.15 44.98 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.004 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.47 -7.77 18.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.56 2.173 . . . . 0.0 111.879 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.98 -16.61 22.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.929 0.395 . . . . 0.0 110.618 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -68.97 -40.65 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.628 . . . . 0.0 110.49 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.83 -1.14 38.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.487 0.66 . . . . 0.0 110.205 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 60.07 3.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.929 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 20' ' ' LEU . 8.1 ptp -79.83 165.17 22.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 175.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.589 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 13.0 pt-20 -100.73 169.51 8.97 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.146 0.498 . . . . 0.0 112.203 -175.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.64 133.3 50.84 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.894 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 69.24 18.63 8.07 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.508 0.723 . . . . 0.0 111.61 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.589 ' OD2' ' HG2' ' A' ' 79' ' ' GLU . 4.0 t0 -67.92 174.77 3.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.414 ' C ' HD11 ' A' ' 84' ' ' ILE . 1.1 m -133.11 150.51 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.687 -0.633 . . . . 0.0 110.899 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.414 HD11 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.57 145.98 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.0 t70 -92.71 133.63 35.82 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.028 0.442 . . . . 0.0 110.521 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.61 137.13 54.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.7 0.762 . . . . 0.0 110.644 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -137.54 148.15 45.72 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.582 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.456 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.313 -1.009 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 . . . . . 0 N--CA 1.443 -0.793 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.56 169.37 20.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.326 0.584 . . . . 0.0 111.56 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.446 ' O ' HD21 ' A' ' 20' ' ' LEU . 19.3 m-80 -98.94 143.2 29.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.638 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.8 mm? -129.96 163.86 25.52 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.084 0.468 . . . . 0.0 110.026 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 55.6 mtpt -135.73 147.61 48.51 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 32' ' ' PHE . 69.6 t -126.53 117.23 47.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.169 0.509 . . . . 0.0 110.264 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.72 121.42 32.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.758 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.85 159.13 30.06 Favored Glycine 0 N--CA 1.42 -2.398 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.17 58.74 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.358 0.599 . . . . 0.0 111.679 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.76 -12.38 60.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.429 0.633 . . . . 0.0 110.499 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 8.46 57.67 Favored Glycine 0 C--N 1.321 -0.28 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.807 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -99.28 159.57 14.9 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.66 135.46 30.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-O 121.483 0.658 . . . . 0.0 111.274 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 14.6 p -104.98 138.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.063 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -108.78 125.62 52.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.465 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 15.7 p90 -147.29 168.82 20.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.228 0.537 . . . . 0.0 111.446 -174.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -112.26 141.18 46.28 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.056 0.455 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 tt -148.2 148.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.088 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.5 mtmm -85.05 157.79 20.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.762 -0.586 . . . . 0.0 110.418 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.451 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 17.3 mmm-85 -64.28 -41.18 97.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.501 . . . . 0.0 110.803 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -89.92 7.42 37.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.421 0.629 . . . . 0.0 110.461 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 19.1 m -93.94 130.27 35.12 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 148.57 91.13 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.818 2.345 . . . . 0.0 113.123 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.424 ' CD2' HD13 ' A' ' 43' ' ' LEU . 82.6 mt -62.76 -12.28 23.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.513 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 12.8 t . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 122.609 0.364 . . . . 0.0 111.065 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.465 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 2.6 tt . . . . . 0 C--O 1.236 0.349 0 CA-C-O 121.249 0.547 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.581 ' SD ' ' HB3' ' A' ' 69' ' ' GLU . 36.4 mtt -61.86 -40.17 94.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.377 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.3 tppp? -66.71 -44.32 81.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.54 -51.58 66.58 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.11 -40.42 95.85 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.003 0.43 . . . . 0.0 111.111 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -42.01 96.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.2 mm-40 -65.21 -39.65 93.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.852 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.8 mmp_? -65.61 -54.2 31.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.188 0.518 . . . . 0.0 111.51 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -21.41 59.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.184 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.08 87.74 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -86.99 177.45 7.23 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.404 -0.468 . . . . 0.0 110.734 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 m -100.25 128.05 46.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.641 0.258 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.44 ' HE3' ' HE3' ' A' ' 45' ' ' LYS . 3.1 ptp -64.35 -24.25 67.58 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.547 . . . . 0.0 111.247 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -77.67 -14.71 59.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.53 . . . . 0.0 110.778 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -99.85 1.0 42.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.156 0.503 . . . . 0.0 111.23 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.416 HG21 ' HG2' ' A' ' 88' ' ' GLN . 29.9 pt -130.71 173.03 15.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 22.0 mmm180 -141.12 149.83 42.06 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.741 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-85 -114.34 132.17 56.28 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.544 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.6 ppt_? -134.25 140.5 46.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 0.0 110.993 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -139.51 138.21 36.15 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.707 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.47 33.82 21.77 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.175 0.512 . . . . 0.0 112.107 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.1 -6.32 67.79 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.758 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.23 145.18 37.81 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 122.13 -0.629 . . . . 0.0 111.045 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.05 151.61 35.1 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.386 2.057 . . . . 0.0 111.179 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.44 141.33 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.458 0.647 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 154.2 17.36 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.581 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.4 pt-20 -62.17 -16.34 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.2 p -79.55 -18.63 51.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.203 0.525 . . . . 0.0 110.874 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.438 ' OD2' ' HG2' ' A' ' 75' ' ' GLN . 0.3 OUTLIER -83.08 161.2 21.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.1 p -117.16 158.42 44.45 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.722 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.27 -8.66 23.56 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.113 1.875 . . . . 0.0 111.529 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 36' ' ' ARG . . . -95.38 -19.56 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.609 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 3.0 tp-100 -62.45 -36.31 82.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.42 0.628 . . . . 0.0 110.307 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.54 -0.3 20.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 51.05 63.09 2.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.507 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.638 ' SD ' HD13 ' A' ' 20' ' ' LEU . 12.1 ptp -77.44 175.47 9.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.825 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -96.19 157.84 15.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.39 143.32 48.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.438 0.637 . . . . 0.0 111.17 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 69.93 20.19 6.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.06 176.92 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.415 ' C ' HD11 ' A' ' 84' ' ' ILE . 1.4 m -133.43 151.58 51.82 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 83' ' ' THR . 3.2 mp -124.19 142.51 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 30.0 t70 -89.42 136.83 32.8 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.2 137.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.631 0.729 . . . . 0.0 110.691 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -138.22 149.11 45.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.703 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.416 ' HG2' HG21 ' A' ' 58' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.681 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.601 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 23.7 p-80 . . . . . 0 N--CA 1.435 -1.216 0 CA-C-O 120.782 0.325 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.05 169.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.516 0.674 . . . . 0.0 112.756 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' HD22 ' A' ' 20' ' ' LEU . 9.5 m-80 -99.35 139.91 34.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.43 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.548 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -131.69 159.91 37.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.211 0.529 . . . . 0.0 110.296 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -134.53 148.39 50.5 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.414 HG23 ' CE1' ' A' ' 32' ' ' PHE . 70.2 t -126.64 117.19 47.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.163 0.506 . . . . 0.0 109.986 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.14 119.29 31.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.95 158.33 30.41 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.2 pp0? -66.24 -10.51 42.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.506 0.67 . . . . 0.0 110.886 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -76.53 -15.5 59.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.329 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 14.23 37.16 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.543 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t -119.59 166.25 13.39 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.23 137.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.171 0.51 . . . . 0.0 111.282 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.6 t -102.95 139.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.904 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -110.24 130.33 55.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.414 ' CE1' HG23 ' A' ' 22' ' ' VAL . 6.0 p90 -150.86 168.91 23.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.181 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -117.27 133.98 55.34 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 16.9 tt -135.2 150.1 29.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.577 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 12.8 mttt -86.92 151.44 23.3 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.082 0.468 . . . . 0.0 110.847 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -61.72 -40.1 93.86 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.241 0.543 . . . . 0.0 110.805 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -87.73 6.17 36.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.289 0.566 . . . . 0.0 111.353 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.6 m -96.81 131.77 27.32 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.459 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.84 154.89 71.84 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.931 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' CD2' HD12 ' A' ' 43' ' ' LEU . 95.4 mt -66.76 -11.25 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.771 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.24 0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.948 178.817 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 40' ' ' LEU . 3.1 tt . . . . . 0 C--O 1.236 0.377 0 CA-C-O 121.306 0.574 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.635 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -60.81 -50.36 73.76 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.402 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.674 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 18.3 tppt? -60.84 -43.1 98.74 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.84 -52.79 61.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.047 0.451 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -61.03 -43.96 98.11 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.333 0.587 . . . . 0.0 110.503 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' HD12 ' A' ' 58' ' ' ILE . 73.4 m -61.02 -39.79 91.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.545 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.674 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.0 mt-10 -66.65 -33.82 76.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.054 0.454 . . . . 0.0 110.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.8 mmm180 -67.65 -48.74 65.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.143 0.497 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -22.7 39.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.069 0.461 . . . . 0.0 111.533 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.23 72.6 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.023 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.73 177.01 6.85 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.177 -0.602 . . . . 0.0 112.266 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.8 m -99.89 140.24 34.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.45 -25.9 66.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.407 ' HG3' HE21 ' A' ' 57' ' ' GLN . 15.2 ptp180 -75.53 -10.7 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.159 0.504 . . . . 0.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.407 HE21 ' HG3' ' A' ' 56' ' ' ARG . 21.9 mm-40 -101.41 4.32 41.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 0.0 110.933 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.53 HD12 ' SG ' ' A' ' 48' ' ' CYS . 31.3 pt -139.92 174.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.289 0.566 . . . . 0.0 111.701 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -141.25 145.02 35.02 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.635 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.7 m-85 -113.43 131.57 55.97 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.673 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.59 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.53 141.78 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.589 . . . . 0.0 111.209 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -145.5 142.76 29.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.353 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 t70 60.64 25.67 15.4 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 120.96 0.409 . . . . 0.0 110.998 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.45 72.28 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.094 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -120.34 145.11 39.68 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.165 -0.609 . . . . 0.0 111.426 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.73 147.9 40.67 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 122.371 2.047 . . . . 0.0 111.181 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.05 136.52 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.255 0.55 . . . . 0.0 111.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.51 152.17 18.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.04 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.726 ' OE2' HG21 ' A' ' 70' ' ' THR . 0.2 OUTLIER -53.46 -21.48 6.24 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.726 HG21 ' OE2' ' A' ' 69' ' ' GLU . 40.6 p -74.16 -15.6 61.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.341 0.591 . . . . 0.0 111.661 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 55.9 m-20 -85.99 159.25 19.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -119.8 155.4 54.96 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.62 -7.64 19.95 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 112.336 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -94.88 -28.19 15.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.945 0.402 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -60.96 -39.62 90.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.5 . . . . 0.0 111.478 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.7 0.76 33.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 50.98 61.0 3.47 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.153 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.548 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.8 ptp -77.02 168.97 19.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -88.02 164.98 15.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.974 0.416 . . . . 0.0 110.169 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.24 141.37 31.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.626 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 73.67 14.4 4.21 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.074 0.95 . . . . 0.0 110.649 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.96 175.51 3.66 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.421 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -133.69 150.62 51.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.272 0.558 . . . . 0.0 111.193 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.94 144.81 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 38.7 t70 -92.17 134.31 34.98 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.077 0.465 . . . . 0.0 110.775 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.52 135.21 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.809 0.814 . . . . 0.0 111.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -138.61 149.5 45.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.163 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' HG2' HG21 ' A' ' 58' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.741 0 CA-C-O 121.452 0.644 . . . . 0.0 110.63 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.445 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 36.1 p-80 . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.39 170.05 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.133 0.492 . . . . 0.0 110.639 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.518 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.9 m-80 -100.22 144.87 28.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.518 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -133.43 162.68 31.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.094 0.473 . . . . 0.0 110.483 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' THR . 58.5 mtpt -137.39 147.5 45.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.407 HG21 ' CE1' ' A' ' 32' ' ' PHE . 76.3 t -125.17 120.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.951 0.405 . . . . 0.0 110.411 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.28 122.54 38.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.597 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' HA3' ' HH ' ' A' ' 47' ' ' TYR . . . -89.0 160.8 30.03 Favored Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.136 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -21.1 65.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.428 0.632 . . . . 0.0 111.022 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.44 -16.5 62.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.477 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.04 49.93 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.675 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 t -101.91 157.54 16.78 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 8.2 p -139.99 137.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 11.4 p -109.43 142.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.85 127.01 56.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.323 0.582 . . . . 0.0 109.542 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CE1' HG21 ' A' ' 22' ' ' VAL . 13.4 p90 -151.04 168.73 23.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.284 0.564 . . . . 0.0 111.561 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -112.51 142.86 44.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.697 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.417 ' CG2' HD21 ' A' ' 20' ' ' LEU . 16.1 tt -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.078 0.466 . . . . 0.0 110.192 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.4 mtmt -83.97 158.45 21.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.874 -0.516 . . . . 0.0 110.738 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 26.1 mmm-85 -65.45 -38.98 91.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 110.485 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.4 6.86 43.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.313 0.578 . . . . 0.0 110.538 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.0 m -93.93 130.03 35.9 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.78 151.16 85.13 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.886 2.39 . . . . 0.0 112.89 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 43' ' ' LEU . 86.8 mt -64.26 -11.77 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.237 0.413 0 CA-C-O 120.924 0.392 . . . . 0.0 111.364 178.877 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 40' ' ' LEU . 3.0 tt . . . . . 0 C--O 1.236 0.369 0 CA-C-O 121.158 0.504 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 69' ' ' GLU . 30.1 mtt -61.54 -41.8 97.88 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.709 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 18.1 tppt? -68.13 -41.59 81.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -47.45 85.82 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.15 0.5 . . . . 0.0 110.957 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.443 ' HH ' ' HA3' ' A' ' 24' ' ' GLY . 42.1 t80 -65.01 -40.19 94.52 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.248 0.547 . . . . 0.0 110.693 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.709 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.97 -36.7 80.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.277 -177.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HG2' ' HG ' ' A' ' 48' ' ' CYS . 10.2 mm-40 -74.46 -39.74 62.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.229 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.413 ' HG3' HG23 ' A' ' 30' ' ' VAL . 17.0 mmt180 -64.04 -46.8 82.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.217 0.532 . . . . 0.0 111.437 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.46 -16.64 51.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.58 57.28 5.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.535 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.44 175.58 10.7 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.749 0.309 . . . . 0.0 110.253 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.453 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 58.3 m -99.93 132.2 45.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.762 0.315 . . . . 0.0 110.984 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.9 ptp -63.74 -26.05 68.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 111.088 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 7.6 ptm180 -74.72 -13.38 60.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.999 0.428 . . . . 0.0 111.347 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -103.25 6.92 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.143 0.497 . . . . 0.0 111.381 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.452 HG23 ' HG2' ' A' ' 88' ' ' GLN . 23.2 pt -133.36 170.31 20.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.122 0.487 . . . . 0.0 111.241 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 6.7 mmm180 -138.1 140.2 39.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.397 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.3 m-85 -108.75 131.36 55.02 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 5.4 ppt_? -131.69 140.93 49.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -141.75 138.8 32.58 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.5 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.94 28.78 18.34 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.45 -3.57 77.4 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.545 -1.312 . . . . 0.0 113.316 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -123.45 144.89 45.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 O-C-N 121.899 -0.765 . . . . 0.0 111.637 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.57 150.44 40.38 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.665 2.244 . . . . 0.0 112.014 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 138.95 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 121.713 0.768 . . . . 0.0 111.267 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.47 154.91 18.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.589 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.596 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.6 pt-20 -62.49 -18.29 61.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.097 0.475 . . . . 0.0 112.227 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -79.63 -14.77 58.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.288 0.566 . . . . 0.0 111.283 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.2 158.61 21.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.001 0.429 . . . . 0.0 110.151 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 p -118.69 151.58 50.16 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.512 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.43 -9.05 18.75 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.47 2.113 . . . . 0.0 112.111 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.68 -20.46 18.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.424 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -69.68 -36.14 75.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.144 0.497 . . . . 0.0 110.814 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.49 -0.34 24.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.344 0.592 . . . . 0.0 110.224 178.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 48.95 62.5 2.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.9 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.429 ' SD ' HD13 ' A' ' 20' ' ' LEU . 9.6 ptp -74.3 166.62 23.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.09 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 39.1 tt0 -87.75 157.02 19.15 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.114 0.483 . . . . 0.0 110.849 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -72.81 139.4 47.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.118 0.485 . . . . 0.0 110.066 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 71.13 15.93 6.42 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.069 0.948 . . . . 0.0 110.594 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -70.37 176.68 3.82 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.448 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -130.14 147.26 51.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.4 0.619 . . . . 0.0 111.45 -177.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.407 HD11 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.82 133.97 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.454 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 2.5 m-20 -86.31 136.31 33.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.045 0.45 . . . . 0.0 111.088 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -123.87 140.36 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.382 0.611 . . . . 0.0 111.145 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.66 147.01 44.54 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.588 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.452 ' HG2' HG23 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.316 -0.867 0 CA-C-O 121.36 0.6 . . . . 0.0 111.107 -176.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.502 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 36.5 p-80 . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 120.999 0.428 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.5 pt -128.59 169.08 20.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.332 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.497 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.9 m-80 -97.46 144.61 27.02 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.547 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -132.75 160.77 35.86 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.292 0.568 . . . . 0.0 110.779 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.8 mtpt -136.11 148.84 48.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.789 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.8 t -129.16 116.6 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 120.955 0.407 . . . . 0.0 110.171 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.54 128.03 35.55 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.9 156.87 22.59 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -64.45 -11.55 34.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.493 0.663 . . . . 0.0 110.879 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.55 -19.29 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.211 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 9.36 36.33 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.297 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 t -113.45 157.36 22.05 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 122.296 -0.532 . . . . 0.0 109.899 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.44 135.02 58.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.425 0.631 . . . . 0.0 111.258 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 50' ' ' ARG . 14.4 p -101.78 142.09 16.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 122.118 -0.364 . . . . 0.0 110.263 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -112.03 130.93 55.7 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.107 0.48 . . . . 0.0 109.73 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -151.37 168.37 25.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.438 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 41.8 mtmt -113.87 136.5 52.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.862 0.363 . . . . 0.0 110.818 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tt -142.62 147.09 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.049 0.452 . . . . 0.0 110.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 27.1 mtmm -85.14 157.62 20.62 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 121.083 0.468 . . . . 0.0 111.376 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -63.16 -41.52 99.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.704 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -88.73 6.86 36.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.322 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 13.6 m -93.99 130.12 35.51 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.87 151.32 84.49 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.696 2.264 . . . . 0.0 112.655 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.458 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 87.3 mt -66.64 -13.19 60.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.296 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.4 m . . . . . 0 C--O 1.241 0.624 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 179.318 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 40' ' ' LEU . 4.0 tt . . . . . 0 C--O 1.237 0.408 0 CA-C-O 120.755 0.312 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -58.51 -50.24 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.963 0.411 . . . . 0.0 110.601 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.7 tppp? -62.82 -37.92 88.69 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.402 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.25 -49.8 76.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.451 . . . . 0.0 110.531 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.05 -40.5 96.43 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.025 0.441 . . . . 0.0 111.036 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.589 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.1 m -63.15 -34.98 78.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 110.997 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.5 mm-40 -71.55 -41.79 68.68 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.789 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.6 mmp_? -66.48 -47.15 73.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.353 0.597 . . . . 0.0 111.303 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.16 -16.61 52.42 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.895 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.78 57.77 5.2 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.606 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.92 173.6 12.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.666 -0.314 . . . . 0.0 110.425 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -98.87 133.73 42.74 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.756 0.312 . . . . 0.0 111.698 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.476 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 9.5 ptp -65.06 -26.36 68.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.078 0.466 . . . . 0.0 111.269 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -74.66 -6.24 47.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.238 0.542 . . . . 0.0 110.836 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -109.35 5.17 23.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.932 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.589 HD11 ' SG ' ' A' ' 48' ' ' CYS . 25.7 pt -137.19 171.99 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.188 0.518 . . . . 0.0 111.177 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 24.2 mmt180 -142.6 147.91 36.61 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.265 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 84' ' ' ILE . 9.0 m-85 -114.28 128.22 56.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.121 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.589 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.8 ppt_? -130.26 136.8 49.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -138.69 133.14 31.92 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.548 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 65.06 26.3 12.58 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.064 0.459 . . . . 0.0 110.57 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.85 -5.13 76.94 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.242 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.05 142.91 34.31 Favored Pre-proline 0 C--N 1.322 -0.603 0 O-C-N 122.054 -0.674 . . . . 0.0 111.381 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 144.55 29.76 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.538 2.159 . . . . 0.0 111.955 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.62 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.589 0.709 . . . . 0.0 110.674 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.21 156.84 18.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.96 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -57.37 -26.49 61.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.134 0.492 . . . . 0.0 112.176 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.2 p -74.29 -17.2 60.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.072 0.463 . . . . 0.0 111.223 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -78.87 158.4 28.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.195 0.521 . . . . 0.0 111.005 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -117.33 153.11 49.97 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.69 -7.35 19.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.449 2.099 . . . . 0.0 112.018 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.23 -23.06 17.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.095 0.474 . . . . 0.0 110.608 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -62.54 -39.46 93.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.391 0.615 . . . . 0.0 110.561 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.441 ' N ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.71 1.48 23.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.863 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 49.16 62.65 2.5 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.658 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.547 ' SD ' HD13 ' A' ' 20' ' ' LEU . 9.3 ptp -76.23 170.44 16.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -88.06 163.91 16.01 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.394 0.616 . . . . 0.0 111.237 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.46 138.83 34.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 72.36 13.46 5.55 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.963 0.905 . . . . 0.0 110.246 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.08 172.8 5.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.92 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' HD13 ' A' ' 84' ' ' ILE . 2.1 m -132.1 151.56 51.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.281 0.562 . . . . 0.0 111.355 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.418 HD13 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -123.85 141.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.589 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 31.8 t70 -90.82 132.32 35.95 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.907 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -116.19 134.58 59.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.555 0.693 . . . . 0.0 110.917 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -141.93 153.24 44.21 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.486 ' HG2' HG23 ' A' ' 58' ' ' ILE . 91.0 mt-30 . . . . . 0 CA--C 1.507 -0.71 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 51.7 p-80 . . . . . 0 N--CA 1.435 -1.219 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.5 pt -121.07 168.94 12.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.451 0.643 . . . . 0.0 111.657 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' O ' HD21 ' A' ' 20' ' ' LEU . 21.7 m-80 -100.47 141.7 32.97 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.751 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.557 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.56 162.78 30.98 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.042 0.449 . . . . 0.0 110.446 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.66 149.04 49.18 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.24 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.5 t -127.36 115.6 40.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.53 118.36 29.93 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.058 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.0 156.96 30.36 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.1 pp0? -63.54 -15.44 58.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.02 -17.49 61.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.763 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.57 36.43 Favored Glycine 0 C--O 1.229 -0.178 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 t -112.41 161.72 16.37 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -138.09 136.84 44.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.452 0.644 . . . . 0.0 110.713 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 87.5 t -102.58 135.03 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -109.59 126.74 53.92 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.438 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -148.18 168.15 23.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.408 0.623 . . . . 0.0 111.755 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 38.2 mtmt -115.53 134.6 54.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.302 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 17.6 tt -139.07 149.82 23.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.6 mtmp? -87.78 155.93 19.66 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.907 -0.496 . . . . 0.0 111.187 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.9 mmm-85 -63.72 -34.69 78.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -96.41 6.53 48.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 110.781 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.9 m -93.65 130.79 33.95 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.49 151.65 79.65 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.717 2.278 . . . . 0.0 112.122 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 33.3 mt -65.61 -11.37 43.81 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.108 -0.497 . . . . 0.0 112.32 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 15.8 p . . . . . 0 C--O 1.239 0.523 0 CA-C-O 121.061 0.457 . . . . 0.0 111.047 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.467 HD13 HD22 ' A' ' 40' ' ' LEU . 4.3 tt . . . . . 0 C--O 1.237 0.434 0 CA-C-O 120.962 0.41 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.412 ' N ' HD22 ' A' ' 43' ' ' LEU . 2.0 mpt? -59.72 -39.85 86.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.113 0.482 . . . . 0.0 110.589 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.8 tppp? -70.12 -40.72 74.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.024 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.9 75.66 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 110.336 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -65.44 -39.43 92.05 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.67 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.01 -38.67 86.87 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.792 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 41.8 mm-40 -67.04 -46.21 75.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.346 0.593 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -59.77 -47.68 84.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.755 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.34 -21.38 30.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.971 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.8 90.13 Favored Glycine 0 C--N 1.322 -0.246 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.647 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -87.39 177.22 7.18 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.995 0.426 . . . . 0.0 111.633 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 43.8 m -95.34 130.38 42.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 ptp -65.17 -24.78 67.48 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.213 0.53 . . . . 0.0 111.341 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -79.37 -12.48 59.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.361 0.6 . . . . 0.0 111.118 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 26.3 mm-40 -98.72 8.24 45.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.476 0.655 . . . . 0.0 111.013 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.452 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.4 pt -137.47 174.78 10.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.803 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 26.8 mmt180 -139.77 146.31 39.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.598 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.409 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 16.8 m-85 -115.26 128.09 55.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.32 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.0 ppt_? -132.02 134.22 45.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.498 0.665 . . . . 0.0 110.866 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -128.09 131.99 49.03 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.224 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.4 31.56 7.41 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.74 83.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -124.19 136.09 27.2 Favored Pre-proline 0 C--N 1.323 -0.562 0 O-C-N 121.95 -0.735 . . . . 0.0 111.576 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.16 146.16 45.61 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.948 2.432 . . . . 0.0 111.944 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.42 136.03 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 111.714 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.97 157.69 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.613 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 4.3 pt-20 -62.87 -18.45 62.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.263 0.554 . . . . 0.0 112.198 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.7 p -80.86 -11.4 59.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.082 0.468 . . . . 0.0 111.266 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -87.52 160.02 18.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.88 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 p -117.35 155.21 50.24 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.575 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.13 -12.86 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.31 2.007 . . . . 0.0 112.163 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.85 -16.99 21.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.188 0.518 . . . . 0.0 110.861 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.28 -34.55 76.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.405 0.621 . . . . 0.0 110.666 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.19 0.96 21.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.336 0.589 . . . . 0.0 110.413 177.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 50.67 59.52 4.53 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.367 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.557 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.84 170.37 15.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.08 0.467 . . . . 0.0 110.043 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -95.13 162.77 13.57 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.027 0.442 . . . . 0.0 110.532 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.27 137.37 41.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.153 0.502 . . . . 0.0 110.491 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 75.19 16.25 2.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.65 177.25 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.8 m -135.18 151.68 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.15 0.5 . . . . 0.0 111.216 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.9 142.69 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.9 t70 -93.06 132.95 36.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.027 0.442 . . . . 0.0 110.838 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.9 t -116.15 132.55 65.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.84 0.828 . . . . 0.0 111.49 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -135.33 143.29 46.07 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.634 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.452 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 121.143 0.497 . . . . 0.0 110.616 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 41.2 p-80 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 120.839 0.352 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 pt -110.74 169.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.542 0.686 . . . . 0.0 112.655 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.437 ' O ' HD23 ' A' ' 20' ' ' LEU . 25.1 m-80 -94.66 140.91 29.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.589 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.63 HD12 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -129.8 159.66 35.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.7 mtpt -134.52 147.17 50.27 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.4 t -127.74 116.94 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.118 0.485 . . . . 0.0 110.372 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.62 31.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.591 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.03 162.25 32.36 Favored Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.201 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -16.42 63.87 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.734 0.778 . . . . 0.0 110.571 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.25 -19.45 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.98 7.87 54.72 Favored Glycine 0 C--N 1.323 -0.166 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.263 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -108.39 165.03 11.82 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.269 0.557 . . . . 0.0 110.674 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 10.0 p -106.32 139.62 27.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.19 124.83 53.45 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -147.75 167.78 23.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -114.7 138.49 50.64 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -144.18 148.65 18.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 110.586 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.1 mtmp? -81.07 154.88 26.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.969 0.414 . . . . 0.0 110.627 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 24.3 mmm-85 -66.14 -37.47 85.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.223 0.535 . . . . 0.0 110.562 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -90.24 6.79 41.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.584 0.707 . . . . 0.0 110.49 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.7 m -94.71 131.52 30.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.79 149.94 86.4 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.804 2.336 . . . . 0.0 113.009 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' CD2' HD11 ' A' ' 43' ' ' LEU . 78.0 mt -64.56 -12.02 40.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.452 0.701 . . . . 0.0 112.132 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.0 t . . . . . 0 C--O 1.239 0.552 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.432 HD11 ' CD2' ' A' ' 40' ' ' LEU . 2.9 tt . . . . . 0 C--O 1.235 0.338 0 CA-C-O 121.138 0.494 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.66 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -58.81 -49.47 77.56 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.101 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.2 tppt? -60.03 -43.0 95.61 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.33 -49.92 72.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.042 0.449 . . . . 0.0 110.95 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -64.17 -41.11 97.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 58' ' ' ILE . 73.4 m -63.72 -33.94 76.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.515 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.8 mm-40 -71.6 -40.86 69.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.23 0.538 . . . . 0.0 110.177 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.2 mmm180 -66.21 -46.69 76.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -22.11 42.25 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.009 0.433 . . . . 0.0 111.436 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.35 58.47 3.61 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.144 -1.026 . . . . 0.0 111.773 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.41 176.06 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.57 -0.37 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -95.4 130.31 42.24 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.821 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.564 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 4.2 ptp -64.5 -21.41 66.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.085 0.469 . . . . 0.0 111.84 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -83.19 -6.72 59.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 0.0 111.274 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.345 0.593 . . . . 0.0 110.725 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.593 HD12 ' SG ' ' A' ' 48' ' ' CYS . 28.8 pt -136.56 170.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 18.0 mmm180 -141.22 143.01 33.93 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.66 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.6 m-85 -110.1 134.39 52.22 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.57 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.556 ' CG ' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.295 0.569 . . . . 0.0 110.599 178.005 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -140.78 139.27 34.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.6 31.09 16.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.07 -4.09 72.99 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.943 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -119.65 140.15 28.98 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 121.955 -0.733 . . . . 0.0 111.358 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.16 146.15 45.62 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.486 2.124 . . . . 0.0 111.641 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.18 135.84 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 121.605 0.716 . . . . 0.0 111.049 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.06 155.93 18.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.335 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -61.9 -19.93 63.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.268 0.556 . . . . 0.0 111.965 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.1 p -80.2 -10.43 59.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.82 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.39 161.11 17.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 p -118.09 153.7 51.38 Favored Pre-proline 0 C--N 1.32 -0.682 0 O-C-N 122.371 -0.206 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.99 -10.67 23.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.653 2.235 . . . . 0.0 112.328 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -95.24 -17.87 21.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.071 0.462 . . . . 0.0 110.962 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -35.55 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 110.855 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.03 1.96 24.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 110.77 179.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 52.39 61.71 3.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.697 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.63 ' SD ' HD12 ' A' ' 20' ' ' LEU . 11.7 ptp -80.29 174.33 11.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.134 -0.354 . . . . 0.0 110.331 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -99.76 169.68 9.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.238 0.542 . . . . 0.0 111.091 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.57 138.56 36.48 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 74.32 12.37 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.056 0.942 . . . . 0.0 111.426 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.63 174.89 3.18 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.5 m -135.33 150.19 49.92 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.363 0.601 . . . . 0.0 111.536 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 61' ' ' ARG . 3.1 mp -121.32 144.33 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.556 ' HB3' ' CG ' ' A' ' 61' ' ' ARG . 25.4 t0 -92.63 138.56 31.39 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.49 137.78 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.571 0.701 . . . . 0.0 110.706 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.407 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 1.7 p90 -134.94 143.3 46.82 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.561 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.422 ' HG2' HG23 ' A' ' 58' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.869 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.872 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 57.2 p-80 . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.6 pt -111.9 169.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.407 0.622 . . . . 0.0 111.666 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.478 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.2 m-80 -97.47 143.4 28.23 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.39 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.519 HD12 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -132.05 162.11 31.58 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.081 0.467 . . . . 0.0 110.054 177.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.4 mtpt -133.94 147.42 51.06 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.071 0.462 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 32' ' ' PHE . 81.1 t -127.99 117.85 47.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.87 122.15 34.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.1 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.04 157.84 28.66 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -66.42 -11.97 54.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.281 0.562 . . . . 0.0 111.242 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.61 -16.56 57.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.289 0.566 . . . . 0.0 110.51 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.73 11.28 30.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.435 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.7 t -111.34 159.07 18.32 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 122.2 -0.588 . . . . 0.0 109.516 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.33 136.17 46.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.269 0.557 . . . . 0.0 110.541 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 90.5 t -103.19 137.58 30.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.225 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -111.41 123.19 49.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.427 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 10.5 p90 -146.5 168.58 20.86 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.181 0.515 . . . . 0.0 111.275 -174.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -112.96 140.36 47.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.081 0.467 . . . . 0.0 111.07 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.85 146.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 110.435 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 30.6 mtmt -81.72 157.67 24.49 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 24.5 mmm-85 -65.18 -38.93 92.07 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.813 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -90.62 6.21 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.585 0.707 . . . . 0.0 110.348 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 21.3 m -94.32 129.94 35.46 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.8 152.18 82.26 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.869 2.379 . . . . 0.0 113.036 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 43' ' ' LEU . 84.0 mt -64.84 -12.03 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.444 0.698 . . . . 0.0 111.884 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.241 0.607 0 CA-C-O 121.082 0.467 . . . . 0.0 111.076 178.738 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 44' ' ' MET . 2.1 tt . . . . . 0 C--O 1.237 0.41 0 CA-C-O 121.302 0.573 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.579 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.4 mtt -61.23 -46.29 91.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HE3' ' HE1' ' A' ' 55' ' ' MET . 3.0 tppp? -64.15 -38.65 91.81 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.887 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.75 -49.92 74.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.096 0.474 . . . . 0.0 110.464 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -63.22 -42.85 99.32 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.171 0.51 . . . . 0.0 110.68 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 58' ' ' ILE . 79.1 m -64.57 -34.47 78.32 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.19 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.72 -42.12 91.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.3 mmm180 -65.33 -44.03 89.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.384 0.611 . . . . 0.0 111.472 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -21.53 27.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.895 0.379 . . . . 0.0 111.653 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.1 5.67 88.91 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.014 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -90.48 177.89 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.397 -0.473 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -99.93 134.94 42.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.438 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.9 ptp -66.74 -21.85 66.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.956 0.408 . . . . 0.0 111.935 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -82.24 -9.56 59.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.117 0.484 . . . . 0.0 110.863 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -103.88 5.83 36.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.72 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 48' ' ' CYS . 24.9 pt -137.48 172.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.809 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -140.82 145.36 36.18 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.071 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.9 m-85 -111.9 128.79 56.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.8 ppt_? -129.98 139.83 51.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.532 0.682 . . . . 0.0 111.395 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -141.94 137.33 31.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.175 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.95 27.91 14.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 110.861 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 -2.31 76.16 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.545 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -126.32 145.81 54.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.914 -0.756 . . . . 0.0 111.244 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.93 150.3 54.82 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.373 2.049 . . . . 0.0 111.899 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.26 138.3 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-O 121.502 0.668 . . . . 0.0 111.055 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.31 150.78 21.16 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.787 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -60.83 -18.56 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.404 0.621 . . . . 0.0 111.784 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -79.68 -10.89 59.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.473 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 162.12 14.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.856 0.36 . . . . 0.0 111.32 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.8 p -118.69 154.28 52.58 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.813 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.95 -9.08 21.87 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.483 2.122 . . . . 0.0 111.932 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -95.53 -22.31 17.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -63.76 -43.69 95.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.55 0.691 . . . . 0.0 110.222 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -101.18 0.92 38.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.853 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 53.75 56.66 6.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.822 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD12 ' A' ' 20' ' ' LEU . 10.4 ptp -73.97 168.99 18.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.823 0.344 . . . . 0.0 110.258 177.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.23 164.83 13.4 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.233 0.54 . . . . 0.0 111.663 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -78.85 133.34 37.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.223 0.535 . . . . 0.0 109.764 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 75.51 15.98 2.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.268 1.027 . . . . 0.0 110.819 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.34 176.05 2.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.76 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' HD11 ' A' ' 84' ' ' ILE . 1.9 m -134.21 150.84 51.08 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.649 -0.657 . . . . 0.0 111.559 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.418 HD11 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -122.7 139.75 48.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.566 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -90.51 134.66 34.21 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.101 0.477 . . . . 0.0 110.718 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.14 135.53 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.847 0.832 . . . . 0.0 111.163 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.3 146.52 46.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.515 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.31 -1.132 0 CA-C-O 121.141 0.496 . . . . 0.0 109.823 -177.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.488 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 11.0 p-80 . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 120.752 0.311 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.67 168.88 10.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.451 0.643 . . . . 0.0 111.473 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.7 m-80 -98.36 141.32 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.687 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.567 HD12 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.44 160.96 35.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.156 0.503 . . . . 0.0 110.365 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.6 mtpt -136.52 147.75 47.26 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.885 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.75 117.87 47.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.031 0.443 . . . . 0.0 110.804 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.22 121.24 31.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.1 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.85 159.88 28.27 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.57 -13.77 44.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.279 0.561 . . . . 0.0 111.615 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.42 -10.4 59.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.61 10.41 57.96 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.609 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -106.96 156.73 18.41 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.71 135.55 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.315 0.579 . . . . 0.0 110.943 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 7.6 p -100.28 138.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.263 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.63 127.81 54.8 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.448 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 14.2 p90 -151.87 168.51 24.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.743 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -119.08 134.73 55.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -138.0 145.77 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 26.8 mtmm -79.33 153.3 29.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.206 0.527 . . . . 0.0 111.29 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -59.58 -40.02 86.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -93.18 9.35 36.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.186 0.517 . . . . 0.0 111.488 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 11.8 m -94.53 128.84 38.54 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.68 150.26 79.36 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.939 2.426 . . . . 0.0 113.625 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.2 mp -60.94 -12.63 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.168 0.987 . . . . 0.0 112.776 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.787 178.73 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.448 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.8 tt . . . . . 0 C--O 1.237 0.398 0 CA-C-O 121.295 0.569 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.677 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.6 mtt -60.34 -37.44 80.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.18 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 14.8 tppt? -68.01 -46.2 71.93 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.042 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.07 -49.17 74.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.227 0.537 . . . . 0.0 110.766 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.81 -37.77 88.75 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.105 0.479 . . . . 0.0 110.924 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -39.28 93.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.215 0.531 . . . . 0.0 110.718 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.5 mm-40 -68.41 -40.01 81.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.099 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -65.52 -51.45 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.333 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.69 -18.96 53.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 111.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.74 89.48 Favored Glycine 0 C--O 1.235 0.17 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.721 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.56 177.6 7.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.705 0.288 . . . . 0.0 111.059 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -96.03 123.85 39.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -23.88 66.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.141 0.496 . . . . 0.0 111.752 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -77.16 -16.05 59.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.354 0.597 . . . . 0.0 110.696 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -99.73 6.48 45.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.183 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 25.7 pt -132.86 168.28 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.264 0.554 . . . . 0.0 111.104 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 18.1 mmt180 -137.42 147.83 45.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.98 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.677 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.3 m-85 -115.68 132.03 56.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.649 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.568 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.7 ppt_? -132.56 135.98 46.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.487 0.66 . . . . 0.0 111.283 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -139.62 139.78 36.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.932 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.64 28.14 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.381 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.05 -6.6 78.61 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.54 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -121.48 145.59 43.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.126 -0.632 . . . . 0.0 111.306 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.33 147.18 46.75 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.354 2.036 . . . . 0.0 110.949 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.97 136.16 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 121.514 0.674 . . . . 0.0 110.78 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.87 153.29 20.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.561 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -58.82 -20.54 51.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.285 0.564 . . . . 0.0 111.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 p -83.48 -0.63 51.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.968 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.542 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -95.53 159.57 14.93 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 121.883 -0.511 . . . . 0.0 110.354 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 p -117.15 149.99 45.36 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.57 -12.97 36.12 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.511 2.14 . . . . 0.0 112.462 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -95.57 -10.8 28.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.305 0.574 . . . . 0.0 110.748 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -78.15 -33.11 50.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.194 0.521 . . . . 0.0 110.517 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.39 2.1 22.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.161 0.505 . . . . 0.0 110.902 178.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 49.42 60.77 3.53 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.567 ' SD ' HD12 ' A' ' 20' ' ' LEU . 9.2 ptp -74.44 170.49 15.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.125 0.488 . . . . 0.0 110.588 176.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 41.8 tt0 -94.64 156.92 16.2 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.46 137.65 42.71 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.342 0.592 . . . . 0.0 110.538 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 73.77 19.04 3.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.572 1.149 . . . . 0.0 111.076 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -71.4 176.57 4.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.204 177.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.87 151.61 52.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.188 0.518 . . . . 0.0 111.565 -177.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.07 144.57 30.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.568 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.9 t0 -93.55 134.65 35.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.49 138.66 51.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.667 0.746 . . . . 0.0 111.151 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -138.21 148.37 44.73 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.67 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.461 ' HG2' HG23 ' A' ' 58' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.745 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.451 ' CD2' ' HD2' ' A' ' 33' ' ' LYS . 46.0 p-80 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.76 167.93 11.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.516 0.674 . . . . 0.0 112.351 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.541 ' O ' HD23 ' A' ' 20' ' ' LEU . 8.5 m-80 -94.65 142.83 26.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.584 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -133.87 159.76 39.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.045 0.45 . . . . 0.0 110.199 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.9 mtpt -134.83 149.04 50.3 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 0.0 110.218 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.422 HG22 ' CE1' ' A' ' 32' ' ' PHE . 97.2 t -128.07 117.65 46.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.085 0.469 . . . . 0.0 110.124 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.95 124.19 37.8 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.876 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.89 159.9 28.24 Favored Glycine 0 N--CA 1.425 -2.072 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.158 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -65.71 -11.96 49.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.439 0.638 . . . . 0.0 111.012 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.03 -16.95 54.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.12 12.0 40.86 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.937 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -106.06 155.4 19.45 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 139.1 41.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.211 0.529 . . . . 0.0 111.126 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 9.7 p -108.89 140.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.167 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.22 123.3 49.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 19.7 p90 -145.03 167.71 22.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.344 0.592 . . . . 0.0 111.459 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HD2' ' CD2' ' A' ' 17' ' ' HIS . 27.8 mmtt -106.32 144.01 33.61 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.553 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.449 ' CG2' HD22 ' A' ' 20' ' ' LEU . 17.9 tt -148.91 144.04 18.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.056 0.455 . . . . 0.0 109.901 176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 5.6 mtmp? -84.46 158.01 21.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.865 -0.522 . . . . 0.0 110.512 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -64.47 -36.73 85.12 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.044 0.449 . . . . 0.0 111.091 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -92.01 5.98 48.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.215 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 18.0 m -93.64 128.65 41.15 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.18 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.69 149.08 73.11 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.944 2.43 . . . . 0.0 113.576 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 71' ' ' ASP . 5.7 mp -59.87 -12.59 7.92 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.191 0.997 . . . . 0.0 112.683 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.3 t . . . . . 0 C--O 1.24 0.599 0 CA-C-O 121.145 0.498 . . . . 0.0 110.742 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.7 tt . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.278 0.561 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.671 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 32.6 mtt -58.17 -50.33 73.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.037 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.583 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 2.9 tppp? -64.57 -38.97 92.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.55 -48.57 81.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -63.04 -40.26 97.18 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.15 0.5 . . . . 0.0 110.991 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.519 ' SG ' HD12 ' A' ' 58' ' ' ILE . 75.2 m -62.96 -36.01 82.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.394 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 28.4 mm-40 -73.18 -35.84 66.46 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.259 0.552 . . . . 0.0 110.763 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 44.1 mmm-85 -70.0 -48.92 56.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.433 0.635 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.95 -18.3 50.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.073 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.68 57.8 4.39 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.828 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.17 172.79 13.25 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.491 -0.417 . . . . 0.0 111.165 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.2 m -97.03 130.34 44.36 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.264 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.491 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.4 ptp -64.67 -25.45 67.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.429 . . . . 0.0 111.414 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.409 ' HG3' HE21 ' A' ' 57' ' ' GLN . 11.5 ptp180 -76.69 -10.51 59.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.4 0.619 . . . . 0.0 110.328 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.409 HE21 ' HG3' ' A' ' 56' ' ' ARG . 26.6 mm-40 -105.01 3.9 31.06 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.519 HD12 ' SG ' ' A' ' 48' ' ' CYS . 20.9 pt -136.71 172.28 15.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.043 0.449 . . . . 0.0 110.87 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 25.6 mmm180 -143.76 148.21 35.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.671 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 11.1 m-85 -113.39 129.66 56.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.657 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.3 ppt_? -131.58 140.79 49.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.411 0.624 . . . . 0.0 111.541 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -145.44 139.32 26.8 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 63.93 26.41 14.18 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.168 0.509 . . . . 0.0 110.815 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 -0.99 80.78 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.896 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -125.16 144.63 47.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 O-C-N 122.11 -0.641 . . . . 0.0 111.528 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.74 147.84 45.59 Favored 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 122.628 2.218 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.14 137.65 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-O 121.468 0.651 . . . . 0.0 111.0 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 155.53 18.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.485 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.611 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -64.41 -16.96 63.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.0 p -81.2 -5.98 58.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.442 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.539 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.74 161.54 14.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.405 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 p -117.6 153.04 50.4 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.743 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 -8.56 21.48 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.353 2.036 . . . . 0.0 112.054 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 36' ' ' ARG . . . -96.03 -18.21 20.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.093 0.473 . . . . 0.0 111.068 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -36.9 78.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.239 0.542 . . . . 0.0 110.848 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.34 1.15 25.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.346 0.593 . . . . 0.0 110.756 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 51.18 58.66 5.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.962 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.584 ' SD ' HD13 ' A' ' 20' ' ' LEU . 8.6 ptp -73.92 164.63 26.38 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 36.2 tt0 -100.55 134.4 43.57 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.19 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -41.69 135.85 2.09 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 26.2 mt-10 74.12 16.47 3.53 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.777 1.231 . . . . 0.0 111.801 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -71.84 178.45 3.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 110.463 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.421 ' C ' HD13 ' A' ' 84' ' ' ILE . 1.8 m -135.23 151.58 50.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.21 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.421 HD13 ' C ' ' A' ' 83' ' ' THR . 2.8 mp -123.12 140.28 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 33.6 t70 -90.03 135.64 33.53 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.008 0.432 . . . . 0.0 110.651 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -119.64 135.34 60.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.777 0.799 . . . . 0.0 110.911 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.7 p90 -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.582 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.451 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.1 mt-30 . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 120.999 0.428 . . . . 0.0 110.432 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 120.948 0.404 . . . . 0.0 111.909 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.8 45.99 1.33 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.822 0.82 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.79 14.93 2.9 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.759 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -90.62 111.95 23.47 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -147.28 93.38 4.69 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-O 120.972 0.415 . . . . 0.0 111.21 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -88.98 137.68 3.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.922 2.415 . . . . 0.0 112.493 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -88.93 19.52 4.07 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.503 0.668 . . . . 0.0 110.126 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.13 171.96 1.17 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.409 0.623 . . . . 0.0 112.123 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.25 43.45 1.71 Allowed Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.9 p -59.6 124.38 13.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.235 0.54 . . . . 0.0 111.384 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -128.76 -58.95 1.15 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.2 t -67.82 -60.31 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.96 96.09 5.65 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.552 0.691 . . . . 0.0 111.707 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -87.94 90.83 8.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 122.261 1.029 . . . . 0.0 111.47 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -137.84 164.12 29.72 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.526 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -155.49 -63.42 0.12 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.567 0.699 . . . . 0.0 110.253 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.423 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 53.0 p-80 -135.0 158.9 43.15 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.317 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -114.82 169.5 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.473 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.7 m-80 -97.76 141.37 30.85 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.67 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.538 HD13 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -132.38 162.42 31.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.111 0.481 . . . . 0.0 110.421 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.97 148.24 48.39 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.065 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 32' ' ' PHE . 80.8 t -126.97 115.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.377 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.82 126.7 37.01 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.86 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.42 ' HA3' ' HH ' ' A' ' 47' ' ' TYR . . . -91.38 164.87 29.68 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -68.41 -14.24 62.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.444 0.64 . . . . 0.0 110.916 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.8 -12.43 58.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.346 0.593 . . . . 0.0 110.525 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.39 48.79 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.83 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -105.43 152.3 23.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.41 137.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 15.0 p -105.41 141.59 20.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.855 0.359 . . . . 0.0 110.262 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -110.23 127.33 54.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.424 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -149.35 168.36 23.58 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.419 0.628 . . . . 0.0 111.883 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -116.52 134.97 54.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -140.48 147.08 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.044 0.45 . . . . 0.0 110.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 24.9 mtmt -82.47 157.93 23.42 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.754 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 15.4 mmm-85 -63.66 -39.74 95.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.995 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -92.76 8.27 40.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.704 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.4 m -91.6 128.3 47.02 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.702 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.47 145.62 77.47 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.822 2.348 . . . . 0.0 113.085 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.599 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.9 mp -60.09 -14.05 14.84 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.611 0.765 . . . . 0.0 112.087 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.444 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.6 m -50.51 -42.7 55.19 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.246 0.545 . . . . 0.0 110.569 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.516 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.3 tt -61.15 -54.2 47.47 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.401 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 1.9 mpt? -58.02 -42.39 85.2 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.01 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -68.66 -42.2 78.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.299 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.68 -52.86 62.41 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' HH ' ' HA3' ' A' ' 24' ' ' GLY . 51.8 t80 -61.19 -40.44 93.95 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.171 0.51 . . . . 0.0 110.887 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -40.82 91.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.92 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.02 -39.5 75.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.897 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 32.2 mmt180 -68.54 -52.85 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -22.14 59.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.981 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.13 57.35 3.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 0.0 111.96 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.6 175.6 10.47 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.691 -0.3 . . . . 0.0 110.332 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.2 m -96.78 128.38 43.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.825 0.345 . . . . 0.0 111.416 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.8 ptp -63.46 -26.24 68.63 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.233 0.539 . . . . 0.0 111.071 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -75.81 -11.43 59.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.203 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -105.23 7.04 33.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.332 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.428 HG21 ' HG2' ' A' ' 88' ' ' GLN . 27.0 pt -136.15 170.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.342 0.591 . . . . 0.0 111.629 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -140.8 148.78 41.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.147 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.471 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.3 m-85 -116.49 130.9 57.01 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.201 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.574 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.3 OUTLIER -132.36 142.67 49.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 0.0 110.045 177.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.404 ' HB2' HG13 ' A' ' 84' ' ' ILE . 87.2 t80 -136.74 134.3 36.99 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.255 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.32 31.7 21.19 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.044 0.449 . . . . 0.0 111.874 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.93 -14.85 59.34 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.356 -1.402 . . . . 0.0 113.251 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -117.33 148.16 42.05 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 121.974 -0.721 . . . . 0.0 112.165 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.04 147.96 21.42 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 123.392 2.728 . . . . 0.0 112.863 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.06 138.01 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.266 0.555 . . . . 0.0 111.284 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.81 158.14 15.68 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.61 -21.14 37.49 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.236 0.614 . . . . 0.0 111.956 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.3 p -79.29 -3.15 44.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.136 0.493 . . . . 0.0 111.539 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.519 ' O ' HD12 ' A' ' 40' ' ' LEU . 1.6 m-20 -98.47 162.81 12.96 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.0 -0.437 . . . . 0.0 110.978 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.5 p -117.03 156.88 47.81 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.74 -11.05 30.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.278 1.985 . . . . 0.0 111.773 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -94.61 -19.29 20.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 110.454 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -63.61 -35.95 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 0.0 110.294 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.07 1.14 17.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.921 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 51.53 62.38 2.74 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.52 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.538 ' SD ' HD13 ' A' ' 20' ' ' LEU . 8.7 ptp -77.69 165.81 23.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 110.42 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.03 161.97 16.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.348 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.26 136.9 42.68 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.022 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 72.03 16.7 5.32 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.979 0.911 . . . . 0.0 111.484 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.72 175.85 5.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.468 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.439 ' C ' HD13 ' A' ' 84' ' ' ILE . 1.6 m -132.44 150.51 52.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.321 0.582 . . . . 0.0 111.721 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.439 HD13 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -120.96 139.04 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.574 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 11.3 m-20 -88.99 134.03 34.12 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.011 0.434 . . . . 0.0 110.596 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.07 137.84 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 121.63 0.729 . . . . 0.0 111.019 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -137.8 146.35 43.43 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.377 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HG2' HG21 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -111.77 109.09 18.75 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -111.63 104.92 13.33 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -98.17 94.93 7.08 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.159 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -126.68 117.39 22.64 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.219 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.99 -10.06 64.17 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.155 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.137 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.832 -179.877 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.965 0 CA-C-O 120.87 0.367 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.93 94.24 1.01 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.92 0.39 . . . . 0.0 110.021 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.434 ' HB2' ' HA3' ' A' ' 9' ' ' GLY . 7.2 m-20 -70.37 -19.45 63.03 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.526 0.679 . . . . 0.0 110.721 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -127.89 -79.45 0.58 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.416 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.517 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 33.4 mmtp -143.28 -55.19 0.02 OUTLIER Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.647 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HD2' ' H ' ' A' ' 5' ' ' LYS . 70.5 Cg_endo -75.39 -168.76 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.547 1.498 . . . . 0.0 111.101 175.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -79.02 -25.48 43.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.318 0.58 . . . . 0.0 110.404 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -90.53 135.95 33.37 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 3' ' ' ASP . . . -109.94 8.47 31.58 Favored Glycine 0 CA--C 1.494 -1.23 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.439 HG21 ' HB2' ' A' ' 13' ' ' GLU . 7.1 p -142.83 122.96 9.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.612 -0.794 . . . . 0.0 109.852 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -129.63 -71.0 0.63 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.107 0.48 . . . . 0.0 110.658 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -94.76 68.67 3.34 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.946 0.879 . . . . 0.0 109.955 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 10.6 mm-40 -145.11 178.92 7.71 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.198 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 14.7 m120 81.84 13.24 0.6 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.582 0.706 . . . . 0.0 110.843 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -82.34 -94.81 0.05 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.539 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.96 119.68 24.27 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.311 0.577 . . . . 0.0 111.244 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -170.28 167.9 8.32 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -122.09 169.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.383 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.483 ' O ' HD23 ' A' ' 20' ' ' LEU . 28.1 m-80 -99.65 144.35 28.83 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.8 mm? -132.4 160.53 36.1 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.102 0.477 . . . . 0.0 110.172 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.5 mtpt -132.5 147.86 52.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.911 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.407 HG22 ' CE1' ' A' ' 32' ' ' PHE . 75.5 t -125.78 118.28 51.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.092 0.472 . . . . 0.0 110.177 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.09 118.28 30.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.056 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.26 155.47 34.44 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.431 ' CG ' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -63.06 -13.78 40.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.29 0.567 . . . . 0.0 111.371 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.05 -11.69 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.76 41.41 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.947 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 t -110.2 162.18 14.85 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.18 141.12 28.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.194 0.521 . . . . 0.0 111.126 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.432 HG21 ' HG3' ' A' ' 50' ' ' ARG . 12.1 p -109.65 142.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.999 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -113.12 124.14 51.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.274 0.559 . . . . 0.0 109.775 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 16.8 p90 -145.29 167.97 21.56 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mtmt -114.95 136.79 52.72 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.59 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.405 ' CG2' HD22 ' A' ' 20' ' ' LEU . 15.9 tt -143.81 148.96 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.032 0.444 . . . . 0.0 110.368 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.4 mtmt -83.97 158.69 21.44 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.793 -0.567 . . . . 0.0 110.973 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.438 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 27.6 mmm-85 -64.24 -40.75 96.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -91.17 8.84 33.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.294 0.569 . . . . 0.0 110.995 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 14.7 m -94.31 130.97 32.3 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.0 149.93 77.55 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.974 2.449 . . . . 0.0 113.586 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD11 ' O ' ' A' ' 71' ' ' ASP . 7.0 mp -61.44 -12.17 13.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.096 0.958 . . . . 0.0 112.873 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 p -53.92 -44.46 70.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.962 0.411 . . . . 0.0 111.049 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.477 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.499 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.4 tt -60.34 -52.99 62.89 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.394 0.616 . . . . 0.0 110.166 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.64 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.9 mtt -60.41 -48.0 83.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HE3' ' HE2' ' A' ' 55' ' ' MET . 3.9 tppp? -61.53 -42.28 98.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.8 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.608 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.38 -52.89 62.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.757 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.28 -41.0 96.21 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.135 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 75.5 m -65.39 -34.89 79.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.079 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -70.31 -34.89 73.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.2 mmp_? -73.77 -46.68 44.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.353 0.596 . . . . 0.0 111.084 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.5 -21.35 42.03 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.056 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.56 57.74 3.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.579 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.58 175.29 10.98 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 122.552 -0.381 . . . . 0.0 110.878 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 26.4 m -97.23 131.37 44.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.012 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.467 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 6.5 ptp -66.28 -26.84 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.217 0.532 . . . . 0.0 110.988 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -76.04 -13.75 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.431 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 22.2 mm-40 -101.26 2.38 39.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.504 0.669 . . . . 0.0 110.443 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.464 HD12 ' SG ' ' A' ' 48' ' ' CYS . 35.0 pt -135.09 176.24 9.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -146.95 154.43 41.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.834 0.35 . . . . 0.0 111.008 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.64 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.5 m-85 -119.03 132.44 56.05 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.092 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.561 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.1 ppt_? -134.63 141.5 46.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 111.098 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -141.39 139.83 33.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.575 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t70 57.99 27.97 15.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 111.305 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.12 -3.54 70.94 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.192 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -118.43 140.98 28.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 122.182 -0.599 . . . . 0.0 111.347 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.08 147.33 38.09 Favored 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 122.67 2.247 . . . . 0.0 112.261 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.22 139.0 51.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 110.594 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.8 165.82 11.6 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.979 0.419 . . . . 0.0 111.202 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.2 pt-20 -61.87 -17.13 55.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.194 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.4 p -82.98 -4.28 58.12 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.933 0.397 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.514 ' O ' HD11 ' A' ' 40' ' ' LEU . 46.5 m-20 -88.75 156.71 18.82 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -117.66 150.74 47.42 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 122.427 0.291 . . . . 0.0 110.222 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.24 -13.04 37.67 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.366 2.044 . . . . 0.0 112.234 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.438 ' HB1' ' HB3' ' A' ' 36' ' ' ARG . . . -94.76 -13.74 25.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 110.817 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -72.2 -35.86 69.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.332 0.587 . . . . 0.0 110.176 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.456 HD11 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.89 1.0 22.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.69 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 53.01 61.34 3.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.321 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.1 ptp -80.24 166.45 21.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.415 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -91.94 167.62 11.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.065 0.459 . . . . 0.0 110.983 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.98 139.67 36.92 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.328 0.585 . . . . 0.0 110.091 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 71.6 15.27 6.06 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.487 1.115 . . . . 0.0 111.341 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.74 176.7 2.87 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -134.84 150.32 50.47 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.546 -0.721 . . . . 0.0 111.731 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 142.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.561 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 29.5 t70 -90.88 136.53 33.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.11 0.481 . . . . 0.0 110.869 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -119.75 134.06 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.948 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -130.76 137.47 49.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.813 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.431 ' HG3' ' CG ' ' A' ' 25' ' ' GLN . 2.2 mt-30 -106.78 113.29 26.69 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 0.0 111.1 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.38 170.8 0.91 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.062 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -78.14 137.02 37.97 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.352 0.596 . . . . 0.0 111.377 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 p -79.07 133.22 36.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.19 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.85 50.33 19.3 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.722 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.968 0 CA-C-O 118.655 -1.081 . . . . 0.0 111.83 -179.725 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.955 0.407 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.38 34.34 22.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.226 0.61 . . . . 0.0 112.483 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.06 26.29 1.41 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.447 0.641 . . . . 0.0 110.715 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -89.55 -77.39 0.39 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.647 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 57.1 tttp -178.46 -54.11 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.589 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 47.3 Cg_endo -66.58 173.48 7.78 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.165 1.91 . . . . 0.0 113.249 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -104.94 -33.7 8.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.054 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.12 12.2 1.23 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.29 0.567 . . . . 0.0 111.023 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.01 176.55 14.48 Favored Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.07 138.22 52.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 121.404 0.621 . . . . 0.0 110.837 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -128.43 144.74 51.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.443 ' O ' HG21 ' A' ' 12' ' ' THR . 5.6 m 64.1 38.54 8.34 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.787 0.803 . . . . 0.0 112.936 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.53 150.28 36.39 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -129.61 -61.28 1.02 Allowed 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.778 -0.577 . . . . 0.0 110.971 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -154.68 141.06 18.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.194 0.521 . . . . 0.0 110.981 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.521 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 10.8 t70 -152.02 -66.77 0.17 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.665 0.745 . . . . 0.0 109.786 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.667 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 -135.29 159.33 41.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.159 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 pt -123.2 170.17 13.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.987 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' O ' HD21 ' A' ' 20' ' ' LEU . 19.3 m-80 -93.89 142.09 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.653 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.581 HD12 ' SD ' ' A' ' 78' ' ' MET . 1.6 mm? -133.24 163.47 29.23 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.288 0.566 . . . . 0.0 110.87 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.4 mtpt -134.82 146.07 48.95 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.905 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.43 HG22 ' CE1' ' A' ' 32' ' ' PHE . 91.2 t -127.29 114.06 34.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.19 0.519 . . . . 0.0 110.132 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.84 130.32 37.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.414 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.421 ' HA3' ' HH ' ' A' ' 47' ' ' TYR . . . -95.93 161.82 22.82 Favored Glycine 0 N--CA 1.42 -2.417 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.959 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.402 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -65.02 -11.76 42.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.562 0.696 . . . . 0.0 110.897 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.87 -15.0 58.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.254 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.17 6.51 56.77 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.0 t -101.24 153.9 19.22 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.57 136.43 46.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.309 0.576 . . . . 0.0 111.507 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 11.6 p -105.19 140.07 24.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.391 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -110.97 124.95 53.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.43 ' CE1' HG22 ' A' ' 22' ' ' VAL . 8.4 p90 -149.56 169.85 19.99 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.135 0.493 . . . . 0.0 111.452 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -113.61 143.27 44.85 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.985 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 14.7 tt -148.75 143.34 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.119 0.485 . . . . 0.0 110.359 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.667 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 25.7 mtmt -79.45 155.36 28.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.374 0.607 . . . . 0.0 111.772 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 16' ' ' ASP . 29.0 mmm-85 -64.95 -36.49 84.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.641 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.19 4.91 53.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.337 0.589 . . . . 0.0 110.753 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 20.6 m -93.57 129.49 38.32 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.23 151.46 85.35 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.891 2.394 . . . . 0.0 112.856 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.461 ' CD2' HD12 ' A' ' 43' ' ' LEU . 81.2 mt -65.38 -11.87 46.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.55 0.74 . . . . 0.0 111.919 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p -51.28 -46.35 62.44 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.117 0.484 . . . . 0.0 111.098 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.499 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 40' ' ' LEU . 4.0 tt -63.85 -48.29 77.34 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.333 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.699 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 37.8 mtt -61.75 -39.69 92.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.168 0.508 . . . . 0.0 110.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.56 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.9 tppp? -70.16 -40.91 74.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.694 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.52 68.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 110.912 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.421 ' HH ' ' HA3' ' A' ' 24' ' ' GLY . 42.9 t80 -63.69 -37.05 85.91 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.061 0.458 . . . . 0.0 110.822 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -34.55 78.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.138 0.494 . . . . 0.0 110.812 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.0 mm-40 -72.59 -42.14 64.87 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.272 0.558 . . . . 0.0 110.62 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HG3' HG23 ' A' ' 30' ' ' VAL . 22.9 mmm-85 -62.99 -52.6 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.452 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -21.41 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.884 0.373 . . . . 0.0 111.927 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.02 2.82 90.65 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.925 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.54 175.95 8.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 0.0 111.208 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 m -97.42 127.02 43.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.698 0.285 . . . . 0.0 110.574 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.6 ptp -60.81 -25.24 66.43 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.093 0.473 . . . . 0.0 111.985 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -78.78 -11.36 59.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.242 0.544 . . . . 0.0 111.129 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -101.22 5.67 42.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.0 110.63 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.47 HG21 ' HG2' ' A' ' 88' ' ' GLN . 31.2 pt -135.22 177.23 7.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.118 0.485 . . . . 0.0 111.065 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -147.42 147.18 29.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.699 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 14.0 m-85 -113.87 128.06 56.25 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.21 0.529 . . . . 0.0 111.237 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.557 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 1.1 ppt_? -132.04 136.64 47.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.395 0.617 . . . . 0.0 110.735 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -135.79 134.77 39.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.538 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.39 28.5 18.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.216 0.531 . . . . 0.0 110.654 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.76 -4.52 64.86 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 119.645 -1.264 . . . . 0.0 113.198 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -115.99 136.81 23.01 Favored Pre-proline 0 C--N 1.322 -0.607 0 O-C-N 121.905 -0.762 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.27 142.91 30.96 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.704 2.269 . . . . 0.0 112.104 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 133.3 68.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.564 0.697 . . . . 0.0 111.365 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 149.47 21.44 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.335 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.0 pp20? -58.27 -20.0 38.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.432 HG21 ' OE2' ' A' ' 69' ' ' GLU . 40.9 p -76.26 -13.11 60.17 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.376 0.608 . . . . 0.0 111.164 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.79 166.79 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -118.13 158.4 46.38 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.07 -5.64 14.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.578 2.186 . . . . 0.0 112.074 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.04 -13.73 24.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.16 0.505 . . . . 0.0 110.525 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -68.6 -35.93 78.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.429 0.633 . . . . 0.0 110.549 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.434 HD23 ' HE2' ' A' ' 78' ' ' MET . 0.0 OUTLIER -111.16 1.47 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.482 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 52.6 60.05 4.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.581 ' SD ' HD12 ' A' ' 20' ' ' LEU . 7.6 ptp -74.97 163.02 28.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -87.89 159.97 18.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.47 131.48 44.81 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 14.3 mt-10 72.88 20.67 3.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 124.288 1.035 . . . . 0.0 111.593 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.75 179.42 3.13 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 m -135.13 150.43 50.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.509 -0.745 . . . . 0.0 111.887 -177.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.4 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.1 mp -118.63 148.81 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.557 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 6.8 t70 -97.97 128.59 44.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.788 0.328 . . . . 0.0 110.334 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.11 135.0 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.576 0.703 . . . . 0.0 110.846 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.454 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -136.85 145.08 44.0 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.64 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.47 ' HG2' HG21 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -110.19 111.39 22.69 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.126 0.488 . . . . 0.0 110.06 -177.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -77.21 79.9 3.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.651 0.738 . . . . 0.0 111.491 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.67 170.87 1.76 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.505 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -159.43 157.32 29.97 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.123 -0.361 . . . . 0.0 110.272 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.81 54.92 27.78 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.662 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.164 0 CA-C-O 118.498 -1.168 . . . . 0.0 111.969 -178.568 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 121.18 0.514 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.99 102.98 3.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -111.41 8.06 21.09 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.631 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 22.9 mt-10 -79.15 173.24 12.78 Favored 'General case' 0 N--CA 1.395 -3.192 0 CA-C-O 122.139 0.971 . . . . 0.0 109.773 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.458 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -73.17 -49.89 6.84 Favored Pre-proline 0 C--N 1.265 -3.086 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.474 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 18.0 Cg_endo -61.82 146.45 96.52 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 121.708 1.606 . . . . 0.0 111.264 174.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -56.95 -39.29 74.26 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.835 0.454 . . . . 0.0 111.824 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -103.25 -170.0 1.73 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.979 0.419 . . . . 0.0 110.946 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.22 -141.71 7.15 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -159.47 135.77 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.073 0.463 . . . . 0.0 110.669 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.539 ' HD3' ' N ' ' A' ' 12' ' ' THR . 4.1 tmtm? -130.95 131.79 44.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.881 0.372 . . . . 0.0 110.112 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.539 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 62.0 m 67.37 -65.38 0.23 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.731 0.812 . . . . 0.0 112.921 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -48.53 94.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.61 119.37 17.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.88 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -121.47 142.38 50.1 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.302 0.572 . . . . 0.0 111.26 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.58 115.96 24.4 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.786 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -159.61 -177.93 6.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.79 169.61 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.349 0.595 . . . . 0.0 111.095 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.463 ' O ' HD22 ' A' ' 20' ' ' LEU . 22.2 m-80 -99.95 145.81 27.41 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.568 HD12 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -132.63 162.39 31.46 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.323 0.582 . . . . 0.0 110.823 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 57.5 mtpt -133.55 147.98 51.61 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.989 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.7 t -128.74 117.96 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.09 0.472 . . . . 0.0 110.265 177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.94 124.93 35.15 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.889 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.31 159.52 27.44 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.7 pp0? -63.32 -14.68 52.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.496 0.665 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.23 -19.25 62.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.55 6.19 50.6 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -107.39 163.66 12.86 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.0 143.39 31.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.488 HG22 ' HG3' ' A' ' 50' ' ' ARG . 6.1 p -112.36 145.28 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.172 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -112.77 131.05 55.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.299 0.571 . . . . 0.0 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 10.8 p90 -152.08 169.12 23.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.219 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -111.95 143.72 42.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.036 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.431 ' CG2' HD21 ' A' ' 20' ' ' LEU . 16.5 tt -150.54 149.23 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.063 0.459 . . . . 0.0 110.333 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.3 mtmt -87.23 158.03 19.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.73 -0.606 . . . . 0.0 110.74 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.9 mmm-85 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -90.48 7.75 37.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.119 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.3 m -93.7 129.98 36.48 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.37 150.22 87.35 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.904 2.402 . . . . 0.0 112.984 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.449 ' CD2' HD11 ' A' ' 43' ' ' LEU . 87.4 mt -65.26 -11.97 46.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.862 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p -52.81 -43.1 65.68 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 111.142 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.445 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.449 HD11 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt -62.68 -48.49 79.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.186 0.517 . . . . 0.0 110.096 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.643 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 29.9 mtt -61.31 -40.88 95.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 17.8 tppt? -70.37 -38.33 74.72 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.967 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.418 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.09 -50.99 71.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.957 0.408 . . . . 0.0 110.566 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.41 -33.61 76.25 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.985 0.421 . . . . 0.0 110.532 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -38.13 89.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.247 0.546 . . . . 0.0 110.547 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 68.2 mm-40 -73.12 -34.64 66.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.071 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.488 ' HG3' HG22 ' A' ' 30' ' ' VAL . 11.5 mmt180 -68.1 -49.54 60.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.011 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -22.38 28.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.81 58.31 3.06 Favored Glycine 0 C--N 1.321 -0.301 0 C-N-CA 119.673 -1.251 . . . . 0.0 111.696 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.52 174.07 11.74 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 122.564 -0.374 . . . . 0.0 110.286 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.9 m -100.05 129.23 46.08 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.86 0.362 . . . . 0.0 110.897 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.1 ptp -64.85 -25.52 67.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.414 ' HG3' ' HG2' ' A' ' 57' ' ' GLN . 12.7 ptt180 -75.81 -11.62 60.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.199 0.523 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 56' ' ' ARG . 19.3 mm-40 -104.53 2.62 31.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.407 HG23 ' HG2' ' A' ' 88' ' ' GLN . 37.7 pt -134.0 172.97 15.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.043 0.449 . . . . 0.0 110.636 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -142.24 149.89 40.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.778 178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.643 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.3 m-85 -114.53 132.8 56.19 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.318 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.6 ppt_? -135.82 140.03 43.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.328 0.585 . . . . 0.0 111.076 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -138.2 137.7 37.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.822 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.85 34.06 21.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.78 -4.55 74.03 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.735 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -120.95 141.49 32.76 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.992 -0.711 . . . . 0.0 111.684 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.51 148.08 32.9 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 111.711 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.82 136.19 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.063 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.25 157.65 16.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -59.74 -22.07 61.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.4 p -74.5 -15.17 60.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.998 0.428 . . . . 0.0 111.229 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.36 165.45 13.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.6 p -117.33 158.76 43.93 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -67.35 -7.46 19.13 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.432 2.088 . . . . 0.0 111.83 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.91 -19.49 20.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.534 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -60.91 -40.01 91.54 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.63 0.729 . . . . 0.0 110.39 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.81 0.35 25.98 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.767 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.5 62.21 2.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' HD12 ' A' ' 20' ' ' LEU . 10.0 ptp -79.8 167.12 21.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.007 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -92.85 167.02 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.286 0.565 . . . . 0.0 110.914 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -75.92 139.74 41.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.134 0.492 . . . . 0.0 110.119 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 68.21 19.56 9.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.755 0.822 . . . . 0.0 111.137 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -72.06 179.76 3.14 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.798 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.431 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.6 m -135.04 150.07 50.23 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 121.602 -0.687 . . . . 0.0 111.618 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.431 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.98 144.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.571 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 28.8 t70 -92.2 139.69 30.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 120.812 0.339 . . . . 0.0 110.685 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.4 t -123.73 139.34 50.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.677 0.751 . . . . 0.0 110.956 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -137.43 146.04 43.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.946 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.426 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 1.3 mt-30 -113.08 114.43 26.82 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.76 -179.55 1.17 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.251 0.548 . . . . 0.0 111.215 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -112.68 101.51 9.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.923 0.392 . . . . 0.0 110.329 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -98.75 112.22 24.36 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 120.905 0.383 . . . . 0.0 110.477 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.02 -61.55 7.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.691 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.352 -1.249 . . . . 0.0 111.471 179.208 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 121.26 0.552 . . . . 0.0 110.939 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.69 103.52 0.56 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -93.58 37.68 1.06 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.846 0.832 . . . . 0.0 108.999 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -121.77 36.77 4.53 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.008 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -121.63 95.06 48.27 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.137 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.46 -170.17 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.845 2.364 . . . . 0.0 111.152 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.88 27.1 1.21 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.439 0.638 . . . . 0.0 110.254 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -82.28 17.17 1.75 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.258 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.3 65.04 3.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.588 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.89 136.42 38.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 12' ' ' THR . 0.1 OUTLIER -106.67 -17.43 14.24 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.559 0.695 . . . . 0.0 110.525 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.505 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 90.0 m -69.55 -32.0 70.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.617 0.723 . . . . 0.0 110.635 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -105.06 176.67 5.09 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.313 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -161.43 -29.09 0.05 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.421 0.629 . . . . 0.0 109.872 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -118.03 172.51 7.36 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.438 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -103.18 -176.38 3.07 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.916 0.389 . . . . 0.0 109.983 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 38.4 p-80 -139.41 159.72 41.5 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 121.97 -0.456 . . . . 0.0 111.763 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.34 170.81 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.577 0.704 . . . . 0.0 112.466 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.448 ' O ' HD23 ' A' ' 20' ' ' LEU . 25.4 m-80 -96.42 139.64 32.23 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.643 HD13 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -128.87 161.38 29.96 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 83' ' ' THR . 60.1 mtpt -136.73 146.91 46.38 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.169 0.509 . . . . 0.0 110.247 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.7 t -128.22 117.25 45.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.201 0.524 . . . . 0.0 110.639 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.58 118.23 28.09 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.46 160.84 33.4 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.169 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -9.14 38.74 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.681 0.753 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -74.72 -15.73 60.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.62 6.94 57.12 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.472 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 t -110.01 167.33 10.26 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.61 140.14 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.458 HG22 ' HG3' ' A' ' 50' ' ' ARG . 9.5 p -103.98 140.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.003 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -113.84 123.51 49.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.43 0.633 . . . . 0.0 109.651 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.429 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 8.8 p90 -147.12 169.04 20.12 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.231 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.425 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 33.5 mtmm -115.28 144.6 43.49 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 111.462 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.7 tt -148.25 146.07 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.023 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.539 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 29.4 mtmt -81.05 155.31 26.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.498 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 18.6 mmm-85 -60.79 -40.19 91.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.094 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -92.91 10.15 32.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.6 m -95.6 130.21 32.54 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.396 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 150.24 83.48 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.765 2.31 . . . . 0.0 112.97 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.412 HD21 HD11 ' A' ' 43' ' ' LEU . 88.5 mt -62.11 -12.18 18.09 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 123.456 0.702 . . . . 0.0 111.799 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.5 t -51.13 -45.52 61.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.956 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.485 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 2.3 tt -62.34 -48.16 81.02 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.23 0.538 . . . . 0.0 110.252 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.536 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 25.8 mtt -63.27 -39.29 94.17 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.651 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.66 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 4.1 tppp? -67.96 -44.51 76.56 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.246 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.648 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -53.97 -53.15 56.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.386 . . . . 0.0 111.016 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CE2' HG12 ' A' ' 86' ' ' VAL . 46.9 t80 -60.55 -41.58 94.82 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -41.55 81.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.288 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.66 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 22.6 mt-10 -71.7 -42.52 67.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.307 0.575 . . . . 0.0 111.211 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.648 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.1 mmt85 -65.09 -50.66 65.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.247 0.546 . . . . 0.0 111.321 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.6 -14.7 59.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.431 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.18 57.19 8.78 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.519 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -146.68 176.13 10.08 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -99.57 128.3 45.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.424 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.405 ' HE1' ' HE3' ' A' ' 45' ' ' LYS . 4.0 ptp -63.12 -19.95 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.111 0.481 . . . . 0.0 111.789 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -83.07 -15.11 52.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.244 0.545 . . . . 0.0 111.011 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -100.04 5.13 45.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.454 0.645 . . . . 0.0 110.47 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.442 HG22 ' HG2' ' A' ' 88' ' ' GLN . 34.2 pt -135.32 171.9 16.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.733 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 21.5 mmm180 -141.99 148.45 38.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.775 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.536 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.7 m-85 -113.68 130.33 56.43 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.726 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.575 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.48 131.86 38.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.092 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -126.56 136.48 52.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.287 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.88 32.56 22.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.285 0.564 . . . . 0.0 111.013 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.35 -3.4 58.88 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.565 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -119.33 135.05 23.77 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 121.847 -0.796 . . . . 0.0 111.215 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.37 150.6 76.13 Favored 'Trans proline' 0 C--N 1.326 -0.619 0 C-N-CA 122.702 2.268 . . . . 0.0 111.831 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.32 142.93 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.805 0.812 . . . . 0.0 111.34 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.22 153.81 17.6 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.105 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.8 pt-20 -63.95 -17.28 63.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.164 0.507 . . . . 0.0 111.731 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.6 p -81.56 -5.97 58.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.26 158.7 15.61 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.154 -0.341 . . . . 0.0 110.365 178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.537 ' OG1' ' HB2' ' A' ' 75' ' ' GLN . 20.0 p -118.16 151.41 49.14 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.54 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.425 ' O ' ' HG2' ' A' ' 78' ' ' MET . 27.6 Cg_endo -63.07 -13.76 37.37 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.428 2.085 . . . . 0.0 112.55 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.498 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.07 -21.31 18.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.106 0.479 . . . . 0.0 110.964 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.537 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 6.1 tt0 -66.0 -33.74 76.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.866 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.32 -1.72 24.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.343 0.592 . . . . 0.0 110.5 177.194 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.47 58.41 4.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.426 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.643 ' SD ' HD13 ' A' ' 20' ' ' LEU . 11.2 ptp -77.49 172.29 13.58 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.878 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.9 tp10 -92.18 156.54 17.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.17 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.88 141.6 49.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.234 0.54 . . . . 0.0 110.839 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 69.08 18.88 8.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.111 0.965 . . . . 0.0 111.04 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -70.47 175.78 4.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.19 150.5 52.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.46 0.647 . . . . 0.0 111.923 -176.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.3 mp -122.69 145.52 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -92.43 135.88 33.67 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.975 0.417 . . . . 0.0 110.607 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG12 ' CE2' ' A' ' 47' ' ' TYR . 2.8 t -120.62 135.58 60.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.781 0.801 . . . . 0.0 111.132 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -135.79 145.2 46.27 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.424 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.442 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.2 mt-30 -103.69 110.98 23.27 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.824 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.46 73.09 6.12 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.566 0.698 . . . . 0.0 110.855 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.08 -171.97 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.4 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.0 m -146.31 112.38 5.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.044 0.45 . . . . 0.0 110.41 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.62 143.88 16.22 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.761 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.078 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.531 -179.878 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.15 0.5 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.02 156.31 27.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.915 0.388 . . . . 0.0 110.566 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.7 32.99 0.94 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.797 0.808 . . . . 0.0 110.757 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -121.98 -172.55 2.47 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.112 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -175.94 86.47 0.29 Allowed Pre-proline 0 C--N 1.289 -2.023 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.291 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.54 163.54 38.26 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.695 2.264 . . . . 0.0 111.015 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -98.58 -11.1 22.48 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.938 0.875 . . . . 0.0 108.871 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -84.06 -9.38 58.66 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.876 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.46 -51.29 5.69 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.754 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.78 133.24 63.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.053 0.454 . . . . 0.0 110.66 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.38 86.3 4.15 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.473 0.654 . . . . 0.0 109.685 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 t -167.19 -177.89 3.89 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -54.92 152.45 7.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.411 0.624 . . . . 0.0 111.883 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -64.18 -23.83 67.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.333 0.587 . . . . 0.0 110.375 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.04 81.89 2.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.338 0.59 . . . . 0.0 111.605 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.74 -34.23 76.77 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.904 0.859 . . . . 0.0 109.964 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 -135.02 174.84 10.16 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.439 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.487 HG22 ' OD1' ' A' ' 80' ' ' ASP . 32.4 pt -130.08 169.1 21.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.34 0.591 . . . . 0.0 111.414 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.2 140.49 32.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.48 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.504 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.2 mm? -128.97 164.34 23.38 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.087 0.47 . . . . 0.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 83' ' ' THR . 62.6 mtpt -133.57 147.19 51.52 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.027 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.452 HG22 ' CE1' ' A' ' 32' ' ' PHE . 71.5 t -125.0 116.39 47.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 120.968 0.413 . . . . 0.0 109.892 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.39 122.62 35.02 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.753 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.3 160.06 34.37 Favored Glycine 0 N--CA 1.424 -2.158 0 C-N-CA 120.439 -0.886 . . . . 0.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -15.16 60.51 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.128 0.49 . . . . 0.0 111.832 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.559 0.695 . . . . 0.0 110.025 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.86 5.52 50.57 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.67 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -95.76 162.75 13.47 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.24 136.74 22.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.479 0.657 . . . . 0.0 111.297 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.3 t -107.65 138.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.933 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.84 128.18 55.16 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.452 ' CE1' HG22 ' A' ' 22' ' ' VAL . 13.7 p90 -147.91 168.35 22.46 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.274 0.559 . . . . 0.0 111.538 -174.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 37.5 mtmt -112.19 135.54 52.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.619 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -144.43 144.15 22.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.19 0.519 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.459 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 24.3 mtmm -82.18 156.79 24.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.484 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 12.4 mmm-85 -64.14 -34.64 78.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.371 0.605 . . . . 0.0 110.547 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -95.21 6.65 48.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.288 0.566 . . . . 0.0 110.914 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.446 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 8.3 m -92.2 129.76 40.27 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.048 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.0 147.16 73.35 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 123.141 2.561 . . . . 0.0 113.595 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.8 mp -61.55 -12.27 14.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.285 1.034 . . . . 0.0 112.99 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.415 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.2 p -54.16 -41.07 68.08 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.046 0.45 . . . . 0.0 110.805 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.461 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 7.2 tt -61.72 -51.97 66.21 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.671 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 mtt -58.85 -42.61 89.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -67.94 -43.35 79.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.009 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.531 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.44 -49.89 73.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.128 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.66 -39.22 93.31 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.194 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -39.17 93.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 110.502 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -68.37 -36.73 79.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.187 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 50' ' ' ARG . 10.7 mmp_? -70.12 -45.55 66.64 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.36 -21.56 39.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.864 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.22 4.5 89.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.368 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.64 177.21 6.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.934 0.397 . . . . 0.0 110.99 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.448 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 37.7 m -93.97 126.45 39.19 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.263 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -62.51 -28.7 70.02 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -76.55 -9.84 58.95 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.457 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 25.0 mm-40 -101.09 4.54 42.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.157 0.503 . . . . 0.0 111.373 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.617 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 23.0 pt -133.17 168.5 24.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.246 0.546 . . . . 0.0 110.786 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.617 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 54.8 mmt-85 -133.78 153.09 51.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.339 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.671 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 13.5 m-85 -119.17 131.03 55.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.315 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.579 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.1 ppt_? -136.56 143.94 43.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.251 0.548 . . . . 0.0 111.316 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.701 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 74.8 t80 -139.39 130.98 27.2 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.55 ' C ' ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER 53.87 32.22 14.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.557 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.52 -33.08 1.38 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.623 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.701 ' HG2' ' O ' ' A' ' 62' ' ' PHE . 7.5 pt20 -70.06 119.82 74.13 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.688 0.756 . . . . 0.0 111.736 -177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.08 144.51 57.88 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.658 2.238 . . . . 0.0 110.724 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.8 133.01 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.354 0.597 . . . . 0.0 110.668 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.94 159.11 15.91 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.456 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.4 pt-20 -58.8 -21.84 57.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.322 0.582 . . . . 0.0 111.79 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.9 p -84.97 0.26 51.96 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.575 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.521 ' O ' HD13 ' A' ' 40' ' ' LEU . 66.9 m-20 -96.07 161.76 13.83 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.885 -0.51 . . . . 0.0 110.325 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.3 p -119.38 153.53 53.71 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.954 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.24 -12.0 33.71 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.722 2.281 . . . . 0.0 112.863 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -95.05 -17.08 22.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.37 0.605 . . . . 0.0 110.937 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -67.94 -32.88 73.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.561 . . . . 0.0 110.771 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.2 3.09 19.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.045 0.45 . . . . 0.0 110.957 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 50.22 57.85 6.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.721 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.504 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -72.81 168.98 17.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.432 . . . . 0.0 110.88 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.5 tp10 -87.97 143.84 26.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.042 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.487 ' OD1' HG22 ' A' ' 18' ' ' ILE . 3.4 m-20 -59.02 138.68 57.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.86 0.362 . . . . 0.0 110.352 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.65 25.55 8.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 112.042 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -77.73 -174.28 3.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 110.964 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.443 ' C ' HD11 ' A' ' 84' ' ' ILE . 2.8 m -136.23 150.97 49.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.443 HD11 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.66 140.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.579 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.8 t70 -89.01 138.03 31.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.256 0.55 . . . . 0.0 110.9 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 136.21 57.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.314 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.449 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 3.8 p90 -146.77 158.95 44.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.095 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.489 ' HG2' HG22 ' A' ' 58' ' ' ILE . 87.6 mt-30 -113.84 109.24 18.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.429 ' O ' HG22 ' A' ' 91' ' ' THR . 6.4 pt20 -137.08 136.64 38.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 47.61 39.61 10.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.719 0.808 . . . . 0.0 112.198 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 89' ' ' GLN . 9.6 p -104.01 -68.74 0.83 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.234 0.54 . . . . 0.0 111.962 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.14 -68.64 0.05 OUTLIER Glycine 0 C--N 1.3 -1.446 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.413 -1.215 . . . . 0.0 111.366 176.947 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.41 137.86 4.27 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 121.96 -0.462 . . . . 0.0 110.937 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -91.56 16.23 10.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.711 0.767 . . . . 0.0 109.842 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -125.63 37.75 4.3 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.84 0.828 . . . . 0.0 108.816 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -166.84 99.21 0.66 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.953 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.06 143.16 14.1 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.328 2.019 . . . . 0.0 111.359 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -119.3 37.1 4.25 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.314 0.578 . . . . 0.0 110.409 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -99.76 -10.38 21.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.283 0.563 . . . . 0.0 110.637 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.7 -49.16 1.41 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.147 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.08 141.01 26.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.384 0.611 . . . . 0.0 110.759 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -129.29 158.17 39.84 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.0 m -48.67 114.08 0.9 Allowed 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.242 0.544 . . . . 0.0 110.714 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -78.96 106.03 10.7 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.425 0.631 . . . . 0.0 112.343 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.42 -176.67 0.47 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.974 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 76.01 10.89 3.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.903 0.881 . . . . 0.0 110.486 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -99.14 -15.2 19.05 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.909 0.861 . . . . 0.0 109.226 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.453 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.9 p-80 -131.91 151.12 51.91 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.023 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.9 pt -106.08 169.73 2.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.674 0.749 . . . . 0.0 111.621 -176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.519 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.4 m-80 -99.71 148.68 24.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.055 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.524 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -136.94 162.77 32.37 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.393 0.616 . . . . 0.0 111.087 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.2 mtpt -136.73 148.18 47.14 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.183 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 71.0 t -129.25 117.97 44.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.434 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.02 122.1 33.4 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.694 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.07 162.91 30.15 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.453 ' CG ' ' HG3' ' A' ' 88' ' ' GLN . 5.4 pp0? -69.18 -12.09 61.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.743 0.782 . . . . 0.0 109.851 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.33 -21.43 60.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.801 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.12 10.82 41.27 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 t -109.77 158.47 18.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p -135.19 134.22 52.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.383 0.611 . . . . 0.0 111.211 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 7.5 p -100.67 139.66 21.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.528 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -154.97 169.57 23.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.074 0.464 . . . . 0.0 111.377 -175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -118.22 138.3 52.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.652 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.471 ' CG2' HD21 ' A' ' 20' ' ' LEU . 14.0 tt -143.35 148.0 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 26.8 mtmt -84.44 157.7 21.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.247 0.546 . . . . 0.0 110.994 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.1 mmm-85 -68.55 -34.46 75.87 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.323 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -95.2 6.49 48.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.587 0.708 . . . . 0.0 110.668 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.7 m -94.54 131.98 29.77 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.205 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.1 151.1 86.78 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.571 2.181 . . . . 0.0 112.265 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.45 ' CD2' HD12 ' A' ' 43' ' ' LEU . 67.2 mt -65.57 -13.7 59.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.746 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.429 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 2.4 p -49.95 -43.29 49.97 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.499 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.45 HD12 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt -63.41 -49.35 74.11 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.389 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -60.15 -37.89 81.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.341 0.591 . . . . 0.0 110.502 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.4 tppp? -69.41 -42.25 75.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.45 -50.24 70.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.29 0.567 . . . . 0.0 110.723 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.31 -39.65 94.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.15 0.5 . . . . 0.0 110.902 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -34.15 77.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm-40 -71.64 -40.84 69.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.675 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' HG3' ' CG2' ' A' ' 30' ' ' VAL . 10.5 mmm180 -68.97 -43.75 74.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.099 0.476 . . . . 0.0 111.657 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.95 -16.65 40.28 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.979 0.418 . . . . 0.0 111.714 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.03 2.93 80.01 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.919 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -83.46 176.46 9.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.075 0.465 . . . . 0.0 111.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.0 m -94.21 130.57 40.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.4 ptp -66.54 -22.01 66.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.063 0.459 . . . . 0.0 111.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -80.05 -8.25 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.269 0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -104.66 7.96 35.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.969 0.414 . . . . 0.0 111.711 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' A' ' 88' ' ' GLN . 22.2 pt -136.53 171.82 16.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.394 0.616 . . . . 0.0 111.364 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 16.6 mmm180 -140.64 145.79 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.573 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.66 130.47 56.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.6 ppt_? -133.1 138.24 46.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.351 0.596 . . . . 0.0 110.986 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -138.48 140.36 39.17 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.551 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.12 26.05 16.0 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.09 0.472 . . . . 0.0 111.297 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.31 -6.8 70.47 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.856 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.56 142.61 31.82 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.073 -0.663 . . . . 0.0 111.411 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.94 148.9 36.2 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 122.431 2.087 . . . . 0.0 111.435 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.96 135.29 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.428 0.633 . . . . 0.0 111.545 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.48 154.65 17.32 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.46 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.4 pt-20 -60.67 -21.28 62.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.054 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -76.46 -12.49 60.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 111.271 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.2 166.43 11.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 p -115.9 158.57 41.95 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.99 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.426 ' O ' ' HG2' ' A' ' 78' ' ' MET . 39.1 Cg_endo -67.79 -3.23 10.0 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.71 2.273 . . . . 0.0 112.124 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.43 -21.3 19.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.0 110.547 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -62.29 -39.49 93.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.378 0.609 . . . . 0.0 110.92 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.426 ' N ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.12 1.42 28.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.174 0.511 . . . . 0.0 111.221 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 3.5 mm-40 51.88 62.62 2.61 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.524 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.7 ptp -76.33 165.22 25.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.05 0.452 . . . . 0.0 110.366 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.82 165.83 11.92 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.1 131.56 44.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 69.67 21.13 6.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.555 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -67.89 176.63 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 1.3 m -132.81 148.67 52.31 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.577 -0.702 . . . . 0.0 111.427 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.05 142.14 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.576 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 36.1 t70 -89.52 134.08 34.28 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.101 0.477 . . . . 0.0 110.531 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.17 137.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.789 0.804 . . . . 0.0 110.75 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.8 p90 -135.07 144.59 47.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.37 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.471 ' HG2' HG21 ' A' ' 58' ' ' ILE . 1.4 mt-30 -110.96 114.11 27.18 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.424 ' H ' ' NE2' ' A' ' 89' ' ' GLN . 1.4 mp0 -64.76 83.39 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.284 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.511 ' H ' ' NE2' ' A' ' 90' ' ' GLN . 0.7 OUTLIER -81.5 179.1 7.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.818 0.342 . . . . 0.0 110.432 177.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 m -92.95 -2.41 55.82 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.694 0.759 . . . . 0.0 110.253 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.29 -52.22 2.14 Favored Glycine 0 CA--C 1.509 -0.334 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.314 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.291 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.662 0.268 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 177.2 -179.76 0.22 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -115.71 10.41 15.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.267 0.556 . . . . 0.0 110.862 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.25 128.14 35.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.878 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.443 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 8.0 tmtm? -177.9 -56.92 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.737 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 56.7 Cg_endo -69.97 150.02 66.32 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.587 1.525 . . . . 0.0 111.611 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -119.49 21.65 12.03 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.441 0.639 . . . . 0.0 109.725 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -85.53 -31.52 22.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.238 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.17 60.61 4.72 Favored Glycine 0 C--N 1.313 -0.707 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.248 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -74.71 143.6 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.081 0.467 . . . . 0.0 110.245 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -69.68 -73.81 0.15 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.02 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -135.89 43.14 2.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.416 0.627 . . . . 0.0 111.402 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 65.73 29.82 10.52 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.499 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -63.78 135.48 56.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.312 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 65.07 61.59 0.75 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.755 0.788 . . . . 0.0 109.988 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -153.1 -59.6 0.14 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.004 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.447 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 46.9 p-80 -141.92 156.38 45.49 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.451 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 pt -108.05 169.87 2.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.502 0.668 . . . . 0.0 112.232 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' O ' HD22 ' A' ' 20' ' ' LEU . 15.6 m-80 -97.34 142.47 29.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.464 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -133.17 163.9 28.24 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.382 0.611 . . . . 0.0 110.887 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.8 mtpt -138.64 148.6 44.26 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.628 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG21 ' CE1' ' A' ' 32' ' ' PHE . 92.7 t -127.88 117.25 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.094 0.473 . . . . 0.0 110.497 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.36 123.19 35.5 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.292 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.88 163.01 26.69 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -19.42 63.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.706 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.1 -6.14 49.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.261 0.553 . . . . 0.0 110.98 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.17 64.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.838 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 t -103.88 158.4 16.43 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.94 136.04 45.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.253 0.549 . . . . 0.0 111.191 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 11.4 p -106.54 141.79 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 122.188 -0.32 . . . . 0.0 110.217 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -111.88 129.87 56.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.229 0.538 . . . . 0.0 109.968 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.437 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 11.7 p90 -154.09 169.95 22.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.585 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -115.56 143.27 45.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.651 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.428 ' CG2' HD21 ' A' ' 20' ' ' LEU . 13.6 tt -148.9 148.53 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.231 0.539 . . . . 0.0 110.398 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.0 mtmt -84.15 158.05 21.48 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.01 0.433 . . . . 0.0 110.782 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 23.8 mmm-85 -69.13 -34.04 74.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.517 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.45 5.13 52.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.58 . . . . 0.0 110.913 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.1 m -93.46 131.26 32.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.778 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.69 149.57 90.53 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.923 2.415 . . . . 0.0 112.784 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.449 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.7 mt -65.13 -12.14 47.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.906 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.3 m -49.63 -45.1 47.97 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.5 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt -61.48 -48.27 81.88 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.392 0.615 . . . . 0.0 109.79 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.736 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 38.5 mtt -61.57 -49.65 75.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.353 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.0 tppp? -59.66 -44.31 93.6 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.56 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.18 -50.79 68.46 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.773 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -62.78 -41.01 99.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.186 0.517 . . . . 0.0 110.813 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 58' ' ' ILE . 79.2 m -65.52 -34.64 78.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.399 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 18.9 mm-40 -68.89 -37.13 78.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.22 0.533 . . . . 0.0 110.99 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 mmt180 -69.63 -44.33 70.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.34 -21.74 33.06 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.295 0.569 . . . . 0.0 110.67 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.71 88.79 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.532 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.69 176.0 7.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.288 0.566 . . . . 0.0 111.815 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.7 m -96.9 134.62 40.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.542 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.6 ptp -68.18 -19.74 64.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.096 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -83.42 -8.05 59.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.167 0.508 . . . . 0.0 111.059 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -106.65 9.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.001 0.429 . . . . 0.0 110.811 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.556 HD13 ' SG ' ' A' ' 48' ' ' CYS . 19.6 pt -137.29 173.41 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.614 0.721 . . . . 0.0 111.856 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.487 ' HG2' ' NE2' ' A' ' 89' ' ' GLN . 21.3 mmm180 -140.27 146.9 39.18 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.071 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.736 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.6 m-85 -113.75 128.15 56.3 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.386 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.56 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.5 OUTLIER -128.63 145.41 51.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.003 0.43 . . . . 0.0 110.211 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -140.96 131.44 25.32 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.039 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 t0 58.33 29.38 18.05 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.893 0.378 . . . . 0.0 111.684 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.9 69.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.089 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -114.03 134.79 22.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.054 -0.674 . . . . 0.0 111.116 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.65 149.33 33.98 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.848 2.365 . . . . 0.0 112.376 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.87 137.52 52.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.9 161.28 13.82 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.216 177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.592 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.4 pt-20 -62.22 -20.91 64.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.093 0.473 . . . . 0.0 112.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -76.33 -6.89 53.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.251 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.419 ' OD1' ' HG2' ' A' ' 75' ' ' GLN . 1.7 m-20 -103.22 166.85 10.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.136 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -116.84 159.89 38.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.407 ' O ' ' HG2' ' A' ' 78' ' ' MET . 35.3 Cg_endo -66.52 -8.71 21.72 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.506 2.137 . . . . 0.0 111.912 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -94.99 -13.09 25.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.303 0.573 . . . . 0.0 110.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.419 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 2.3 tp-100 -68.26 -35.49 77.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.511 0.672 . . . . 0.0 110.16 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.449 HD22 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -110.52 1.19 18.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.366 -179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 54.16 61.73 2.91 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.382 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.553 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.8 ptp -77.18 164.39 25.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 110.734 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 38.1 tt0 -95.09 161.58 14.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.128 -175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.54 134.56 53.62 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.061 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 70.05 19.67 6.74 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.836 0.855 . . . . 0.0 111.555 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t0 -71.49 176.14 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.429 . . . . 0.0 110.111 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.463 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.5 m -131.32 150.26 52.22 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.22 0.534 . . . . 0.0 111.246 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.463 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.19 136.69 58.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.56 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 19.4 m-20 -89.83 138.07 31.8 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.041 0.448 . . . . 0.0 110.833 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -122.7 139.56 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.98 151.28 45.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.499 ' HG2' ' CG2' ' A' ' 58' ' ' ILE . 91.4 mt-30 -108.68 112.57 24.96 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.998 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.487 ' NE2' ' HG2' ' A' ' 59' ' ' ARG . 14.0 mp0 -57.55 164.17 2.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.734 0.778 . . . . 0.0 111.661 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -71.4 158.0 37.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.39 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.3 p -87.17 -44.28 11.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.685 0.755 . . . . 0.0 110.376 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.77 47.97 13.51 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.236 0 CA-C-O 118.387 -1.23 . . . . 0.0 111.136 -177.318 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 121.055 0.455 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.32 100.49 2.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.29 0.567 . . . . 0.0 109.926 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -128.19 8.46 6.09 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.731 0.777 . . . . 0.0 109.668 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.6 -79.7 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.469 -175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.483 ' HZ2' ' HB2' ' A' ' 5' ' ' LYS . 4.8 ttmp? 57.21 84.03 0.21 Allowed Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 123.064 0.546 . . . . 0.0 110.627 -174.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.08 -153.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.916 3.077 . . . . 0.0 113.592 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -91.57 -6.61 52.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.712 0.768 . . . . 0.0 109.92 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -92.17 165.1 13.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.796 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.87 -12.04 72.41 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.141 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' CG2' ' HB2' ' A' ' 13' ' ' GLU . 3.1 p -92.04 114.38 29.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.373 0.606 . . . . 0.0 111.913 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.556 ' HG3' ' N ' ' A' ' 12' ' ' THR . 19.8 ptpt -76.3 -49.58 16.58 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.262 0.553 . . . . 0.0 111.139 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.556 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 91.8 m -160.35 99.3 1.31 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.249 0.547 . . . . 0.0 109.744 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 4.7 mm-40 -155.37 -173.49 4.58 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.827 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 19.4 m120 77.76 16.65 1.45 Allowed 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 123.624 0.77 . . . . 0.0 111.604 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -85.09 -83.25 0.17 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.701 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.97 114.24 18.74 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 45.8 p-80 -167.66 174.64 7.56 Favored 'General case' 0 N--CA 1.437 -1.119 0 O-C-N 121.975 -0.453 . . . . 0.0 111.009 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.44 170.51 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.369 0.604 . . . . 0.0 111.332 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' O ' HD21 ' A' ' 20' ' ' LEU . 23.6 m-80 -96.77 142.32 28.93 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.586 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -130.49 162.31 29.49 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.987 0.422 . . . . 0.0 109.889 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.2 mtpt -136.3 145.52 45.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.102 0.477 . . . . 0.0 110.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.408 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.6 t -125.56 116.67 47.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.156 0.503 . . . . 0.0 109.961 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.9 122.55 35.38 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.53 159.61 32.18 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -64.13 -11.9 34.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.166 0.508 . . . . 0.0 111.775 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -80.36 -15.51 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.356 0.598 . . . . 0.0 110.072 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 4.99 48.29 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.072 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 t -99.61 160.05 14.58 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.25 136.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.468 0.651 . . . . 0.0 111.496 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 50' ' ' ARG . 7.4 p -102.28 142.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -113.64 125.04 53.71 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.409 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 12.2 p90 -146.42 167.98 22.28 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.533 -174.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 40.8 mtmt -114.99 134.16 55.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 111.255 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.435 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.0 tt -144.71 150.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.106 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.563 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.8 mtmt -81.03 163.89 22.89 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.863 -0.523 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.43 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 22.4 mmm-85 -70.74 -40.24 72.84 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 110.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -91.8 5.97 47.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.568 0.699 . . . . 0.0 110.517 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.8 m -90.98 130.4 40.6 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.14 149.01 92.68 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.049 2.499 . . . . 0.0 113.233 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' CD2' HD13 ' A' ' 43' ' ' LEU . 83.7 mt -64.05 -12.59 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.406 0.683 . . . . 0.0 111.994 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.5 t -52.89 -43.54 66.25 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.86 0.362 . . . . 0.0 110.991 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.508 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.429 HD13 ' CD2' ' A' ' 40' ' ' LEU . 2.4 tt -60.72 -49.77 76.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.32 0.581 . . . . 0.0 110.318 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.596 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 28.1 mtt -60.04 -47.28 86.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.369 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.0 tppt? -63.08 -41.87 99.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.752 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.73 74.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.958 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.67 -39.8 95.06 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.157 0.503 . . . . 0.0 110.71 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.525 ' SG ' HD12 ' A' ' 58' ' ' ILE . 70.7 m -67.68 -34.87 77.77 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 16.2 mm-40 -70.72 -33.99 71.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.2 0.524 . . . . 0.0 110.505 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HG3' HG23 ' A' ' 30' ' ' VAL . 15.9 mmt180 -65.45 -49.01 70.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.302 0.572 . . . . 0.0 110.511 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.63 -20.76 35.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.674 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.83 14.25 79.95 Favored Glycine 0 C--N 1.321 -0.269 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.371 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.99 178.54 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.451 0.643 . . . . 0.0 112.25 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.0 m -100.36 129.57 46.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.759 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.501 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.7 ptp -63.13 -24.04 67.71 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.119 0.485 . . . . 0.0 112.087 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -78.91 -12.48 60.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.351 0.596 . . . . 0.0 111.142 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -99.33 -0.29 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.146 0.498 . . . . 0.0 110.999 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.525 HD12 ' SG ' ' A' ' 48' ' ' CYS . 29.2 pt -132.77 169.9 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.229 0.537 . . . . 0.0 111.567 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.432 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 17.7 mmm180 -138.83 146.88 41.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.988 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.596 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.1 m-85 -112.72 130.73 55.96 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.825 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -130.71 145.22 51.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 0.0 110.66 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -146.51 135.79 22.77 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 60.88 28.04 17.83 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.427 0.632 . . . . 0.0 110.743 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.18 -1.2 70.94 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.445 -1.359 . . . . 0.0 113.51 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -118.53 139.84 27.5 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 117.527 0.664 . . . . 0.0 110.853 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.81 145.66 36.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.341 2.028 . . . . 0.0 111.577 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.7 137.58 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-O 121.543 0.687 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.53 154.25 17.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.544 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.575 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.2 pt-20 -61.7 -18.04 58.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.522 . . . . 0.0 112.325 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -79.51 -15.65 57.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.021 0.439 . . . . 0.0 111.278 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.39 164.07 15.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.942 0.401 . . . . 0.0 111.345 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -118.04 155.18 51.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.221 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.45 -11.35 29.97 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.754 2.303 . . . . 0.0 112.243 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 36' ' ' ARG . . . -94.93 -14.81 24.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.896 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -69.31 -38.79 78.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.438 0.637 . . . . 0.0 110.168 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.437 HD11 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -104.92 1.28 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.432 0.634 . . . . 0.0 110.15 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 50.85 60.83 3.59 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.784 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.586 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -77.0 163.6 26.55 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.5 tp10 -92.96 161.83 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.453 . . . . 0.0 110.814 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.36 138.65 51.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.286 0.565 . . . . 0.0 111.215 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 73.03 19.45 3.69 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.413 1.085 . . . . 0.0 110.9 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -72.82 175.35 6.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.731 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.463 ' C ' HD11 ' A' ' 84' ' ' ILE . 1.2 m -133.33 147.26 51.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.578 0.704 . . . . 0.0 111.506 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.463 HD11 ' C ' ' A' ' 83' ' ' THR . 2.5 mp -121.4 137.87 53.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.562 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 13.4 m-20 -88.73 136.38 33.03 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.1 0.476 . . . . 0.0 111.022 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -120.88 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-O 121.465 0.65 . . . . 0.0 110.609 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -137.94 147.15 44.06 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.305 179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -109.55 111.65 23.29 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.191 0.52 . . . . 0.0 109.9 -175.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -132.85 135.27 45.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.496 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -115.57 117.78 31.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.29 0.567 . . . . 0.0 110.293 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.8 t -64.93 -24.69 67.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 111.749 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.1 143.37 15.05 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.094 0 CA-C-O 118.837 -0.979 . . . . 0.0 112.138 -177.607 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.084 0.469 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.66 108.71 4.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.04 0.448 . . . . 0.0 110.899 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.13 32.38 0.55 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.628 0.728 . . . . 0.0 110.452 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -122.47 17.41 10.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.433 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -122.85 92.17 49.28 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.949 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -80.3 146.74 17.79 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.503 2.135 . . . . 0.0 112.261 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 9.6 mmpt? -96.07 -10.14 29.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.564 0.697 . . . . 0.0 109.382 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -78.19 -3.02 40.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.008 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.38 -77.29 0.29 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.217 -0.516 . . . . 0.0 113.304 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -135.6 139.08 47.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 122.471 -0.429 . . . . 0.0 110.458 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -82.79 -53.26 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.349 . . . . 0.0 111.705 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -61.94 -19.13 62.41 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -100.7 125.66 47.17 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -155.7 144.56 20.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.222 0.534 . . . . 0.0 110.584 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -129.18 140.74 51.39 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.488 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 168.84 168.31 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.621 1.168 . . . . 0.0 108.655 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.495 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 10.6 p-80 40.97 -159.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.681 0.792 . . . . 0.0 111.852 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 pt -129.66 169.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.353 -0.842 . . . . 0.0 112.125 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.563 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.3 m-80 -103.87 144.49 31.44 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.215 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.568 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -135.23 160.69 37.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.336 0.589 . . . . 0.0 110.936 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.2 mtpt -135.93 148.32 48.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 29' ' ' VAL . 96.9 t -125.38 119.32 55.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.244 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.75 119.9 35.06 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.338 0.59 . . . . 0.0 110.222 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.84 157.98 32.96 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -64.43 -16.41 62.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.276 0.56 . . . . 0.0 111.369 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.98 -10.95 58.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 0.0 110.916 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.59 30.41 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.31 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -105.43 155.6 18.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.3 p -141.01 134.11 31.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.384 0.611 . . . . 0.0 110.958 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 85.9 t -107.24 138.45 33.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.99 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -110.11 131.75 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.422 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 7.1 p90 -155.9 170.07 22.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.305 0.574 . . . . 0.0 111.887 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -116.45 138.38 51.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.744 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.5 tt -143.52 150.52 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.103 0.477 . . . . 0.0 110.069 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 25.8 mtmm -86.47 158.39 19.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.404 ' NH2' ' HA ' ' A' ' 74' ' ' ALA . 24.0 mmm-85 -63.25 -38.29 90.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.647 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -95.47 9.41 40.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.027 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.478 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.9 m -93.95 128.34 41.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.378 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.0 149.42 89.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.685 2.256 . . . . 0.0 112.925 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.43 ' CD2' HD12 ' A' ' 43' ' ' LEU . 83.8 mt -63.91 -11.71 30.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.971 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.41 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 21.9 p -51.67 -46.0 63.63 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.508 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD12 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt -63.37 -49.33 74.29 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.397 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.608 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 34.0 mtt -62.32 -46.57 88.15 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.227 0.537 . . . . 0.0 110.648 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.692 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 17.6 tppt? -64.99 -41.44 95.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.793 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.39 -50.96 71.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.796 0.332 . . . . 0.0 110.655 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.17 -42.34 99.37 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.362 0.601 . . . . 0.0 110.262 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.692 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.09 -40.17 88.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.958 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.578 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 7.8 mt-10 -73.38 -33.51 65.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.866 0.365 . . . . 0.0 111.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 7.1 mmp_? -65.44 -47.71 75.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.314 0.578 . . . . 0.0 110.417 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.12 46.16 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.124 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.79 2.6 78.37 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.975 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.86 176.27 7.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.459 0.647 . . . . 0.0 112.47 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.4 m -97.52 136.68 37.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.651 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 6.5 ptp -68.09 -26.64 65.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.158 0.504 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -75.17 -10.28 59.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.407 0.623 . . . . 0.0 110.665 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -102.66 5.67 39.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.231 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.432 HG23 ' HG2' ' A' ' 88' ' ' GLN . 28.6 pt -138.8 176.66 6.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.118 0.485 . . . . 0.0 110.983 -177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -146.94 148.03 31.34 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.631 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.608 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.6 m-85 -114.55 132.33 56.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.789 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.54 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -131.0 142.58 50.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.46 0.648 . . . . 0.0 111.028 177.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -146.55 140.1 25.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t70 64.44 25.35 13.32 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.068 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.41 -0.39 64.34 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 119.819 -1.181 . . . . 0.0 113.161 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -120.79 143.3 36.27 Favored Pre-proline 0 N--CA 1.445 -0.695 0 O-C-N 122.134 -0.627 . . . . 0.0 110.808 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.62 148.7 47.87 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 122.233 1.956 . . . . 0.0 111.716 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.29 137.09 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-O 121.334 0.588 . . . . 0.0 110.648 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.19 156.24 16.96 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.574 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -60.66 -20.15 60.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.183 0.516 . . . . 0.0 112.062 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -79.54 -10.95 59.89 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.22 162.73 14.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.679 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -118.45 158.63 46.43 Favored Pre-proline 0 C--N 1.307 -1.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.16 -6.04 13.77 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.649 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.404 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . . . -95.42 -14.07 24.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.557 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -68.06 -37.02 80.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.444 0.64 . . . . 0.0 110.102 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.444 HD22 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -111.75 1.72 16.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.546 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 53.11 60.36 3.82 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.568 ' SD ' HD13 ' A' ' 20' ' ' LEU . 9.9 ptp -78.72 167.37 21.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.855 0.36 . . . . 0.0 110.534 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HG2' ' N ' ' A' ' 80' ' ' ASP . 43.1 tt0 -93.29 165.64 12.7 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.095 0.474 . . . . 0.0 110.568 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 3.9 p-10 -77.25 137.87 39.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.063 0.459 . . . . 0.0 110.036 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.13 16.72 4.21 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.356 1.062 . . . . 0.0 111.317 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.07 176.43 3.81 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.6 m -136.41 151.04 49.09 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 121.805 -0.56 . . . . 0.0 111.004 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.53 HG23 ' O ' ' A' ' 61' ' ' ARG . 2.8 mp -120.81 144.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.5 t0 -88.87 130.96 35.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.146 0.498 . . . . 0.0 110.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.48 134.89 60.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.653 0.739 . . . . 0.0 111.046 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -135.65 145.96 47.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.432 ' HG2' HG23 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -110.32 112.14 23.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.085 0.469 . . . . 0.0 110.659 -177.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -69.51 -178.9 1.53 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.423 0.63 . . . . 0.0 111.575 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -84.51 -171.41 3.61 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.222 -177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -166.54 162.01 16.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.069 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.01 -179.13 44.48 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.845 0 CA-C-O 118.725 -1.042 . . . . 0.0 112.329 -178.599 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.836 0.35 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.651 ' HB3' ' OE2' ' A' ' 4' ' ' GLU . . . -63.61 159.91 17.9 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.908 0.385 . . . . 0.0 111.47 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -106.23 28.16 7.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.475 0.655 . . . . 0.0 111.126 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.651 ' OE2' ' HB3' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -155.34 88.3 1.15 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.11 0.957 . . . . 0.0 112.552 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -141.95 105.64 5.74 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.93 128.31 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.548 2.166 . . . . 0.0 113.602 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.32 29.23 3.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.927 0.87 . . . . 0.0 109.747 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.91 103.38 7.82 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.998 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.59 -121.95 2.94 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -159.82 147.91 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.06 -54.46 4.83 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.794 0.331 . . . . 0.0 111.75 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -139.59 119.77 13.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.914 0.388 . . . . 0.0 110.726 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.23 124.61 42.91 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -36.92 113.03 0.22 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.096 0.951 . . . . 0.0 113.205 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -140.67 3.9 1.9 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.475 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -52.86 -39.04 62.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.959 0.885 . . . . 0.0 110.801 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 21.5 p-80 -141.94 164.78 29.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.7 pt -104.22 168.8 2.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-O 121.662 0.744 . . . . 0.0 112.217 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.43 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.9 m-80 -101.47 144.93 29.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.948 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -132.28 161.78 32.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.233 0.539 . . . . 0.0 110.459 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.0 mtpt -135.76 147.64 48.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.759 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.3 t -127.48 113.91 33.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 121.082 0.468 . . . . 0.0 110.294 178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.07 123.02 34.21 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.778 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.01 163.75 29.47 Favored Glycine 0 N--CA 1.418 -2.545 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -12.08 59.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.574 0.702 . . . . 0.0 111.28 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.41 -13.15 58.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.734 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.73 9.3 56.5 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.764 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -103.28 155.39 18.49 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.32 130.71 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.635 0.731 . . . . 0.0 111.377 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 94.2 t -101.81 135.85 36.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.325 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -108.44 128.82 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -151.42 169.7 21.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.216 0.531 . . . . 0.0 111.528 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -115.46 138.21 51.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.842 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tt -145.54 149.31 16.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.467 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 30.5 mtmt -83.62 159.86 21.5 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 25.3 mmm-85 -69.46 -36.03 76.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.165 0.507 . . . . 0.0 110.594 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.99 5.95 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.272 0.558 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.2 m -91.29 131.57 36.23 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.321 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.45 147.89 93.0 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 70.9 mt -64.54 -13.44 52.67 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.408 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p -49.96 -40.85 45.27 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 111.7 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.492 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.447 HD11 ' CD2' ' A' ' 40' ' ' LEU . 3.9 tt -63.08 -51.69 65.66 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.521 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -60.56 -39.45 87.99 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.513 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 tppp? -68.72 -43.11 76.66 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.2 -51.15 65.33 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.78 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -64.68 -39.9 94.47 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.18 83.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 5.9 mm-40 -72.23 -35.36 68.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.273 0.558 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 27.6 mmm180 -69.43 -45.55 68.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.392 0.615 . . . . 0.0 111.402 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -21.74 33.54 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.676 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.09 89.78 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.908 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.79 178.04 7.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.912 0.386 . . . . 0.0 111.502 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.8 m -96.87 124.67 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.17 -27.77 64.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -79.05 -9.47 59.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.218 0.532 . . . . 0.0 111.622 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.48 2.11 35.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.556 0.693 . . . . 0.0 110.617 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.456 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.9 pt -130.78 170.68 19.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.235 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 16.2 mmm180 -140.51 147.27 39.29 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.252 0.549 . . . . 0.0 111.253 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -113.26 129.16 56.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.112 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.2 ppt_? -132.86 136.38 46.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 111.468 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -136.23 137.31 40.68 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 60.89 29.8 19.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.324 0.583 . . . . 0.0 111.134 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.51 67.99 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.197 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.03 139.78 31.02 Favored Pre-proline 0 C--N 1.323 -0.576 0 O-C-N 122.175 -0.603 . . . . 0.0 111.251 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 151.28 44.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.413 2.075 . . . . 0.0 111.851 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.88 136.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.353 0.597 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.71 154.51 17.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.508 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -59.11 -20.6 54.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.395 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.5 p -80.29 -10.37 59.75 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.304 0.573 . . . . 0.0 111.399 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.78 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 p -113.31 155.15 44.98 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.004 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.47 -7.77 18.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.56 2.173 . . . . 0.0 111.879 178.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.98 -16.61 22.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.929 0.395 . . . . 0.0 110.618 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -68.97 -40.65 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.628 . . . . 0.0 110.49 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.83 -1.14 38.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.487 0.66 . . . . 0.0 110.205 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 60.07 3.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.929 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 20' ' ' LEU . 8.1 ptp -79.83 165.17 22.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 175.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.589 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 13.0 pt-20 -100.73 169.51 8.97 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.146 0.498 . . . . 0.0 112.203 -175.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.64 133.3 50.84 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.894 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 69.24 18.63 8.07 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.508 0.723 . . . . 0.0 111.61 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.589 ' OD2' ' HG2' ' A' ' 79' ' ' GLU . 4.0 t0 -67.92 174.77 3.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.414 ' C ' HD11 ' A' ' 84' ' ' ILE . 1.1 m -133.11 150.51 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.687 -0.633 . . . . 0.0 110.899 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.414 HD11 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.57 145.98 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.0 t70 -92.71 133.63 35.82 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.028 0.442 . . . . 0.0 110.521 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.61 137.13 54.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.7 0.762 . . . . 0.0 110.644 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -137.54 148.15 45.72 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.582 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.456 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -107.21 111.84 24.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -59.98 167.55 2.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.78 0.8 . . . . 0.0 111.766 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -106.3 87.0 2.45 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.991 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -148.56 139.97 23.42 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.073 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.5 159.16 22.39 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.054 0 CA-C-O 118.515 -1.158 . . . . 0.0 111.678 179.653 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.959 0.409 . . . . 0.0 111.449 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.22 97.95 9.93 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -81.16 36.58 0.42 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.325 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -60.77 107.87 0.76 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.125 0.488 . . . . 0.0 109.999 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.481 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 37.3 ttpt -174.28 -48.7 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.104 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 2.8 Cg_exo -77.48 170.82 18.67 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 121.938 1.758 . . . . 0.0 111.959 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -114.24 31.97 6.23 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.632 0.73 . . . . 0.0 109.746 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -68.41 -179.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.992 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.21 -27.96 16.42 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.16 121.22 64.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.345 0.593 . . . . 0.0 110.529 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.607 ' HD3' ' N ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -74.14 -37.11 64.15 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 120.958 0.409 . . . . 0.0 111.941 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.607 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 35.9 m -158.43 145.91 17.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.452 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 1.7 mp0 -63.63 103.41 0.54 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -83.5 -31.65 26.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.084 0.468 . . . . 0.0 109.932 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.98 154.52 37.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 17' ' ' HIS . 12.5 t70 -140.16 -161.55 1.21 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.463 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 50.1 p-80 -155.06 177.04 11.78 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.56 169.37 20.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.326 0.584 . . . . 0.0 111.56 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.446 ' O ' HD21 ' A' ' 20' ' ' LEU . 19.3 m-80 -98.94 143.2 29.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.638 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.8 mm? -129.96 163.86 25.52 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.084 0.468 . . . . 0.0 110.026 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 55.6 mtpt -135.73 147.61 48.51 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.416 HG22 ' CE1' ' A' ' 32' ' ' PHE . 69.6 t -126.53 117.23 47.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.169 0.509 . . . . 0.0 110.264 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.72 121.42 32.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.758 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.85 159.13 30.06 Favored Glycine 0 N--CA 1.42 -2.398 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.17 58.74 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.358 0.599 . . . . 0.0 111.679 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.76 -12.38 60.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.429 0.633 . . . . 0.0 110.499 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 8.46 57.67 Favored Glycine 0 C--N 1.321 -0.28 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.807 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -99.28 159.57 14.9 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.66 135.46 30.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-O 121.483 0.658 . . . . 0.0 111.274 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 14.6 p -104.98 138.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.063 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -108.78 125.62 52.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.465 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 15.7 p90 -147.29 168.82 20.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.228 0.537 . . . . 0.0 111.446 -174.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -112.26 141.18 46.28 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.056 0.455 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 tt -148.2 148.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.088 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.5 mtmm -85.05 157.79 20.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.762 -0.586 . . . . 0.0 110.418 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.451 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 17.3 mmm-85 -64.28 -41.18 97.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.501 . . . . 0.0 110.803 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -89.92 7.42 37.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.421 0.629 . . . . 0.0 110.461 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 19.1 m -93.94 130.27 35.12 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 148.57 91.13 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.818 2.345 . . . . 0.0 113.123 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.424 ' CD2' HD13 ' A' ' 43' ' ' LEU . 82.6 mt -62.76 -12.28 23.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.513 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 12.8 t -52.03 -43.79 63.88 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.609 0.364 . . . . 0.0 111.065 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.549 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.465 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 2.6 tt -62.28 -51.33 68.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.35 178.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.581 ' SD ' ' HB3' ' A' ' 69' ' ' GLU . 36.4 mtt -61.86 -40.17 94.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.377 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.3 tppp? -66.71 -44.32 81.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.51 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.54 -51.58 66.58 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.11 -40.42 95.85 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.003 0.43 . . . . 0.0 111.111 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -42.01 96.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.2 mm-40 -65.21 -39.65 93.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.852 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.8 mmp_? -65.61 -54.2 31.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.188 0.518 . . . . 0.0 111.51 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -21.41 59.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.184 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.08 87.74 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -86.99 177.45 7.23 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.404 -0.468 . . . . 0.0 110.734 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 m -100.25 128.05 46.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.641 0.258 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.44 ' HE3' ' HE3' ' A' ' 45' ' ' LYS . 3.1 ptp -64.35 -24.25 67.58 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.547 . . . . 0.0 111.247 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -77.67 -14.71 59.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.53 . . . . 0.0 110.778 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -99.85 1.0 42.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.156 0.503 . . . . 0.0 111.23 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.416 HG21 ' HG2' ' A' ' 88' ' ' GLN . 29.9 pt -130.71 173.03 15.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 22.0 mmm180 -141.12 149.83 42.06 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.741 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-85 -114.34 132.17 56.28 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.544 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.6 ppt_? -134.25 140.5 46.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 0.0 110.993 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -139.51 138.21 36.15 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.707 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.47 33.82 21.77 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.175 0.512 . . . . 0.0 112.107 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.1 -6.32 67.79 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.758 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.23 145.18 37.81 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 122.13 -0.629 . . . . 0.0 111.045 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.05 151.61 35.1 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.386 2.057 . . . . 0.0 111.179 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.44 141.33 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.458 0.647 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 154.2 17.36 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.581 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.4 pt-20 -62.17 -16.34 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.2 p -79.55 -18.63 51.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.203 0.525 . . . . 0.0 110.874 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.438 ' OD2' ' HG2' ' A' ' 75' ' ' GLN . 0.3 OUTLIER -83.08 161.2 21.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.1 p -117.16 158.42 44.45 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.722 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -68.27 -8.66 23.56 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.113 1.875 . . . . 0.0 111.529 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 36' ' ' ARG . . . -95.38 -19.56 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.609 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.438 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 3.0 tp-100 -62.45 -36.31 82.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.42 0.628 . . . . 0.0 110.307 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.54 -0.3 20.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 51.05 63.09 2.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.507 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.638 ' SD ' HD13 ' A' ' 20' ' ' LEU . 12.1 ptp -77.44 175.47 9.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.825 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -96.19 157.84 15.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.39 143.32 48.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.438 0.637 . . . . 0.0 111.17 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 69.93 20.19 6.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.06 176.92 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.415 ' C ' HD11 ' A' ' 84' ' ' ILE . 1.4 m -133.43 151.58 51.82 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.415 HD11 ' C ' ' A' ' 83' ' ' THR . 3.2 mp -124.19 142.51 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 30.0 t70 -89.42 136.83 32.8 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.2 137.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.631 0.729 . . . . 0.0 110.691 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -138.22 149.11 45.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.703 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.416 ' HG2' HG21 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -107.49 110.26 22.14 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -121.54 116.12 24.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.571 0.7 . . . . 0.0 112.29 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.07 -83.25 0.31 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.129 174.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.0 p -147.27 136.86 22.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.23 106.31 0.2 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.917 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.288 0 CA-C-O 118.56 -1.134 . . . . 0.0 111.766 -179.13 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 121.045 0.45 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.04 139.8 31.49 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.131 0.491 . . . . 0.0 110.822 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -94.07 11.53 29.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.449 0.642 . . . . 0.0 110.461 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -110.66 99.1 8.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.237 0.542 . . . . 0.0 110.785 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -148.83 89.85 4.91 Favored Pre-proline 0 C--N 1.322 -0.595 0 O-C-N 121.871 -0.518 . . . . 0.0 110.396 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.39 135.7 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.783 2.322 . . . . 0.0 111.094 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -99.87 20.08 14.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.447 0.641 . . . . 0.0 110.649 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.58 171.6 14.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.158 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.44 -65.84 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.569 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.523 HG21 ' OD1' ' A' ' 14' ' ' ASN . 11.3 p -110.77 140.51 29.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.155 0.503 . . . . 0.0 111.475 -177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -63.62 -69.96 0.24 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.624 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -85.84 150.97 24.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.158 0.504 . . . . 0.0 111.167 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.76 114.72 4.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.523 ' OD1' HG21 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -126.83 119.16 26.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.257 0.551 . . . . 0.0 110.646 172.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -175.26 164.14 3.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -22.55 124.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 124.439 1.087 . . . . 0.0 112.032 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.601 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 23.7 p-80 -141.81 179.2 6.99 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.28 -173.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.05 169.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.516 0.674 . . . . 0.0 112.756 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' HD22 ' A' ' 20' ' ' LEU . 9.5 m-80 -99.35 139.91 34.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.43 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -131.69 159.91 37.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.211 0.529 . . . . 0.0 110.296 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -134.53 148.39 50.5 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.414 HG23 ' CE1' ' A' ' 32' ' ' PHE . 70.2 t -126.64 117.19 47.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.163 0.506 . . . . 0.0 109.986 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.14 119.29 31.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.95 158.33 30.41 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.2 pp0? -66.24 -10.51 42.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.506 0.67 . . . . 0.0 110.886 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -76.53 -15.5 59.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.329 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 14.23 37.16 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.543 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t -119.59 166.25 13.39 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.23 137.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.171 0.51 . . . . 0.0 111.282 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 96.6 t -102.95 139.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.904 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -110.24 130.33 55.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.414 ' CE1' HG23 ' A' ' 22' ' ' VAL . 6.0 p90 -150.86 168.91 23.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.181 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -117.27 133.98 55.34 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.601 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 16.9 tt -135.2 150.1 29.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.577 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 12.8 mttt -86.92 151.44 23.3 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.082 0.468 . . . . 0.0 110.847 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -61.72 -40.1 93.86 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.241 0.543 . . . . 0.0 110.805 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -87.73 6.17 36.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.289 0.566 . . . . 0.0 111.353 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.4 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.6 m -96.81 131.77 27.32 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.459 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.84 154.89 71.84 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.931 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' CD2' HD12 ' A' ' 43' ' ' LEU . 95.4 mt -66.76 -11.25 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.771 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.4 p -50.74 -47.43 59.34 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.948 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.485 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 40' ' ' LEU . 3.1 tt -61.01 -47.95 84.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.306 0.574 . . . . 0.0 110.331 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.635 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -60.81 -50.36 73.76 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.402 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.674 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 18.3 tppt? -60.84 -43.1 98.74 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.84 -52.79 61.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.047 0.451 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -61.03 -43.96 98.11 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.333 0.587 . . . . 0.0 110.503 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.53 ' SG ' HD12 ' A' ' 58' ' ' ILE . 73.4 m -61.02 -39.79 91.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.545 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.674 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.0 mt-10 -66.65 -33.82 76.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.054 0.454 . . . . 0.0 110.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.8 mmm180 -67.65 -48.74 65.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.143 0.497 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -22.7 39.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.069 0.461 . . . . 0.0 111.533 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.23 72.6 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.023 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.73 177.01 6.85 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.177 -0.602 . . . . 0.0 112.266 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.8 m -99.89 140.24 34.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.45 -25.9 66.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.407 ' HG3' HE21 ' A' ' 57' ' ' GLN . 15.2 ptp180 -75.53 -10.7 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.159 0.504 . . . . 0.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.407 HE21 ' HG3' ' A' ' 56' ' ' ARG . 21.9 mm-40 -101.41 4.32 41.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 0.0 110.933 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.53 HD12 ' SG ' ' A' ' 48' ' ' CYS . 31.3 pt -139.92 174.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.289 0.566 . . . . 0.0 111.701 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -141.25 145.02 35.02 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.635 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.7 m-85 -113.43 131.57 55.97 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.673 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.59 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.53 141.78 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.589 . . . . 0.0 111.209 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -145.5 142.76 29.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.353 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 t70 60.64 25.67 15.4 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 120.96 0.409 . . . . 0.0 110.998 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.45 72.28 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.094 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -120.34 145.11 39.68 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.165 -0.609 . . . . 0.0 111.426 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.73 147.9 40.67 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 122.371 2.047 . . . . 0.0 111.181 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.05 136.52 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.255 0.55 . . . . 0.0 111.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.51 152.17 18.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.04 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.726 ' OE2' HG21 ' A' ' 70' ' ' THR . 0.2 OUTLIER -53.46 -21.48 6.24 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.726 HG21 ' OE2' ' A' ' 69' ' ' GLU . 40.6 p -74.16 -15.6 61.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.341 0.591 . . . . 0.0 111.661 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.416 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 55.9 m-20 -85.99 159.25 19.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -119.8 155.4 54.96 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.62 -7.64 19.95 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 112.336 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.432 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -94.88 -28.19 15.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.945 0.402 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -60.96 -39.62 90.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.5 . . . . 0.0 111.478 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.7 0.76 33.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 50.98 61.0 3.47 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.153 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.548 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.8 ptp -77.02 168.97 19.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -88.02 164.98 15.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.974 0.416 . . . . 0.0 110.169 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.24 141.37 31.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.626 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 73.67 14.4 4.21 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.074 0.95 . . . . 0.0 110.649 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.96 175.51 3.66 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.421 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -133.69 150.62 51.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.272 0.558 . . . . 0.0 111.193 -176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mp -120.94 144.81 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.59 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 38.7 t70 -92.17 134.31 34.98 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.077 0.465 . . . . 0.0 110.775 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.52 135.21 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.809 0.814 . . . . 0.0 111.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -138.61 149.5 45.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.163 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' HG2' HG21 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -110.71 110.48 21.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.452 0.644 . . . . 0.0 110.63 -177.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -82.94 75.7 9.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.271 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -127.09 104.82 8.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.737 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -164.82 165.82 20.23 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.67 -46.44 61.55 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.752 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.548 -1.14 . . . . 0.0 112.172 178.024 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -43.11 107.12 0.08 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.368 0.604 . . . . 0.0 111.901 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -115.64 30.97 7.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.846 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.83 -26.56 65.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.329 0.585 . . . . 0.0 110.369 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -138.62 92.37 11.58 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.79 170.56 16.32 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.597 2.198 . . . . 0.0 112.237 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -104.02 7.18 36.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.986 0.898 . . . . 0.0 108.95 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.91 166.17 25.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.147 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.04 60.37 0.36 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.489 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -127.31 104.09 11.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.879 0.847 . . . . 0.0 111.293 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -104.82 -35.67 7.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.631 0.729 . . . . 0.0 109.873 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.0 161.94 37.46 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.185 -177.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 44.4 mt-10 -126.18 174.4 8.53 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.976 -0.452 . . . . 0.0 111.365 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 62.3 m-80 80.25 10.49 1.19 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 124.272 1.029 . . . . 0.0 111.556 177.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.32 -73.56 0.25 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.041 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -105.63 124.62 49.85 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.445 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 36.1 p-80 -173.4 -178.82 1.76 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.39 170.05 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.133 0.492 . . . . 0.0 110.639 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.518 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.9 m-80 -100.22 144.87 28.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.518 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -133.43 162.68 31.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.094 0.473 . . . . 0.0 110.483 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' THR . 58.5 mtpt -137.39 147.5 45.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.407 HG21 ' CE1' ' A' ' 32' ' ' PHE . 76.3 t -125.17 120.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.951 0.405 . . . . 0.0 110.411 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.28 122.54 38.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.597 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' HA3' ' HH ' ' A' ' 47' ' ' TYR . . . -89.0 160.8 30.03 Favored Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.136 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -21.1 65.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.428 0.632 . . . . 0.0 111.022 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.44 -16.5 62.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.477 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.04 49.93 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.675 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 t -101.91 157.54 16.78 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 8.2 p -139.99 137.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 11.4 p -109.43 142.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.85 127.01 56.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.323 0.582 . . . . 0.0 109.542 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' CE1' HG21 ' A' ' 22' ' ' VAL . 13.4 p90 -151.04 168.73 23.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.284 0.564 . . . . 0.0 111.561 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -112.51 142.86 44.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.697 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.417 ' CG2' HD21 ' A' ' 20' ' ' LEU . 16.1 tt -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.078 0.466 . . . . 0.0 110.192 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.488 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.4 mtmt -83.97 158.45 21.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.874 -0.516 . . . . 0.0 110.738 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 26.1 mmm-85 -65.45 -38.98 91.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 110.485 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.4 6.86 43.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.313 0.578 . . . . 0.0 110.538 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.0 m -93.93 130.03 35.9 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.78 151.16 85.13 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.886 2.39 . . . . 0.0 112.89 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 43' ' ' LEU . 86.8 mt -64.26 -11.77 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 p -51.51 -45.11 62.76 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.924 0.392 . . . . 0.0 111.364 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.489 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.423 HD11 ' CD2' ' A' ' 40' ' ' LEU . 3.0 tt -62.5 -48.64 78.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.21 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 69' ' ' GLU . 30.1 mtt -61.54 -41.8 97.88 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.709 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 18.1 tppt? -68.13 -41.59 81.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -47.45 85.82 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.15 0.5 . . . . 0.0 110.957 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.443 ' HH ' ' HA3' ' A' ' 24' ' ' GLY . 42.1 t80 -65.01 -40.19 94.52 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.248 0.547 . . . . 0.0 110.693 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.709 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.97 -36.7 80.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.277 -177.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' HG2' ' HG ' ' A' ' 48' ' ' CYS . 10.2 mm-40 -74.46 -39.74 62.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.229 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.413 ' HG3' HG23 ' A' ' 30' ' ' VAL . 17.0 mmt180 -64.04 -46.8 82.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.217 0.532 . . . . 0.0 111.437 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.46 -16.64 51.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.58 57.28 5.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.535 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.44 175.58 10.7 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.749 0.309 . . . . 0.0 110.253 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.453 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 58.3 m -99.93 132.2 45.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.762 0.315 . . . . 0.0 110.984 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.9 ptp -63.74 -26.05 68.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 111.088 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.453 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 7.6 ptm180 -74.72 -13.38 60.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.999 0.428 . . . . 0.0 111.347 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -103.25 6.92 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.143 0.497 . . . . 0.0 111.381 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.452 HG23 ' HG2' ' A' ' 88' ' ' GLN . 23.2 pt -133.36 170.31 20.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.122 0.487 . . . . 0.0 111.241 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 6.7 mmm180 -138.1 140.2 39.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.397 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.3 m-85 -108.75 131.36 55.02 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.454 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 5.4 ppt_? -131.69 140.93 49.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -141.75 138.8 32.58 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.5 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.94 28.78 18.34 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.45 -3.57 77.4 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.545 -1.312 . . . . 0.0 113.316 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -123.45 144.89 45.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 O-C-N 121.899 -0.765 . . . . 0.0 111.637 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.57 150.44 40.38 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.665 2.244 . . . . 0.0 112.014 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 138.95 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 121.713 0.768 . . . . 0.0 111.267 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.47 154.91 18.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.589 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.596 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.6 pt-20 -62.49 -18.29 61.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.097 0.475 . . . . 0.0 112.227 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -79.63 -14.77 58.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.288 0.566 . . . . 0.0 111.283 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.2 158.61 21.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.001 0.429 . . . . 0.0 110.151 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 p -118.69 151.58 50.16 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.512 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.43 -9.05 18.75 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.47 2.113 . . . . 0.0 112.111 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.68 -20.46 18.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.424 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -69.68 -36.14 75.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.144 0.497 . . . . 0.0 110.814 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.49 -0.34 24.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.344 0.592 . . . . 0.0 110.224 178.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 48.95 62.5 2.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.9 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.429 ' SD ' HD13 ' A' ' 20' ' ' LEU . 9.6 ptp -74.3 166.62 23.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.09 176.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 39.1 tt0 -87.75 157.02 19.15 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.114 0.483 . . . . 0.0 110.849 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -72.81 139.4 47.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.118 0.485 . . . . 0.0 110.066 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 71.13 15.93 6.42 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.069 0.948 . . . . 0.0 110.594 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -70.37 176.68 3.82 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.448 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -130.14 147.26 51.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.4 0.619 . . . . 0.0 111.45 -177.207 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.407 HD11 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.82 133.97 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.454 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 2.5 m-20 -86.31 136.31 33.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.045 0.45 . . . . 0.0 111.088 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -123.87 140.36 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.382 0.611 . . . . 0.0 111.145 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.66 147.01 44.54 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.588 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.452 ' HG2' HG23 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -105.15 111.48 24.26 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.36 0.6 . . . . 0.0 111.107 -176.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -130.43 121.32 25.67 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.868 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.41 -59.66 2.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.962 0.411 . . . . 0.0 110.543 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 m 59.74 67.97 0.83 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.615 0.721 . . . . 0.0 110.168 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.3 -47.95 3.84 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.289 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.155 0 CA-C-O 118.305 -1.275 . . . . 0.0 111.863 -179.931 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.75 0.309 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.4 133.99 43.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.956 0.408 . . . . 0.0 111.141 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -112.34 38.78 2.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.087 0.946 . . . . 0.0 109.694 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.4 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 48.3 mt-10 -139.79 150.06 44.27 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' HB3' ' CD ' ' A' ' 6' ' ' PRO . 19.9 ttmm -48.01 -53.61 31.26 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.448 176.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.456 ' CD ' ' HB3' ' A' ' 5' ' ' LYS . 72.7 Cg_endo -74.17 163.0 37.6 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.88 1.72 . . . . 0.0 111.33 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -93.83 -16.45 24.09 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.39 0.614 . . . . 0.0 110.321 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.35 22.57 1.23 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.333 0.587 . . . . 0.0 111.29 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 -22.79 49.98 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.08 141.4 20.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.201 -0.499 . . . . 0.0 110.202 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -117.17 -69.7 0.84 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.299 0.571 . . . . 0.0 110.551 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -143.68 137.26 28.1 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.651 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -141.76 91.69 2.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.582 0.706 . . . . 0.0 111.498 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -124.15 16.4 9.16 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 122.003 0.906 . . . . 0.0 108.84 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -108.2 15.83 23.8 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.058 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.5 89.37 0.23 Allowed 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.454 0.645 . . . . 0.0 110.741 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.502 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 36.5 p-80 -137.92 174.65 10.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 120.999 0.428 . . . . 0.0 110.312 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.5 pt -128.59 169.08 20.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.332 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.497 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.9 m-80 -97.46 144.61 27.02 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.547 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -132.75 160.77 35.86 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.292 0.568 . . . . 0.0 110.779 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.8 mtpt -136.11 148.84 48.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.789 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.8 t -129.16 116.6 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 120.955 0.407 . . . . 0.0 110.171 179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.54 128.03 35.55 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.9 156.87 22.59 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -64.45 -11.55 34.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.493 0.663 . . . . 0.0 110.879 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.55 -19.29 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.211 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 9.36 36.33 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.297 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 t -113.45 157.36 22.05 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 122.296 -0.532 . . . . 0.0 109.899 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.44 135.02 58.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.425 0.631 . . . . 0.0 111.258 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 50' ' ' ARG . 14.4 p -101.78 142.09 16.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 122.118 -0.364 . . . . 0.0 110.263 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -112.03 130.93 55.7 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.107 0.48 . . . . 0.0 109.73 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -151.37 168.37 25.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.438 -175.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.48 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 41.8 mtmt -113.87 136.5 52.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.862 0.363 . . . . 0.0 110.818 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.494 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tt -142.62 147.09 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.049 0.452 . . . . 0.0 110.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 27.1 mtmm -85.14 157.62 20.62 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 121.083 0.468 . . . . 0.0 111.376 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.486 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -63.16 -41.52 99.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.704 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -88.73 6.86 36.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.322 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.456 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 13.6 m -93.99 130.12 35.51 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.87 151.32 84.49 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.696 2.264 . . . . 0.0 112.655 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.458 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 87.3 mt -66.64 -13.19 60.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.296 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.4 m -47.92 -44.34 29.76 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.518 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.451 HD11 ' CD2' ' A' ' 40' ' ' LEU . 4.0 tt -61.73 -51.67 67.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.789 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.458 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -58.51 -50.24 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.963 0.411 . . . . 0.0 110.601 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.7 tppp? -62.82 -37.92 88.69 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.402 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.609 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.25 -49.8 76.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.451 . . . . 0.0 110.531 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.05 -40.5 96.43 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.025 0.441 . . . . 0.0 111.036 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.589 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.1 m -63.15 -34.98 78.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 110.997 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.5 mm-40 -71.55 -41.79 68.68 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.789 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.6 mmp_? -66.48 -47.15 73.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.353 0.597 . . . . 0.0 111.303 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.16 -16.61 52.42 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.895 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.78 57.77 5.2 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.606 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.92 173.6 12.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.666 -0.314 . . . . 0.0 110.425 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -98.87 133.73 42.74 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.756 0.312 . . . . 0.0 111.698 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.476 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 9.5 ptp -65.06 -26.36 68.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.078 0.466 . . . . 0.0 111.269 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -74.66 -6.24 47.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.238 0.542 . . . . 0.0 110.836 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -109.35 5.17 23.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.932 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.589 HD11 ' SG ' ' A' ' 48' ' ' CYS . 25.7 pt -137.19 171.99 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.188 0.518 . . . . 0.0 111.177 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 24.2 mmt180 -142.6 147.91 36.61 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.265 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.408 ' HB3' HG22 ' A' ' 84' ' ' ILE . 9.0 m-85 -114.28 128.22 56.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.121 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.589 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.8 ppt_? -130.26 136.8 49.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -138.69 133.14 31.92 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.548 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 65.06 26.3 12.58 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.064 0.459 . . . . 0.0 110.57 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.85 -5.13 76.94 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.242 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.05 142.91 34.31 Favored Pre-proline 0 C--N 1.322 -0.603 0 O-C-N 122.054 -0.674 . . . . 0.0 111.381 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 144.55 29.76 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.538 2.159 . . . . 0.0 111.955 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.62 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.589 0.709 . . . . 0.0 110.674 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.21 156.84 18.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.96 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -57.37 -26.49 61.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.134 0.492 . . . . 0.0 112.176 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.2 p -74.29 -17.2 60.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.072 0.463 . . . . 0.0 111.223 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -78.87 158.4 28.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.195 0.521 . . . . 0.0 111.005 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -117.33 153.11 49.97 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.69 -7.35 19.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.449 2.099 . . . . 0.0 112.018 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.486 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.23 -23.06 17.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.095 0.474 . . . . 0.0 110.608 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -62.54 -39.46 93.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.391 0.615 . . . . 0.0 110.561 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.441 ' N ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.71 1.48 23.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.863 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 49.16 62.65 2.5 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.658 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.547 ' SD ' HD13 ' A' ' 20' ' ' LEU . 9.3 ptp -76.23 170.44 16.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -88.06 163.91 16.01 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.394 0.616 . . . . 0.0 111.237 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.46 138.83 34.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 72.36 13.46 5.55 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.963 0.905 . . . . 0.0 110.246 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.08 172.8 5.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.92 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' HD13 ' A' ' 84' ' ' ILE . 2.1 m -132.1 151.56 51.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.281 0.562 . . . . 0.0 111.355 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.418 HD13 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -123.85 141.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.589 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 31.8 t70 -90.82 132.32 35.95 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.907 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -116.19 134.58 59.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.555 0.693 . . . . 0.0 110.917 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -141.93 153.24 44.21 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.486 ' HG2' HG23 ' A' ' 58' ' ' ILE . 91.0 mt-30 -107.79 108.64 19.93 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -126.79 15.0 7.5 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.17 135.93 53.65 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.658 -0.651 . . . . 0.0 110.026 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -106.71 -22.75 12.63 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.757 0.789 . . . . 0.0 109.725 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.57 -136.27 2.46 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.544 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.108 0 CA-C-O 118.363 -1.243 . . . . 0.0 111.394 -178.41 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 1' ' ' MET . 25.0 ttt . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.769 0.795 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.1 107.23 17.46 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.964 -0.46 . . . . 0.0 110.079 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -84.98 -29.18 25.27 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 121.748 0.785 . . . . 0.0 109.509 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 62.65 54.55 2.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.063 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 62.9 mttm -73.1 -50.71 6.47 Favored Pre-proline 0 CA--C 1.539 0.537 0 O-C-N 122.203 -0.31 . . . . 0.0 111.081 176.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 6.3 Cg_exo -80.32 142.76 15.16 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 121.823 1.682 . . . . 0.0 110.828 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -85.17 61.16 6.7 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.554 0.692 . . . . 0.0 110.337 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.3 98.69 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.263 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.9 28.38 0.04 OUTLIER Glycine 0 C--N 1.309 -0.943 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.511 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 m -132.68 -177.73 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -57.5 -67.15 0.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.571 . . . . 0.0 111.172 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -124.06 87.69 2.78 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.301 0.572 . . . . 0.0 109.907 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.09 152.01 38.36 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.999 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.51 122.43 38.23 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -126.49 -170.63 2.23 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.672 0.749 . . . . 0.0 111.975 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.36 118.76 13.58 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.45 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 51.7 p-80 -157.69 167.57 29.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -175.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.5 pt -121.07 168.94 12.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.451 0.643 . . . . 0.0 111.657 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' O ' HD21 ' A' ' 20' ' ' LEU . 21.7 m-80 -100.47 141.7 32.97 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.751 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.557 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.56 162.78 30.98 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.042 0.449 . . . . 0.0 110.446 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.66 149.04 49.18 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.24 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.438 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.5 t -127.36 115.6 40.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.53 118.36 29.93 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.058 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.0 156.96 30.36 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.409 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.1 pp0? -63.54 -15.44 58.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.02 -17.49 61.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.763 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.57 36.43 Favored Glycine 0 C--O 1.229 -0.178 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 t -112.41 161.72 16.37 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -138.09 136.84 44.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.452 0.644 . . . . 0.0 110.713 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 87.5 t -102.58 135.03 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -109.59 126.74 53.92 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.438 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -148.18 168.15 23.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.408 0.623 . . . . 0.0 111.755 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 38.2 mtmt -115.53 134.6 54.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.302 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.416 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 17.6 tt -139.07 149.82 23.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.6 mtmp? -87.78 155.93 19.66 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.907 -0.496 . . . . 0.0 111.187 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.9 mmm-85 -63.72 -34.69 78.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -177.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -96.41 6.53 48.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 110.781 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.9 m -93.65 130.79 33.95 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.49 151.65 79.65 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.717 2.278 . . . . 0.0 112.122 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 33.3 mt -65.61 -11.37 43.81 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.108 -0.497 . . . . 0.0 112.32 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 15.8 p -48.91 -42.34 36.67 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.061 0.457 . . . . 0.0 111.047 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.51 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.467 HD13 HD22 ' A' ' 40' ' ' LEU . 4.3 tt -61.72 -53.35 57.26 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.473 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.412 ' N ' HD22 ' A' ' 43' ' ' LEU . 2.0 mpt? -59.72 -39.85 86.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.113 0.482 . . . . 0.0 110.589 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.8 tppp? -70.12 -40.72 74.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.024 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.9 75.66 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 110.336 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -65.44 -39.43 92.05 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.67 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.01 -38.67 86.87 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.792 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 41.8 mm-40 -67.04 -46.21 75.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.346 0.593 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -59.77 -47.68 84.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.755 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.34 -21.38 30.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.971 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.8 90.13 Favored Glycine 0 C--N 1.322 -0.246 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.647 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -87.39 177.22 7.18 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.995 0.426 . . . . 0.0 111.633 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 43.8 m -95.34 130.38 42.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 ptp -65.17 -24.78 67.48 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.213 0.53 . . . . 0.0 111.341 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -79.37 -12.48 59.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.361 0.6 . . . . 0.0 111.118 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 26.3 mm-40 -98.72 8.24 45.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.476 0.655 . . . . 0.0 111.013 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.452 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.4 pt -137.47 174.78 10.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.803 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 26.8 mmt180 -139.77 146.31 39.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.598 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.409 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 16.8 m-85 -115.26 128.09 55.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.32 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.569 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.0 ppt_? -132.02 134.22 45.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.498 0.665 . . . . 0.0 110.866 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -128.09 131.99 49.03 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.224 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.4 31.56 7.41 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.74 83.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -124.19 136.09 27.2 Favored Pre-proline 0 C--N 1.323 -0.562 0 O-C-N 121.95 -0.735 . . . . 0.0 111.576 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.16 146.16 45.61 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.948 2.432 . . . . 0.0 111.944 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.42 136.03 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 111.714 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.97 157.69 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.613 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.448 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 4.3 pt-20 -62.87 -18.45 62.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.263 0.554 . . . . 0.0 112.198 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.7 p -80.86 -11.4 59.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.082 0.468 . . . . 0.0 111.266 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -87.52 160.02 18.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.88 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 p -117.35 155.21 50.24 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.575 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.13 -12.86 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.31 2.007 . . . . 0.0 112.163 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.85 -16.99 21.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.188 0.518 . . . . 0.0 110.861 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.28 -34.55 76.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.405 0.621 . . . . 0.0 110.666 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.19 0.96 21.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.336 0.589 . . . . 0.0 110.413 177.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 50.67 59.52 4.53 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.367 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.557 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.84 170.37 15.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.08 0.467 . . . . 0.0 110.043 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -95.13 162.77 13.57 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.027 0.442 . . . . 0.0 110.532 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.27 137.37 41.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.153 0.502 . . . . 0.0 110.491 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 75.19 16.25 2.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.65 177.25 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.8 m -135.18 151.68 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.15 0.5 . . . . 0.0 111.216 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.9 142.69 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.9 t70 -93.06 132.95 36.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.027 0.442 . . . . 0.0 110.838 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.9 t -116.15 132.55 65.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.84 0.828 . . . . 0.0 111.49 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -135.33 143.29 46.07 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.634 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.452 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -110.38 111.87 23.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.143 0.497 . . . . 0.0 110.616 -176.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -107.17 82.3 1.66 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -168.81 103.02 0.4 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.349 0.595 . . . . 0.0 112.294 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -60.21 107.73 0.69 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.111 0.481 . . . . 0.0 110.971 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.96 56.42 0.48 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.733 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.622 -179.132 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.112 0.482 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.16 106.36 6.02 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.088 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -118.62 11.99 12.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.225 0.536 . . . . 0.0 110.286 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.71 -71.41 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.078 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 54.73 74.08 0.79 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.159 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.31 164.71 29.49 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.692 2.261 . . . . 0.0 112.876 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -83.32 -39.8 20.31 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.453 0.644 . . . . 0.0 109.786 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.24 159.42 12.76 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.78 57.97 4.07 Favored Glycine 0 C--N 1.316 -0.538 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.004 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.06 135.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.322 0.582 . . . . 0.0 110.397 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -97.81 136.06 38.68 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -44.75 133.79 5.89 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.575 0.702 . . . . 0.0 111.336 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -88.19 177.82 6.79 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.236 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.41 140.31 58.86 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.868 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -94.56 79.47 3.82 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.522 0.677 . . . . 0.0 111.002 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -100.89 -169.41 1.7 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.023 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 41.2 p-80 -139.27 161.17 38.09 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.629 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 pt -110.74 169.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.542 0.686 . . . . 0.0 112.655 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.437 ' O ' HD23 ' A' ' 20' ' ' LEU . 25.1 m-80 -94.66 140.91 29.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.589 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.63 HD12 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -129.8 159.66 35.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.7 mtpt -134.52 147.17 50.27 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 77.4 t -127.74 116.94 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.118 0.485 . . . . 0.0 110.372 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.62 31.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.591 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.03 162.25 32.36 Favored Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.201 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -16.42 63.87 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.734 0.778 . . . . 0.0 110.571 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.25 -19.45 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.98 7.87 54.72 Favored Glycine 0 C--N 1.323 -0.166 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.263 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -108.39 165.03 11.82 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.269 0.557 . . . . 0.0 110.674 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 10.0 p -106.32 139.62 27.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.19 124.83 53.45 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -147.75 167.78 23.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -114.7 138.49 50.64 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.445 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -144.18 148.65 18.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 110.586 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.1 mtmp? -81.07 154.88 26.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.969 0.414 . . . . 0.0 110.627 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 24.3 mmm-85 -66.14 -37.47 85.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.223 0.535 . . . . 0.0 110.562 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -90.24 6.79 41.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.584 0.707 . . . . 0.0 110.49 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.7 m -94.71 131.52 30.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.79 149.94 86.4 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.804 2.336 . . . . 0.0 113.009 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' CD2' HD11 ' A' ' 43' ' ' LEU . 78.0 mt -64.56 -12.02 40.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.452 0.701 . . . . 0.0 112.132 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.0 t -52.07 -46.54 65.21 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.477 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.432 HD11 ' CD2' ' A' ' 40' ' ' LEU . 2.9 tt -61.95 -49.06 77.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.306 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.66 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -58.81 -49.47 77.56 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.101 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.2 tppt? -60.03 -43.0 95.61 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.33 -49.92 72.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.042 0.449 . . . . 0.0 110.95 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -64.17 -41.11 97.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.593 ' SG ' HD12 ' A' ' 58' ' ' ILE . 73.4 m -63.72 -33.94 76.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.515 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.8 mm-40 -71.6 -40.86 69.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.23 0.538 . . . . 0.0 110.177 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.2 mmm180 -66.21 -46.69 76.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -22.11 42.25 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.009 0.433 . . . . 0.0 111.436 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.35 58.47 3.61 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.144 -1.026 . . . . 0.0 111.773 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.41 176.06 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.57 -0.37 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -95.4 130.31 42.24 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.821 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.564 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 4.2 ptp -64.5 -21.41 66.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.085 0.469 . . . . 0.0 111.84 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -83.19 -6.72 59.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 0.0 111.274 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.345 0.593 . . . . 0.0 110.725 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.593 HD12 ' SG ' ' A' ' 48' ' ' CYS . 28.8 pt -136.56 170.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 18.0 mmm180 -141.22 143.01 33.93 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.66 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.6 m-85 -110.1 134.39 52.22 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.57 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.556 ' CG ' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.295 0.569 . . . . 0.0 110.599 178.005 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -140.78 139.27 34.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.6 31.09 16.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.07 -4.09 72.99 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.943 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -119.65 140.15 28.98 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 121.955 -0.733 . . . . 0.0 111.358 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.16 146.15 45.62 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.486 2.124 . . . . 0.0 111.641 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.18 135.84 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 121.605 0.716 . . . . 0.0 111.049 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.06 155.93 18.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.335 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -61.9 -19.93 63.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.268 0.556 . . . . 0.0 111.965 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.1 p -80.2 -10.43 59.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.82 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.39 161.11 17.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 p -118.09 153.7 51.38 Favored Pre-proline 0 C--N 1.32 -0.682 0 O-C-N 122.371 -0.206 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -63.99 -10.67 23.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.653 2.235 . . . . 0.0 112.328 178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -95.24 -17.87 21.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.071 0.462 . . . . 0.0 110.962 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -35.55 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 110.855 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.446 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.03 1.96 24.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 110.77 179.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 52.39 61.71 3.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.697 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.63 ' SD ' HD12 ' A' ' 20' ' ' LEU . 11.7 ptp -80.29 174.33 11.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.134 -0.354 . . . . 0.0 110.331 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -99.76 169.68 9.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.238 0.542 . . . . 0.0 111.091 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.57 138.56 36.48 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 74.32 12.37 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.056 0.942 . . . . 0.0 111.426 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.63 174.89 3.18 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.5 m -135.33 150.19 49.92 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.363 0.601 . . . . 0.0 111.536 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 61' ' ' ARG . 3.1 mp -121.32 144.33 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.556 ' HB3' ' CG ' ' A' ' 61' ' ' ARG . 25.4 t0 -92.63 138.56 31.39 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.49 137.78 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.571 0.701 . . . . 0.0 110.706 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.407 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 1.7 p90 -134.94 143.3 46.82 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.561 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.422 ' HG2' HG23 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -97.13 111.09 23.48 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.872 -178.127 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -56.25 156.18 6.0 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.673 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -78.23 161.89 26.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.36 0.6 . . . . 0.0 111.306 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 p -83.83 -10.93 57.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.525 0.679 . . . . 0.0 110.494 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.17 -178.34 19.32 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.447 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.387 0 CA-C-O 118.72 -1.044 . . . . 0.0 111.377 179.362 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.989 0.423 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.54 97.09 5.62 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.269 0.557 . . . . 0.0 110.976 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.95 -12.04 42.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.599 0.714 . . . . 0.0 110.627 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -98.68 31.53 2.88 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.701 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -66.48 -47.65 57.62 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.797 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.54 141.4 34.6 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 121.471 1.447 . . . . 0.0 111.846 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -102.87 22.79 13.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.825 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.64 129.16 39.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.202 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.75 57.98 5.03 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.113 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.413 ' CG1' ' HG2' ' A' ' 13' ' ' GLU . 14.3 t -104.18 150.86 7.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -126.95 -34.49 2.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.179 0.514 . . . . 0.0 111.076 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 t -85.09 22.16 1.49 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.855 0.836 . . . . 0.0 111.497 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.413 ' HG2' ' CG1' ' A' ' 10' ' ' VAL . 34.5 mm-40 -58.94 -71.63 0.11 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.173 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.82 25.1 15.01 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.165 0.507 . . . . 0.0 112.02 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -69.56 120.72 15.77 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.372 0.605 . . . . 0.0 109.652 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -161.35 -174.28 4.22 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.0 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.531 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 57.2 p-80 -132.75 153.93 50.72 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.6 pt -111.9 169.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.407 0.622 . . . . 0.0 111.666 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.2 m-80 -97.47 143.4 28.23 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.39 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.519 HD12 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -132.05 162.11 31.58 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.081 0.467 . . . . 0.0 110.054 177.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.4 mtpt -133.94 147.42 51.06 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.071 0.462 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG22 ' CE1' ' A' ' 32' ' ' PHE . 81.1 t -127.99 117.85 47.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.87 122.15 34.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.1 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.04 157.84 28.66 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -66.42 -11.97 54.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.281 0.562 . . . . 0.0 111.242 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.61 -16.56 57.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.289 0.566 . . . . 0.0 110.51 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.73 11.28 30.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.435 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.7 t -111.34 159.07 18.32 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 122.2 -0.588 . . . . 0.0 109.516 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.33 136.17 46.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.269 0.557 . . . . 0.0 110.541 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 90.5 t -103.19 137.58 30.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.225 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -111.41 123.19 49.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.427 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 10.5 p90 -146.5 168.58 20.86 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.181 0.515 . . . . 0.0 111.275 -174.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -112.96 140.36 47.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.081 0.467 . . . . 0.0 111.07 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.85 146.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 110.435 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 30.6 mtmt -81.72 157.67 24.49 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 24.5 mmm-85 -65.18 -38.93 92.07 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.813 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -90.62 6.21 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.585 0.707 . . . . 0.0 110.348 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 21.3 m -94.32 129.94 35.46 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.8 152.18 82.26 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.869 2.379 . . . . 0.0 113.036 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' CD2' HD11 ' A' ' 43' ' ' LEU . 84.0 mt -64.84 -12.03 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.444 0.698 . . . . 0.0 111.884 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.1 p -51.16 -46.9 62.2 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.082 0.467 . . . . 0.0 111.076 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.508 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD22 ' N ' ' A' ' 44' ' ' MET . 2.1 tt -59.78 -49.43 77.74 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.302 0.573 . . . . 0.0 110.137 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.579 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.4 mtt -61.23 -46.29 91.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HE3' ' HE1' ' A' ' 55' ' ' MET . 3.0 tppp? -64.15 -38.65 91.81 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.887 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.75 -49.92 74.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.096 0.474 . . . . 0.0 110.464 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -63.22 -42.85 99.32 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.171 0.51 . . . . 0.0 110.68 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.444 ' SG ' HD11 ' A' ' 58' ' ' ILE . 79.1 m -64.57 -34.47 78.32 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.19 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.72 -42.12 91.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.3 mmm180 -65.33 -44.03 89.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.384 0.611 . . . . 0.0 111.472 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -21.53 27.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.895 0.379 . . . . 0.0 111.653 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.1 5.67 88.91 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.014 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -90.48 177.89 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.397 -0.473 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -99.93 134.94 42.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.438 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.9 ptp -66.74 -21.85 66.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.956 0.408 . . . . 0.0 111.935 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -82.24 -9.56 59.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.117 0.484 . . . . 0.0 110.863 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -103.88 5.83 36.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.72 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.444 HD11 ' SG ' ' A' ' 48' ' ' CYS . 24.9 pt -137.48 172.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.809 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.2 mmm180 -140.82 145.36 36.18 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.071 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.9 m-85 -111.9 128.79 56.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.566 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.8 ppt_? -129.98 139.83 51.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.532 0.682 . . . . 0.0 111.395 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -141.94 137.33 31.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.175 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.95 27.91 14.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 110.861 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 -2.31 76.16 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.545 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -126.32 145.81 54.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.914 -0.756 . . . . 0.0 111.244 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.93 150.3 54.82 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.373 2.049 . . . . 0.0 111.899 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.26 138.3 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-O 121.502 0.668 . . . . 0.0 111.055 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.31 150.78 21.16 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.787 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -60.83 -18.56 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.404 0.621 . . . . 0.0 111.784 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -79.68 -10.89 59.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.473 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 162.12 14.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.856 0.36 . . . . 0.0 111.32 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.8 p -118.69 154.28 52.58 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.813 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.95 -9.08 21.87 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.483 2.122 . . . . 0.0 111.932 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -95.53 -22.31 17.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -63.76 -43.69 95.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.55 0.691 . . . . 0.0 110.222 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -101.18 0.92 38.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.853 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 53.75 56.66 6.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.822 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.519 ' SD ' HD12 ' A' ' 20' ' ' LEU . 10.4 ptp -73.97 168.99 18.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.823 0.344 . . . . 0.0 110.258 177.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.23 164.83 13.4 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.233 0.54 . . . . 0.0 111.663 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -78.85 133.34 37.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.223 0.535 . . . . 0.0 109.764 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 75.51 15.98 2.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.268 1.027 . . . . 0.0 110.819 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.34 176.05 2.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.76 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' HD11 ' A' ' 84' ' ' ILE . 1.9 m -134.21 150.84 51.08 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.649 -0.657 . . . . 0.0 111.559 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.418 HD11 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -122.7 139.75 48.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.566 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -90.51 134.66 34.21 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.101 0.477 . . . . 0.0 110.718 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.0 t -119.14 135.53 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.847 0.832 . . . . 0.0 111.163 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.3 146.52 46.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.515 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -110.0 111.3 22.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.141 0.496 . . . . 0.0 109.823 -177.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.408 ' OE1' ' HG2' ' A' ' 90' ' ' GLN . 3.5 pp0? -144.26 144.77 31.65 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.118 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.408 ' HG2' ' OE1' ' A' ' 89' ' ' GLN . 85.7 mm-40 72.67 98.57 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.725 0.774 . . . . 0.0 111.097 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -120.77 17.67 11.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.029 0.918 . . . . 0.0 109.291 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.41 -52.56 2.42 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.89 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.332 0 CA-C-O 118.253 -1.304 . . . . 0.0 111.253 179.115 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.594 0.235 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -53.32 115.86 2.13 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.455 0.645 . . . . 0.0 111.814 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -133.74 39.72 3.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.854 0.835 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.29 103.86 13.01 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.871 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -134.01 77.53 61.86 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.68 -35.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.775 2.317 . . . . 0.0 113.372 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 39.63 37.76 0.35 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.615 1.166 . . . . 0.0 113.834 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -92.45 -80.36 0.37 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.188 0.518 . . . . 0.0 111.09 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.16 53.69 0.17 Allowed Glycine 0 C--N 1.306 -1.095 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.863 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.63 151.2 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.49 -65.72 0.64 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.037 0.446 . . . . 0.0 110.815 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.3 m -104.85 171.02 7.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 1.9 mp0 -116.59 -65.97 1.13 Allowed 'General case' 0 CA--C 1.517 -0.308 0 O-C-N 121.421 -0.799 . . . . 0.0 110.642 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 50.9 m-80 74.4 8.81 4.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.013 0.925 . . . . 0.0 110.492 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -78.99 74.66 5.51 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.496 ' CG ' ' H ' ' A' ' 17' ' ' HIS . 42.5 t0 -112.74 -179.13 3.57 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.361 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.496 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 11.0 p-80 -134.43 167.28 21.04 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.325 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.67 168.88 10.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.451 0.643 . . . . 0.0 111.473 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD23 ' A' ' 20' ' ' LEU . 20.7 m-80 -98.36 141.32 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.687 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.567 HD12 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.44 160.96 35.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.156 0.503 . . . . 0.0 110.365 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.6 mtpt -136.52 147.75 47.26 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.885 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 73.2 t -127.75 117.87 47.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.031 0.443 . . . . 0.0 110.804 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.22 121.24 31.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.1 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.85 159.88 28.27 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.57 -13.77 44.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.279 0.561 . . . . 0.0 111.615 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.42 -10.4 59.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.61 10.41 57.96 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.609 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -106.96 156.73 18.41 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.71 135.55 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.315 0.579 . . . . 0.0 110.943 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 7.6 p -100.28 138.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.263 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.63 127.81 54.8 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.448 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 14.2 p90 -151.87 168.51 24.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.743 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -119.08 134.73 55.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -138.0 145.77 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 26.8 mtmm -79.33 153.3 29.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.206 0.527 . . . . 0.0 111.29 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -59.58 -40.02 86.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -93.18 9.35 36.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.186 0.517 . . . . 0.0 111.488 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.513 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 11.8 m -94.53 128.84 38.54 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.68 150.26 79.36 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.939 2.426 . . . . 0.0 113.625 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.542 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.2 mp -60.94 -12.63 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.168 0.987 . . . . 0.0 112.776 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.3 p -54.29 -41.14 68.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.787 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.477 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.448 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.8 tt -62.3 -50.66 70.76 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.295 0.569 . . . . 0.0 109.804 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.677 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.6 mtt -60.34 -37.44 80.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.18 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 14.8 tppt? -68.01 -46.2 71.93 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.042 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.07 -49.17 74.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.227 0.537 . . . . 0.0 110.766 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.81 -37.77 88.75 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.105 0.479 . . . . 0.0 110.924 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -39.28 93.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.215 0.531 . . . . 0.0 110.718 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.5 mm-40 -68.41 -40.01 81.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.099 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -65.52 -51.45 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.333 -179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.69 -18.96 53.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 111.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.74 89.48 Favored Glycine 0 C--O 1.235 0.17 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.721 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.56 177.6 7.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.705 0.288 . . . . 0.0 111.059 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -96.03 123.85 39.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -23.88 66.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.141 0.496 . . . . 0.0 111.752 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -77.16 -16.05 59.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.354 0.597 . . . . 0.0 110.696 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -99.73 6.48 45.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.183 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.501 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 25.7 pt -132.86 168.28 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.264 0.554 . . . . 0.0 111.104 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 18.1 mmt180 -137.42 147.83 45.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.98 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.677 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.3 m-85 -115.68 132.03 56.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.649 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.568 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.7 ppt_? -132.56 135.98 46.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.487 0.66 . . . . 0.0 111.283 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -139.62 139.78 36.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.932 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.64 28.14 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.381 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.05 -6.6 78.61 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.54 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -121.48 145.59 43.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.126 -0.632 . . . . 0.0 111.306 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.33 147.18 46.75 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.354 2.036 . . . . 0.0 110.949 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.97 136.16 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 121.514 0.674 . . . . 0.0 110.78 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.87 153.29 20.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.561 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -58.82 -20.54 51.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.285 0.564 . . . . 0.0 111.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 p -83.48 -0.63 51.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.968 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.542 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -95.53 159.57 14.93 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 121.883 -0.511 . . . . 0.0 110.354 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 p -117.15 149.99 45.36 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.57 -12.97 36.12 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.511 2.14 . . . . 0.0 112.462 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 36' ' ' ARG . . . -95.57 -10.8 28.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.305 0.574 . . . . 0.0 110.748 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -78.15 -33.11 50.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.194 0.521 . . . . 0.0 110.517 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.39 2.1 22.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.161 0.505 . . . . 0.0 110.902 178.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 49.42 60.77 3.53 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.567 ' SD ' HD12 ' A' ' 20' ' ' LEU . 9.2 ptp -74.44 170.49 15.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.125 0.488 . . . . 0.0 110.588 176.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 41.8 tt0 -94.64 156.92 16.2 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.46 137.65 42.71 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.342 0.592 . . . . 0.0 110.538 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 73.77 19.04 3.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.572 1.149 . . . . 0.0 111.076 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -71.4 176.57 4.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.204 177.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.87 151.61 52.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.188 0.518 . . . . 0.0 111.565 -177.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.07 144.57 30.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.568 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.9 t0 -93.55 134.65 35.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.49 138.66 51.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.667 0.746 . . . . 0.0 111.151 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -138.21 148.37 44.73 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.67 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.461 ' HG2' HG23 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -109.08 111.13 22.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -108.99 89.86 3.12 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.425 0.631 . . . . 0.0 111.917 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.412 ' C ' ' HG1' ' A' ' 91' ' ' THR . 4.8 pm0 -96.6 108.22 20.78 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.885 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.412 ' HG1' ' C ' ' A' ' 90' ' ' GLN . 57.9 p 56.96 47.72 17.14 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.67 0.788 . . . . 0.0 111.336 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.98 -152.37 20.56 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.091 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.242 0 CA-C-O 118.403 -1.221 . . . . 0.0 111.491 179.934 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.978 0.418 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.32 85.49 2.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.458 0.647 . . . . 0.0 110.947 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -103.81 19.16 20.45 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.898 0.856 . . . . 0.0 109.882 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -121.77 -53.42 1.98 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.843 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? 51.31 71.23 1.58 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.553 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.41 128.29 15.23 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.08 1.853 . . . . 0.0 111.619 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -88.7 -0.66 57.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.143 0.497 . . . . 0.0 111.017 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -81.14 110.38 16.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.404 0.621 . . . . 0.0 109.878 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.64 58.74 0.18 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.23 116.75 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.441 0.639 . . . . 0.0 111.397 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -131.41 122.12 25.76 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m 68.2 112.01 0.04 OUTLIER 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.829 0.823 . . . . 0.0 112.329 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -108.74 151.7 25.84 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -94.37 -9.09 36.88 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 71.67 43.97 0.54 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.349 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -75.35 111.74 10.94 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.451 ' CD2' ' HD2' ' A' ' 33' ' ' LYS . 46.0 p-80 -161.83 162.06 29.26 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.76 167.93 11.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.516 0.674 . . . . 0.0 112.351 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.541 ' O ' HD23 ' A' ' 20' ' ' LEU . 8.5 m-80 -94.65 142.83 26.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.584 HD13 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -133.87 159.76 39.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.045 0.45 . . . . 0.0 110.199 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.9 mtpt -134.83 149.04 50.3 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 0.0 110.218 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 HG22 ' CE1' ' A' ' 32' ' ' PHE . 97.2 t -128.07 117.65 46.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.085 0.469 . . . . 0.0 110.124 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.95 124.19 37.8 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.876 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.89 159.9 28.24 Favored Glycine 0 N--CA 1.425 -2.072 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.158 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -65.71 -11.96 49.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.439 0.638 . . . . 0.0 111.012 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.03 -16.95 54.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.12 12.0 40.86 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.937 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -106.06 155.4 19.45 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 139.1 41.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.211 0.529 . . . . 0.0 111.126 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 9.7 p -108.89 140.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.167 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.22 123.3 49.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.516 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 19.7 p90 -145.03 167.71 22.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.344 0.592 . . . . 0.0 111.459 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.451 ' HD2' ' CD2' ' A' ' 17' ' ' HIS . 27.8 mmtt -106.32 144.01 33.61 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.553 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.449 ' CG2' HD22 ' A' ' 20' ' ' LEU . 17.9 tt -148.91 144.04 18.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.056 0.455 . . . . 0.0 109.901 176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 5.6 mtmp? -84.46 158.01 21.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.865 -0.522 . . . . 0.0 110.512 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HB3' ' HB1' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -64.47 -36.73 85.12 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.044 0.449 . . . . 0.0 111.091 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -92.01 5.98 48.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.215 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 18.0 m -93.64 128.65 41.15 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.18 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.69 149.08 73.11 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.944 2.43 . . . . 0.0 113.576 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 71' ' ' ASP . 5.7 mp -59.87 -12.59 7.92 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.191 0.997 . . . . 0.0 112.683 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.3 t -54.24 -40.77 68.03 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.145 0.498 . . . . 0.0 110.742 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALY . . . . . 0.505 ' HD3' ' C ' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.516 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.7 tt -60.81 -51.64 68.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.193 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.671 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 32.6 mtt -58.17 -50.33 73.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.037 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.583 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 2.9 tppp? -64.57 -38.97 92.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.55 -48.57 81.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -63.04 -40.26 97.18 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.15 0.5 . . . . 0.0 110.991 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.519 ' SG ' HD12 ' A' ' 58' ' ' ILE . 75.2 m -62.96 -36.01 82.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.394 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 28.4 mm-40 -73.18 -35.84 66.46 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.259 0.552 . . . . 0.0 110.763 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 44.1 mmm-85 -70.0 -48.92 56.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.433 0.635 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.95 -18.3 50.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.073 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.68 57.8 4.39 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.828 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.17 172.79 13.25 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.491 -0.417 . . . . 0.0 111.165 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.2 m -97.03 130.34 44.36 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.264 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.491 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.4 ptp -64.67 -25.45 67.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.429 . . . . 0.0 111.414 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.409 ' HG3' HE21 ' A' ' 57' ' ' GLN . 11.5 ptp180 -76.69 -10.51 59.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.4 0.619 . . . . 0.0 110.328 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.409 HE21 ' HG3' ' A' ' 56' ' ' ARG . 26.6 mm-40 -105.01 3.9 31.06 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.519 HD12 ' SG ' ' A' ' 48' ' ' CYS . 20.9 pt -136.71 172.28 15.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.043 0.449 . . . . 0.0 110.87 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 25.6 mmm180 -143.76 148.21 35.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.671 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 11.1 m-85 -113.39 129.66 56.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.657 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.558 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.3 ppt_? -131.58 140.79 49.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.411 0.624 . . . . 0.0 111.541 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -145.44 139.32 26.8 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 63.93 26.41 14.18 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.168 0.509 . . . . 0.0 110.815 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 -0.99 80.78 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.896 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -125.16 144.63 47.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 O-C-N 122.11 -0.641 . . . . 0.0 111.528 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.74 147.84 45.59 Favored 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 122.628 2.218 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.14 137.65 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-O 121.468 0.651 . . . . 0.0 111.0 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 155.53 18.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.485 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.611 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -64.41 -16.96 63.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.0 p -81.2 -5.98 58.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.442 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.539 ' O ' HD12 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.74 161.54 14.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.405 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 p -117.6 153.04 50.4 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.743 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 -8.56 21.48 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.353 2.036 . . . . 0.0 112.054 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 36' ' ' ARG . . . -96.03 -18.21 20.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.093 0.473 . . . . 0.0 111.068 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -36.9 78.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.239 0.542 . . . . 0.0 110.848 -177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.34 1.15 25.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.346 0.593 . . . . 0.0 110.756 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 51.18 58.66 5.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.962 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.584 ' SD ' HD13 ' A' ' 20' ' ' LEU . 8.6 ptp -73.92 164.63 26.38 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 36.2 tt0 -100.55 134.4 43.57 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.19 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -41.69 135.85 2.09 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 26.2 mt-10 74.12 16.47 3.53 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.777 1.231 . . . . 0.0 111.801 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.657 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -71.84 178.45 3.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 110.463 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.421 ' C ' HD13 ' A' ' 84' ' ' ILE . 1.8 m -135.23 151.58 50.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.21 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.421 HD13 ' C ' ' A' ' 83' ' ' THR . 2.8 mp -123.12 140.28 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.558 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 33.6 t70 -90.03 135.64 33.53 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.008 0.432 . . . . 0.0 110.651 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -119.64 135.34 60.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.777 0.799 . . . . 0.0 110.911 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.7 p90 -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.582 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.451 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.1 mt-30 -104.11 112.41 25.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.999 0.428 . . . . 0.0 110.432 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -69.43 78.52 0.39 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.403 0.621 . . . . 0.0 111.302 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.28 179.35 3.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.904 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 t -147.02 135.29 21.69 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.067 0.46 . . . . 0.0 110.224 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.94 -169.23 42.39 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.886 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.167 0 CA-C-O 118.321 -1.266 . . . . 0.0 111.322 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 21.5 p80 . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -114.82 169.5 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.7 m-80 -97.76 141.37 30.85 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.67 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.499 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -132.38 162.42 31.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.111 0.481 . . . . 0.0 110.421 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.97 148.24 48.39 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.065 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' CE1' ' A' ' 32' ' ' PHE . 80.8 t -126.97 115.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.377 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.82 126.7 37.01 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.86 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.38 164.87 29.68 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.405 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -68.41 -14.24 62.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.444 0.64 . . . . 0.0 110.916 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.8 -12.43 58.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.346 0.593 . . . . 0.0 110.525 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.39 48.79 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.83 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -105.43 152.3 23.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.0 p -136.41 137.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 15.0 p -105.41 141.59 20.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.855 0.359 . . . . 0.0 110.262 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -110.23 127.33 54.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.508 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -149.35 168.36 23.58 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.419 0.628 . . . . 0.0 111.883 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -116.52 134.97 54.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -140.48 147.08 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.044 0.45 . . . . 0.0 110.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 24.9 mtmt -82.47 157.93 23.42 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.754 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 15.4 mmm-85 -63.66 -39.74 95.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.995 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -92.76 8.27 40.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.704 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.4 m -91.6 128.3 47.02 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.702 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.47 145.62 77.47 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.822 2.348 . . . . 0.0 113.085 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.607 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.9 mp -60.09 -14.05 14.84 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.611 0.765 . . . . 0.0 112.087 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.6 m . . . . . 0 C--O 1.242 0.692 0 CA-C-O 121.246 0.545 . . . . 0.0 110.569 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.3 tt . . . . . 0 C--O 1.238 0.461 0 CA-C-O 120.959 0.409 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 1.9 mpt? -58.02 -42.39 85.2 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.01 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -68.66 -42.2 78.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.299 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.68 -52.86 62.41 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.19 -40.44 93.95 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.171 0.51 . . . . 0.0 110.887 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -40.82 91.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.92 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.02 -39.5 75.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.897 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 32.2 mmt180 -68.54 -52.85 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -22.14 59.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.981 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.13 57.35 3.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 0.0 111.96 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.6 175.6 10.47 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.691 -0.3 . . . . 0.0 110.332 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 71.2 m -96.78 128.38 43.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.825 0.345 . . . . 0.0 111.416 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.8 ptp -63.46 -26.24 68.63 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.233 0.539 . . . . 0.0 111.071 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 5.4 ptm180 -75.81 -11.43 59.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.203 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -105.23 7.04 33.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.332 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.477 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.0 pt -136.15 170.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.342 0.591 . . . . 0.0 111.629 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -140.8 148.78 41.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.147 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.495 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.3 m-85 -116.49 130.9 57.01 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.201 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.645 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.3 OUTLIER -132.36 142.67 49.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 0.0 110.045 177.2 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' A' ' 84' ' ' ILE . 87.2 t80 -136.74 134.3 36.99 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.255 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.32 31.7 21.19 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.044 0.449 . . . . 0.0 111.874 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.93 -14.85 59.34 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.356 -1.402 . . . . 0.0 113.251 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -117.33 148.16 42.05 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 121.974 -0.721 . . . . 0.0 112.165 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.04 147.96 21.42 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 123.392 2.728 . . . . 0.0 112.863 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.06 138.01 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.266 0.555 . . . . 0.0 111.284 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -97.81 158.14 15.68 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.61 -21.14 37.49 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.236 0.614 . . . . 0.0 111.956 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.3 p -79.29 -3.15 44.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.136 0.493 . . . . 0.0 111.539 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.6 m-20 -98.47 162.81 12.96 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.0 -0.437 . . . . 0.0 110.978 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.5 p -117.03 156.88 47.81 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.74 -11.05 30.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.278 1.985 . . . . 0.0 111.773 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.61 -19.29 20.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 110.454 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -63.61 -35.95 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 0.0 110.294 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.07 1.14 17.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.921 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 51.53 62.38 2.74 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.52 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.499 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.7 ptp -77.69 165.81 23.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 110.42 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.03 161.97 16.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.348 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.26 136.9 42.68 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.022 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 72.03 16.7 5.32 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.979 0.911 . . . . 0.0 111.484 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.72 175.85 5.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.468 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.439 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.6 m -132.44 150.51 52.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.321 0.582 . . . . 0.0 111.721 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -120.96 139.04 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.645 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 11.3 m-20 -88.99 134.03 34.12 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.011 0.434 . . . . 0.0 110.596 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.07 137.84 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 121.63 0.729 . . . . 0.0 111.019 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -137.8 146.35 43.43 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.377 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.314 -0.937 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 50.6 p-80 . . . . . 0 N--CA 1.429 -1.494 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -122.09 169.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.383 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD22 ' A' ' 20' ' ' LEU . 28.1 m-80 -99.65 144.35 28.83 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -132.4 160.53 36.1 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.102 0.477 . . . . 0.0 110.172 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.5 mtpt -132.5 147.86 52.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.911 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.491 HG23 ' CE1' ' A' ' 32' ' ' PHE . 75.5 t -125.78 118.28 51.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.092 0.472 . . . . 0.0 110.177 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.09 118.28 30.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.056 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.26 155.47 34.44 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -63.06 -13.78 40.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.29 0.567 . . . . 0.0 111.371 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.05 -11.69 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.76 41.41 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.947 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 t -110.2 162.18 14.85 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.18 141.12 28.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.194 0.521 . . . . 0.0 111.126 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG21 ' HG3' ' A' ' 50' ' ' ARG . 12.1 p -109.65 142.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.999 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -113.12 124.14 51.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.274 0.559 . . . . 0.0 109.775 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 22' ' ' VAL . 16.8 p90 -145.29 167.97 21.56 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 29.2 mtmt -114.95 136.79 52.72 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.59 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.413 ' CG2' HD23 ' A' ' 20' ' ' LEU . 15.9 tt -143.81 148.96 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.032 0.444 . . . . 0.0 110.368 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.4 mtmt -83.97 158.69 21.44 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.793 -0.567 . . . . 0.0 110.973 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.496 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 27.6 mmm-85 -64.24 -40.75 96.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -91.17 8.84 33.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.294 0.569 . . . . 0.0 110.995 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 14.7 m -94.31 130.97 32.3 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.0 149.93 77.55 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.974 2.449 . . . . 0.0 113.586 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 71' ' ' ASP . 7.0 mp -61.44 -12.17 13.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.096 0.958 . . . . 0.0 112.873 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 p . . . . . 0 C--N 1.326 -0.456 0 CA-C-O 120.962 0.411 . . . . 0.0 111.049 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.4 tt . . . . . 0 C--O 1.236 0.358 0 CA-C-O 121.394 0.616 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.655 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.9 mtt -60.41 -48.0 83.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -61.53 -42.28 98.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.8 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.38 -52.89 62.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.757 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.28 -41.0 96.21 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.135 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 75.5 m -65.39 -34.89 79.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.079 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -70.31 -34.89 73.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.2 mmp_? -73.77 -46.68 44.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.353 0.596 . . . . 0.0 111.084 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.5 -21.35 42.03 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.056 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.56 57.74 3.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.579 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.58 175.29 10.98 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 122.552 -0.381 . . . . 0.0 110.878 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 26.4 m -97.23 131.37 44.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.012 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 6.5 ptp -66.28 -26.84 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.217 0.532 . . . . 0.0 110.988 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -76.04 -13.75 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 12.8 mm100 -101.26 2.38 39.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.504 0.669 . . . . 0.0 110.443 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 48' ' ' CYS . 35.0 pt -135.09 176.24 9.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 15.9 mmm180 -146.95 154.43 41.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.834 0.35 . . . . 0.0 111.008 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.5 m-85 -119.03 132.44 56.05 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.092 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.1 ppt_? -134.63 141.5 46.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 111.098 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -141.39 139.83 33.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.575 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t70 57.99 27.97 15.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 111.305 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.12 -3.54 70.94 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.192 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -118.43 140.98 28.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 122.182 -0.599 . . . . 0.0 111.347 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.08 147.33 38.09 Favored 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 122.67 2.247 . . . . 0.0 112.261 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.22 139.0 51.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 110.594 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -98.8 165.82 11.6 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.979 0.419 . . . . 0.0 111.202 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.2 pt-20 -61.87 -17.13 55.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.194 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.4 p -82.98 -4.28 58.12 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.933 0.397 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.522 ' O ' HD13 ' A' ' 40' ' ' LEU . 46.5 m-20 -88.75 156.71 18.82 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -117.66 150.74 47.42 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 122.427 0.291 . . . . 0.0 110.222 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.413 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 36.9 Cg_endo -65.24 -13.04 37.67 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.366 2.044 . . . . 0.0 112.234 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.76 -13.74 25.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 110.817 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -72.2 -35.86 69.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.332 0.587 . . . . 0.0 110.176 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.89 1.0 22.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.69 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 53.01 61.34 3.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.321 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.481 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.1 ptp -80.24 166.45 21.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.415 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -91.94 167.62 11.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.065 0.459 . . . . 0.0 110.983 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.98 139.67 36.92 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.328 0.585 . . . . 0.0 110.091 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 71.6 15.27 6.06 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.487 1.115 . . . . 0.0 111.341 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.74 176.7 2.87 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.2 m -134.84 150.32 50.47 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.546 -0.721 . . . . 0.0 111.731 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 142.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.587 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 29.5 t70 -90.88 136.53 33.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.11 0.481 . . . . 0.0 110.869 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 134.06 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.948 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.1 p90 -130.76 137.47 49.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.813 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.2 mt-30 . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 0.0 111.1 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.684 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 17.9 p80 . . . . . 0 N--CA 1.429 -1.479 0 CA-C-O 121.077 0.465 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 pt -123.2 170.17 13.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.987 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.507 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . 19.3 m-80 -93.89 142.09 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.653 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.53 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.6 mm? -133.24 163.47 29.23 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.288 0.566 . . . . 0.0 110.87 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.4 mtpt -134.82 146.07 48.95 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.905 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' CE1' ' A' ' 32' ' ' PHE . 91.2 t -127.29 114.06 34.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.19 0.519 . . . . 0.0 110.132 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.84 130.32 37.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.414 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.93 161.82 22.82 Favored Glycine 0 N--CA 1.42 -2.417 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.959 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.45 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -65.02 -11.76 42.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.562 0.696 . . . . 0.0 110.897 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.87 -15.0 58.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.254 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.17 6.51 56.77 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.0 t -101.24 153.9 19.22 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.57 136.43 46.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.309 0.576 . . . . 0.0 111.507 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.593 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.6 p -105.19 140.07 24.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.391 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -110.97 124.95 53.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.526 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.4 p90 -149.56 169.85 19.99 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.135 0.493 . . . . 0.0 111.452 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -113.61 143.27 44.85 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.985 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 14.7 tt -148.75 143.34 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.119 0.485 . . . . 0.0 110.359 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 25.7 mtmt -79.45 155.36 28.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.374 0.607 . . . . 0.0 111.772 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 29.0 mmm-85 -64.95 -36.49 84.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.641 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.19 4.91 53.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.337 0.589 . . . . 0.0 110.753 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 20.6 m -93.57 129.49 38.32 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.23 151.46 85.35 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.891 2.394 . . . . 0.0 112.856 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.474 ' CD2' HD13 ' A' ' 43' ' ' LEU . 81.2 mt -65.38 -11.87 46.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.55 0.74 . . . . 0.0 111.919 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.238 0.466 0 CA-C-O 121.117 0.484 . . . . 0.0 111.098 178.546 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD13 ' CD2' ' A' ' 40' ' ' LEU . 4.0 tt . . . . . 0 C--O 1.235 0.341 0 CA-C-O 121.011 0.434 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.71 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 37.8 mtt -61.75 -39.69 92.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.168 0.508 . . . . 0.0 110.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.9 tppp? -70.16 -40.91 74.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.694 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.52 68.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 110.912 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -63.69 -37.05 85.91 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.061 0.458 . . . . 0.0 110.822 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -34.55 78.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.138 0.494 . . . . 0.0 110.812 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.0 mm-40 -72.59 -42.14 64.87 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.272 0.558 . . . . 0.0 110.62 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.593 ' HG3' HG21 ' A' ' 30' ' ' VAL . 22.9 mmm-85 -62.99 -52.6 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.452 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -79.73 -21.41 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.884 0.373 . . . . 0.0 111.927 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.02 2.82 90.65 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.925 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.54 175.95 8.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 0.0 111.208 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 54.7 m -97.42 127.02 43.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.698 0.285 . . . . 0.0 110.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.6 ptp -60.81 -25.24 66.43 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.093 0.473 . . . . 0.0 111.985 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -78.78 -11.36 59.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.242 0.544 . . . . 0.0 111.129 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.405 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 13.0 mm100 -101.22 5.67 42.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.0 110.63 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.566 HG22 ' HG2' ' A' ' 88' ' ' GLN . 31.2 pt -135.22 177.23 7.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.118 0.485 . . . . 0.0 111.065 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -147.42 147.18 29.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.71 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 14.0 m-85 -113.87 128.06 56.25 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.21 0.529 . . . . 0.0 111.237 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 1.1 ppt_? -132.04 136.64 47.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.395 0.617 . . . . 0.0 110.735 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -135.79 134.77 39.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.538 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.39 28.5 18.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.216 0.531 . . . . 0.0 110.654 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.76 -4.52 64.86 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 119.645 -1.264 . . . . 0.0 113.198 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -115.99 136.81 23.01 Favored Pre-proline 0 C--N 1.322 -0.607 0 O-C-N 121.905 -0.762 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.27 142.91 30.96 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.704 2.269 . . . . 0.0 112.104 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 133.3 68.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.564 0.697 . . . . 0.0 111.365 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 149.47 21.44 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.335 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.541 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.0 pp20? -58.27 -20.0 38.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.453 HG23 ' OE2' ' A' ' 69' ' ' GLU . 40.9 p -76.26 -13.11 60.17 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.376 0.608 . . . . 0.0 111.164 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.79 166.79 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -118.13 158.4 46.38 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.07 -5.64 14.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.578 2.186 . . . . 0.0 112.074 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.04 -13.73 24.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.16 0.505 . . . . 0.0 110.525 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -68.6 -35.93 78.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.429 0.633 . . . . 0.0 110.549 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.456 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.16 1.47 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.482 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 52.6 60.05 4.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.53 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.6 ptp -74.97 163.02 28.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -87.89 159.97 18.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.47 131.48 44.81 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 14.3 mt-10 72.88 20.67 3.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 124.288 1.035 . . . . 0.0 111.593 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.75 179.42 3.13 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.4 m -135.13 150.43 50.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.509 -0.745 . . . . 0.0 111.887 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.63 148.81 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 6.8 t70 -97.97 128.59 44.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.788 0.328 . . . . 0.0 110.334 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.11 135.0 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.576 0.703 . . . . 0.0 110.846 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.484 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -136.85 145.08 44.0 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.64 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.313 -1.002 0 CA-C-O 121.126 0.488 . . . . 0.0 110.06 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 41.7 p-80 . . . . . 0 N--CA 1.43 -1.452 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.79 169.61 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.349 0.595 . . . . 0.0 111.095 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' O ' HD22 ' A' ' 20' ' ' LEU . 22.2 m-80 -99.95 145.81 27.41 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -132.63 162.39 31.46 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.323 0.582 . . . . 0.0 110.823 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 57.5 mtpt -133.55 147.98 51.61 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.989 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.7 t -128.74 117.96 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.09 0.472 . . . . 0.0 110.265 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.94 124.93 35.15 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.889 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.31 159.52 27.44 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.7 pp0? -63.32 -14.68 52.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.496 0.665 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.23 -19.25 62.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.55 6.19 50.6 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -107.39 163.66 12.86 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.0 143.39 31.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.576 HG21 ' HG3' ' A' ' 50' ' ' ARG . 6.1 p -112.36 145.28 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.172 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -112.77 131.05 55.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.299 0.571 . . . . 0.0 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 22' ' ' VAL . 10.8 p90 -152.08 169.12 23.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.219 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -111.95 143.72 42.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.036 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.441 ' CG2' HD23 ' A' ' 20' ' ' LEU . 16.5 tt -150.54 149.23 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.063 0.459 . . . . 0.0 110.333 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.3 mtmt -87.23 158.03 19.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.73 -0.606 . . . . 0.0 110.74 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.9 mmm-85 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -90.48 7.75 37.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.119 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.3 m -93.7 129.98 36.48 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.37 150.22 87.35 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.904 2.402 . . . . 0.0 112.984 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.463 ' CD2' HD13 ' A' ' 43' ' ' LEU . 87.4 mt -65.26 -11.97 46.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.862 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p . . . . . 0 C--O 1.235 0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 111.142 178.817 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt . . . . . 0 C--O 1.238 0.487 0 CA-C-O 121.186 0.517 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.666 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 29.9 mtt -61.31 -40.88 95.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 17.8 tppt? -70.37 -38.33 74.72 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.967 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.09 -50.99 71.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.957 0.408 . . . . 0.0 110.566 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.41 -33.61 76.25 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.985 0.421 . . . . 0.0 110.532 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -38.13 89.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.247 0.546 . . . . 0.0 110.547 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 68.2 mm-40 -73.12 -34.64 66.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.071 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HG3' HG21 ' A' ' 30' ' ' VAL . 11.5 mmt180 -68.1 -49.54 60.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.011 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -85.48 -22.38 28.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.81 58.31 3.06 Favored Glycine 0 C--N 1.321 -0.301 0 C-N-CA 119.673 -1.251 . . . . 0.0 111.696 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.52 174.07 11.74 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 122.564 -0.374 . . . . 0.0 110.286 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.9 m -100.05 129.23 46.08 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.86 0.362 . . . . 0.0 110.897 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.1 ptp -64.85 -25.52 67.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HG3' ' HG2' ' A' ' 57' ' ' GLN . 12.7 ptt180 -75.81 -11.62 60.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.199 0.523 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.431 ' HG2' ' HG3' ' A' ' 56' ' ' ARG . 19.3 mm-40 -104.53 2.62 31.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HG2' ' A' ' 88' ' ' GLN . 37.7 pt -134.0 172.97 15.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.043 0.449 . . . . 0.0 110.636 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 19.6 mmt180 -142.24 149.89 40.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.778 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.666 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.3 m-85 -114.53 132.8 56.19 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.318 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.6 ppt_? -135.82 140.03 43.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.328 0.585 . . . . 0.0 111.076 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -138.2 137.7 37.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.822 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.85 34.06 21.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.78 -4.55 74.03 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.735 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -120.95 141.49 32.76 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.992 -0.711 . . . . 0.0 111.684 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.51 148.08 32.9 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 111.711 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.82 136.19 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.063 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -93.25 157.65 16.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -59.74 -22.07 61.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.4 p -74.5 -15.17 60.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.998 0.428 . . . . 0.0 111.229 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.36 165.45 13.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.6 p -117.33 158.76 43.93 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -67.35 -7.46 19.13 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.432 2.088 . . . . 0.0 111.83 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.91 -19.49 20.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.534 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -60.91 -40.01 91.54 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.63 0.729 . . . . 0.0 110.39 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.45 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.81 0.35 25.98 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.767 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.5 62.21 2.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.535 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.0 ptp -79.8 167.12 21.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.007 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -92.85 167.02 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.286 0.565 . . . . 0.0 110.914 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -75.92 139.74 41.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.134 0.492 . . . . 0.0 110.119 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 68.21 19.56 9.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.755 0.822 . . . . 0.0 111.137 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -72.06 179.76 3.14 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.798 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.432 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.6 m -135.04 150.07 50.23 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 121.602 -0.687 . . . . 0.0 111.618 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.432 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.98 144.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 28.8 t70 -92.2 139.69 30.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 120.812 0.339 . . . . 0.0 110.685 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -123.73 139.34 50.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.677 0.751 . . . . 0.0 110.956 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -137.43 146.04 43.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.946 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 1.3 mt-30 . . . . . 0 C--N 1.319 -0.761 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 23.5 p80 . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 120.84 0.352 . . . . 0.0 111.763 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.34 170.81 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.577 0.704 . . . . 0.0 112.466 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.45 ' O ' HD22 ' A' ' 20' ' ' LEU . 25.4 m-80 -96.42 139.64 32.23 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.632 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -128.87 161.38 29.96 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 83' ' ' THR . 60.1 mtpt -136.73 146.91 46.38 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.169 0.509 . . . . 0.0 110.247 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.7 t -128.22 117.25 45.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.201 0.524 . . . . 0.0 110.639 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.58 118.23 28.09 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.46 160.84 33.4 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.169 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -9.14 38.74 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.681 0.753 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -74.72 -15.73 60.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.62 6.94 57.12 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.472 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 t -110.01 167.33 10.26 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.61 140.14 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.611 HG21 ' HG3' ' A' ' 50' ' ' ARG . 9.5 p -103.98 140.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.003 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -113.84 123.51 49.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.43 0.633 . . . . 0.0 109.651 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 8.8 p90 -147.12 169.04 20.12 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.231 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 33.5 mtmm -115.28 144.6 43.49 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 111.462 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.7 tt -148.25 146.07 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.023 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 29.4 mtmt -81.05 155.31 26.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 18.6 mmm-85 -60.79 -40.19 91.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.094 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -92.91 10.15 32.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.6 m -95.6 130.21 32.54 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.396 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 150.24 83.48 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.765 2.31 . . . . 0.0 112.97 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.535 HD22 HD13 ' A' ' 43' ' ' LEU . 88.5 mt -62.11 -12.18 18.09 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 123.456 0.702 . . . . 0.0 111.799 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.5 t . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.956 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.535 HD13 HD22 ' A' ' 40' ' ' LEU . 2.3 tt . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.23 0.538 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.568 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 25.8 mtt -63.27 -39.29 94.17 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.651 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.678 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 4.1 tppp? -67.96 -44.51 76.56 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.246 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.663 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -53.97 -53.15 56.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.386 . . . . 0.0 111.016 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CE2' HG11 ' A' ' 86' ' ' VAL . 46.9 t80 -60.55 -41.58 94.82 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -41.55 81.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.288 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.678 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 22.6 mt-10 -71.7 -42.52 67.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.307 0.575 . . . . 0.0 111.211 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.1 mmt85 -65.09 -50.66 65.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.247 0.546 . . . . 0.0 111.321 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -77.6 -14.7 59.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.431 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.18 57.19 8.78 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.519 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -146.68 176.13 10.08 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -99.57 128.3 45.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.424 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 ptp -63.12 -19.95 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.111 0.481 . . . . 0.0 111.789 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -83.07 -15.11 52.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.244 0.545 . . . . 0.0 111.011 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -100.04 5.13 45.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.454 0.645 . . . . 0.0 110.47 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.509 HG22 ' HG2' ' A' ' 88' ' ' GLN . 34.2 pt -135.32 171.9 16.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.733 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 21.5 mmm180 -141.99 148.45 38.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.775 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.7 m-85 -113.68 130.33 56.43 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.726 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.48 131.86 38.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.092 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' HG13 ' A' ' 84' ' ' ILE . 82.5 t80 -126.56 136.48 52.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.287 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.88 32.56 22.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.285 0.564 . . . . 0.0 111.013 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.35 -3.4 58.88 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.565 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -119.33 135.05 23.77 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 121.847 -0.796 . . . . 0.0 111.215 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.37 150.6 76.13 Favored 'Trans proline' 0 C--N 1.326 -0.619 0 C-N-CA 122.702 2.268 . . . . 0.0 111.831 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.32 142.93 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.805 0.812 . . . . 0.0 111.34 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.22 153.81 17.6 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.105 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.8 pt-20 -63.95 -17.28 63.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.164 0.507 . . . . 0.0 111.731 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.6 p -81.56 -5.97 58.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -93.26 158.7 15.61 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.154 -0.341 . . . . 0.0 110.365 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.55 ' OG1' ' HB2' ' A' ' 75' ' ' GLN . 20.0 p -118.16 151.41 49.14 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.54 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 78' ' ' MET . 27.6 Cg_endo -63.07 -13.76 37.37 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.428 2.085 . . . . 0.0 112.55 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.07 -21.31 18.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.106 0.479 . . . . 0.0 110.964 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.55 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 34.0 tt0 -66.0 -33.74 76.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.866 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.32 -1.72 24.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.343 0.592 . . . . 0.0 110.5 177.194 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.47 58.41 4.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.426 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.632 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.2 ptp -77.49 172.29 13.58 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.878 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.9 tp10 -92.18 156.54 17.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.17 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.88 141.6 49.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.234 0.54 . . . . 0.0 110.839 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 69.08 18.88 8.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.111 0.965 . . . . 0.0 111.04 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -70.47 175.78 4.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.19 150.5 52.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.46 0.647 . . . . 0.0 111.923 -176.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 62' ' ' PHE . 3.3 mp -122.69 145.52 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -92.43 135.88 33.67 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.975 0.417 . . . . 0.0 110.607 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.427 HG11 ' CE2' ' A' ' 47' ' ' TYR . 2.8 t -120.62 135.58 60.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.781 0.801 . . . . 0.0 111.132 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 1.5 p90 -135.79 145.2 46.27 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.509 ' HG2' HG22 ' A' ' 58' ' ' ILE . 8.2 mt-30 . . . . . 0 C--N 1.318 -0.784 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.824 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.52 HG21 ' OD1' ' A' ' 80' ' ' ASP . 32.4 pt -130.08 169.1 21.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.34 0.591 . . . . 0.0 111.414 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.2 140.49 32.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.48 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.474 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.2 mm? -128.97 164.34 23.38 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.087 0.47 . . . . 0.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 83' ' ' THR . 62.6 mtpt -133.57 147.19 51.52 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.027 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.534 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.5 t -125.0 116.39 47.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 120.968 0.413 . . . . 0.0 109.892 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.39 122.62 35.02 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.753 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.3 160.06 34.37 Favored Glycine 0 N--CA 1.424 -2.158 0 C-N-CA 120.439 -0.886 . . . . 0.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -15.16 60.51 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.128 0.49 . . . . 0.0 111.832 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.559 0.695 . . . . 0.0 110.025 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.86 5.52 50.57 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.67 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -95.76 162.75 13.47 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.24 136.74 22.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.479 0.657 . . . . 0.0 111.297 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.428 HG11 ' HG3' ' A' ' 50' ' ' ARG . 89.3 t -107.65 138.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.933 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -109.84 128.18 55.16 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 22' ' ' VAL . 13.7 p90 -147.91 168.35 22.46 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.274 0.559 . . . . 0.0 111.538 -174.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 37.5 mtmt -112.19 135.54 52.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.619 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -144.43 144.15 22.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.19 0.519 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 24.3 mtmm -82.18 156.79 24.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 12.4 mmm-85 -64.14 -34.64 78.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.371 0.605 . . . . 0.0 110.547 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -95.21 6.65 48.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.288 0.566 . . . . 0.0 110.914 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 8.3 m -92.2 129.76 40.27 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.048 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.0 147.16 73.35 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 123.141 2.561 . . . . 0.0 113.595 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.8 mp -61.55 -12.27 14.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.285 1.034 . . . . 0.0 112.99 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.2 p . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 121.046 0.45 . . . . 0.0 110.805 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 7.2 tt . . . . . 0 C--O 1.236 0.347 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 mtt -58.85 -42.61 89.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -67.94 -43.35 79.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.009 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.44 -49.89 73.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.128 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.66 -39.22 93.31 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.194 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -39.17 93.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 110.502 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -68.37 -36.73 79.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.187 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 50' ' ' ARG . 10.7 mmp_? -70.12 -45.55 66.64 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -81.36 -21.56 39.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.864 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.22 4.5 89.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.368 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.64 177.21 6.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.934 0.397 . . . . 0.0 110.99 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 37.7 m -93.97 126.45 39.19 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.263 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -62.51 -28.7 70.02 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -76.55 -9.84 58.95 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.457 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.48 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 14.0 mm100 -101.09 4.54 42.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.157 0.503 . . . . 0.0 111.373 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.77 HG22 ' HG2' ' A' ' 88' ' ' GLN . 23.0 pt -133.17 168.5 24.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.246 0.546 . . . . 0.0 110.786 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 54.8 mmt-85 -133.78 153.09 51.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.339 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.706 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 13.5 m-85 -119.17 131.03 55.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.315 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.617 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.1 ppt_? -136.56 143.94 43.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.251 0.548 . . . . 0.0 111.316 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.721 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 74.8 t80 -139.39 130.98 27.2 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER 53.87 32.22 14.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.557 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.52 -33.08 1.38 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.623 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.721 ' HG2' ' O ' ' A' ' 62' ' ' PHE . 7.5 pt20 -70.06 119.82 74.13 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.688 0.756 . . . . 0.0 111.736 -177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.08 144.51 57.88 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.658 2.238 . . . . 0.0 110.724 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.403 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -124.8 133.01 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.354 0.597 . . . . 0.0 110.668 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.94 159.11 15.91 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.456 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.4 pt-20 -58.8 -21.84 57.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.322 0.582 . . . . 0.0 111.79 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.9 p -84.97 0.26 51.96 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.575 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.525 ' O ' HD13 ' A' ' 40' ' ' LEU . 66.9 m-20 -96.07 161.76 13.83 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.885 -0.51 . . . . 0.0 110.325 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.3 p -119.38 153.53 53.71 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.954 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 37.3 Cg_endo -66.24 -12.0 33.71 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.722 2.281 . . . . 0.0 112.863 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.05 -17.08 22.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.37 0.605 . . . . 0.0 110.937 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.94 -32.88 73.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.561 . . . . 0.0 110.771 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.2 3.09 19.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.045 0.45 . . . . 0.0 110.957 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 50.22 57.85 6.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.721 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -72.81 168.98 17.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.432 . . . . 0.0 110.88 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.5 tp10 -87.97 143.84 26.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.042 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.52 ' OD1' HG21 ' A' ' 18' ' ' ILE . 3.4 m-20 -59.02 138.68 57.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.86 0.362 . . . . 0.0 110.352 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.65 25.55 8.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 112.042 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -77.73 -174.28 3.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 110.964 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.447 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 m -136.23 150.97 49.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.447 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.66 140.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.8 t70 -89.01 138.03 31.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.256 0.55 . . . . 0.0 110.9 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 136.21 57.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.314 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.463 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 3.8 p90 -146.77 158.95 44.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.095 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.77 ' HG2' HG22 ' A' ' 58' ' ' ILE . 87.6 mt-30 . . . . . 0 C--N 1.317 -0.828 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.464 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 16.1 p80 . . . . . 0 N--CA 1.417 -2.085 0 CA-C-O 121.225 0.536 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.43 HG23 ' HD3' ' A' ' 36' ' ' ARG . 33.9 pt -106.08 169.73 2.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.674 0.749 . . . . 0.0 111.621 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.4 m-80 -99.71 148.68 24.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.055 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.3 mm? -136.94 162.77 32.37 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.393 0.616 . . . . 0.0 111.087 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.2 mtpt -136.73 148.18 47.14 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.183 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.0 t -129.25 117.97 44.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.434 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.02 122.1 33.4 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.694 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.07 162.91 30.15 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.4 pp0? -69.18 -12.09 61.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.743 0.782 . . . . 0.0 109.851 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.33 -21.43 60.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.801 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.12 10.82 41.27 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 t -109.77 158.47 18.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 7.6 p -135.19 134.22 52.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.383 0.611 . . . . 0.0 111.211 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 7.5 p -100.67 139.66 21.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.528 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE1' HG23 ' A' ' 22' ' ' VAL . 7.3 p90 -154.97 169.57 23.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.074 0.464 . . . . 0.0 111.377 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -118.22 138.3 52.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.652 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.481 ' CG2' HD23 ' A' ' 20' ' ' LEU . 14.0 tt -143.35 148.0 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 26.8 mtmt -84.44 157.7 21.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.247 0.546 . . . . 0.0 110.994 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 28.1 mmm-85 -68.55 -34.46 75.87 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.323 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -95.2 6.49 48.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.587 0.708 . . . . 0.0 110.668 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.7 m -94.54 131.98 29.77 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.205 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.1 151.1 86.78 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.571 2.181 . . . . 0.0 112.265 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 43' ' ' LEU . 67.2 mt -65.57 -13.7 59.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.746 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 2.4 p . . . . . 0 C--O 1.235 0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.239 0.506 0 CA-C-O 120.839 0.352 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.403 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.0 mpt? -60.15 -37.89 81.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.341 0.591 . . . . 0.0 110.502 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.4 tppp? -69.41 -42.25 75.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.45 -50.24 70.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.29 0.567 . . . . 0.0 110.723 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.31 -39.65 94.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.15 0.5 . . . . 0.0 110.902 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -34.15 77.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm-40 -71.64 -40.84 69.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.675 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG3' HG21 ' A' ' 30' ' ' VAL . 10.5 mmm180 -68.97 -43.75 74.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.099 0.476 . . . . 0.0 111.657 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -84.95 -16.65 40.28 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.979 0.418 . . . . 0.0 111.714 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.03 2.93 80.01 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.919 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -83.46 176.46 9.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.075 0.465 . . . . 0.0 111.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.0 m -94.21 130.57 40.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.4 ptp -66.54 -22.01 66.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.063 0.459 . . . . 0.0 111.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -80.05 -8.25 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.269 0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -104.66 7.96 35.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.969 0.414 . . . . 0.0 111.711 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' HG2' ' A' ' 88' ' ' GLN . 22.2 pt -136.53 171.82 16.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.394 0.616 . . . . 0.0 111.364 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.436 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 16.6 mmm180 -140.64 145.79 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.573 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.66 130.47 56.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.593 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.6 ppt_? -133.1 138.24 46.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.351 0.596 . . . . 0.0 110.986 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -138.48 140.36 39.17 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.551 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.12 26.05 16.0 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.09 0.472 . . . . 0.0 111.297 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.31 -6.8 70.47 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.856 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.56 142.61 31.82 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.073 -0.663 . . . . 0.0 111.411 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.94 148.9 36.2 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 122.431 2.087 . . . . 0.0 111.435 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.96 135.29 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.428 0.633 . . . . 0.0 111.545 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.48 154.65 17.32 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.46 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.4 pt-20 -60.67 -21.28 62.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.054 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -76.46 -12.49 60.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 111.271 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.2 166.43 11.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 p -115.9 158.57 41.95 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.99 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' MET . 39.1 Cg_endo -67.79 -3.23 10.0 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.71 2.273 . . . . 0.0 112.124 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.43 -21.3 19.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.0 110.547 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -62.29 -39.49 93.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.378 0.609 . . . . 0.0 110.92 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.449 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.12 1.42 28.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.174 0.511 . . . . 0.0 111.221 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 3.5 mm-40 51.88 62.62 2.61 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.496 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.7 ptp -76.33 165.22 25.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.05 0.452 . . . . 0.0 110.366 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.82 165.83 11.92 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.1 131.56 44.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 21.8 mt-10 69.67 21.13 6.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.555 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -67.89 176.63 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 1.3 m -132.81 148.67 52.31 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.577 -0.702 . . . . 0.0 111.427 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.05 142.14 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.593 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 36.1 t70 -89.52 134.08 34.28 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.101 0.477 . . . . 0.0 110.531 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.17 137.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.789 0.804 . . . . 0.0 110.75 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.8 p90 -135.07 144.59 47.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.37 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.572 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.4 mt-30 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 46.9 p-80 . . . . . 0 N--CA 1.443 -0.803 0 CA-C-O 120.759 0.314 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 pt -108.05 169.87 2.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.502 0.668 . . . . 0.0 112.232 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' O ' HD22 ' A' ' 20' ' ' LEU . 15.6 m-80 -97.34 142.47 29.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.464 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -133.17 163.9 28.24 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.382 0.611 . . . . 0.0 110.887 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.8 mtpt -138.64 148.6 44.26 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.628 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG23 ' CE1' ' A' ' 32' ' ' PHE . 92.7 t -127.88 117.25 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.094 0.473 . . . . 0.0 110.497 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.36 123.19 35.5 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.292 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.88 163.01 26.69 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -19.42 63.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.706 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.1 -6.14 49.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.261 0.553 . . . . 0.0 110.98 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.17 64.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.838 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 t -103.88 158.4 16.43 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.94 136.04 45.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.253 0.549 . . . . 0.0 111.191 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.57 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.4 p -106.54 141.79 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 122.188 -0.32 . . . . 0.0 110.217 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -111.88 129.87 56.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.229 0.538 . . . . 0.0 109.968 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.7 p90 -154.09 169.95 22.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.585 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -115.56 143.27 45.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.651 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.436 ' CG2' HD23 ' A' ' 20' ' ' LEU . 13.6 tt -148.9 148.53 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.231 0.539 . . . . 0.0 110.398 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.459 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.0 mtmt -84.15 158.05 21.48 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.01 0.433 . . . . 0.0 110.782 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 23.8 mmm-85 -69.13 -34.04 74.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.517 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.45 5.13 52.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.58 . . . . 0.0 110.913 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.1 m -93.46 131.26 32.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.778 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.69 149.57 90.53 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.923 2.415 . . . . 0.0 112.784 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.7 mt -65.13 -12.14 47.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.906 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 177.42 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.392 0.615 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.751 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 38.5 mtt -61.57 -49.65 75.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.353 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.0 tppp? -59.66 -44.31 93.6 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.18 -50.79 68.46 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.773 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -62.78 -41.01 99.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.186 0.517 . . . . 0.0 110.813 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.562 ' SG ' HD11 ' A' ' 58' ' ' ILE . 79.2 m -65.52 -34.64 78.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.399 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 18.9 mm-40 -68.89 -37.13 78.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.22 0.533 . . . . 0.0 110.99 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 mmt180 -69.63 -44.33 70.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -83.34 -21.74 33.06 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.295 0.569 . . . . 0.0 110.67 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.71 88.79 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.532 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.69 176.0 7.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.288 0.566 . . . . 0.0 111.815 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.403 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 70.7 m -96.9 134.62 40.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.548 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.6 ptp -68.18 -19.74 64.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.096 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -83.42 -8.05 59.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.167 0.508 . . . . 0.0 111.059 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 11.9 mm100 -106.65 9.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.001 0.429 . . . . 0.0 110.811 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.676 HG22 ' HG2' ' A' ' 88' ' ' GLN . 19.6 pt -137.29 173.41 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.614 0.721 . . . . 0.0 111.856 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 21.3 mmm180 -140.27 146.9 39.18 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.071 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.751 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.6 m-85 -113.75 128.15 56.3 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.386 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.618 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.5 OUTLIER -128.63 145.41 51.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.003 0.43 . . . . 0.0 110.211 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -140.96 131.44 25.32 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.039 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 t0 58.33 29.38 18.05 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.893 0.378 . . . . 0.0 111.684 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.9 69.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.089 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -114.03 134.79 22.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.054 -0.674 . . . . 0.0 111.116 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.65 149.33 33.98 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.848 2.365 . . . . 0.0 112.376 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.87 137.52 52.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -97.9 161.28 13.82 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.216 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.597 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.4 pt-20 -62.22 -20.91 64.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.093 0.473 . . . . 0.0 112.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -76.33 -6.89 53.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.251 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' OD1' ' HG2' ' A' ' 75' ' ' GLN . 1.7 m-20 -103.22 166.85 10.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.136 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -116.84 159.89 38.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 78' ' ' MET . 35.3 Cg_endo -66.52 -8.71 21.72 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.506 2.137 . . . . 0.0 111.912 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.99 -13.09 25.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.303 0.573 . . . . 0.0 110.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.412 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 2.3 tp-100 -68.26 -35.49 77.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.511 0.672 . . . . 0.0 110.16 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.472 HD21 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -110.52 1.19 18.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.366 -179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 54.16 61.73 2.91 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.382 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.8 ptp -77.18 164.39 25.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 110.734 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 38.1 tt0 -95.09 161.58 14.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.128 -175.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.54 134.56 53.62 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.061 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 70.05 19.67 6.74 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.836 0.855 . . . . 0.0 111.555 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t0 -71.49 176.14 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.429 . . . . 0.0 110.111 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.46 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.5 m -131.32 150.26 52.22 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.22 0.534 . . . . 0.0 111.246 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.46 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.19 136.69 58.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.618 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 19.4 m-20 -89.83 138.07 31.8 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.041 0.448 . . . . 0.0 110.833 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -122.7 139.56 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.98 151.28 45.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.676 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.4 mt-30 . . . . . 0 CA--C 1.512 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.998 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 45.8 p-80 . . . . . 0 N--CA 1.437 -1.119 0 CA-C-O 120.886 0.374 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.44 170.51 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.369 0.604 . . . . 0.0 111.332 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.437 ' O ' HD22 ' A' ' 20' ' ' LEU . 23.6 m-80 -96.77 142.32 28.93 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.56 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -130.49 162.31 29.49 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.987 0.422 . . . . 0.0 109.889 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.2 mtpt -136.3 145.52 45.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.102 0.477 . . . . 0.0 110.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.6 t -125.56 116.67 47.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.156 0.503 . . . . 0.0 109.961 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.9 122.55 35.38 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.53 159.61 32.18 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -64.13 -11.9 34.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.166 0.508 . . . . 0.0 111.775 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -80.36 -15.51 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.356 0.598 . . . . 0.0 110.072 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 4.99 48.29 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.072 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 t -99.61 160.05 14.58 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.25 136.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.468 0.651 . . . . 0.0 111.496 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.74 HG21 ' HG3' ' A' ' 50' ' ' ARG . 7.4 p -102.28 142.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -113.64 125.04 53.71 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 22' ' ' VAL . 12.2 p90 -146.42 167.98 22.28 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.533 -174.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 40.8 mtmt -114.99 134.16 55.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 111.255 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.0 tt -144.71 150.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.106 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.8 mtmt -81.03 163.89 22.89 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.863 -0.523 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 22.4 mmm-85 -70.74 -40.24 72.84 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 110.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -91.8 5.97 47.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.568 0.699 . . . . 0.0 110.517 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.8 m -90.98 130.4 40.6 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.14 149.01 92.68 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.049 2.499 . . . . 0.0 113.233 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 43' ' ' LEU . 83.7 mt -64.05 -12.59 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.406 0.683 . . . . 0.0 111.994 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 13.5 t . . . . . 0 C--O 1.239 0.519 0 CA-C-O 120.86 0.362 . . . . 0.0 110.991 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 44' ' ' MET . 2.4 tt . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.32 0.581 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.614 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 28.1 mtt -60.04 -47.28 86.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.369 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.0 tppt? -63.08 -41.87 99.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.752 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.73 74.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.958 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.67 -39.8 95.06 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.157 0.503 . . . . 0.0 110.71 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 58' ' ' ILE . 70.7 m -67.68 -34.87 77.77 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 16.2 mm-40 -70.72 -33.99 71.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.2 0.524 . . . . 0.0 110.505 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.74 ' HG3' HG21 ' A' ' 30' ' ' VAL . 15.9 mmt180 -65.45 -49.01 70.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.302 0.572 . . . . 0.0 110.511 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.63 -20.76 35.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.674 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.83 14.25 79.95 Favored Glycine 0 C--N 1.321 -0.269 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.371 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.99 178.54 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.451 0.643 . . . . 0.0 112.25 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.0 m -100.36 129.57 46.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.759 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.505 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.7 ptp -63.13 -24.04 67.71 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.119 0.485 . . . . 0.0 112.087 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -78.91 -12.48 60.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.351 0.596 . . . . 0.0 111.142 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -99.33 -0.29 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.146 0.498 . . . . 0.0 110.999 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.523 HD11 ' SG ' ' A' ' 48' ' ' CYS . 29.2 pt -132.77 169.9 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.229 0.537 . . . . 0.0 111.567 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 17.7 mmm180 -138.83 146.88 41.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.988 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.614 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.1 m-85 -112.72 130.73 55.96 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.825 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.625 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -130.71 145.22 51.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 0.0 110.66 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -146.51 135.79 22.77 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 60.88 28.04 17.83 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.427 0.632 . . . . 0.0 110.743 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.18 -1.2 70.94 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.445 -1.359 . . . . 0.0 113.51 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -118.53 139.84 27.5 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 117.527 0.664 . . . . 0.0 110.853 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.81 145.66 36.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.341 2.028 . . . . 0.0 111.577 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.7 137.58 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-O 121.543 0.687 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.53 154.25 17.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.544 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.584 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.2 pt-20 -61.7 -18.04 58.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.522 . . . . 0.0 112.325 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -79.51 -15.65 57.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.021 0.439 . . . . 0.0 111.278 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.39 164.07 15.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.942 0.401 . . . . 0.0 111.345 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -118.04 155.18 51.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.221 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.45 -11.35 29.97 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.754 2.303 . . . . 0.0 112.243 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.93 -14.81 24.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.896 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -69.31 -38.79 78.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.438 0.637 . . . . 0.0 110.168 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -104.92 1.28 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.432 0.634 . . . . 0.0 110.15 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 50.85 60.83 3.59 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.784 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.56 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -77.0 163.6 26.55 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.5 tp10 -92.96 161.83 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.453 . . . . 0.0 110.814 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.36 138.65 51.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.286 0.565 . . . . 0.0 111.215 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 73.03 19.45 3.69 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.413 1.085 . . . . 0.0 110.9 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -72.82 175.35 6.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.731 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.459 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.2 m -133.33 147.26 51.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.578 0.704 . . . . 0.0 111.506 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.459 HD12 ' C ' ' A' ' 83' ' ' THR . 2.5 mp -121.4 137.87 53.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.625 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 13.4 m-20 -88.73 136.38 33.03 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.1 0.476 . . . . 0.0 111.022 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -120.88 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-O 121.465 0.65 . . . . 0.0 110.609 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.6 p90 -137.94 147.15 44.06 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.305 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.459 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 121.191 0.52 . . . . 0.0 109.9 -175.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 15.8 p80 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 120.989 0.423 . . . . 0.0 111.852 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 pt -129.66 169.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.353 -0.842 . . . . 0.0 112.125 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.57 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.3 m-80 -103.87 144.49 31.44 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.215 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.3 mm? -135.23 160.69 37.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.336 0.589 . . . . 0.0 110.936 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.2 mtpt -135.93 148.32 48.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG23 ' CE1' ' A' ' 32' ' ' PHE . 96.9 t -125.38 119.32 55.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.244 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.75 119.9 35.06 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.338 0.59 . . . . 0.0 110.222 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.84 157.98 32.96 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.9 pp0? -64.43 -16.41 62.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.276 0.56 . . . . 0.0 111.369 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.98 -10.95 58.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 0.0 110.916 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.59 30.41 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.31 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -105.43 155.6 18.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.3 p -141.01 134.11 31.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.384 0.611 . . . . 0.0 110.958 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 85.9 t -107.24 138.45 33.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.99 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -110.11 131.75 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 22' ' ' VAL . 7.1 p90 -155.9 170.07 22.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.305 0.574 . . . . 0.0 111.887 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -116.45 138.38 51.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.744 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' CG2' HD23 ' A' ' 20' ' ' LEU . 15.5 tt -143.52 150.52 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.103 0.477 . . . . 0.0 110.069 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 25.8 mtmm -86.47 158.39 19.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.408 ' NH2' ' HA ' ' A' ' 74' ' ' ALA . 24.0 mmm-85 -63.25 -38.29 90.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.647 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -95.47 9.41 40.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.027 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.9 m -93.95 128.34 41.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.378 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.0 149.42 89.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.685 2.256 . . . . 0.0 112.925 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD2' HD13 ' A' ' 43' ' ' LEU . 83.8 mt -63.91 -11.71 30.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.971 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 21.9 p . . . . . 0 C--O 1.236 0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt . . . . . 0 C--O 1.237 0.431 0 CA-C-O 121.135 0.493 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.63 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 34.0 mtt -62.32 -46.57 88.15 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.227 0.537 . . . . 0.0 110.648 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.711 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 17.6 tppt? -64.99 -41.44 95.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.793 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.586 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.39 -50.96 71.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.796 0.332 . . . . 0.0 110.655 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.17 -42.34 99.37 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.362 0.601 . . . . 0.0 110.262 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.711 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.09 -40.17 88.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.958 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 7.8 mt-10 -73.38 -33.51 65.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.866 0.365 . . . . 0.0 111.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 50' ' ' ARG . 7.1 mmp_? -65.44 -47.71 75.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.314 0.578 . . . . 0.0 110.417 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -78.96 -22.12 46.16 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.124 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.79 2.6 78.37 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.975 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.86 176.27 7.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.459 0.647 . . . . 0.0 112.47 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.4 m -97.52 136.68 37.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.651 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 6.5 ptp -68.09 -26.64 65.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.158 0.504 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -75.17 -10.28 59.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.407 0.623 . . . . 0.0 110.665 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -102.66 5.67 39.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.231 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 88' ' ' GLN . 28.6 pt -138.8 176.66 6.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.118 0.485 . . . . 0.0 110.983 -177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.419 HH21 ' HB2' ' A' ' 66' ' ' PRO . 22.7 mmm180 -146.94 148.03 31.34 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.631 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.6 m-85 -114.55 132.33 56.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.789 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.625 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -131.0 142.58 50.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.46 0.648 . . . . 0.0 111.028 177.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -146.55 140.1 25.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t70 64.44 25.35 13.32 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.068 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.41 -0.39 64.34 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 119.819 -1.181 . . . . 0.0 113.161 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -120.79 143.3 36.27 Favored Pre-proline 0 N--CA 1.445 -0.695 0 O-C-N 122.134 -0.627 . . . . 0.0 110.808 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HB2' HH21 ' A' ' 59' ' ' ARG . 58.3 Cg_endo -72.62 148.7 47.87 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 122.233 1.956 . . . . 0.0 111.716 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.29 137.09 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-O 121.334 0.588 . . . . 0.0 110.648 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.19 156.24 16.96 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -60.66 -20.15 60.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.183 0.516 . . . . 0.0 112.062 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -79.54 -10.95 59.89 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.22 162.73 14.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.679 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -118.45 158.63 46.43 Favored Pre-proline 0 C--N 1.307 -1.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.16 -6.04 13.77 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.649 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . . . -95.42 -14.07 24.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.557 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -68.06 -37.02 80.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.444 0.64 . . . . 0.0 110.102 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.468 HD21 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -111.75 1.72 16.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.546 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 53.11 60.36 3.82 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.9 ptp -78.72 167.37 21.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.855 0.36 . . . . 0.0 110.534 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 80' ' ' ASP . 43.1 tt0 -93.29 165.64 12.7 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.095 0.474 . . . . 0.0 110.568 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 3.9 p-10 -77.25 137.87 39.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.063 0.459 . . . . 0.0 110.036 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.13 16.72 4.21 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.356 1.062 . . . . 0.0 111.317 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.07 176.43 3.81 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.6 m -136.41 151.04 49.09 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 121.805 -0.56 . . . . 0.0 111.004 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 61' ' ' ARG . 2.8 mp -120.81 144.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.625 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.5 t0 -88.87 130.96 35.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.146 0.498 . . . . 0.0 110.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.48 134.89 60.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.653 0.739 . . . . 0.0 111.046 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.411 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 4.3 p90 -135.65 145.96 47.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.317 -0.809 0 CA-C-O 121.085 0.469 . . . . 0.0 110.659 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 21.5 p-80 . . . . . 0 N--CA 1.429 -1.518 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.7 pt -104.22 168.8 2.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-O 121.662 0.744 . . . . 0.0 112.217 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.9 m-80 -101.47 144.93 29.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.948 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -132.28 161.78 32.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.233 0.539 . . . . 0.0 110.459 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.0 mtpt -135.76 147.64 48.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.759 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 32' ' ' PHE . 79.3 t -127.48 113.91 33.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 121.082 0.468 . . . . 0.0 110.294 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.07 123.02 34.21 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.778 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.01 163.75 29.47 Favored Glycine 0 N--CA 1.418 -2.545 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -12.08 59.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.574 0.702 . . . . 0.0 111.28 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.41 -13.15 58.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.734 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.73 9.3 56.5 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.764 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -103.28 155.39 18.49 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.32 130.71 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.635 0.731 . . . . 0.0 111.377 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 94.2 t -101.81 135.85 36.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.325 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -108.44 128.82 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.2 p90 -151.42 169.7 21.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.216 0.531 . . . . 0.0 111.528 -174.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -115.46 138.21 51.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.842 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tt -145.54 149.31 16.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 30.5 mtmt -83.62 159.86 21.5 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.504 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 25.3 mmm-85 -69.46 -36.03 76.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.165 0.507 . . . . 0.0 110.594 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.99 5.95 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.272 0.558 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.2 m -91.29 131.57 36.23 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.321 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.45 147.89 93.0 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 70.9 mt -64.54 -13.44 52.67 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.408 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.238 0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 111.7 179.733 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.476 HD13 HD22 ' A' ' 40' ' ' LEU . 3.9 tt . . . . . 0 C--O 1.238 0.496 0 CA-C-O 120.822 0.344 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -60.56 -39.45 87.99 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.513 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 tppp? -68.72 -43.11 76.66 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.2 -51.15 65.33 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.78 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -64.68 -39.9 94.47 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.18 83.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 5.9 mm-40 -72.23 -35.36 68.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.273 0.558 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 27.6 mmm180 -69.43 -45.55 68.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.392 0.615 . . . . 0.0 111.402 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -83.12 -21.74 33.54 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.676 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.09 89.78 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.908 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.79 178.04 7.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.912 0.386 . . . . 0.0 111.502 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.8 m -96.87 124.67 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.17 -27.77 64.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -79.05 -9.47 59.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.218 0.532 . . . . 0.0 111.622 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -102.48 2.11 35.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.556 0.693 . . . . 0.0 110.617 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.529 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.9 pt -130.78 170.68 19.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.235 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 16.2 mmm180 -140.51 147.27 39.29 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.252 0.549 . . . . 0.0 111.253 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.2 m-85 -113.26 129.16 56.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.112 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.598 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.2 ppt_? -132.86 136.38 46.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 111.468 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -136.23 137.31 40.68 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 60.89 29.8 19.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.324 0.583 . . . . 0.0 111.134 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.51 67.99 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.197 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.03 139.78 31.02 Favored Pre-proline 0 C--N 1.323 -0.576 0 O-C-N 122.175 -0.603 . . . . 0.0 111.251 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 151.28 44.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.413 2.075 . . . . 0.0 111.851 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.88 136.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.353 0.597 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.71 154.51 17.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.508 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -59.11 -20.6 54.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.395 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.5 p -80.29 -10.37 59.75 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.304 0.573 . . . . 0.0 111.399 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.78 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 p -113.31 155.15 44.98 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.004 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -66.47 -7.77 18.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.56 2.173 . . . . 0.0 111.879 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.98 -16.61 22.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.929 0.395 . . . . 0.0 110.618 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -68.97 -40.65 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.628 . . . . 0.0 110.49 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.488 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.83 -1.14 38.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.487 0.66 . . . . 0.0 110.205 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 60.07 3.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.929 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.1 ptp -79.83 165.17 22.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 175.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.608 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 13.0 pt-20 -100.73 169.51 8.97 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.146 0.498 . . . . 0.0 112.203 -175.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.64 133.3 50.84 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.894 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 69.24 18.63 8.07 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.508 0.723 . . . . 0.0 111.61 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.608 ' OD2' ' HG2' ' A' ' 79' ' ' GLU . 4.0 t0 -67.92 174.77 3.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.1 m -133.11 150.51 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.687 -0.633 . . . . 0.0 110.899 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.57 145.98 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.0 t70 -92.71 133.63 35.82 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.028 0.442 . . . . 0.0 110.521 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.61 137.13 54.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.7 0.762 . . . . 0.0 110.644 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -137.54 148.15 45.72 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.582 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HG2' HG22 ' A' ' 58' ' ' ILE . 7.0 mt-30 . . . . . 0 C--N 1.313 -1.009 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 50.1 p-80 . . . . . 0 N--CA 1.443 -0.793 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.56 169.37 20.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.326 0.584 . . . . 0.0 111.56 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.453 ' O ' HD22 ' A' ' 20' ' ' LEU . 19.3 m-80 -98.94 143.2 29.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.634 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.8 mm? -129.96 163.86 25.52 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.084 0.468 . . . . 0.0 110.026 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 55.6 mtpt -135.73 147.61 48.51 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 32' ' ' PHE . 69.6 t -126.53 117.23 47.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.169 0.509 . . . . 0.0 110.264 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.72 121.42 32.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.758 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.85 159.13 30.06 Favored Glycine 0 N--CA 1.42 -2.398 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.17 58.74 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.358 0.599 . . . . 0.0 111.679 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.76 -12.38 60.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.429 0.633 . . . . 0.0 110.499 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 8.46 57.67 Favored Glycine 0 C--N 1.321 -0.28 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.807 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -99.28 159.57 14.9 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.66 135.46 30.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-O 121.483 0.658 . . . . 0.0 111.274 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 14.6 p -104.98 138.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.063 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -108.78 125.62 52.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CE1' HG23 ' A' ' 22' ' ' VAL . 15.7 p90 -147.29 168.82 20.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.228 0.537 . . . . 0.0 111.446 -174.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -112.26 141.18 46.28 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.056 0.455 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.402 ' CG2' HD23 ' A' ' 20' ' ' LEU . 14.9 tt -148.2 148.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.088 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.5 mtmm -85.05 157.79 20.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.762 -0.586 . . . . 0.0 110.418 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.53 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 17.3 mmm-85 -64.28 -41.18 97.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.501 . . . . 0.0 110.803 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -89.92 7.42 37.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.421 0.629 . . . . 0.0 110.461 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 19.1 m -93.94 130.27 35.12 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 148.57 91.13 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.818 2.345 . . . . 0.0 113.123 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 43' ' ' LEU . 82.6 mt -62.76 -12.28 23.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.513 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 12.8 t . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 122.609 0.364 . . . . 0.0 111.065 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 44' ' ' MET . 2.6 tt . . . . . 0 C--O 1.236 0.349 0 CA-C-O 121.249 0.547 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.589 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 36.4 mtt -61.86 -40.17 94.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.377 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.3 tppp? -66.71 -44.32 81.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.54 -51.58 66.58 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.11 -40.42 95.85 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.003 0.43 . . . . 0.0 111.111 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -42.01 96.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.2 mm-40 -65.21 -39.65 93.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.852 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.8 mmp_? -65.61 -54.2 31.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.188 0.518 . . . . 0.0 111.51 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -21.41 59.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.184 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.08 87.74 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -86.99 177.45 7.23 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.404 -0.468 . . . . 0.0 110.734 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 m -100.25 128.05 46.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.641 0.258 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -64.35 -24.25 67.58 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.547 . . . . 0.0 111.247 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -77.67 -14.71 59.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.53 . . . . 0.0 110.778 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -99.85 1.0 42.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.156 0.503 . . . . 0.0 111.23 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.462 HG22 ' HG2' ' A' ' 88' ' ' GLN . 29.9 pt -130.71 173.03 15.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 22.0 mmm180 -141.12 149.83 42.06 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.741 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-85 -114.34 132.17 56.28 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.544 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.6 ppt_? -134.25 140.5 46.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 0.0 110.993 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -139.51 138.21 36.15 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.707 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.47 33.82 21.77 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.175 0.512 . . . . 0.0 112.107 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.1 -6.32 67.79 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.758 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.23 145.18 37.81 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 122.13 -0.629 . . . . 0.0 111.045 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.05 151.61 35.1 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.386 2.057 . . . . 0.0 111.179 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.44 141.33 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.458 0.647 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 154.2 17.36 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.589 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.4 pt-20 -62.17 -16.34 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.2 p -79.55 -18.63 51.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.203 0.525 . . . . 0.0 110.874 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 75' ' ' GLN . 0.3 OUTLIER -83.08 161.2 21.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.1 p -117.16 158.42 44.45 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.722 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 78' ' ' MET . 38.1 Cg_endo -68.27 -8.66 23.56 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.113 1.875 . . . . 0.0 111.529 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.38 -19.56 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.609 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.446 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 3.0 tp-100 -62.45 -36.31 82.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.42 0.628 . . . . 0.0 110.307 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.461 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.54 -0.3 20.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 51.05 63.09 2.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.507 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.634 ' SD ' HD11 ' A' ' 20' ' ' LEU . 12.1 ptp -77.44 175.47 9.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.825 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -96.19 157.84 15.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.39 143.32 48.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.438 0.637 . . . . 0.0 111.17 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 69.93 20.19 6.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.06 176.92 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.419 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.4 m -133.43 151.58 51.82 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 83' ' ' THR . 3.2 mp -124.19 142.51 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 30.0 t70 -89.42 136.83 32.8 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.2 137.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.631 0.729 . . . . 0.0 110.691 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -138.22 149.11 45.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.703 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HG2' HG22 ' A' ' 58' ' ' ILE . 5.3 mt-30 . . . . . 0 C--N 1.32 -0.681 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.611 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 11.6 p80 . . . . . 0 N--CA 1.435 -1.216 0 CA-C-O 120.782 0.325 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.05 169.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.516 0.674 . . . . 0.0 112.756 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD22 ' A' ' 20' ' ' LEU . 9.5 m-80 -99.35 139.91 34.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.43 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.529 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -131.69 159.91 37.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.211 0.529 . . . . 0.0 110.296 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -134.53 148.39 50.5 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.494 HG23 ' CE1' ' A' ' 32' ' ' PHE . 70.2 t -126.64 117.19 47.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.163 0.506 . . . . 0.0 109.986 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.14 119.29 31.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.95 158.33 30.41 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.453 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -66.24 -10.51 42.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.506 0.67 . . . . 0.0 110.886 -179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -76.53 -15.5 59.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.329 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 14.23 37.16 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.543 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t -119.59 166.25 13.39 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.23 137.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.171 0.51 . . . . 0.0 111.282 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.516 HG11 ' HG3' ' A' ' 50' ' ' ARG . 96.6 t -102.95 139.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.904 176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -110.24 130.33 55.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CE1' HG23 ' A' ' 22' ' ' VAL . 6.0 p90 -150.86 168.91 23.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.181 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -117.27 133.98 55.34 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 16.9 tt -135.2 150.1 29.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 12.8 mttt -86.92 151.44 23.3 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.082 0.468 . . . . 0.0 110.847 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -61.72 -40.1 93.86 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.241 0.543 . . . . 0.0 110.805 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -87.73 6.17 36.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.289 0.566 . . . . 0.0 111.353 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.6 m -96.81 131.77 27.32 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.84 154.89 71.84 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.931 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 43' ' ' LEU . 95.4 mt -66.76 -11.25 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.771 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.24 0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.948 178.817 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.537 HD13 HD22 ' A' ' 40' ' ' LEU . 3.1 tt . . . . . 0 C--O 1.236 0.377 0 CA-C-O 121.306 0.574 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.656 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -60.81 -50.36 73.76 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.402 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.682 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 18.3 tppt? -60.84 -43.1 98.74 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.84 -52.79 61.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.047 0.451 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -61.03 -43.96 98.11 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.333 0.587 . . . . 0.0 110.503 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.4 m -61.02 -39.79 91.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.545 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.0 mt-10 -66.65 -33.82 76.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.054 0.454 . . . . 0.0 110.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.516 ' HG3' HG11 ' A' ' 30' ' ' VAL . 10.8 mmm180 -67.65 -48.74 65.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.143 0.497 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -80.76 -22.7 39.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.069 0.461 . . . . 0.0 111.533 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.23 72.6 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.023 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.73 177.01 6.85 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.177 -0.602 . . . . 0.0 112.266 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.8 m -99.89 140.24 34.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.45 -25.9 66.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -75.53 -10.7 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.159 0.504 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -101.41 4.32 41.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 0.0 110.933 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.524 HD11 ' SG ' ' A' ' 48' ' ' CYS . 31.3 pt -139.92 174.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.289 0.566 . . . . 0.0 111.701 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -141.25 145.02 35.02 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.656 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.7 m-85 -113.43 131.57 55.97 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.673 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.612 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.53 141.78 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.589 . . . . 0.0 111.209 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -145.5 142.76 29.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.353 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 t70 60.64 25.67 15.4 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 120.96 0.409 . . . . 0.0 110.998 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.45 72.28 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.094 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -120.34 145.11 39.68 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.165 -0.609 . . . . 0.0 111.426 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.73 147.9 40.67 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 122.371 2.047 . . . . 0.0 111.181 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.05 136.52 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.255 0.55 . . . . 0.0 111.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -95.51 152.17 18.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.04 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.739 ' OE2' HG23 ' A' ' 70' ' ' THR . 0.2 OUTLIER -53.46 -21.48 6.24 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.739 HG23 ' OE2' ' A' ' 69' ' ' GLU . 40.6 p -74.16 -15.6 61.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.341 0.591 . . . . 0.0 111.661 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 55.9 m-20 -85.99 159.25 19.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -119.8 155.4 54.96 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.62 -7.64 19.95 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 112.336 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.88 -28.19 15.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.945 0.402 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -60.96 -39.62 90.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.5 . . . . 0.0 111.478 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.7 0.76 33.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 50.98 61.0 3.47 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.153 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.529 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.8 ptp -77.02 168.97 19.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -88.02 164.98 15.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.974 0.416 . . . . 0.0 110.169 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.24 141.37 31.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.626 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 73.67 14.4 4.21 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.074 0.95 . . . . 0.0 110.649 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.96 175.51 3.66 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.421 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.401 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.4 m -133.69 150.62 51.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.272 0.558 . . . . 0.0 111.193 -176.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.94 144.81 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.612 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 38.7 t70 -92.17 134.31 34.98 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.077 0.465 . . . . 0.0 110.775 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.52 135.21 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.809 0.814 . . . . 0.0 111.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -138.61 149.5 45.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.163 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.511 ' HG2' HG22 ' A' ' 58' ' ' ILE . 5.0 mt-30 . . . . . 0 C--N 1.319 -0.741 0 CA-C-O 121.452 0.644 . . . . 0.0 110.63 -177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 36.1 p-80 . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.39 170.05 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.133 0.492 . . . . 0.0 110.639 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.523 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.9 m-80 -100.22 144.87 28.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -133.43 162.68 31.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.094 0.473 . . . . 0.0 110.483 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 83' ' ' THR . 58.5 mtpt -137.39 147.5 45.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG23 ' CE1' ' A' ' 32' ' ' PHE . 76.3 t -125.17 120.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.951 0.405 . . . . 0.0 110.411 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.28 122.54 38.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.597 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.0 160.8 30.03 Favored Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -21.1 65.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.428 0.632 . . . . 0.0 111.022 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.44 -16.5 62.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.477 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.04 49.93 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.675 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 t -101.91 157.54 16.78 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 8.2 p -139.99 137.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.561 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.4 p -109.43 142.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -112.85 127.01 56.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.323 0.582 . . . . 0.0 109.542 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' HG23 ' A' ' 22' ' ' VAL . 13.4 p90 -151.04 168.73 23.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.284 0.564 . . . . 0.0 111.561 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -112.51 142.86 44.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.697 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.426 ' CG2' HD23 ' A' ' 20' ' ' LEU . 16.1 tt -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.078 0.466 . . . . 0.0 110.192 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.4 mtmt -83.97 158.45 21.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.874 -0.516 . . . . 0.0 110.738 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.714 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 26.1 mmm-85 -65.45 -38.98 91.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 110.485 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.4 6.86 43.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.313 0.578 . . . . 0.0 110.538 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.0 m -93.93 130.03 35.9 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.78 151.16 85.13 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.886 2.39 . . . . 0.0 112.89 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.483 HD22 HD13 ' A' ' 43' ' ' LEU . 86.8 mt -64.26 -11.77 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.237 0.413 0 CA-C-O 120.924 0.392 . . . . 0.0 111.364 178.877 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD13 HD22 ' A' ' 40' ' ' LEU . 3.0 tt . . . . . 0 C--O 1.236 0.369 0 CA-C-O 121.158 0.504 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.625 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.1 mtt -61.54 -41.8 97.88 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.719 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 18.1 tppt? -68.13 -41.59 81.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -47.45 85.82 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.15 0.5 . . . . 0.0 110.957 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -65.01 -40.19 94.52 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.248 0.547 . . . . 0.0 110.693 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.719 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.97 -36.7 80.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.277 -177.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.2 mm-40 -74.46 -39.74 62.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.229 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.561 ' HG3' HG21 ' A' ' 30' ' ' VAL . 17.0 mmt180 -64.04 -46.8 82.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.217 0.532 . . . . 0.0 111.437 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.46 -16.64 51.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.58 57.28 5.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.535 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.44 175.58 10.7 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.749 0.309 . . . . 0.0 110.253 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 58.3 m -99.93 132.2 45.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.762 0.315 . . . . 0.0 110.984 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.9 ptp -63.74 -26.05 68.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 111.088 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 7.6 ptm180 -74.72 -13.38 60.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.999 0.428 . . . . 0.0 111.347 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -103.25 6.92 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.143 0.497 . . . . 0.0 111.381 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.495 HG22 ' HG2' ' A' ' 88' ' ' GLN . 23.2 pt -133.36 170.31 20.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.122 0.487 . . . . 0.0 111.241 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 6.7 mmm180 -138.1 140.2 39.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.397 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.3 m-85 -108.75 131.36 55.02 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 5.4 ppt_? -131.69 140.93 49.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -141.75 138.8 32.58 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.5 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.94 28.78 18.34 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.45 -3.57 77.4 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.545 -1.312 . . . . 0.0 113.316 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -123.45 144.89 45.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 O-C-N 121.899 -0.765 . . . . 0.0 111.637 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.57 150.44 40.38 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.665 2.244 . . . . 0.0 112.014 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 138.95 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 121.713 0.768 . . . . 0.0 111.267 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.47 154.91 18.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.589 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.602 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.6 pt-20 -62.49 -18.29 61.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.097 0.475 . . . . 0.0 112.227 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -79.63 -14.77 58.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.288 0.566 . . . . 0.0 111.283 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.2 158.61 21.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.001 0.429 . . . . 0.0 110.151 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 p -118.69 151.58 50.16 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.512 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.43 -9.05 18.75 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.47 2.113 . . . . 0.0 112.111 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.68 -20.46 18.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.424 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -69.68 -36.14 75.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.144 0.497 . . . . 0.0 110.814 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.49 -0.34 24.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.344 0.592 . . . . 0.0 110.224 178.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 48.95 62.5 2.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.9 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ptp -74.3 166.62 23.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.09 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 39.1 tt0 -87.75 157.02 19.15 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.114 0.483 . . . . 0.0 110.849 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -72.81 139.4 47.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.118 0.485 . . . . 0.0 110.066 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 71.13 15.93 6.42 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.069 0.948 . . . . 0.0 110.594 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -70.37 176.68 3.82 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.448 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -130.14 147.26 51.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.4 0.619 . . . . 0.0 111.45 -177.207 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.82 133.97 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 2.5 m-20 -86.31 136.31 33.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.045 0.45 . . . . 0.0 111.088 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -123.87 140.36 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.382 0.611 . . . . 0.0 111.145 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.66 147.01 44.54 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.588 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.495 ' HG2' HG22 ' A' ' 58' ' ' ILE . 7.4 mt-30 . . . . . 0 C--N 1.316 -0.867 0 CA-C-O 121.36 0.6 . . . . 0.0 111.107 -176.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 36.5 p-80 . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 120.999 0.428 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.5 pt -128.59 169.08 20.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.332 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.507 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.9 m-80 -97.46 144.61 27.02 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -132.75 160.77 35.86 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.292 0.568 . . . . 0.0 110.779 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.8 mtpt -136.11 148.84 48.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.789 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.46 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.8 t -129.16 116.6 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 120.955 0.407 . . . . 0.0 110.171 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.54 128.03 35.55 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.9 156.87 22.59 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -64.45 -11.55 34.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.493 0.663 . . . . 0.0 110.879 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.55 -19.29 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.211 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 9.36 36.33 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.297 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 t -113.45 157.36 22.05 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 122.296 -0.532 . . . . 0.0 109.899 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.44 135.02 58.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.425 0.631 . . . . 0.0 111.258 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 50' ' ' ARG . 14.4 p -101.78 142.09 16.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 122.118 -0.364 . . . . 0.0 110.263 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -112.03 130.93 55.7 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.107 0.48 . . . . 0.0 109.73 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 22' ' ' VAL . 9.5 p90 -151.37 168.37 25.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.438 -175.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 41.8 mtmt -113.87 136.5 52.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.862 0.363 . . . . 0.0 110.818 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tt -142.62 147.09 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.049 0.452 . . . . 0.0 110.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 27.1 mtmm -85.14 157.62 20.62 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 121.083 0.468 . . . . 0.0 111.376 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -63.16 -41.52 99.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.704 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -88.73 6.86 36.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.322 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 13.6 m -93.99 130.12 35.51 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.87 151.32 84.49 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.696 2.264 . . . . 0.0 112.655 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 43' ' ' LEU . 87.3 mt -66.64 -13.19 60.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.296 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 14.4 m . . . . . 0 C--O 1.241 0.624 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 HD22 ' A' ' 40' ' ' LEU . 4.0 tt . . . . . 0 C--O 1.237 0.408 0 CA-C-O 120.755 0.312 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -58.51 -50.24 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.963 0.411 . . . . 0.0 110.601 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.7 tppp? -62.82 -37.92 88.69 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.402 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.25 -49.8 76.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.451 . . . . 0.0 110.531 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.05 -40.5 96.43 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.025 0.441 . . . . 0.0 111.036 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.1 m -63.15 -34.98 78.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 110.997 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.5 mm-40 -71.55 -41.79 68.68 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.789 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.6 mmp_? -66.48 -47.15 73.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.353 0.597 . . . . 0.0 111.303 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -81.16 -16.61 52.42 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.895 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.78 57.77 5.2 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.606 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.92 173.6 12.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.666 -0.314 . . . . 0.0 110.425 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -98.87 133.73 42.74 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.756 0.312 . . . . 0.0 111.698 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.483 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 9.5 ptp -65.06 -26.36 68.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.078 0.466 . . . . 0.0 111.269 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -74.66 -6.24 47.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.238 0.542 . . . . 0.0 110.836 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -109.35 5.17 23.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.932 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.724 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.7 pt -137.19 171.99 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.188 0.518 . . . . 0.0 111.177 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 24.2 mmt180 -142.6 147.91 36.61 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.265 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.423 ' HB3' HG21 ' A' ' 84' ' ' ILE . 9.0 m-85 -114.28 128.22 56.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.121 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.8 ppt_? -130.26 136.8 49.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 84' ' ' ILE . 81.9 t80 -138.69 133.14 31.92 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.548 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 65.06 26.3 12.58 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.064 0.459 . . . . 0.0 110.57 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.85 -5.13 76.94 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.242 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.05 142.91 34.31 Favored Pre-proline 0 C--N 1.322 -0.603 0 O-C-N 122.054 -0.674 . . . . 0.0 111.381 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 144.55 29.76 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.538 2.159 . . . . 0.0 111.955 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.62 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.589 0.709 . . . . 0.0 110.674 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.21 156.84 18.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.96 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.37 -26.49 61.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.134 0.492 . . . . 0.0 112.176 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.2 p -74.29 -17.2 60.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.072 0.463 . . . . 0.0 111.223 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -78.87 158.4 28.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.195 0.521 . . . . 0.0 111.005 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -117.33 153.11 49.97 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.69 -7.35 19.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.449 2.099 . . . . 0.0 112.018 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.23 -23.06 17.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.095 0.474 . . . . 0.0 110.608 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -62.54 -39.46 93.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.391 0.615 . . . . 0.0 110.561 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.71 1.48 23.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.863 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 49.16 62.65 2.5 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.658 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -76.23 170.44 16.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -88.06 163.91 16.01 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.394 0.616 . . . . 0.0 111.237 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.46 138.83 34.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 72.36 13.46 5.55 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.963 0.905 . . . . 0.0 110.246 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.08 172.8 5.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.92 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.1 m -132.1 151.56 51.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.281 0.562 . . . . 0.0 111.355 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -123.85 141.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.62 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 31.8 t70 -90.82 132.32 35.95 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.907 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -116.19 134.58 59.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.555 0.693 . . . . 0.0 110.917 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -141.93 153.24 44.21 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.724 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.0 mt-30 . . . . . 0 CA--C 1.507 -0.71 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 51.7 p-80 . . . . . 0 N--CA 1.435 -1.219 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.5 pt -121.07 168.94 12.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.451 0.643 . . . . 0.0 111.657 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.505 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.7 m-80 -100.47 141.7 32.97 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.751 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.534 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.56 162.78 30.98 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.042 0.449 . . . . 0.0 110.446 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.66 149.04 49.18 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.24 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.517 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.5 t -127.36 115.6 40.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.53 118.36 29.93 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.058 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.0 156.96 30.36 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.1 pp0? -63.54 -15.44 58.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.02 -17.49 61.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.763 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.57 36.43 Favored Glycine 0 C--O 1.229 -0.178 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 t -112.41 161.72 16.37 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -138.09 136.84 44.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.452 0.644 . . . . 0.0 110.713 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 87.5 t -102.58 135.03 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -109.59 126.74 53.92 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.517 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -148.18 168.15 23.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.408 0.623 . . . . 0.0 111.755 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 38.2 mtmt -115.53 134.6 54.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.302 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 17.6 tt -139.07 149.82 23.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.6 mtmp? -87.78 155.93 19.66 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.907 -0.496 . . . . 0.0 111.187 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 28.9 mmm-85 -63.72 -34.69 78.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -96.41 6.53 48.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 110.781 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.9 m -93.65 130.79 33.95 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.49 151.65 79.65 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.717 2.278 . . . . 0.0 112.122 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.823 HD22 HD13 ' A' ' 43' ' ' LEU . 33.3 mt -65.61 -11.37 43.81 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.108 -0.497 . . . . 0.0 112.32 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 15.8 p . . . . . 0 C--O 1.239 0.523 0 CA-C-O 121.061 0.457 . . . . 0.0 111.047 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.823 HD13 HD22 ' A' ' 40' ' ' LEU . 4.3 tt . . . . . 0 C--O 1.237 0.434 0 CA-C-O 120.962 0.41 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.433 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.0 mpt? -59.72 -39.85 86.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.113 0.482 . . . . 0.0 110.589 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.8 tppp? -70.12 -40.72 74.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.024 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.9 75.66 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 110.336 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -65.44 -39.43 92.05 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.67 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.01 -38.67 86.87 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.792 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 41.8 mm-40 -67.04 -46.21 75.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.346 0.593 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -59.77 -47.68 84.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.755 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -84.34 -21.38 30.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.971 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.8 90.13 Favored Glycine 0 C--N 1.322 -0.246 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.647 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -87.39 177.22 7.18 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.995 0.426 . . . . 0.0 111.633 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.482 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 43.8 m -95.34 130.38 42.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 ptp -65.17 -24.78 67.48 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.213 0.53 . . . . 0.0 111.341 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -79.37 -12.48 59.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.361 0.6 . . . . 0.0 111.118 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.482 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 14.5 mm100 -98.72 8.24 45.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.476 0.655 . . . . 0.0 111.013 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.4 pt -137.47 174.78 10.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.803 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 26.8 mmt180 -139.77 146.31 39.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.598 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 16.8 m-85 -115.26 128.09 55.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.32 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.0 ppt_? -132.02 134.22 45.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.498 0.665 . . . . 0.0 110.866 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -128.09 131.99 49.03 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.224 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.4 31.56 7.41 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.74 83.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -124.19 136.09 27.2 Favored Pre-proline 0 C--N 1.323 -0.562 0 O-C-N 121.95 -0.735 . . . . 0.0 111.576 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.16 146.16 45.61 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.948 2.432 . . . . 0.0 111.944 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.42 136.03 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 111.714 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.97 157.69 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.613 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 4.3 pt-20 -62.87 -18.45 62.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.263 0.554 . . . . 0.0 112.198 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.7 p -80.86 -11.4 59.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.082 0.468 . . . . 0.0 111.266 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -87.52 160.02 18.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.88 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 p -117.35 155.21 50.24 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.575 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 78' ' ' MET . 43.7 Cg_endo -67.13 -12.86 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.31 2.007 . . . . 0.0 112.163 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.85 -16.99 21.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.188 0.518 . . . . 0.0 110.861 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.28 -34.55 76.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.405 0.621 . . . . 0.0 110.666 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.19 0.96 21.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.336 0.589 . . . . 0.0 110.413 177.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 50.67 59.52 4.53 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.367 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.534 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.84 170.37 15.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.08 0.467 . . . . 0.0 110.043 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -95.13 162.77 13.57 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.027 0.442 . . . . 0.0 110.532 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.27 137.37 41.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.153 0.502 . . . . 0.0 110.491 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 75.19 16.25 2.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.65 177.25 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.8 m -135.18 151.68 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.15 0.5 . . . . 0.0 111.216 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.9 142.69 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.9 t70 -93.06 132.95 36.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.027 0.442 . . . . 0.0 110.838 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.9 t -116.15 132.55 65.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.84 0.828 . . . . 0.0 111.49 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -135.33 143.29 46.07 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.634 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 121.143 0.497 . . . . 0.0 110.616 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 41.2 p-80 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 120.839 0.352 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 pt -110.74 169.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.542 0.686 . . . . 0.0 112.655 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.446 ' O ' HD22 ' A' ' 20' ' ' LEU . 25.1 m-80 -94.66 140.91 29.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.589 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.593 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -129.8 159.66 35.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.7 mtpt -134.52 147.17 50.27 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 32' ' ' PHE . 77.4 t -127.74 116.94 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.118 0.485 . . . . 0.0 110.372 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.62 31.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.591 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.03 162.25 32.36 Favored Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.201 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -16.42 63.87 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.734 0.778 . . . . 0.0 110.571 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.25 -19.45 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.98 7.87 54.72 Favored Glycine 0 C--N 1.323 -0.166 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.263 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -108.39 165.03 11.82 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.269 0.557 . . . . 0.0 110.674 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.498 HG21 ' HG3' ' A' ' 50' ' ' ARG . 10.0 p -106.32 139.62 27.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.19 124.83 53.45 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.0 p90 -147.75 167.78 23.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 -174.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -114.7 138.49 50.64 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -144.18 148.65 18.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 110.586 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.1 mtmp? -81.07 154.88 26.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.969 0.414 . . . . 0.0 110.627 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 24.3 mmm-85 -66.14 -37.47 85.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.223 0.535 . . . . 0.0 110.562 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -90.24 6.79 41.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.584 0.707 . . . . 0.0 110.49 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.536 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.7 m -94.71 131.52 30.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.79 149.94 86.4 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.804 2.336 . . . . 0.0 113.009 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.0 mt -64.56 -12.02 40.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.452 0.701 . . . . 0.0 112.132 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.0 t . . . . . 0 C--O 1.239 0.552 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 40' ' ' LEU . 2.9 tt . . . . . 0 C--O 1.235 0.338 0 CA-C-O 121.138 0.494 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.686 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -58.81 -49.47 77.56 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.101 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.677 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.2 tppt? -60.03 -43.0 95.61 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.33 -49.92 72.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.042 0.449 . . . . 0.0 110.95 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -64.17 -41.11 97.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.4 m -63.72 -33.94 76.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.515 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.8 mm-40 -71.6 -40.86 69.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.23 0.538 . . . . 0.0 110.177 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.498 ' HG3' HG21 ' A' ' 30' ' ' VAL . 10.2 mmm180 -66.21 -46.69 76.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.19 -22.11 42.25 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.009 0.433 . . . . 0.0 111.436 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.35 58.47 3.61 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.144 -1.026 . . . . 0.0 111.773 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.41 176.06 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.57 -0.37 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -95.4 130.31 42.24 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.821 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.571 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 4.2 ptp -64.5 -21.41 66.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.085 0.469 . . . . 0.0 111.84 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -83.19 -6.72 59.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 0.0 111.274 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.345 0.593 . . . . 0.0 110.725 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.582 HD11 ' SG ' ' A' ' 48' ' ' CYS . 28.8 pt -136.56 170.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 18.0 mmm180 -141.22 143.01 33.93 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.6 m-85 -110.1 134.39 52.22 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.57 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.58 ' CG ' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.295 0.569 . . . . 0.0 110.599 178.005 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -140.78 139.27 34.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.6 31.09 16.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.07 -4.09 72.99 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.943 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -119.65 140.15 28.98 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 121.955 -0.733 . . . . 0.0 111.358 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.16 146.15 45.62 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.486 2.124 . . . . 0.0 111.641 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.18 135.84 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 121.605 0.716 . . . . 0.0 111.049 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.06 155.93 18.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.335 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.589 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -61.9 -19.93 63.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.268 0.556 . . . . 0.0 111.965 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.1 p -80.2 -10.43 59.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.82 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.39 161.11 17.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 p -118.09 153.7 51.38 Favored Pre-proline 0 C--N 1.32 -0.682 0 O-C-N 122.371 -0.206 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 25.6 Cg_endo -63.99 -10.67 23.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.653 2.235 . . . . 0.0 112.328 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.24 -17.87 21.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.071 0.462 . . . . 0.0 110.962 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -69.14 -35.55 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 110.855 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.03 1.96 24.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 110.77 179.146 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 52.39 61.71 3.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.697 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.593 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.7 ptp -80.29 174.33 11.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.134 -0.354 . . . . 0.0 110.331 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -99.76 169.68 9.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.238 0.542 . . . . 0.0 111.091 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.57 138.56 36.48 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 74.32 12.37 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.056 0.942 . . . . 0.0 111.426 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.63 174.89 3.18 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.5 m -135.33 150.19 49.92 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.363 0.601 . . . . 0.0 111.536 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 61' ' ' ARG . 3.1 mp -121.32 144.33 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.58 ' HB3' ' CG ' ' A' ' 61' ' ' ARG . 25.4 t0 -92.63 138.56 31.39 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.49 137.78 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.571 0.701 . . . . 0.0 110.706 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.434 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 1.7 p90 -134.94 143.3 46.82 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.561 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.454 ' HG2' HG22 ' A' ' 58' ' ' ILE . 6.4 mt-30 . . . . . 0 N--CA 1.442 -0.869 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.872 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.551 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 17.1 p80 . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.6 pt -111.9 169.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.407 0.622 . . . . 0.0 111.666 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.2 m-80 -97.47 143.4 28.23 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.39 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -132.05 162.11 31.58 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.081 0.467 . . . . 0.0 110.054 177.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.4 mtpt -133.94 147.42 51.06 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.071 0.462 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 32' ' ' PHE . 81.1 t -127.99 117.85 47.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.87 122.15 34.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.1 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.04 157.84 28.66 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -66.42 -11.97 54.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.281 0.562 . . . . 0.0 111.242 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.61 -16.56 57.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.289 0.566 . . . . 0.0 110.51 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.73 11.28 30.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.435 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.7 t -111.34 159.07 18.32 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 122.2 -0.588 . . . . 0.0 109.516 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.33 136.17 46.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.269 0.557 . . . . 0.0 110.541 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 90.5 t -103.19 137.58 30.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.225 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -111.41 123.19 49.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CE1' HG23 ' A' ' 22' ' ' VAL . 10.5 p90 -146.5 168.58 20.86 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.181 0.515 . . . . 0.0 111.275 -174.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -112.96 140.36 47.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.081 0.467 . . . . 0.0 111.07 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.85 146.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 110.435 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.6 mtmt -81.72 157.67 24.49 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 24.5 mmm-85 -65.18 -38.93 92.07 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.813 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -90.62 6.21 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.585 0.707 . . . . 0.0 110.348 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 21.3 m -94.32 129.94 35.46 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.8 152.18 82.26 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.869 2.379 . . . . 0.0 113.036 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.474 HD22 HD13 ' A' ' 43' ' ' LEU . 84.0 mt -64.84 -12.03 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.444 0.698 . . . . 0.0 111.884 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.241 0.607 0 CA-C-O 121.082 0.467 . . . . 0.0 111.076 178.738 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD13 HD22 ' A' ' 40' ' ' LEU . 2.1 tt . . . . . 0 C--O 1.237 0.41 0 CA-C-O 121.302 0.573 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.588 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.4 mtt -61.23 -46.29 91.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -64.15 -38.65 91.81 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.75 -49.92 74.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.096 0.474 . . . . 0.0 110.464 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -63.22 -42.85 99.32 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.171 0.51 . . . . 0.0 110.68 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 79.1 m -64.57 -34.47 78.32 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.19 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.72 -42.12 91.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.3 mmm180 -65.33 -44.03 89.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.384 0.611 . . . . 0.0 111.472 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -85.93 -21.53 27.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.895 0.379 . . . . 0.0 111.653 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.1 5.67 88.91 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.014 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -90.48 177.89 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.397 -0.473 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -99.93 134.94 42.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.446 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.9 ptp -66.74 -21.85 66.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.956 0.408 . . . . 0.0 111.935 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.7 ptp85 -82.24 -9.56 59.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.117 0.484 . . . . 0.0 110.863 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -103.88 5.83 36.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.72 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.51 HG22 ' HG2' ' A' ' 88' ' ' GLN . 24.9 pt -137.48 172.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.809 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 26.2 mmm180 -140.82 145.36 36.18 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.071 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.9 m-85 -111.9 128.79 56.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.8 ppt_? -129.98 139.83 51.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.532 0.682 . . . . 0.0 111.395 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -141.94 137.33 31.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.175 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.95 27.91 14.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 110.861 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 -2.31 76.16 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.545 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -126.32 145.81 54.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.914 -0.756 . . . . 0.0 111.244 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.93 150.3 54.82 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.373 2.049 . . . . 0.0 111.899 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.26 138.3 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-O 121.502 0.668 . . . . 0.0 111.055 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.31 150.78 21.16 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.787 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.521 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -60.83 -18.56 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.404 0.621 . . . . 0.0 111.784 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -79.68 -10.89 59.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.473 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 162.12 14.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.856 0.36 . . . . 0.0 111.32 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.8 p -118.69 154.28 52.58 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.813 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.95 -9.08 21.87 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.483 2.122 . . . . 0.0 111.932 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.53 -22.31 17.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -63.76 -43.69 95.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.55 0.691 . . . . 0.0 110.222 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -101.18 0.92 38.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.853 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 53.75 56.66 6.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.822 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.97 168.99 18.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.823 0.344 . . . . 0.0 110.258 177.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.23 164.83 13.4 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.233 0.54 . . . . 0.0 111.663 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -78.85 133.34 37.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.223 0.535 . . . . 0.0 109.764 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 75.51 15.98 2.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.268 1.027 . . . . 0.0 110.819 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.34 176.05 2.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.76 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.9 m -134.21 150.84 51.08 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.649 -0.657 . . . . 0.0 111.559 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.425 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -122.7 139.75 48.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -90.51 134.66 34.21 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.101 0.477 . . . . 0.0 110.718 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.14 135.53 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.847 0.832 . . . . 0.0 111.163 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.3 146.52 46.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.515 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.51 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.31 -1.132 0 CA-C-O 121.141 0.496 . . . . 0.0 109.823 -177.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 11.0 p-80 . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 120.752 0.311 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.67 168.88 10.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.451 0.643 . . . . 0.0 111.473 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.7 m-80 -98.36 141.32 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.687 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.544 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.44 160.96 35.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.156 0.503 . . . . 0.0 110.365 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.6 mtpt -136.52 147.75 47.26 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.885 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.2 t -127.75 117.87 47.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.031 0.443 . . . . 0.0 110.804 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.22 121.24 31.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.1 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.85 159.88 28.27 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -13.77 44.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.279 0.561 . . . . 0.0 111.615 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.42 -10.4 59.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.61 10.41 57.96 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.609 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -106.96 156.73 18.41 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.71 135.55 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.315 0.579 . . . . 0.0 110.943 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG21 ' HG3' ' A' ' 50' ' ' ARG . 7.6 p -100.28 138.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.263 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.63 127.81 54.8 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE1' HG23 ' A' ' 22' ' ' VAL . 14.2 p90 -151.87 168.51 24.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.743 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -119.08 134.73 55.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -138.0 145.77 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 26.8 mtmm -79.33 153.3 29.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.206 0.527 . . . . 0.0 111.29 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -59.58 -40.02 86.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -93.18 9.35 36.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.186 0.517 . . . . 0.0 111.488 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 11.8 m -94.53 128.84 38.54 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.68 150.26 79.36 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.939 2.426 . . . . 0.0 113.625 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.2 mp -60.94 -12.63 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.168 0.987 . . . . 0.0 112.776 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.787 178.73 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.8 tt . . . . . 0 C--O 1.237 0.398 0 CA-C-O 121.295 0.569 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.695 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.6 mtt -60.34 -37.44 80.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.18 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 14.8 tppt? -68.01 -46.2 71.93 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.042 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.07 -49.17 74.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.227 0.537 . . . . 0.0 110.766 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.81 -37.77 88.75 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.105 0.479 . . . . 0.0 110.924 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -39.28 93.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.215 0.531 . . . . 0.0 110.718 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.5 mm-40 -68.41 -40.01 81.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.099 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG3' HG21 ' A' ' 30' ' ' VAL . 17.3 mmt180 -65.52 -51.45 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.333 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.69 -18.96 53.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 111.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.74 89.48 Favored Glycine 0 C--O 1.235 0.17 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.721 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.56 177.6 7.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.705 0.288 . . . . 0.0 111.059 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -96.03 123.85 39.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -23.88 66.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.141 0.496 . . . . 0.0 111.752 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -77.16 -16.05 59.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.354 0.597 . . . . 0.0 110.696 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -99.73 6.48 45.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.183 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.52 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.7 pt -132.86 168.28 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.264 0.554 . . . . 0.0 111.104 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 18.1 mmt180 -137.42 147.83 45.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.98 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.3 m-85 -115.68 132.03 56.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.649 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.7 ppt_? -132.56 135.98 46.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.487 0.66 . . . . 0.0 111.283 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -139.62 139.78 36.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.932 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.64 28.14 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.381 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.05 -6.6 78.61 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.54 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -121.48 145.59 43.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.126 -0.632 . . . . 0.0 111.306 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.33 147.18 46.75 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.354 2.036 . . . . 0.0 110.949 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.97 136.16 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 121.514 0.674 . . . . 0.0 110.78 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.87 153.29 20.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -58.82 -20.54 51.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.285 0.564 . . . . 0.0 111.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 p -83.48 -0.63 51.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.968 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -95.53 159.57 14.93 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 121.883 -0.511 . . . . 0.0 110.354 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 p -117.15 149.99 45.36 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.57 -12.97 36.12 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.511 2.14 . . . . 0.0 112.462 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.57 -10.8 28.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.305 0.574 . . . . 0.0 110.748 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -78.15 -33.11 50.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.194 0.521 . . . . 0.0 110.517 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.39 2.1 22.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.161 0.505 . . . . 0.0 110.902 178.557 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 49.42 60.77 3.53 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.544 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.2 ptp -74.44 170.49 15.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.125 0.488 . . . . 0.0 110.588 176.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 41.8 tt0 -94.64 156.92 16.2 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.46 137.65 42.71 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.342 0.592 . . . . 0.0 110.538 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 73.77 19.04 3.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.572 1.149 . . . . 0.0 111.076 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -71.4 176.57 4.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.204 177.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.87 151.61 52.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.188 0.518 . . . . 0.0 111.565 -177.286 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.07 144.57 30.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.9 t0 -93.55 134.65 35.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.49 138.66 51.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.667 0.746 . . . . 0.0 111.151 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -138.21 148.37 44.73 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.67 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' A' ' 58' ' ' ILE . 6.6 mt-30 . . . . . 0 C--N 1.319 -0.745 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.575 ' CE1' ' HD2' ' A' ' 33' ' ' LYS . 8.4 p80 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.76 167.93 11.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.516 0.674 . . . . 0.0 112.351 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.55 ' O ' HD22 ' A' ' 20' ' ' LEU . 8.5 m-80 -94.65 142.83 26.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.561 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -133.87 159.76 39.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.045 0.45 . . . . 0.0 110.199 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.9 mtpt -134.83 149.04 50.3 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 0.0 110.218 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 32' ' ' PHE . 97.2 t -128.07 117.65 46.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.085 0.469 . . . . 0.0 110.124 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.95 124.19 37.8 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.876 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.89 159.9 28.24 Favored Glycine 0 N--CA 1.425 -2.072 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.158 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -65.71 -11.96 49.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.439 0.638 . . . . 0.0 111.012 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.03 -16.95 54.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.12 12.0 40.86 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.937 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -106.06 155.4 19.45 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 139.1 41.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.211 0.529 . . . . 0.0 111.126 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.564 HG21 ' HG3' ' A' ' 50' ' ' ARG . 9.7 p -108.89 140.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.167 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.22 123.3 49.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.51 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 19.7 p90 -145.03 167.71 22.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.344 0.592 . . . . 0.0 111.459 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.575 ' HD2' ' CE1' ' A' ' 17' ' ' HIS . 27.8 mmtt -106.32 144.01 33.61 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.553 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.459 ' CG2' HD23 ' A' ' 20' ' ' LEU . 17.9 tt -148.91 144.04 18.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.056 0.455 . . . . 0.0 109.901 176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 5.6 mtmp? -84.46 158.01 21.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.865 -0.522 . . . . 0.0 110.512 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -64.47 -36.73 85.12 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.044 0.449 . . . . 0.0 111.091 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -92.01 5.98 48.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.215 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 18.0 m -93.64 128.65 41.15 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.18 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.69 149.08 73.11 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.944 2.43 . . . . 0.0 113.576 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.7 mp -59.87 -12.59 7.92 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.191 0.997 . . . . 0.0 112.683 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.3 t . . . . . 0 C--O 1.24 0.599 0 CA-C-O 121.145 0.498 . . . . 0.0 110.742 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.7 tt . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.278 0.561 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.69 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 32.6 mtt -58.17 -50.33 73.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.037 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.608 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 2.9 tppp? -64.57 -38.97 92.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.55 -48.57 81.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -63.04 -40.26 97.18 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.15 0.5 . . . . 0.0 110.991 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 58' ' ' ILE . 75.2 m -62.96 -36.01 82.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.394 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 28.4 mm-40 -73.18 -35.84 66.46 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.259 0.552 . . . . 0.0 110.763 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.564 ' HG3' HG21 ' A' ' 30' ' ' VAL . 44.1 mmm-85 -70.0 -48.92 56.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.433 0.635 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.95 -18.3 50.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.073 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.68 57.8 4.39 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.828 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.17 172.79 13.25 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.491 -0.417 . . . . 0.0 111.165 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.2 m -97.03 130.34 44.36 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.264 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.496 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.4 ptp -64.67 -25.45 67.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.429 . . . . 0.0 111.414 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -76.69 -10.51 59.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.4 0.619 . . . . 0.0 110.328 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -105.01 3.9 31.06 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.403 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.536 HG22 ' HG2' ' A' ' 88' ' ' GLN . 20.9 pt -136.71 172.28 15.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.043 0.449 . . . . 0.0 110.87 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 25.6 mmm180 -143.76 148.21 35.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 11.1 m-85 -113.39 129.66 56.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.657 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.3 ppt_? -131.58 140.79 49.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.411 0.624 . . . . 0.0 111.541 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.415 ' HB2' HG13 ' A' ' 84' ' ' ILE . 80.6 t80 -145.44 139.32 26.8 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 63.93 26.41 14.18 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.168 0.509 . . . . 0.0 110.815 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 -0.99 80.78 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.896 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -125.16 144.63 47.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 O-C-N 122.11 -0.641 . . . . 0.0 111.528 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.74 147.84 45.59 Favored 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 122.628 2.218 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.14 137.65 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-O 121.468 0.651 . . . . 0.0 111.0 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 155.53 18.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.485 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.622 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -64.41 -16.96 63.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.0 p -81.2 -5.98 58.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.442 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.74 161.54 14.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.405 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 p -117.6 153.04 50.4 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.743 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 -8.56 21.48 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.353 2.036 . . . . 0.0 112.054 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.03 -18.21 20.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.093 0.473 . . . . 0.0 111.068 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -68.92 -36.9 78.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.239 0.542 . . . . 0.0 110.848 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.34 1.15 25.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.346 0.593 . . . . 0.0 110.756 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 51.18 58.66 5.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.962 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.6 ptp -73.92 164.63 26.38 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.664 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 36.2 tt0 -100.55 134.4 43.57 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.19 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -41.69 135.85 2.09 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 26.2 mt-10 74.12 16.47 3.53 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.777 1.231 . . . . 0.0 111.801 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.664 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -71.84 178.45 3.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 110.463 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.423 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.8 m -135.23 151.58 50.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.21 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.423 HD12 ' C ' ' A' ' 83' ' ' THR . 2.8 mp -123.12 140.28 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.563 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 33.6 t70 -90.03 135.64 33.53 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.008 0.432 . . . . 0.0 110.651 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -119.64 135.34 60.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.777 0.799 . . . . 0.0 110.911 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.7 p90 -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.582 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.1 mt-30 . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 120.999 0.428 . . . . 0.0 110.432 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 120.948 0.404 . . . . 0.0 111.909 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.8 45.99 1.33 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.822 0.82 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.79 14.93 2.9 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.759 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -90.62 111.95 23.47 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -147.28 93.38 4.69 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-O 120.972 0.415 . . . . 0.0 111.21 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -88.98 137.68 3.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.922 2.415 . . . . 0.0 112.493 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -88.93 19.52 4.07 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.503 0.668 . . . . 0.0 110.126 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.13 171.96 1.17 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.409 0.623 . . . . 0.0 112.123 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.25 43.45 1.71 Allowed Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 14' ' ' ASN . 5.9 p -59.6 124.38 13.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.235 0.54 . . . . 0.0 111.384 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -128.76 -58.95 1.15 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.2 t -67.82 -60.31 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.96 96.09 5.65 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.552 0.691 . . . . 0.0 111.707 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' HA ' HG21 ' A' ' 10' ' ' VAL . 1.8 p30 -87.94 90.83 8.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 122.261 1.029 . . . . 0.0 111.47 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -137.84 164.12 29.72 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.526 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -155.49 -63.42 0.12 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.567 0.699 . . . . 0.0 110.253 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 53.0 p-80 -135.0 158.9 43.15 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.317 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -114.82 169.5 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.7 m-80 -97.76 141.37 30.85 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.67 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.499 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -132.38 162.42 31.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.111 0.481 . . . . 0.0 110.421 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.97 148.24 48.39 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.065 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' CE1' ' A' ' 32' ' ' PHE . 80.8 t -126.97 115.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.377 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.82 126.7 37.01 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.86 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.38 164.87 29.68 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.405 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -68.41 -14.24 62.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.444 0.64 . . . . 0.0 110.916 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.8 -12.43 58.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.346 0.593 . . . . 0.0 110.525 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.39 48.79 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.83 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -105.43 152.3 23.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.0 p -136.41 137.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 15.0 p -105.41 141.59 20.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.855 0.359 . . . . 0.0 110.262 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -110.23 127.33 54.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.508 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -149.35 168.36 23.58 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.419 0.628 . . . . 0.0 111.883 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -116.52 134.97 54.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -140.48 147.08 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.044 0.45 . . . . 0.0 110.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 24.9 mtmt -82.47 157.93 23.42 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.754 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 15.4 mmm-85 -63.66 -39.74 95.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.995 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -92.76 8.27 40.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.704 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.4 m -91.6 128.3 47.02 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.702 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.47 145.62 77.47 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.822 2.348 . . . . 0.0 113.085 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.607 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.9 mp -60.09 -14.05 14.84 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.611 0.765 . . . . 0.0 112.087 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.6 m -50.51 -42.7 55.19 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.246 0.545 . . . . 0.0 110.569 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.502 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.3 tt -61.15 -54.2 47.47 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.401 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 1.9 mpt? -58.02 -42.39 85.2 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.01 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -68.66 -42.2 78.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.299 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.68 -52.86 62.41 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.19 -40.44 93.95 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.171 0.51 . . . . 0.0 110.887 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -40.82 91.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.92 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.02 -39.5 75.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.897 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 32.2 mmt180 -68.54 -52.85 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -22.14 59.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.981 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.13 57.35 3.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 0.0 111.96 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.6 175.6 10.47 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.691 -0.3 . . . . 0.0 110.332 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 71.2 m -96.78 128.38 43.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.825 0.345 . . . . 0.0 111.416 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.8 ptp -63.46 -26.24 68.63 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.233 0.539 . . . . 0.0 111.071 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 5.4 ptm180 -75.81 -11.43 59.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.203 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -105.23 7.04 33.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.332 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.0 pt -136.15 170.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.342 0.591 . . . . 0.0 111.629 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -140.8 148.78 41.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.147 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.495 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.3 m-85 -116.49 130.9 57.01 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.201 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.645 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.3 OUTLIER -132.36 142.67 49.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 0.0 110.045 177.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' A' ' 84' ' ' ILE . 87.2 t80 -136.74 134.3 36.99 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.255 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.32 31.7 21.19 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.044 0.449 . . . . 0.0 111.874 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.93 -14.85 59.34 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.356 -1.402 . . . . 0.0 113.251 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -117.33 148.16 42.05 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 121.974 -0.721 . . . . 0.0 112.165 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.04 147.96 21.42 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 123.392 2.728 . . . . 0.0 112.863 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.06 138.01 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.266 0.555 . . . . 0.0 111.284 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -97.81 158.14 15.68 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.61 -21.14 37.49 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.236 0.614 . . . . 0.0 111.956 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.3 p -79.29 -3.15 44.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.136 0.493 . . . . 0.0 111.539 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.6 m-20 -98.47 162.81 12.96 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.0 -0.437 . . . . 0.0 110.978 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.5 p -117.03 156.88 47.81 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.74 -11.05 30.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.278 1.985 . . . . 0.0 111.773 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.61 -19.29 20.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 110.454 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -63.61 -35.95 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 0.0 110.294 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.07 1.14 17.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.921 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 51.53 62.38 2.74 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.52 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.499 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.7 ptp -77.69 165.81 23.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 110.42 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.03 161.97 16.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.348 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.26 136.9 42.68 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.022 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 72.03 16.7 5.32 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.979 0.911 . . . . 0.0 111.484 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.72 175.85 5.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.468 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.439 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.6 m -132.44 150.51 52.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.321 0.582 . . . . 0.0 111.721 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -120.96 139.04 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.645 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 11.3 m-20 -88.99 134.03 34.12 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.011 0.434 . . . . 0.0 110.596 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.07 137.84 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 121.63 0.729 . . . . 0.0 111.019 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -137.8 146.35 43.43 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.377 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -111.77 109.09 18.75 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -111.63 104.92 13.33 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -98.17 94.93 7.08 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.159 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -126.68 117.39 22.64 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.219 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.99 -10.06 64.17 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.155 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.137 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.832 -179.877 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.965 0 CA-C-O 120.87 0.367 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.93 94.24 1.01 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.92 0.39 . . . . 0.0 110.021 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' HB2' ' HA3' ' A' ' 9' ' ' GLY . 7.2 m-20 -70.37 -19.45 63.03 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.526 0.679 . . . . 0.0 110.721 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -127.89 -79.45 0.58 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.416 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.608 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 33.4 mmtp -143.28 -55.19 0.02 OUTLIER Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.647 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 5' ' ' LYS . 70.5 Cg_endo -75.39 -168.76 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.547 1.498 . . . . 0.0 111.101 175.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -79.02 -25.48 43.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.318 0.58 . . . . 0.0 110.404 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -90.53 135.95 33.37 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 3' ' ' ASP . . . -109.94 8.47 31.58 Favored Glycine 0 CA--C 1.494 -1.23 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 ' HB2' ' A' ' 13' ' ' GLU . 7.1 p -142.83 122.96 9.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.612 -0.794 . . . . 0.0 109.852 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -129.63 -71.0 0.63 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.107 0.48 . . . . 0.0 110.658 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -94.76 68.67 3.34 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.946 0.879 . . . . 0.0 109.955 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' VAL . 10.6 mm-40 -145.11 178.92 7.71 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.198 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 91.7 m-20 81.84 13.24 0.6 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.582 0.706 . . . . 0.0 110.843 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -82.34 -94.81 0.05 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.539 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.96 119.68 24.27 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.311 0.577 . . . . 0.0 111.244 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 50.6 p-80 -170.28 167.9 8.32 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -122.09 169.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.383 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD22 ' A' ' 20' ' ' LEU . 28.1 m-80 -99.65 144.35 28.83 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -132.4 160.53 36.1 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.102 0.477 . . . . 0.0 110.172 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.5 mtpt -132.5 147.86 52.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.911 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.491 HG23 ' CE1' ' A' ' 32' ' ' PHE . 75.5 t -125.78 118.28 51.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.092 0.472 . . . . 0.0 110.177 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.09 118.28 30.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.056 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.26 155.47 34.44 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -63.06 -13.78 40.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.29 0.567 . . . . 0.0 111.371 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.05 -11.69 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.76 41.41 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.947 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 t -110.2 162.18 14.85 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.18 141.12 28.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.194 0.521 . . . . 0.0 111.126 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG21 ' HG3' ' A' ' 50' ' ' ARG . 12.1 p -109.65 142.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.999 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -113.12 124.14 51.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.274 0.559 . . . . 0.0 109.775 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 22' ' ' VAL . 16.8 p90 -145.29 167.97 21.56 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 29.2 mtmt -114.95 136.79 52.72 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.59 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.413 ' CG2' HD23 ' A' ' 20' ' ' LEU . 15.9 tt -143.81 148.96 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.032 0.444 . . . . 0.0 110.368 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.4 mtmt -83.97 158.69 21.44 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.793 -0.567 . . . . 0.0 110.973 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.496 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 27.6 mmm-85 -64.24 -40.75 96.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -91.17 8.84 33.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.294 0.569 . . . . 0.0 110.995 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 14.7 m -94.31 130.97 32.3 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.0 149.93 77.55 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.974 2.449 . . . . 0.0 113.586 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 71' ' ' ASP . 7.0 mp -61.44 -12.17 13.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.096 0.958 . . . . 0.0 112.873 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 p -53.92 -44.46 70.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.962 0.411 . . . . 0.0 111.049 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.47 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.4 tt -60.34 -52.99 62.89 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.394 0.616 . . . . 0.0 110.166 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.655 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.9 mtt -60.41 -48.0 83.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -61.53 -42.28 98.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.8 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.38 -52.89 62.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.757 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.28 -41.0 96.21 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.135 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 75.5 m -65.39 -34.89 79.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.079 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -70.31 -34.89 73.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.2 mmp_? -73.77 -46.68 44.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.353 0.596 . . . . 0.0 111.084 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -80.5 -21.35 42.03 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.056 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.56 57.74 3.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.579 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.58 175.29 10.98 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 122.552 -0.381 . . . . 0.0 110.878 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 26.4 m -97.23 131.37 44.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.012 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 6.5 ptp -66.28 -26.84 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.217 0.532 . . . . 0.0 110.988 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -76.04 -13.75 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 12.8 mm100 -101.26 2.38 39.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.504 0.669 . . . . 0.0 110.443 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 48' ' ' CYS . 35.0 pt -135.09 176.24 9.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 15.9 mmm180 -146.95 154.43 41.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.834 0.35 . . . . 0.0 111.008 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.5 m-85 -119.03 132.44 56.05 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.092 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.1 ppt_? -134.63 141.5 46.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 111.098 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -141.39 139.83 33.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.575 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t70 57.99 27.97 15.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 111.305 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.12 -3.54 70.94 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.192 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -118.43 140.98 28.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 122.182 -0.599 . . . . 0.0 111.347 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.08 147.33 38.09 Favored 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 122.67 2.247 . . . . 0.0 112.261 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.22 139.0 51.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 110.594 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -98.8 165.82 11.6 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.979 0.419 . . . . 0.0 111.202 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.2 pt-20 -61.87 -17.13 55.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.194 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.4 p -82.98 -4.28 58.12 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.933 0.397 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.522 ' O ' HD13 ' A' ' 40' ' ' LEU . 46.5 m-20 -88.75 156.71 18.82 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -117.66 150.74 47.42 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 122.427 0.291 . . . . 0.0 110.222 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.413 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 36.9 Cg_endo -65.24 -13.04 37.67 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.366 2.044 . . . . 0.0 112.234 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.76 -13.74 25.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 110.817 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -72.2 -35.86 69.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.332 0.587 . . . . 0.0 110.176 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.89 1.0 22.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.69 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 53.01 61.34 3.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.321 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.481 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.1 ptp -80.24 166.45 21.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.415 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -91.94 167.62 11.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.065 0.459 . . . . 0.0 110.983 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.98 139.67 36.92 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.328 0.585 . . . . 0.0 110.091 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 71.6 15.27 6.06 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.487 1.115 . . . . 0.0 111.341 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.74 176.7 2.87 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.2 m -134.84 150.32 50.47 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.546 -0.721 . . . . 0.0 111.731 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 142.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.587 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 29.5 t70 -90.88 136.53 33.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.11 0.481 . . . . 0.0 110.869 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 134.06 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.948 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.1 p90 -130.76 137.47 49.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.813 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.2 mt-30 -106.78 113.29 26.69 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 0.0 111.1 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.38 170.8 0.91 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.062 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -78.14 137.02 37.97 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.352 0.596 . . . . 0.0 111.377 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 p -79.07 133.22 36.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.19 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.85 50.33 19.3 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.722 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.968 0 CA-C-O 118.655 -1.081 . . . . 0.0 111.83 -179.725 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.955 0.407 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.38 34.34 22.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.226 0.61 . . . . 0.0 112.483 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.06 26.29 1.41 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.447 0.641 . . . . 0.0 110.715 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -89.55 -77.39 0.39 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.647 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 57.1 tttp -178.46 -54.11 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.589 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 47.3 Cg_endo -66.58 173.48 7.78 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.165 1.91 . . . . 0.0 113.249 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -104.94 -33.7 8.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.054 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.12 12.2 1.23 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.29 0.567 . . . . 0.0 111.023 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.01 176.55 14.48 Favored Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.07 138.22 52.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 121.404 0.621 . . . . 0.0 110.837 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -128.43 144.74 51.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' THR . 5.6 m 64.1 38.54 8.34 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.787 0.803 . . . . 0.0 112.936 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.53 150.28 36.39 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -129.61 -61.28 1.02 Allowed 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.778 -0.577 . . . . 0.0 110.971 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -154.68 141.06 18.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.194 0.521 . . . . 0.0 110.981 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 10.8 t70 -152.02 -66.77 0.17 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.665 0.745 . . . . 0.0 109.786 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.684 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 -135.29 159.33 41.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.159 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 pt -123.2 170.17 13.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.987 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.507 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . 19.3 m-80 -93.89 142.09 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.653 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.53 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.6 mm? -133.24 163.47 29.23 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.288 0.566 . . . . 0.0 110.87 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.4 mtpt -134.82 146.07 48.95 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.905 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' CE1' ' A' ' 32' ' ' PHE . 91.2 t -127.29 114.06 34.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.19 0.519 . . . . 0.0 110.132 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.84 130.32 37.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.414 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.93 161.82 22.82 Favored Glycine 0 N--CA 1.42 -2.417 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.959 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.45 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -65.02 -11.76 42.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.562 0.696 . . . . 0.0 110.897 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.87 -15.0 58.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.254 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.17 6.51 56.77 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.0 t -101.24 153.9 19.22 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.57 136.43 46.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.309 0.576 . . . . 0.0 111.507 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.593 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.6 p -105.19 140.07 24.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.391 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -110.97 124.95 53.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.526 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.4 p90 -149.56 169.85 19.99 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.135 0.493 . . . . 0.0 111.452 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -113.61 143.27 44.85 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.985 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 14.7 tt -148.75 143.34 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.119 0.485 . . . . 0.0 110.359 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 25.7 mtmt -79.45 155.36 28.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.374 0.607 . . . . 0.0 111.772 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 16' ' ' ASP . 29.0 mmm-85 -64.95 -36.49 84.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.641 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.19 4.91 53.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.337 0.589 . . . . 0.0 110.753 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 20.6 m -93.57 129.49 38.32 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.23 151.46 85.35 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.891 2.394 . . . . 0.0 112.856 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.474 ' CD2' HD13 ' A' ' 43' ' ' LEU . 81.2 mt -65.38 -11.87 46.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.55 0.74 . . . . 0.0 111.919 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p -51.28 -46.35 62.44 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.117 0.484 . . . . 0.0 111.098 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.488 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD13 ' CD2' ' A' ' 40' ' ' LEU . 4.0 tt -63.85 -48.29 77.34 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.333 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.71 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 37.8 mtt -61.75 -39.69 92.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.168 0.508 . . . . 0.0 110.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.9 tppp? -70.16 -40.91 74.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.694 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.52 68.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 110.912 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -63.69 -37.05 85.91 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.061 0.458 . . . . 0.0 110.822 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -34.55 78.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.138 0.494 . . . . 0.0 110.812 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.0 mm-40 -72.59 -42.14 64.87 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.272 0.558 . . . . 0.0 110.62 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.593 ' HG3' HG21 ' A' ' 30' ' ' VAL . 22.9 mmm-85 -62.99 -52.6 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.452 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.0 mp0 -79.73 -21.41 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.884 0.373 . . . . 0.0 111.927 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.02 2.82 90.65 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.925 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.54 175.95 8.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 0.0 111.208 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 54.7 m -97.42 127.02 43.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.698 0.285 . . . . 0.0 110.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.6 ptp -60.81 -25.24 66.43 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.093 0.473 . . . . 0.0 111.985 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -78.78 -11.36 59.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.242 0.544 . . . . 0.0 111.129 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.405 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 13.0 mm100 -101.22 5.67 42.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.0 110.63 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.566 HG22 ' HG2' ' A' ' 88' ' ' GLN . 31.2 pt -135.22 177.23 7.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.118 0.485 . . . . 0.0 111.065 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -147.42 147.18 29.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.71 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 14.0 m-85 -113.87 128.06 56.25 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.21 0.529 . . . . 0.0 111.237 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 1.1 ppt_? -132.04 136.64 47.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.395 0.617 . . . . 0.0 110.735 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -135.79 134.77 39.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.538 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.39 28.5 18.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.216 0.531 . . . . 0.0 110.654 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.76 -4.52 64.86 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 119.645 -1.264 . . . . 0.0 113.198 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -115.99 136.81 23.01 Favored Pre-proline 0 C--N 1.322 -0.607 0 O-C-N 121.905 -0.762 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.27 142.91 30.96 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.704 2.269 . . . . 0.0 112.104 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 133.3 68.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.564 0.697 . . . . 0.0 111.365 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 149.47 21.44 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.335 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.541 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.0 pp20? -58.27 -20.0 38.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.453 HG23 ' OE2' ' A' ' 69' ' ' GLU . 40.9 p -76.26 -13.11 60.17 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.376 0.608 . . . . 0.0 111.164 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.79 166.79 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -118.13 158.4 46.38 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.07 -5.64 14.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.578 2.186 . . . . 0.0 112.074 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.04 -13.73 24.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.16 0.505 . . . . 0.0 110.525 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -68.6 -35.93 78.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.429 0.633 . . . . 0.0 110.549 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.456 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.16 1.47 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.482 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 52.6 60.05 4.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.53 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.6 ptp -74.97 163.02 28.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -87.89 159.97 18.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.47 131.48 44.81 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 14.3 mt-10 72.88 20.67 3.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 124.288 1.035 . . . . 0.0 111.593 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.75 179.42 3.13 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.4 m -135.13 150.43 50.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.509 -0.745 . . . . 0.0 111.887 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.63 148.81 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 6.8 t70 -97.97 128.59 44.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.788 0.328 . . . . 0.0 110.334 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.11 135.0 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.576 0.703 . . . . 0.0 110.846 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.484 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -136.85 145.08 44.0 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.64 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -110.19 111.39 22.69 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.126 0.488 . . . . 0.0 110.06 -177.145 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -77.21 79.9 3.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.651 0.738 . . . . 0.0 111.491 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.67 170.87 1.76 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.505 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -159.43 157.32 29.97 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.123 -0.361 . . . . 0.0 110.272 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.81 54.92 27.78 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.662 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.164 0 CA-C-O 118.498 -1.168 . . . . 0.0 111.969 -178.568 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 121.18 0.514 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.99 102.98 3.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -111.41 8.06 21.09 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.631 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 22.9 mt-10 -79.15 173.24 12.78 Favored 'General case' 0 N--CA 1.395 -3.192 0 CA-C-O 122.139 0.971 . . . . 0.0 109.773 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -73.17 -49.89 6.84 Favored Pre-proline 0 C--N 1.265 -3.086 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.474 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 18.0 Cg_endo -61.82 146.45 96.52 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 121.708 1.606 . . . . 0.0 111.264 174.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -56.95 -39.29 74.26 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.835 0.454 . . . . 0.0 111.824 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -103.25 -170.0 1.73 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.979 0.419 . . . . 0.0 110.946 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.22 -141.71 7.15 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -159.47 135.77 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.073 0.463 . . . . 0.0 110.669 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 12' ' ' THR . 4.1 tmtm? -130.95 131.79 44.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.881 0.372 . . . . 0.0 110.112 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.552 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 62.0 m 67.37 -65.38 0.23 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.731 0.812 . . . . 0.0 112.921 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -48.53 94.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.61 119.37 17.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.88 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -121.47 142.38 50.1 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.302 0.572 . . . . 0.0 111.26 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.58 115.96 24.4 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.786 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 41.7 p-80 -159.61 -177.93 6.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.79 169.61 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.349 0.595 . . . . 0.0 111.095 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.47 ' O ' HD22 ' A' ' 20' ' ' LEU . 22.2 m-80 -99.95 145.81 27.41 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -132.63 162.39 31.46 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.323 0.582 . . . . 0.0 110.823 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 57.5 mtpt -133.55 147.98 51.61 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.989 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.7 t -128.74 117.96 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.09 0.472 . . . . 0.0 110.265 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.94 124.93 35.15 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.889 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.31 159.52 27.44 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.7 pp0? -63.32 -14.68 52.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.496 0.665 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.23 -19.25 62.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.55 6.19 50.6 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -107.39 163.66 12.86 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.0 143.39 31.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.576 HG21 ' HG3' ' A' ' 50' ' ' ARG . 6.1 p -112.36 145.28 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.172 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -112.77 131.05 55.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.299 0.571 . . . . 0.0 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 22' ' ' VAL . 10.8 p90 -152.08 169.12 23.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.219 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -111.95 143.72 42.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.036 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.441 ' CG2' HD23 ' A' ' 20' ' ' LEU . 16.5 tt -150.54 149.23 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.063 0.459 . . . . 0.0 110.333 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.3 mtmt -87.23 158.03 19.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.73 -0.606 . . . . 0.0 110.74 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.9 mmm-85 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -90.48 7.75 37.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.119 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.3 m -93.7 129.98 36.48 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.37 150.22 87.35 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.904 2.402 . . . . 0.0 112.984 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.463 ' CD2' HD13 ' A' ' 43' ' ' LEU . 87.4 mt -65.26 -11.97 46.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.862 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p -52.81 -43.1 65.68 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 111.142 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.437 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt -62.68 -48.49 79.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.186 0.517 . . . . 0.0 110.096 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.666 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 29.9 mtt -61.31 -40.88 95.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 17.8 tppt? -70.37 -38.33 74.72 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.967 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.09 -50.99 71.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.957 0.408 . . . . 0.0 110.566 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.41 -33.61 76.25 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.985 0.421 . . . . 0.0 110.532 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -38.13 89.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.247 0.546 . . . . 0.0 110.547 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 68.2 mm-40 -73.12 -34.64 66.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.071 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HG3' HG21 ' A' ' 30' ' ' VAL . 11.5 mmt180 -68.1 -49.54 60.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.011 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -85.48 -22.38 28.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.81 58.31 3.06 Favored Glycine 0 C--N 1.321 -0.301 0 C-N-CA 119.673 -1.251 . . . . 0.0 111.696 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.52 174.07 11.74 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 122.564 -0.374 . . . . 0.0 110.286 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.9 m -100.05 129.23 46.08 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.86 0.362 . . . . 0.0 110.897 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.1 ptp -64.85 -25.52 67.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HG3' ' HG2' ' A' ' 57' ' ' GLN . 12.7 ptt180 -75.81 -11.62 60.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.199 0.523 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.431 ' HG2' ' HG3' ' A' ' 56' ' ' ARG . 19.3 mm-40 -104.53 2.62 31.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HG2' ' A' ' 88' ' ' GLN . 37.7 pt -134.0 172.97 15.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.043 0.449 . . . . 0.0 110.636 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 19.6 mmt180 -142.24 149.89 40.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.778 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.666 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.3 m-85 -114.53 132.8 56.19 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.318 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.6 ppt_? -135.82 140.03 43.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.328 0.585 . . . . 0.0 111.076 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -138.2 137.7 37.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.822 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.85 34.06 21.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.78 -4.55 74.03 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.735 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -120.95 141.49 32.76 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.992 -0.711 . . . . 0.0 111.684 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.51 148.08 32.9 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 111.711 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.82 136.19 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.063 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -93.25 157.65 16.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -59.74 -22.07 61.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.4 p -74.5 -15.17 60.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.998 0.428 . . . . 0.0 111.229 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.36 165.45 13.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.6 p -117.33 158.76 43.93 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -67.35 -7.46 19.13 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.432 2.088 . . . . 0.0 111.83 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.91 -19.49 20.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.534 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -60.91 -40.01 91.54 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.63 0.729 . . . . 0.0 110.39 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.45 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.81 0.35 25.98 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.767 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.5 62.21 2.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.535 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.0 ptp -79.8 167.12 21.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.007 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -92.85 167.02 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.286 0.565 . . . . 0.0 110.914 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -75.92 139.74 41.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.134 0.492 . . . . 0.0 110.119 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 68.21 19.56 9.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.755 0.822 . . . . 0.0 111.137 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -72.06 179.76 3.14 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.798 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.432 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.6 m -135.04 150.07 50.23 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 121.602 -0.687 . . . . 0.0 111.618 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.432 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.98 144.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 28.8 t70 -92.2 139.69 30.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 120.812 0.339 . . . . 0.0 110.685 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -123.73 139.34 50.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.677 0.751 . . . . 0.0 110.956 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -137.43 146.04 43.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.946 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 1.3 mt-30 -113.08 114.43 26.82 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.76 -179.55 1.17 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.251 0.548 . . . . 0.0 111.215 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -112.68 101.51 9.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.923 0.392 . . . . 0.0 110.329 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -98.75 112.22 24.36 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 120.905 0.383 . . . . 0.0 110.477 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.02 -61.55 7.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.691 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.352 -1.249 . . . . 0.0 111.471 179.208 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 121.26 0.552 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.69 103.52 0.56 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -93.58 37.68 1.06 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.846 0.832 . . . . 0.0 108.999 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -121.77 36.77 4.53 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.008 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -121.63 95.06 48.27 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.137 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.46 -170.17 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.845 2.364 . . . . 0.0 111.152 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.88 27.1 1.21 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.439 0.638 . . . . 0.0 110.254 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -82.28 17.17 1.75 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.258 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.3 65.04 3.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.588 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 13' ' ' GLU . 7.3 p -104.89 136.42 38.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 12' ' ' THR . 0.1 OUTLIER -106.67 -17.43 14.24 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.559 0.695 . . . . 0.0 110.525 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 90.0 m -69.55 -32.0 70.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.617 0.723 . . . . 0.0 110.635 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' H ' HG22 ' A' ' 10' ' ' VAL . 19.1 mm-40 -105.06 176.67 5.09 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.313 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -161.43 -29.09 0.05 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.421 0.629 . . . . 0.0 109.872 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -118.03 172.51 7.36 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.438 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -103.18 -176.38 3.07 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.916 0.389 . . . . 0.0 109.983 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 23.5 p80 -139.41 159.72 41.5 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 121.97 -0.456 . . . . 0.0 111.763 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.34 170.81 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.577 0.704 . . . . 0.0 112.466 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.45 ' O ' HD22 ' A' ' 20' ' ' LEU . 25.4 m-80 -96.42 139.64 32.23 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.632 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -128.87 161.38 29.96 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 83' ' ' THR . 60.1 mtpt -136.73 146.91 46.38 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.169 0.509 . . . . 0.0 110.247 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.7 t -128.22 117.25 45.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.201 0.524 . . . . 0.0 110.639 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.58 118.23 28.09 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.46 160.84 33.4 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.169 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -9.14 38.74 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.681 0.753 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -74.72 -15.73 60.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.62 6.94 57.12 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.472 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 t -110.01 167.33 10.26 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.61 140.14 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.611 HG21 ' HG3' ' A' ' 50' ' ' ARG . 9.5 p -103.98 140.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.003 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -113.84 123.51 49.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.43 0.633 . . . . 0.0 109.651 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 8.8 p90 -147.12 169.04 20.12 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.231 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 33.5 mtmm -115.28 144.6 43.49 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 111.462 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.7 tt -148.25 146.07 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.023 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 29.4 mtmt -81.05 155.31 26.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 18.6 mmm-85 -60.79 -40.19 91.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.094 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -92.91 10.15 32.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.6 m -95.6 130.21 32.54 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.396 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 150.24 83.48 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.765 2.31 . . . . 0.0 112.97 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.535 HD22 HD13 ' A' ' 43' ' ' LEU . 88.5 mt -62.11 -12.18 18.09 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 123.456 0.702 . . . . 0.0 111.799 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.5 t -51.13 -45.52 61.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.956 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.471 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.535 HD13 HD22 ' A' ' 40' ' ' LEU . 2.3 tt -62.34 -48.16 81.02 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.23 0.538 . . . . 0.0 110.252 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.568 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 25.8 mtt -63.27 -39.29 94.17 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.651 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.678 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 4.1 tppp? -67.96 -44.51 76.56 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.246 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -53.97 -53.15 56.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.386 . . . . 0.0 111.016 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CE2' HG11 ' A' ' 86' ' ' VAL . 46.9 t80 -60.55 -41.58 94.82 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -41.55 81.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.288 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.678 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 22.6 mt-10 -71.7 -42.52 67.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.307 0.575 . . . . 0.0 111.211 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.1 mmt85 -65.09 -50.66 65.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.247 0.546 . . . . 0.0 111.321 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -77.6 -14.7 59.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.431 -177.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.18 57.19 8.78 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.519 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -146.68 176.13 10.08 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -99.57 128.3 45.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.424 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 ptp -63.12 -19.95 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.111 0.481 . . . . 0.0 111.789 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -83.07 -15.11 52.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.244 0.545 . . . . 0.0 111.011 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -100.04 5.13 45.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.454 0.645 . . . . 0.0 110.47 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.509 HG22 ' HG2' ' A' ' 88' ' ' GLN . 34.2 pt -135.32 171.9 16.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.733 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 21.5 mmm180 -141.99 148.45 38.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.775 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.7 m-85 -113.68 130.33 56.43 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.726 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.48 131.86 38.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.092 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' HG13 ' A' ' 84' ' ' ILE . 82.5 t80 -126.56 136.48 52.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.287 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.88 32.56 22.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.285 0.564 . . . . 0.0 111.013 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.35 -3.4 58.88 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.565 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -119.33 135.05 23.77 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 121.847 -0.796 . . . . 0.0 111.215 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.37 150.6 76.13 Favored 'Trans proline' 0 C--N 1.326 -0.619 0 C-N-CA 122.702 2.268 . . . . 0.0 111.831 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.32 142.93 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.805 0.812 . . . . 0.0 111.34 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.22 153.81 17.6 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.105 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.8 pt-20 -63.95 -17.28 63.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.164 0.507 . . . . 0.0 111.731 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.6 p -81.56 -5.97 58.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -93.26 158.7 15.61 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.154 -0.341 . . . . 0.0 110.365 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.55 ' OG1' ' HB2' ' A' ' 75' ' ' GLN . 20.0 p -118.16 151.41 49.14 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.54 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 78' ' ' MET . 27.6 Cg_endo -63.07 -13.76 37.37 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.428 2.085 . . . . 0.0 112.55 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.07 -21.31 18.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.106 0.479 . . . . 0.0 110.964 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.55 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 34.0 tt0 -66.0 -33.74 76.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.866 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.32 -1.72 24.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.343 0.592 . . . . 0.0 110.5 177.194 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.47 58.41 4.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.426 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.632 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.2 ptp -77.49 172.29 13.58 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.878 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.9 tp10 -92.18 156.54 17.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.17 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.88 141.6 49.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.234 0.54 . . . . 0.0 110.839 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 69.08 18.88 8.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.111 0.965 . . . . 0.0 111.04 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -70.47 175.78 4.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.19 150.5 52.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.46 0.647 . . . . 0.0 111.923 -176.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 62' ' ' PHE . 3.3 mp -122.69 145.52 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -92.43 135.88 33.67 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.975 0.417 . . . . 0.0 110.607 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.427 HG11 ' CE2' ' A' ' 47' ' ' TYR . 2.8 t -120.62 135.58 60.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.781 0.801 . . . . 0.0 111.132 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 1.5 p90 -135.79 145.2 46.27 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.509 ' HG2' HG22 ' A' ' 58' ' ' ILE . 8.2 mt-30 -103.69 110.98 23.27 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.824 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.46 73.09 6.12 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.566 0.698 . . . . 0.0 110.855 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.08 -171.97 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.4 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.0 m -146.31 112.38 5.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.044 0.45 . . . . 0.0 110.41 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.62 143.88 16.22 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.761 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.078 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.531 -179.878 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.15 0.5 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.02 156.31 27.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.915 0.388 . . . . 0.0 110.566 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.7 32.99 0.94 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.797 0.808 . . . . 0.0 110.757 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -121.98 -172.55 2.47 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.112 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -175.94 86.47 0.29 Allowed Pre-proline 0 C--N 1.289 -2.023 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.291 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.54 163.54 38.26 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.695 2.264 . . . . 0.0 111.015 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -98.58 -11.1 22.48 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.938 0.875 . . . . 0.0 108.871 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -84.06 -9.38 58.66 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.876 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.46 -51.29 5.69 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.754 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.78 133.24 63.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.053 0.454 . . . . 0.0 110.66 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.38 86.3 4.15 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.473 0.654 . . . . 0.0 109.685 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 t -167.19 -177.89 3.89 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -54.92 152.45 7.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.411 0.624 . . . . 0.0 111.883 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -64.18 -23.83 67.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.333 0.587 . . . . 0.0 110.375 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.04 81.89 2.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.338 0.59 . . . . 0.0 111.605 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.74 -34.23 76.77 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.904 0.859 . . . . 0.0 109.964 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 -135.02 174.84 10.16 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.439 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.52 HG21 ' OD1' ' A' ' 80' ' ' ASP . 32.4 pt -130.08 169.1 21.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.34 0.591 . . . . 0.0 111.414 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.2 140.49 32.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.48 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.474 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.2 mm? -128.97 164.34 23.38 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.087 0.47 . . . . 0.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 83' ' ' THR . 62.6 mtpt -133.57 147.19 51.52 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.027 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.534 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.5 t -125.0 116.39 47.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 120.968 0.413 . . . . 0.0 109.892 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.39 122.62 35.02 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.753 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.3 160.06 34.37 Favored Glycine 0 N--CA 1.424 -2.158 0 C-N-CA 120.439 -0.886 . . . . 0.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -15.16 60.51 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.128 0.49 . . . . 0.0 111.832 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.559 0.695 . . . . 0.0 110.025 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.86 5.52 50.57 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.67 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -95.76 162.75 13.47 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.24 136.74 22.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.479 0.657 . . . . 0.0 111.297 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.428 HG11 ' HG3' ' A' ' 50' ' ' ARG . 89.3 t -107.65 138.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.933 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -109.84 128.18 55.16 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 22' ' ' VAL . 13.7 p90 -147.91 168.35 22.46 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.274 0.559 . . . . 0.0 111.538 -174.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 37.5 mtmt -112.19 135.54 52.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.619 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -144.43 144.15 22.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.19 0.519 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 24.3 mtmm -82.18 156.79 24.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 12.4 mmm-85 -64.14 -34.64 78.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.371 0.605 . . . . 0.0 110.547 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -95.21 6.65 48.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.288 0.566 . . . . 0.0 110.914 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 8.3 m -92.2 129.76 40.27 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.048 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.0 147.16 73.35 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 123.141 2.561 . . . . 0.0 113.595 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.8 mp -61.55 -12.27 14.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.285 1.034 . . . . 0.0 112.99 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.2 p -54.16 -41.07 68.08 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.046 0.45 . . . . 0.0 110.805 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.451 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 7.2 tt -61.72 -51.97 66.21 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 mtt -58.85 -42.61 89.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -67.94 -43.35 79.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.009 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.44 -49.89 73.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.128 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.66 -39.22 93.31 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.194 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -39.17 93.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 110.502 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -68.37 -36.73 79.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.187 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 50' ' ' ARG . 10.7 mmp_? -70.12 -45.55 66.64 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -81.36 -21.56 39.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.864 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.22 4.5 89.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.368 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.64 177.21 6.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.934 0.397 . . . . 0.0 110.99 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 37.7 m -93.97 126.45 39.19 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.263 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -62.51 -28.7 70.02 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -76.55 -9.84 58.95 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.457 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.48 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 14.0 mm100 -101.09 4.54 42.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.157 0.503 . . . . 0.0 111.373 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.77 HG22 ' HG2' ' A' ' 88' ' ' GLN . 23.0 pt -133.17 168.5 24.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.246 0.546 . . . . 0.0 110.786 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 54.8 mmt-85 -133.78 153.09 51.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.339 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.706 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 13.5 m-85 -119.17 131.03 55.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.315 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.617 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.1 ppt_? -136.56 143.94 43.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.251 0.548 . . . . 0.0 111.316 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.721 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 74.8 t80 -139.39 130.98 27.2 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER 53.87 32.22 14.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.557 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.52 -33.08 1.38 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.623 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.721 ' HG2' ' O ' ' A' ' 62' ' ' PHE . 7.5 pt20 -70.06 119.82 74.13 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.688 0.756 . . . . 0.0 111.736 -177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.08 144.51 57.88 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.658 2.238 . . . . 0.0 110.724 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.403 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -124.8 133.01 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.354 0.597 . . . . 0.0 110.668 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.94 159.11 15.91 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.456 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.4 pt-20 -58.8 -21.84 57.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.322 0.582 . . . . 0.0 111.79 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.9 p -84.97 0.26 51.96 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.575 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.525 ' O ' HD13 ' A' ' 40' ' ' LEU . 66.9 m-20 -96.07 161.76 13.83 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.885 -0.51 . . . . 0.0 110.325 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.3 p -119.38 153.53 53.71 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.954 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 37.3 Cg_endo -66.24 -12.0 33.71 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.722 2.281 . . . . 0.0 112.863 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.05 -17.08 22.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.37 0.605 . . . . 0.0 110.937 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.94 -32.88 73.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.561 . . . . 0.0 110.771 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.2 3.09 19.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.045 0.45 . . . . 0.0 110.957 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 50.22 57.85 6.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.721 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -72.81 168.98 17.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.432 . . . . 0.0 110.88 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.5 tp10 -87.97 143.84 26.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.042 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' OD1' HG21 ' A' ' 18' ' ' ILE . 3.4 m-20 -59.02 138.68 57.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.86 0.362 . . . . 0.0 110.352 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.65 25.55 8.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 112.042 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -77.73 -174.28 3.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 110.964 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.447 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 m -136.23 150.97 49.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.447 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.66 140.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.8 t70 -89.01 138.03 31.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.256 0.55 . . . . 0.0 110.9 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 136.21 57.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.314 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.463 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 3.8 p90 -146.77 158.95 44.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.095 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.77 ' HG2' HG22 ' A' ' 58' ' ' ILE . 87.6 mt-30 -113.84 109.24 18.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 91' ' ' THR . 6.4 pt20 -137.08 136.64 38.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 47.61 39.61 10.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.719 0.808 . . . . 0.0 112.198 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 89' ' ' GLN . 9.6 p -104.01 -68.74 0.83 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.234 0.54 . . . . 0.0 111.962 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.14 -68.64 0.05 OUTLIER Glycine 0 C--N 1.3 -1.446 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.413 -1.215 . . . . 0.0 111.366 176.947 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.41 137.86 4.27 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 121.96 -0.462 . . . . 0.0 110.937 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -91.56 16.23 10.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.711 0.767 . . . . 0.0 109.842 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -125.63 37.75 4.3 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.84 0.828 . . . . 0.0 108.816 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -166.84 99.21 0.66 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.953 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.06 143.16 14.1 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.328 2.019 . . . . 0.0 111.359 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -119.3 37.1 4.25 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.314 0.578 . . . . 0.0 110.409 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -99.76 -10.38 21.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.283 0.563 . . . . 0.0 110.637 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.7 -49.16 1.41 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.147 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.08 141.01 26.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.384 0.611 . . . . 0.0 110.759 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -129.29 158.17 39.84 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.0 m -48.67 114.08 0.9 Allowed 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.242 0.544 . . . . 0.0 110.714 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -78.96 106.03 10.7 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.425 0.631 . . . . 0.0 112.343 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -66.42 -176.67 0.47 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.974 176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 76.01 10.89 3.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.903 0.881 . . . . 0.0 110.486 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -99.14 -15.2 19.05 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.909 0.861 . . . . 0.0 109.226 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.464 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.9 p-80 -131.91 151.12 51.91 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.023 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.43 HG23 ' HD3' ' A' ' 36' ' ' ARG . 33.9 pt -106.08 169.73 2.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.674 0.749 . . . . 0.0 111.621 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.4 m-80 -99.71 148.68 24.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.055 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.3 mm? -136.94 162.77 32.37 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.393 0.616 . . . . 0.0 111.087 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.2 mtpt -136.73 148.18 47.14 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.183 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.466 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.0 t -129.25 117.97 44.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.434 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.02 122.1 33.4 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.694 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.07 162.91 30.15 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.4 pp0? -69.18 -12.09 61.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.743 0.782 . . . . 0.0 109.851 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.33 -21.43 60.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.801 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.12 10.82 41.27 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 t -109.77 158.47 18.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 7.6 p -135.19 134.22 52.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.383 0.611 . . . . 0.0 111.211 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 7.5 p -100.67 139.66 21.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.528 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE1' HG23 ' A' ' 22' ' ' VAL . 7.3 p90 -154.97 169.57 23.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.074 0.464 . . . . 0.0 111.377 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -118.22 138.3 52.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.652 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.481 ' CG2' HD23 ' A' ' 20' ' ' LEU . 14.0 tt -143.35 148.0 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 26.8 mtmt -84.44 157.7 21.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.247 0.546 . . . . 0.0 110.994 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 28.1 mmm-85 -68.55 -34.46 75.87 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.323 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -95.2 6.49 48.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.587 0.708 . . . . 0.0 110.668 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.7 m -94.54 131.98 29.77 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.205 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.1 151.1 86.78 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.571 2.181 . . . . 0.0 112.265 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 43' ' ' LEU . 67.2 mt -65.57 -13.7 59.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.746 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 2.4 p -49.95 -43.29 49.97 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.49 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt -63.41 -49.35 74.11 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.389 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.403 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.0 mpt? -60.15 -37.89 81.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.341 0.591 . . . . 0.0 110.502 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.4 tppp? -69.41 -42.25 75.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.45 -50.24 70.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.29 0.567 . . . . 0.0 110.723 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.31 -39.65 94.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.15 0.5 . . . . 0.0 110.902 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -34.15 77.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm-40 -71.64 -40.84 69.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.675 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG3' HG21 ' A' ' 30' ' ' VAL . 10.5 mmm180 -68.97 -43.75 74.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.099 0.476 . . . . 0.0 111.657 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -84.95 -16.65 40.28 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.979 0.418 . . . . 0.0 111.714 -178.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.03 2.93 80.01 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.919 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -83.46 176.46 9.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.075 0.465 . . . . 0.0 111.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.0 m -94.21 130.57 40.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.4 ptp -66.54 -22.01 66.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.063 0.459 . . . . 0.0 111.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.4 ptp180 -80.05 -8.25 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.269 0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -104.66 7.96 35.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.969 0.414 . . . . 0.0 111.711 -178.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' HG2' ' A' ' 88' ' ' GLN . 22.2 pt -136.53 171.82 16.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.394 0.616 . . . . 0.0 111.364 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.436 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 16.6 mmm180 -140.64 145.79 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.573 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.66 130.47 56.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.593 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.6 ppt_? -133.1 138.24 46.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.351 0.596 . . . . 0.0 110.986 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -138.48 140.36 39.17 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.551 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.12 26.05 16.0 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.09 0.472 . . . . 0.0 111.297 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.31 -6.8 70.47 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.856 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.56 142.61 31.82 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.073 -0.663 . . . . 0.0 111.411 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.94 148.9 36.2 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 122.431 2.087 . . . . 0.0 111.435 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.96 135.29 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.428 0.633 . . . . 0.0 111.545 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.48 154.65 17.32 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.46 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.4 pt-20 -60.67 -21.28 62.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.054 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -76.46 -12.49 60.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 111.271 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.2 166.43 11.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 p -115.9 158.57 41.95 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.99 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' MET . 39.1 Cg_endo -67.79 -3.23 10.0 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.71 2.273 . . . . 0.0 112.124 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.43 -21.3 19.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.0 110.547 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -62.29 -39.49 93.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.378 0.609 . . . . 0.0 110.92 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.449 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.12 1.42 28.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.174 0.511 . . . . 0.0 111.221 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 3.5 mm-40 51.88 62.62 2.61 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.496 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.7 ptp -76.33 165.22 25.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.05 0.452 . . . . 0.0 110.366 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.82 165.83 11.92 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.1 131.56 44.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 21.8 mt-10 69.67 21.13 6.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.555 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -67.89 176.63 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 1.3 m -132.81 148.67 52.31 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.577 -0.702 . . . . 0.0 111.427 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.05 142.14 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.593 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 36.1 t70 -89.52 134.08 34.28 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.101 0.477 . . . . 0.0 110.531 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.17 137.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.789 0.804 . . . . 0.0 110.75 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.8 p90 -135.07 144.59 47.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.37 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.572 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.4 mt-30 -110.96 114.11 27.18 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.41 ' NE2' ' H ' ' A' ' 89' ' ' GLN . 1.4 mp0 -64.76 83.39 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.284 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.5 179.1 7.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.818 0.342 . . . . 0.0 110.432 177.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 m -92.95 -2.41 55.82 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.694 0.759 . . . . 0.0 110.253 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.29 -52.22 2.14 Favored Glycine 0 CA--C 1.509 -0.334 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.314 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.291 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.662 0.268 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 177.2 -179.76 0.22 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -115.71 10.41 15.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.267 0.556 . . . . 0.0 110.862 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.25 128.14 35.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.878 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 8.0 tmtm? -177.9 -56.92 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.737 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 56.7 Cg_endo -69.97 150.02 66.32 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.587 1.525 . . . . 0.0 111.611 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -119.49 21.65 12.03 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.441 0.639 . . . . 0.0 109.725 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -85.53 -31.52 22.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.238 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.17 60.61 4.72 Favored Glycine 0 C--N 1.313 -0.707 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.248 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -74.71 143.6 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.081 0.467 . . . . 0.0 110.245 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -69.68 -73.81 0.15 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.02 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -135.89 43.14 2.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.416 0.627 . . . . 0.0 111.402 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 65.73 29.82 10.52 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.499 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -63.78 135.48 56.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.312 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 65.07 61.59 0.75 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.755 0.788 . . . . 0.0 109.988 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -153.1 -59.6 0.14 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.004 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 46.9 p-80 -141.92 156.38 45.49 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.451 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 pt -108.05 169.87 2.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.502 0.668 . . . . 0.0 112.232 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' O ' HD22 ' A' ' 20' ' ' LEU . 15.6 m-80 -97.34 142.47 29.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.464 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -133.17 163.9 28.24 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.382 0.611 . . . . 0.0 110.887 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.8 mtpt -138.64 148.6 44.26 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.628 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG23 ' CE1' ' A' ' 32' ' ' PHE . 92.7 t -127.88 117.25 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.094 0.473 . . . . 0.0 110.497 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.36 123.19 35.5 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.292 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.88 163.01 26.69 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -19.42 63.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.706 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.1 -6.14 49.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.261 0.553 . . . . 0.0 110.98 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.17 64.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.838 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 t -103.88 158.4 16.43 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.94 136.04 45.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.253 0.549 . . . . 0.0 111.191 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.57 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.4 p -106.54 141.79 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 122.188 -0.32 . . . . 0.0 110.217 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -111.88 129.87 56.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.229 0.538 . . . . 0.0 109.968 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.7 p90 -154.09 169.95 22.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.585 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -115.56 143.27 45.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.651 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.436 ' CG2' HD23 ' A' ' 20' ' ' LEU . 13.6 tt -148.9 148.53 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.231 0.539 . . . . 0.0 110.398 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.459 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.0 mtmt -84.15 158.05 21.48 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.01 0.433 . . . . 0.0 110.782 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 23.8 mmm-85 -69.13 -34.04 74.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.517 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.45 5.13 52.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.58 . . . . 0.0 110.913 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.1 m -93.46 131.26 32.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.778 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.69 149.57 90.53 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.923 2.415 . . . . 0.0 112.784 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.7 mt -65.13 -12.14 47.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.906 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.3 m -49.63 -45.1 47.97 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.49 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt -61.48 -48.27 81.88 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.392 0.615 . . . . 0.0 109.79 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.751 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 38.5 mtt -61.57 -49.65 75.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.353 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.0 tppp? -59.66 -44.31 93.6 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.18 -50.79 68.46 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.773 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -62.78 -41.01 99.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.186 0.517 . . . . 0.0 110.813 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.562 ' SG ' HD11 ' A' ' 58' ' ' ILE . 79.2 m -65.52 -34.64 78.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.399 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 18.9 mm-40 -68.89 -37.13 78.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.22 0.533 . . . . 0.0 110.99 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 mmt180 -69.63 -44.33 70.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -83.34 -21.74 33.06 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.295 0.569 . . . . 0.0 110.67 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.71 88.79 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.532 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.69 176.0 7.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.288 0.566 . . . . 0.0 111.815 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.403 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 70.7 m -96.9 134.62 40.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.548 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.6 ptp -68.18 -19.74 64.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.096 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -83.42 -8.05 59.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.167 0.508 . . . . 0.0 111.059 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 11.9 mm100 -106.65 9.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.001 0.429 . . . . 0.0 110.811 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.676 HG22 ' HG2' ' A' ' 88' ' ' GLN . 19.6 pt -137.29 173.41 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.614 0.721 . . . . 0.0 111.856 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG2' ' NE2' ' A' ' 89' ' ' GLN . 21.3 mmm180 -140.27 146.9 39.18 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.071 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.751 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.6 m-85 -113.75 128.15 56.3 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.386 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.618 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.5 OUTLIER -128.63 145.41 51.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.003 0.43 . . . . 0.0 110.211 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -140.96 131.44 25.32 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.039 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 t0 58.33 29.38 18.05 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.893 0.378 . . . . 0.0 111.684 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.9 69.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.089 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -114.03 134.79 22.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.054 -0.674 . . . . 0.0 111.116 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.65 149.33 33.98 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.848 2.365 . . . . 0.0 112.376 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.87 137.52 52.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -97.9 161.28 13.82 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.216 177.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.597 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.4 pt-20 -62.22 -20.91 64.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.093 0.473 . . . . 0.0 112.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -76.33 -6.89 53.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.251 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' OD1' ' HG2' ' A' ' 75' ' ' GLN . 1.7 m-20 -103.22 166.85 10.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.136 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -116.84 159.89 38.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 78' ' ' MET . 35.3 Cg_endo -66.52 -8.71 21.72 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.506 2.137 . . . . 0.0 111.912 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.99 -13.09 25.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.303 0.573 . . . . 0.0 110.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.412 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 2.3 tp-100 -68.26 -35.49 77.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.511 0.672 . . . . 0.0 110.16 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.472 HD21 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -110.52 1.19 18.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.366 -179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 54.16 61.73 2.91 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.382 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.8 ptp -77.18 164.39 25.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 110.734 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 38.1 tt0 -95.09 161.58 14.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.128 -175.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.54 134.56 53.62 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.061 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 70.05 19.67 6.74 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.836 0.855 . . . . 0.0 111.555 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t0 -71.49 176.14 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.429 . . . . 0.0 110.111 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.46 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.5 m -131.32 150.26 52.22 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.22 0.534 . . . . 0.0 111.246 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.46 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.19 136.69 58.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.618 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 19.4 m-20 -89.83 138.07 31.8 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.041 0.448 . . . . 0.0 110.833 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -122.7 139.56 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.98 151.28 45.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.676 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.4 mt-30 -108.68 112.57 24.96 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.998 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.515 ' NE2' ' HG2' ' A' ' 59' ' ' ARG . 14.0 mp0 -57.55 164.17 2.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.734 0.778 . . . . 0.0 111.661 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -71.4 158.0 37.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.39 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.3 p -87.17 -44.28 11.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.685 0.755 . . . . 0.0 110.376 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.77 47.97 13.51 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.236 0 CA-C-O 118.387 -1.23 . . . . 0.0 111.136 -177.318 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 121.055 0.455 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.32 100.49 2.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.29 0.567 . . . . 0.0 109.926 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -128.19 8.46 6.09 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.731 0.777 . . . . 0.0 109.668 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.6 -79.7 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.469 -175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? 57.21 84.03 0.21 Allowed Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 123.064 0.546 . . . . 0.0 110.627 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.08 -153.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.916 3.077 . . . . 0.0 113.592 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -91.57 -6.61 52.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.712 0.768 . . . . 0.0 109.92 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -92.17 165.1 13.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.796 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.87 -12.04 72.41 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.141 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 13' ' ' GLU . 3.1 p -92.04 114.38 29.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.373 0.606 . . . . 0.0 111.913 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.563 ' HG3' ' N ' ' A' ' 12' ' ' THR . 19.8 ptpt -76.3 -49.58 16.58 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.262 0.553 . . . . 0.0 111.139 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.563 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 91.8 m -160.35 99.3 1.31 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.249 0.547 . . . . 0.0 109.744 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . 4.7 mm-40 -155.37 -173.49 4.58 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.827 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 19.4 m120 77.76 16.65 1.45 Allowed 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 123.624 0.77 . . . . 0.0 111.604 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -85.09 -83.25 0.17 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.701 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.97 114.24 18.74 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 45.8 p-80 -167.66 174.64 7.56 Favored 'General case' 0 N--CA 1.437 -1.119 0 O-C-N 121.975 -0.453 . . . . 0.0 111.009 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.44 170.51 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.369 0.604 . . . . 0.0 111.332 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.437 ' O ' HD22 ' A' ' 20' ' ' LEU . 23.6 m-80 -96.77 142.32 28.93 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.56 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -130.49 162.31 29.49 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.987 0.422 . . . . 0.0 109.889 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.2 mtpt -136.3 145.52 45.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.102 0.477 . . . . 0.0 110.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.6 t -125.56 116.67 47.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.156 0.503 . . . . 0.0 109.961 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.9 122.55 35.38 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.53 159.61 32.18 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -64.13 -11.9 34.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.166 0.508 . . . . 0.0 111.775 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -80.36 -15.51 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.356 0.598 . . . . 0.0 110.072 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 4.99 48.29 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.072 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 t -99.61 160.05 14.58 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.25 136.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.468 0.651 . . . . 0.0 111.496 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.74 HG21 ' HG3' ' A' ' 50' ' ' ARG . 7.4 p -102.28 142.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -113.64 125.04 53.71 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 22' ' ' VAL . 12.2 p90 -146.42 167.98 22.28 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.533 -174.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 40.8 mtmt -114.99 134.16 55.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 111.255 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.0 tt -144.71 150.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.106 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.8 mtmt -81.03 163.89 22.89 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.863 -0.523 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 22.4 mmm-85 -70.74 -40.24 72.84 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 110.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -91.8 5.97 47.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.568 0.699 . . . . 0.0 110.517 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.8 m -90.98 130.4 40.6 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.14 149.01 92.68 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.049 2.499 . . . . 0.0 113.233 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 43' ' ' LEU . 83.7 mt -64.05 -12.59 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.406 0.683 . . . . 0.0 111.994 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 13.5 t -52.89 -43.54 66.25 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.86 0.362 . . . . 0.0 110.991 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.497 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 44' ' ' MET . 2.4 tt -60.72 -49.77 76.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.32 0.581 . . . . 0.0 110.318 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.614 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 28.1 mtt -60.04 -47.28 86.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.369 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.0 tppt? -63.08 -41.87 99.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.752 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.73 74.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.958 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.67 -39.8 95.06 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.157 0.503 . . . . 0.0 110.71 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 58' ' ' ILE . 70.7 m -67.68 -34.87 77.77 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 16.2 mm-40 -70.72 -33.99 71.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.2 0.524 . . . . 0.0 110.505 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.74 ' HG3' HG21 ' A' ' 30' ' ' VAL . 15.9 mmt180 -65.45 -49.01 70.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.302 0.572 . . . . 0.0 110.511 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.63 -20.76 35.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.674 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.83 14.25 79.95 Favored Glycine 0 C--N 1.321 -0.269 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.371 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.99 178.54 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.451 0.643 . . . . 0.0 112.25 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.0 m -100.36 129.57 46.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.759 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.505 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.7 ptp -63.13 -24.04 67.71 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.119 0.485 . . . . 0.0 112.087 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -78.91 -12.48 60.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.351 0.596 . . . . 0.0 111.142 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -99.33 -0.29 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.146 0.498 . . . . 0.0 110.999 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.523 HD11 ' SG ' ' A' ' 48' ' ' CYS . 29.2 pt -132.77 169.9 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.229 0.537 . . . . 0.0 111.567 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 17.7 mmm180 -138.83 146.88 41.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.988 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.614 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.1 m-85 -112.72 130.73 55.96 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.825 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.625 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -130.71 145.22 51.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 0.0 110.66 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -146.51 135.79 22.77 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 60.88 28.04 17.83 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.427 0.632 . . . . 0.0 110.743 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.18 -1.2 70.94 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.445 -1.359 . . . . 0.0 113.51 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -118.53 139.84 27.5 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 117.527 0.664 . . . . 0.0 110.853 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.81 145.66 36.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.341 2.028 . . . . 0.0 111.577 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.7 137.58 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-O 121.543 0.687 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.53 154.25 17.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.544 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.584 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.2 pt-20 -61.7 -18.04 58.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.522 . . . . 0.0 112.325 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -79.51 -15.65 57.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.021 0.439 . . . . 0.0 111.278 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.39 164.07 15.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.942 0.401 . . . . 0.0 111.345 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -118.04 155.18 51.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.221 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.45 -11.35 29.97 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.754 2.303 . . . . 0.0 112.243 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.93 -14.81 24.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.896 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -69.31 -38.79 78.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.438 0.637 . . . . 0.0 110.168 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -104.92 1.28 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.432 0.634 . . . . 0.0 110.15 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 50.85 60.83 3.59 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.784 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.56 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -77.0 163.6 26.55 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.5 tp10 -92.96 161.83 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.453 . . . . 0.0 110.814 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.36 138.65 51.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.286 0.565 . . . . 0.0 111.215 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 73.03 19.45 3.69 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.413 1.085 . . . . 0.0 110.9 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -72.82 175.35 6.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.731 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.459 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.2 m -133.33 147.26 51.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.578 0.704 . . . . 0.0 111.506 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.459 HD12 ' C ' ' A' ' 83' ' ' THR . 2.5 mp -121.4 137.87 53.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.625 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 13.4 m-20 -88.73 136.38 33.03 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.1 0.476 . . . . 0.0 111.022 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -120.88 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-O 121.465 0.65 . . . . 0.0 110.609 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.6 p90 -137.94 147.15 44.06 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.305 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.459 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -109.55 111.65 23.29 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.191 0.52 . . . . 0.0 109.9 -175.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -132.85 135.27 45.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.496 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -115.57 117.78 31.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.29 0.567 . . . . 0.0 110.293 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.8 t -64.93 -24.69 67.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 111.749 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.1 143.37 15.05 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.094 0 CA-C-O 118.837 -0.979 . . . . 0.0 112.138 -177.607 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.084 0.469 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.66 108.71 4.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.04 0.448 . . . . 0.0 110.899 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.13 32.38 0.55 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.628 0.728 . . . . 0.0 110.452 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -122.47 17.41 10.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.433 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -122.85 92.17 49.28 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.949 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -80.3 146.74 17.79 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.503 2.135 . . . . 0.0 112.261 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 9.6 mmpt? -96.07 -10.14 29.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.564 0.697 . . . . 0.0 109.382 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -78.19 -3.02 40.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.008 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.38 -77.29 0.29 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.217 -0.516 . . . . 0.0 113.304 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -135.6 139.08 47.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 122.471 -0.429 . . . . 0.0 110.458 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -82.79 -53.26 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.349 . . . . 0.0 111.705 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -61.94 -19.13 62.41 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -100.7 125.66 47.17 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -155.7 144.56 20.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.222 0.534 . . . . 0.0 110.584 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 55.9 m-80 -129.18 140.74 51.39 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.488 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 15' ' ' ASN . 13.6 p-10 168.84 168.31 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.621 1.168 . . . . 0.0 108.655 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 10.6 p-80 40.97 -159.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.681 0.792 . . . . 0.0 111.852 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 pt -129.66 169.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.353 -0.842 . . . . 0.0 112.125 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.57 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.3 m-80 -103.87 144.49 31.44 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.215 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.3 mm? -135.23 160.69 37.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.336 0.589 . . . . 0.0 110.936 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.2 mtpt -135.93 148.32 48.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG23 ' CE1' ' A' ' 32' ' ' PHE . 96.9 t -125.38 119.32 55.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.244 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.75 119.9 35.06 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.338 0.59 . . . . 0.0 110.222 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.84 157.98 32.96 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.9 pp0? -64.43 -16.41 62.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.276 0.56 . . . . 0.0 111.369 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.98 -10.95 58.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 0.0 110.916 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.59 30.41 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.31 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -105.43 155.6 18.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.3 p -141.01 134.11 31.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.384 0.611 . . . . 0.0 110.958 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 85.9 t -107.24 138.45 33.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.99 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -110.11 131.75 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 22' ' ' VAL . 7.1 p90 -155.9 170.07 22.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.305 0.574 . . . . 0.0 111.887 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -116.45 138.38 51.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.744 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' CG2' HD23 ' A' ' 20' ' ' LEU . 15.5 tt -143.52 150.52 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.103 0.477 . . . . 0.0 110.069 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 25.8 mtmm -86.47 158.39 19.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.408 ' NH2' ' HA ' ' A' ' 74' ' ' ALA . 24.0 mmm-85 -63.25 -38.29 90.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.647 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -95.47 9.41 40.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.027 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.9 m -93.95 128.34 41.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.378 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.0 149.42 89.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.685 2.256 . . . . 0.0 112.925 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD2' HD13 ' A' ' 43' ' ' LEU . 83.8 mt -63.91 -11.71 30.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.971 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 21.9 p -51.67 -46.0 63.63 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.493 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt -63.37 -49.33 74.29 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.397 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.63 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 34.0 mtt -62.32 -46.57 88.15 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.227 0.537 . . . . 0.0 110.648 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.711 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 17.6 tppt? -64.99 -41.44 95.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.793 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.586 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.39 -50.96 71.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.796 0.332 . . . . 0.0 110.655 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.17 -42.34 99.37 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.362 0.601 . . . . 0.0 110.262 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.711 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.09 -40.17 88.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.958 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 7.8 mt-10 -73.38 -33.51 65.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.866 0.365 . . . . 0.0 111.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 50' ' ' ARG . 7.1 mmp_? -65.44 -47.71 75.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.314 0.578 . . . . 0.0 110.417 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -78.96 -22.12 46.16 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.124 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.79 2.6 78.37 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.975 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.86 176.27 7.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.459 0.647 . . . . 0.0 112.47 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.4 m -97.52 136.68 37.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.651 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 6.5 ptp -68.09 -26.64 65.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.158 0.504 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -75.17 -10.28 59.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.407 0.623 . . . . 0.0 110.665 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -102.66 5.67 39.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.231 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 88' ' ' GLN . 28.6 pt -138.8 176.66 6.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.118 0.485 . . . . 0.0 110.983 -177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.419 HH21 ' HB2' ' A' ' 66' ' ' PRO . 22.7 mmm180 -146.94 148.03 31.34 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.631 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.6 m-85 -114.55 132.33 56.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.789 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.625 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -131.0 142.58 50.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.46 0.648 . . . . 0.0 111.028 177.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -146.55 140.1 25.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t70 64.44 25.35 13.32 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.068 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.41 -0.39 64.34 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 119.819 -1.181 . . . . 0.0 113.161 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -120.79 143.3 36.27 Favored Pre-proline 0 N--CA 1.445 -0.695 0 O-C-N 122.134 -0.627 . . . . 0.0 110.808 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HB2' HH21 ' A' ' 59' ' ' ARG . 58.3 Cg_endo -72.62 148.7 47.87 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 122.233 1.956 . . . . 0.0 111.716 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.29 137.09 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-O 121.334 0.588 . . . . 0.0 110.648 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.19 156.24 16.96 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -60.66 -20.15 60.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.183 0.516 . . . . 0.0 112.062 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -79.54 -10.95 59.89 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.22 162.73 14.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.679 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -118.45 158.63 46.43 Favored Pre-proline 0 C--N 1.307 -1.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.16 -6.04 13.77 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.649 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . . . -95.42 -14.07 24.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.557 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -68.06 -37.02 80.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.444 0.64 . . . . 0.0 110.102 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.468 HD21 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -111.75 1.72 16.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.546 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 53.11 60.36 3.82 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.9 ptp -78.72 167.37 21.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.855 0.36 . . . . 0.0 110.534 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 80' ' ' ASP . 43.1 tt0 -93.29 165.64 12.7 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.095 0.474 . . . . 0.0 110.568 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 3.9 p-10 -77.25 137.87 39.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.063 0.459 . . . . 0.0 110.036 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.13 16.72 4.21 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.356 1.062 . . . . 0.0 111.317 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.07 176.43 3.81 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.6 m -136.41 151.04 49.09 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 121.805 -0.56 . . . . 0.0 111.004 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 61' ' ' ARG . 2.8 mp -120.81 144.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.625 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.5 t0 -88.87 130.96 35.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.146 0.498 . . . . 0.0 110.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.48 134.89 60.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.653 0.739 . . . . 0.0 111.046 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.411 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 4.3 p90 -135.65 145.96 47.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -110.32 112.14 23.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.085 0.469 . . . . 0.0 110.659 -177.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -69.51 -178.9 1.53 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.423 0.63 . . . . 0.0 111.575 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.476 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -84.51 -171.41 3.61 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.222 -177.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -166.54 162.01 16.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.069 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.01 -179.13 44.48 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.845 0 CA-C-O 118.725 -1.042 . . . . 0.0 112.329 -178.599 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.836 0.35 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.67 ' HB1' ' OE2' ' A' ' 4' ' ' GLU . . . -63.61 159.91 17.9 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.908 0.385 . . . . 0.0 111.47 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -106.23 28.16 7.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.475 0.655 . . . . 0.0 111.126 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.67 ' OE2' ' HB1' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -155.34 88.3 1.15 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.11 0.957 . . . . 0.0 112.552 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -141.95 105.64 5.74 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.93 128.31 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.548 2.166 . . . . 0.0 113.602 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.32 29.23 3.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.927 0.87 . . . . 0.0 109.747 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.91 103.38 7.82 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.998 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.59 -121.95 2.94 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -159.82 147.91 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.06 -54.46 4.83 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.794 0.331 . . . . 0.0 111.75 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -139.59 119.77 13.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.914 0.388 . . . . 0.0 110.726 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.23 124.61 42.91 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -36.92 113.03 0.22 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.096 0.951 . . . . 0.0 113.205 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -140.67 3.9 1.9 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.475 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -52.86 -39.04 62.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.959 0.885 . . . . 0.0 110.801 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 21.5 p-80 -141.94 164.78 29.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.7 pt -104.22 168.8 2.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-O 121.662 0.744 . . . . 0.0 112.217 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.9 m-80 -101.47 144.93 29.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.948 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -132.28 161.78 32.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.233 0.539 . . . . 0.0 110.459 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.0 mtpt -135.76 147.64 48.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.759 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 32' ' ' PHE . 79.3 t -127.48 113.91 33.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 121.082 0.468 . . . . 0.0 110.294 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.07 123.02 34.21 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.778 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.01 163.75 29.47 Favored Glycine 0 N--CA 1.418 -2.545 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -12.08 59.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.574 0.702 . . . . 0.0 111.28 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.41 -13.15 58.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.734 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.73 9.3 56.5 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.764 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -103.28 155.39 18.49 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.32 130.71 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.635 0.731 . . . . 0.0 111.377 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 94.2 t -101.81 135.85 36.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.325 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -108.44 128.82 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.2 p90 -151.42 169.7 21.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.216 0.531 . . . . 0.0 111.528 -174.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -115.46 138.21 51.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.842 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tt -145.54 149.31 16.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 30.5 mtmt -83.62 159.86 21.5 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.504 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 25.3 mmm-85 -69.46 -36.03 76.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.165 0.507 . . . . 0.0 110.594 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.99 5.95 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.272 0.558 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.2 m -91.29 131.57 36.23 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.321 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.45 147.89 93.0 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 70.9 mt -64.54 -13.44 52.67 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.408 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p -49.96 -40.85 45.27 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 111.7 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.48 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.476 HD13 HD22 ' A' ' 40' ' ' LEU . 3.9 tt -63.08 -51.69 65.66 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.521 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -60.56 -39.45 87.99 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.513 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 tppp? -68.72 -43.11 76.66 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.2 -51.15 65.33 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.78 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -64.68 -39.9 94.47 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.18 83.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 5.9 mm-40 -72.23 -35.36 68.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.273 0.558 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 27.6 mmm180 -69.43 -45.55 68.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.392 0.615 . . . . 0.0 111.402 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -83.12 -21.74 33.54 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.676 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.09 89.78 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.908 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.79 178.04 7.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.912 0.386 . . . . 0.0 111.502 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.8 m -96.87 124.67 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.17 -27.77 64.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -79.05 -9.47 59.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.218 0.532 . . . . 0.0 111.622 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -102.48 2.11 35.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.556 0.693 . . . . 0.0 110.617 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.529 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.9 pt -130.78 170.68 19.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.235 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 16.2 mmm180 -140.51 147.27 39.29 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.252 0.549 . . . . 0.0 111.253 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.2 m-85 -113.26 129.16 56.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.112 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.598 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.2 ppt_? -132.86 136.38 46.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 111.468 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -136.23 137.31 40.68 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 60.89 29.8 19.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.324 0.583 . . . . 0.0 111.134 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.51 67.99 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.197 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.03 139.78 31.02 Favored Pre-proline 0 C--N 1.323 -0.576 0 O-C-N 122.175 -0.603 . . . . 0.0 111.251 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 151.28 44.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.413 2.075 . . . . 0.0 111.851 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.88 136.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.353 0.597 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.71 154.51 17.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.508 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -59.11 -20.6 54.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.395 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.5 p -80.29 -10.37 59.75 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.304 0.573 . . . . 0.0 111.399 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.78 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 p -113.31 155.15 44.98 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.004 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -66.47 -7.77 18.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.56 2.173 . . . . 0.0 111.879 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.98 -16.61 22.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.929 0.395 . . . . 0.0 110.618 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 32.3 tp60 -68.97 -40.65 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.628 . . . . 0.0 110.49 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.488 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.83 -1.14 38.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.487 0.66 . . . . 0.0 110.205 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 60.07 3.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.929 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.1 ptp -79.83 165.17 22.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 175.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.608 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 13.0 pt-20 -100.73 169.51 8.97 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.146 0.498 . . . . 0.0 112.203 -175.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.64 133.3 50.84 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.894 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 69.24 18.63 8.07 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.508 0.723 . . . . 0.0 111.61 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.608 ' OD2' ' HG2' ' A' ' 79' ' ' GLU . 4.0 t0 -67.92 174.77 3.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.1 m -133.11 150.51 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.687 -0.633 . . . . 0.0 110.899 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.57 145.98 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.0 t70 -92.71 133.63 35.82 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.028 0.442 . . . . 0.0 110.521 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.61 137.13 54.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.7 0.762 . . . . 0.0 110.644 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -137.54 148.15 45.72 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.582 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HG2' HG22 ' A' ' 58' ' ' ILE . 7.0 mt-30 -107.21 111.84 24.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -59.98 167.55 2.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.78 0.8 . . . . 0.0 111.766 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -106.3 87.0 2.45 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.991 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -148.56 139.97 23.42 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.073 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.5 159.16 22.39 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.054 0 CA-C-O 118.515 -1.158 . . . . 0.0 111.678 179.653 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.959 0.409 . . . . 0.0 111.449 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.22 97.95 9.93 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -81.16 36.58 0.42 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.325 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -60.77 107.87 0.76 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.125 0.488 . . . . 0.0 109.999 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 37.3 ttpt -174.28 -48.7 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.104 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 2.8 Cg_exo -77.48 170.82 18.67 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 121.938 1.758 . . . . 0.0 111.959 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -114.24 31.97 6.23 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.632 0.73 . . . . 0.0 109.746 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -68.41 -179.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.992 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.21 -27.96 16.42 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.16 121.22 64.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.345 0.593 . . . . 0.0 110.529 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.611 ' HD3' ' N ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -74.14 -37.11 64.15 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 120.958 0.409 . . . . 0.0 111.941 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.611 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 35.9 m -158.43 145.91 17.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 1.7 mp0 -63.63 103.41 0.54 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -83.5 -31.65 26.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.084 0.468 . . . . 0.0 109.932 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -64.98 154.52 37.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 17' ' ' HIS . 12.5 t70 -140.16 -161.55 1.21 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.45 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 50.1 p-80 -155.06 177.04 11.78 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.56 169.37 20.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.326 0.584 . . . . 0.0 111.56 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.453 ' O ' HD22 ' A' ' 20' ' ' LEU . 19.3 m-80 -98.94 143.2 29.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.634 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.8 mm? -129.96 163.86 25.52 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.084 0.468 . . . . 0.0 110.026 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 55.6 mtpt -135.73 147.61 48.51 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 32' ' ' PHE . 69.6 t -126.53 117.23 47.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.169 0.509 . . . . 0.0 110.264 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.72 121.42 32.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.758 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.85 159.13 30.06 Favored Glycine 0 N--CA 1.42 -2.398 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.17 58.74 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.358 0.599 . . . . 0.0 111.679 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.76 -12.38 60.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.429 0.633 . . . . 0.0 110.499 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 8.46 57.67 Favored Glycine 0 C--N 1.321 -0.28 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.807 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -99.28 159.57 14.9 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.66 135.46 30.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-O 121.483 0.658 . . . . 0.0 111.274 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 14.6 p -104.98 138.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.063 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -108.78 125.62 52.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CE1' HG23 ' A' ' 22' ' ' VAL . 15.7 p90 -147.29 168.82 20.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.228 0.537 . . . . 0.0 111.446 -174.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -112.26 141.18 46.28 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.056 0.455 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' CG2' HD23 ' A' ' 20' ' ' LEU . 14.9 tt -148.2 148.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.088 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.5 mtmm -85.05 157.79 20.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.762 -0.586 . . . . 0.0 110.418 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.53 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 17.3 mmm-85 -64.28 -41.18 97.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.501 . . . . 0.0 110.803 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -89.92 7.42 37.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.421 0.629 . . . . 0.0 110.461 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 19.1 m -93.94 130.27 35.12 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 148.57 91.13 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.818 2.345 . . . . 0.0 113.123 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 43' ' ' LEU . 82.6 mt -62.76 -12.28 23.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.513 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 12.8 t -52.03 -43.79 63.88 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.609 0.364 . . . . 0.0 111.065 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.538 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 44' ' ' MET . 2.6 tt -62.28 -51.33 68.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.35 178.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.589 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 36.4 mtt -61.86 -40.17 94.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.377 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.3 tppp? -66.71 -44.32 81.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.54 -51.58 66.58 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.11 -40.42 95.85 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.003 0.43 . . . . 0.0 111.111 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -42.01 96.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.2 mm-40 -65.21 -39.65 93.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.852 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.8 mmp_? -65.61 -54.2 31.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.188 0.518 . . . . 0.0 111.51 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -21.41 59.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.184 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.08 87.74 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -86.99 177.45 7.23 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.404 -0.468 . . . . 0.0 110.734 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 m -100.25 128.05 46.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.641 0.258 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -64.35 -24.25 67.58 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.547 . . . . 0.0 111.247 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.6 ptp85 -77.67 -14.71 59.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.53 . . . . 0.0 110.778 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -99.85 1.0 42.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.156 0.503 . . . . 0.0 111.23 -178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.462 HG22 ' HG2' ' A' ' 88' ' ' GLN . 29.9 pt -130.71 173.03 15.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 22.0 mmm180 -141.12 149.83 42.06 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.741 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-85 -114.34 132.17 56.28 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.544 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.6 ppt_? -134.25 140.5 46.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 0.0 110.993 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -139.51 138.21 36.15 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.707 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.47 33.82 21.77 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.175 0.512 . . . . 0.0 112.107 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.1 -6.32 67.79 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.758 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.23 145.18 37.81 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 122.13 -0.629 . . . . 0.0 111.045 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.05 151.61 35.1 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.386 2.057 . . . . 0.0 111.179 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.44 141.33 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.458 0.647 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 154.2 17.36 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.4 pt-20 -62.17 -16.34 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.2 p -79.55 -18.63 51.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.203 0.525 . . . . 0.0 110.874 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 75' ' ' GLN . 0.3 OUTLIER -83.08 161.2 21.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.1 p -117.16 158.42 44.45 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.722 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 78' ' ' MET . 38.1 Cg_endo -68.27 -8.66 23.56 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.113 1.875 . . . . 0.0 111.529 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.38 -19.56 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.609 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.446 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 3.0 tp-100 -62.45 -36.31 82.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.42 0.628 . . . . 0.0 110.307 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.461 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.54 -0.3 20.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 51.05 63.09 2.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.507 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.634 ' SD ' HD11 ' A' ' 20' ' ' LEU . 12.1 ptp -77.44 175.47 9.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.825 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -96.19 157.84 15.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.39 143.32 48.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.438 0.637 . . . . 0.0 111.17 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 69.93 20.19 6.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.06 176.92 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.419 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.4 m -133.43 151.58 51.82 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 83' ' ' THR . 3.2 mp -124.19 142.51 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 30.0 t70 -89.42 136.83 32.8 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.2 137.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.631 0.729 . . . . 0.0 110.691 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -138.22 149.11 45.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.703 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HG2' HG22 ' A' ' 58' ' ' ILE . 5.3 mt-30 -107.49 110.26 22.14 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -121.54 116.12 24.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.571 0.7 . . . . 0.0 112.29 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -138.07 -83.25 0.31 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.129 174.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.0 p -147.27 136.86 22.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.23 106.31 0.2 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.917 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.288 0 CA-C-O 118.56 -1.134 . . . . 0.0 111.766 -179.13 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 121.045 0.45 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.04 139.8 31.49 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.131 0.491 . . . . 0.0 110.822 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -94.07 11.53 29.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.449 0.642 . . . . 0.0 110.461 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -110.66 99.1 8.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.237 0.542 . . . . 0.0 110.785 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -148.83 89.85 4.91 Favored Pre-proline 0 C--N 1.322 -0.595 0 O-C-N 121.871 -0.518 . . . . 0.0 110.396 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.39 135.7 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.783 2.322 . . . . 0.0 111.094 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -99.87 20.08 14.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.447 0.641 . . . . 0.0 110.649 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.58 171.6 14.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.158 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.44 -65.84 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.569 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.535 HG21 ' OD1' ' A' ' 14' ' ' ASN . 11.3 p -110.77 140.51 29.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.155 0.503 . . . . 0.0 111.475 -177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -63.62 -69.96 0.24 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.624 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -85.84 150.97 24.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.158 0.504 . . . . 0.0 111.167 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.76 114.72 4.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.535 ' OD1' HG21 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -126.83 119.16 26.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.257 0.551 . . . . 0.0 110.646 172.235 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -175.26 164.14 3.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -22.55 124.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 124.439 1.087 . . . . 0.0 112.032 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.611 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 23.7 p-80 -141.81 179.2 6.99 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.28 -173.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.05 169.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.516 0.674 . . . . 0.0 112.756 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD22 ' A' ' 20' ' ' LEU . 9.5 m-80 -99.35 139.91 34.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.43 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.529 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -131.69 159.91 37.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.211 0.529 . . . . 0.0 110.296 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -134.53 148.39 50.5 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.494 HG23 ' CE1' ' A' ' 32' ' ' PHE . 70.2 t -126.64 117.19 47.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.163 0.506 . . . . 0.0 109.986 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.14 119.29 31.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.95 158.33 30.41 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.453 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -66.24 -10.51 42.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.506 0.67 . . . . 0.0 110.886 -179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -76.53 -15.5 59.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.329 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 14.23 37.16 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.543 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t -119.59 166.25 13.39 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.23 137.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.171 0.51 . . . . 0.0 111.282 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.516 HG11 ' HG3' ' A' ' 50' ' ' ARG . 96.6 t -102.95 139.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.904 176.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -110.24 130.33 55.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CE1' HG23 ' A' ' 22' ' ' VAL . 6.0 p90 -150.86 168.91 23.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.181 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -117.27 133.98 55.34 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 16.9 tt -135.2 150.1 29.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 12.8 mttt -86.92 151.44 23.3 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.082 0.468 . . . . 0.0 110.847 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -61.72 -40.1 93.86 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.241 0.543 . . . . 0.0 110.805 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -87.73 6.17 36.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.289 0.566 . . . . 0.0 111.353 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.6 m -96.81 131.77 27.32 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.84 154.89 71.84 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.931 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 43' ' ' LEU . 95.4 mt -66.76 -11.25 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.771 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.4 p -50.74 -47.43 59.34 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.948 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.476 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.537 HD13 HD22 ' A' ' 40' ' ' LEU . 3.1 tt -61.01 -47.95 84.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.306 0.574 . . . . 0.0 110.331 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.656 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -60.81 -50.36 73.76 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.402 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.682 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 18.3 tppt? -60.84 -43.1 98.74 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.84 -52.79 61.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.047 0.451 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -61.03 -43.96 98.11 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.333 0.587 . . . . 0.0 110.503 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.4 m -61.02 -39.79 91.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.545 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.0 mt-10 -66.65 -33.82 76.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.054 0.454 . . . . 0.0 110.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.516 ' HG3' HG11 ' A' ' 30' ' ' VAL . 10.8 mmm180 -67.65 -48.74 65.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.143 0.497 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.3 mp0 -80.76 -22.7 39.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.069 0.461 . . . . 0.0 111.533 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.23 72.6 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.023 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.73 177.01 6.85 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.177 -0.602 . . . . 0.0 112.266 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.8 m -99.89 140.24 34.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.45 -25.9 66.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -75.53 -10.7 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.159 0.504 . . . . 0.0 110.953 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -101.41 4.32 41.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 0.0 110.933 -177.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.524 HD11 ' SG ' ' A' ' 48' ' ' CYS . 31.3 pt -139.92 174.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.289 0.566 . . . . 0.0 111.701 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -141.25 145.02 35.02 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.656 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.7 m-85 -113.43 131.57 55.97 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.673 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.612 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.53 141.78 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.589 . . . . 0.0 111.209 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -145.5 142.76 29.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.353 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 t70 60.64 25.67 15.4 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 120.96 0.409 . . . . 0.0 110.998 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.45 72.28 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.094 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -120.34 145.11 39.68 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.165 -0.609 . . . . 0.0 111.426 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.73 147.9 40.67 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 122.371 2.047 . . . . 0.0 111.181 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.05 136.52 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.255 0.55 . . . . 0.0 111.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -95.51 152.17 18.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.04 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.739 ' OE2' HG23 ' A' ' 70' ' ' THR . 0.2 OUTLIER -53.46 -21.48 6.24 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.739 HG23 ' OE2' ' A' ' 69' ' ' GLU . 40.6 p -74.16 -15.6 61.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.341 0.591 . . . . 0.0 111.661 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 55.9 m-20 -85.99 159.25 19.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -119.8 155.4 54.96 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.62 -7.64 19.95 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 112.336 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.88 -28.19 15.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.945 0.402 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -60.96 -39.62 90.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.5 . . . . 0.0 111.478 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.7 0.76 33.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 50.98 61.0 3.47 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.153 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.529 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.8 ptp -77.02 168.97 19.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -88.02 164.98 15.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.974 0.416 . . . . 0.0 110.169 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.24 141.37 31.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.626 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 73.67 14.4 4.21 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.074 0.95 . . . . 0.0 110.649 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.96 175.51 3.66 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.421 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.401 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.4 m -133.69 150.62 51.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.272 0.558 . . . . 0.0 111.193 -176.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.94 144.81 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.612 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 38.7 t70 -92.17 134.31 34.98 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.077 0.465 . . . . 0.0 110.775 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.52 135.21 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.809 0.814 . . . . 0.0 111.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -138.61 149.5 45.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.163 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.511 ' HG2' HG22 ' A' ' 58' ' ' ILE . 5.0 mt-30 -110.71 110.48 21.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.452 0.644 . . . . 0.0 110.63 -177.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -82.94 75.7 9.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.271 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -127.09 104.82 8.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.737 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -164.82 165.82 20.23 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.67 -46.44 61.55 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.752 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.548 -1.14 . . . . 0.0 112.172 178.024 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -43.11 107.12 0.08 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.368 0.604 . . . . 0.0 111.901 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -115.64 30.97 7.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.846 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.83 -26.56 65.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.329 0.585 . . . . 0.0 110.369 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -138.62 92.37 11.58 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.79 170.56 16.32 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.597 2.198 . . . . 0.0 112.237 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -104.02 7.18 36.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.986 0.898 . . . . 0.0 108.95 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.91 166.17 25.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.147 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.04 60.37 0.36 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.489 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -127.31 104.09 11.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.879 0.847 . . . . 0.0 111.293 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -104.82 -35.67 7.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.631 0.729 . . . . 0.0 109.873 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.0 161.94 37.46 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.185 -177.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 44.4 mt-10 -126.18 174.4 8.53 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.976 -0.452 . . . . 0.0 111.365 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 62.3 m-80 80.25 10.49 1.19 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 124.272 1.029 . . . . 0.0 111.556 177.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.32 -73.56 0.25 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.041 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -105.63 124.62 49.85 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 36.1 p-80 -173.4 -178.82 1.76 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.39 170.05 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.133 0.492 . . . . 0.0 110.639 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.523 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.9 m-80 -100.22 144.87 28.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -133.43 162.68 31.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.094 0.473 . . . . 0.0 110.483 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 83' ' ' THR . 58.5 mtpt -137.39 147.5 45.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG23 ' CE1' ' A' ' 32' ' ' PHE . 76.3 t -125.17 120.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.951 0.405 . . . . 0.0 110.411 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.28 122.54 38.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.597 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.0 160.8 30.03 Favored Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -21.1 65.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.428 0.632 . . . . 0.0 111.022 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.44 -16.5 62.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.477 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.04 49.93 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.675 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 t -101.91 157.54 16.78 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 8.2 p -139.99 137.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.561 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.4 p -109.43 142.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -112.85 127.01 56.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.323 0.582 . . . . 0.0 109.542 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' HG23 ' A' ' 22' ' ' VAL . 13.4 p90 -151.04 168.73 23.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.284 0.564 . . . . 0.0 111.561 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -112.51 142.86 44.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.697 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.426 ' CG2' HD23 ' A' ' 20' ' ' LEU . 16.1 tt -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.078 0.466 . . . . 0.0 110.192 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.4 mtmt -83.97 158.45 21.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.874 -0.516 . . . . 0.0 110.738 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.714 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 26.1 mmm-85 -65.45 -38.98 91.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 110.485 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.4 6.86 43.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.313 0.578 . . . . 0.0 110.538 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.0 m -93.93 130.03 35.9 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.78 151.16 85.13 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.886 2.39 . . . . 0.0 112.89 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.483 HD22 HD13 ' A' ' 43' ' ' LEU . 86.8 mt -64.26 -11.77 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 p -51.51 -45.11 62.76 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.924 0.392 . . . . 0.0 111.364 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.482 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD13 HD22 ' A' ' 40' ' ' LEU . 3.0 tt -62.5 -48.64 78.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.21 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.625 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.1 mtt -61.54 -41.8 97.88 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.719 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 18.1 tppt? -68.13 -41.59 81.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -47.45 85.82 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.15 0.5 . . . . 0.0 110.957 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -65.01 -40.19 94.52 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.248 0.547 . . . . 0.0 110.693 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.719 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.97 -36.7 80.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.277 -177.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.2 mm-40 -74.46 -39.74 62.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.229 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.561 ' HG3' HG21 ' A' ' 30' ' ' VAL . 17.0 mmt180 -64.04 -46.8 82.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.217 0.532 . . . . 0.0 111.437 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.46 -16.64 51.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.58 57.28 5.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.535 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.44 175.58 10.7 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.749 0.309 . . . . 0.0 110.253 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 58.3 m -99.93 132.2 45.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.762 0.315 . . . . 0.0 110.984 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.9 ptp -63.74 -26.05 68.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 111.088 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 7.6 ptm180 -74.72 -13.38 60.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.999 0.428 . . . . 0.0 111.347 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -103.25 6.92 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.143 0.497 . . . . 0.0 111.381 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.495 HG22 ' HG2' ' A' ' 88' ' ' GLN . 23.2 pt -133.36 170.31 20.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.122 0.487 . . . . 0.0 111.241 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 6.7 mmm180 -138.1 140.2 39.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.397 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.3 m-85 -108.75 131.36 55.02 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 5.4 ppt_? -131.69 140.93 49.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -141.75 138.8 32.58 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.5 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.94 28.78 18.34 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.45 -3.57 77.4 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.545 -1.312 . . . . 0.0 113.316 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -123.45 144.89 45.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 O-C-N 121.899 -0.765 . . . . 0.0 111.637 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.57 150.44 40.38 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.665 2.244 . . . . 0.0 112.014 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 138.95 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 121.713 0.768 . . . . 0.0 111.267 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.47 154.91 18.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.589 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.602 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.6 pt-20 -62.49 -18.29 61.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.097 0.475 . . . . 0.0 112.227 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -79.63 -14.77 58.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.288 0.566 . . . . 0.0 111.283 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.2 158.61 21.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.001 0.429 . . . . 0.0 110.151 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 p -118.69 151.58 50.16 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.512 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.43 -9.05 18.75 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.47 2.113 . . . . 0.0 112.111 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.68 -20.46 18.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.424 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -69.68 -36.14 75.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.144 0.497 . . . . 0.0 110.814 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.49 -0.34 24.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.344 0.592 . . . . 0.0 110.224 178.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 48.95 62.5 2.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.9 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ptp -74.3 166.62 23.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.09 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 39.1 tt0 -87.75 157.02 19.15 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.114 0.483 . . . . 0.0 110.849 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -72.81 139.4 47.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.118 0.485 . . . . 0.0 110.066 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 71.13 15.93 6.42 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.069 0.948 . . . . 0.0 110.594 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -70.37 176.68 3.82 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.448 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -130.14 147.26 51.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.4 0.619 . . . . 0.0 111.45 -177.207 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.82 133.97 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 2.5 m-20 -86.31 136.31 33.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.045 0.45 . . . . 0.0 111.088 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -123.87 140.36 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.382 0.611 . . . . 0.0 111.145 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.66 147.01 44.54 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.588 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.495 ' HG2' HG22 ' A' ' 58' ' ' ILE . 7.4 mt-30 -105.15 111.48 24.26 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.36 0.6 . . . . 0.0 111.107 -176.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -130.43 121.32 25.67 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.868 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.41 -59.66 2.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.962 0.411 . . . . 0.0 110.543 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 m 59.74 67.97 0.83 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.615 0.721 . . . . 0.0 110.168 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.3 -47.95 3.84 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.289 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.155 0 CA-C-O 118.305 -1.275 . . . . 0.0 111.863 -179.931 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.75 0.309 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.4 133.99 43.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.956 0.408 . . . . 0.0 111.141 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -112.34 38.78 2.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.087 0.946 . . . . 0.0 109.694 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.414 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 48.3 mt-10 -139.79 150.06 44.27 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 19.9 ttmm -48.01 -53.61 31.26 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.448 176.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 72.7 Cg_endo -74.17 163.0 37.6 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.88 1.72 . . . . 0.0 111.33 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -93.83 -16.45 24.09 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.39 0.614 . . . . 0.0 110.321 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.35 22.57 1.23 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.333 0.587 . . . . 0.0 111.29 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 -22.79 49.98 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.08 141.4 20.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.201 -0.499 . . . . 0.0 110.202 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -117.17 -69.7 0.84 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.299 0.571 . . . . 0.0 110.551 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -143.68 137.26 28.1 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.651 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -141.76 91.69 2.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.582 0.706 . . . . 0.0 111.498 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -124.15 16.4 9.16 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 122.003 0.906 . . . . 0.0 108.84 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -108.2 15.83 23.8 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.058 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.5 89.37 0.23 Allowed 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.454 0.645 . . . . 0.0 110.741 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 36.5 p-80 -137.92 174.65 10.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 120.999 0.428 . . . . 0.0 110.312 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.5 pt -128.59 169.08 20.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.332 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.507 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.9 m-80 -97.46 144.61 27.02 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -132.75 160.77 35.86 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.292 0.568 . . . . 0.0 110.779 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.8 mtpt -136.11 148.84 48.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.789 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.46 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.8 t -129.16 116.6 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 120.955 0.407 . . . . 0.0 110.171 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.54 128.03 35.55 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.9 156.87 22.59 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -64.45 -11.55 34.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.493 0.663 . . . . 0.0 110.879 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.55 -19.29 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.211 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 9.36 36.33 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.297 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 t -113.45 157.36 22.05 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 122.296 -0.532 . . . . 0.0 109.899 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.44 135.02 58.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.425 0.631 . . . . 0.0 111.258 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 50' ' ' ARG . 14.4 p -101.78 142.09 16.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 122.118 -0.364 . . . . 0.0 110.263 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -112.03 130.93 55.7 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.107 0.48 . . . . 0.0 109.73 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 22' ' ' VAL . 9.5 p90 -151.37 168.37 25.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.438 -175.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 41.8 mtmt -113.87 136.5 52.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.862 0.363 . . . . 0.0 110.818 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tt -142.62 147.09 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.049 0.452 . . . . 0.0 110.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 27.1 mtmm -85.14 157.62 20.62 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 121.083 0.468 . . . . 0.0 111.376 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -63.16 -41.52 99.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.704 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -88.73 6.86 36.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.322 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 13.6 m -93.99 130.12 35.51 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.87 151.32 84.49 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.696 2.264 . . . . 0.0 112.655 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 43' ' ' LEU . 87.3 mt -66.64 -13.19 60.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.296 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 14.4 m -47.92 -44.34 29.76 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.502 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 HD22 ' A' ' 40' ' ' LEU . 4.0 tt -61.73 -51.67 67.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.789 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -58.51 -50.24 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.963 0.411 . . . . 0.0 110.601 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.7 tppp? -62.82 -37.92 88.69 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.402 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.25 -49.8 76.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.451 . . . . 0.0 110.531 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.05 -40.5 96.43 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.025 0.441 . . . . 0.0 111.036 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.1 m -63.15 -34.98 78.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 110.997 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.5 mm-40 -71.55 -41.79 68.68 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.789 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.6 mmp_? -66.48 -47.15 73.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.353 0.597 . . . . 0.0 111.303 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -81.16 -16.61 52.42 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.895 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.78 57.77 5.2 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.606 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.92 173.6 12.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.666 -0.314 . . . . 0.0 110.425 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -98.87 133.73 42.74 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.756 0.312 . . . . 0.0 111.698 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.483 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 9.5 ptp -65.06 -26.36 68.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.078 0.466 . . . . 0.0 111.269 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 19.1 ptp180 -74.66 -6.24 47.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.238 0.542 . . . . 0.0 110.836 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -109.35 5.17 23.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.932 -179.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.724 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.7 pt -137.19 171.99 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.188 0.518 . . . . 0.0 111.177 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 24.2 mmt180 -142.6 147.91 36.61 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.265 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.423 ' HB3' HG21 ' A' ' 84' ' ' ILE . 9.0 m-85 -114.28 128.22 56.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.121 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.8 ppt_? -130.26 136.8 49.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 84' ' ' ILE . 81.9 t80 -138.69 133.14 31.92 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.548 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 65.06 26.3 12.58 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.064 0.459 . . . . 0.0 110.57 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.85 -5.13 76.94 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.242 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.05 142.91 34.31 Favored Pre-proline 0 C--N 1.322 -0.603 0 O-C-N 122.054 -0.674 . . . . 0.0 111.381 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 144.55 29.76 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.538 2.159 . . . . 0.0 111.955 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.62 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.589 0.709 . . . . 0.0 110.674 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.21 156.84 18.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.96 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.37 -26.49 61.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.134 0.492 . . . . 0.0 112.176 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.2 p -74.29 -17.2 60.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.072 0.463 . . . . 0.0 111.223 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -78.87 158.4 28.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.195 0.521 . . . . 0.0 111.005 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -117.33 153.11 49.97 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.69 -7.35 19.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.449 2.099 . . . . 0.0 112.018 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.23 -23.06 17.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.095 0.474 . . . . 0.0 110.608 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -62.54 -39.46 93.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.391 0.615 . . . . 0.0 110.561 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.71 1.48 23.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.863 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 49.16 62.65 2.5 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.658 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -76.23 170.44 16.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -88.06 163.91 16.01 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.394 0.616 . . . . 0.0 111.237 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.46 138.83 34.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 72.36 13.46 5.55 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.963 0.905 . . . . 0.0 110.246 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.08 172.8 5.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.92 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.1 m -132.1 151.56 51.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.281 0.562 . . . . 0.0 111.355 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -123.85 141.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.62 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 31.8 t70 -90.82 132.32 35.95 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.907 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -116.19 134.58 59.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.555 0.693 . . . . 0.0 110.917 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -141.93 153.24 44.21 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.724 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.0 mt-30 -107.79 108.64 19.93 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -126.79 15.0 7.5 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.17 135.93 53.65 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.658 -0.651 . . . . 0.0 110.026 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -106.71 -22.75 12.63 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.757 0.789 . . . . 0.0 109.725 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.57 -136.27 2.46 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.544 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.108 0 CA-C-O 118.363 -1.243 . . . . 0.0 111.394 -178.41 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 1' ' ' MET . 25.0 ttt . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.769 0.795 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.1 107.23 17.46 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.964 -0.46 . . . . 0.0 110.079 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -84.98 -29.18 25.27 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 121.748 0.785 . . . . 0.0 109.509 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 62.65 54.55 2.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.063 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 62.9 mttm -73.1 -50.71 6.47 Favored Pre-proline 0 CA--C 1.539 0.537 0 O-C-N 122.203 -0.31 . . . . 0.0 111.081 176.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 6.3 Cg_exo -80.32 142.76 15.16 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 121.823 1.682 . . . . 0.0 110.828 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -85.17 61.16 6.7 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.554 0.692 . . . . 0.0 110.337 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.3 98.69 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.263 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.9 28.38 0.04 OUTLIER Glycine 0 C--N 1.309 -0.943 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.511 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 m -132.68 -177.73 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -57.5 -67.15 0.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.571 . . . . 0.0 111.172 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -124.06 87.69 2.78 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.301 0.572 . . . . 0.0 109.907 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.09 152.01 38.36 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.999 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -95.51 122.43 38.23 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -126.49 -170.63 2.23 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.672 0.749 . . . . 0.0 111.975 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.36 118.76 13.58 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 51.7 p-80 -157.69 167.57 29.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -175.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.5 pt -121.07 168.94 12.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.451 0.643 . . . . 0.0 111.657 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.505 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.7 m-80 -100.47 141.7 32.97 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.751 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.534 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.56 162.78 30.98 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.042 0.449 . . . . 0.0 110.446 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.66 149.04 49.18 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.24 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.517 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.5 t -127.36 115.6 40.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.53 118.36 29.93 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.058 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.0 156.96 30.36 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.1 pp0? -63.54 -15.44 58.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.02 -17.49 61.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.763 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.57 36.43 Favored Glycine 0 C--O 1.229 -0.178 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 t -112.41 161.72 16.37 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -138.09 136.84 44.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.452 0.644 . . . . 0.0 110.713 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 87.5 t -102.58 135.03 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -109.59 126.74 53.92 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.605 ' HB2' HH31 ' A' ' 42' ' ' ALY . 11.9 p90 -148.18 168.15 23.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.408 0.623 . . . . 0.0 111.755 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 38.2 mtmt -115.53 134.6 54.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.302 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 17.6 tt -139.07 149.82 23.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.6 mtmp? -87.78 155.93 19.66 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.907 -0.496 . . . . 0.0 111.187 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 28.9 mmm-85 -63.72 -34.69 78.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -96.41 6.53 48.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 110.781 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.9 m -93.65 130.79 33.95 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.49 151.65 79.65 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.717 2.278 . . . . 0.0 112.122 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.823 HD22 HD13 ' A' ' 43' ' ' LEU . 33.3 mt -65.61 -11.37 43.81 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.108 -0.497 . . . . 0.0 112.32 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 15.8 p -48.91 -42.34 36.67 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.061 0.457 . . . . 0.0 111.047 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.605 HH31 ' HB2' ' A' ' 32' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.823 HD13 HD22 ' A' ' 40' ' ' LEU . 4.3 tt -61.72 -53.35 57.26 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.473 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.433 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.0 mpt? -59.72 -39.85 86.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.113 0.482 . . . . 0.0 110.589 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.8 tppp? -70.12 -40.72 74.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.024 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.9 75.66 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 110.336 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -65.44 -39.43 92.05 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.67 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.01 -38.67 86.87 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.792 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 41.8 mm-40 -67.04 -46.21 75.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.346 0.593 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -59.77 -47.68 84.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.755 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.5 mp0 -84.34 -21.38 30.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.971 -178.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.8 90.13 Favored Glycine 0 C--N 1.322 -0.246 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.647 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -87.39 177.22 7.18 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.995 0.426 . . . . 0.0 111.633 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.482 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 43.8 m -95.34 130.38 42.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 ptp -65.17 -24.78 67.48 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.213 0.53 . . . . 0.0 111.341 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -79.37 -12.48 59.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.361 0.6 . . . . 0.0 111.118 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.482 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 14.5 mm100 -98.72 8.24 45.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.476 0.655 . . . . 0.0 111.013 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.4 pt -137.47 174.78 10.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.803 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 26.8 mmt180 -139.77 146.31 39.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.598 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 16.8 m-85 -115.26 128.09 55.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.32 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.0 ppt_? -132.02 134.22 45.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.498 0.665 . . . . 0.0 110.866 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -128.09 131.99 49.03 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.224 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.4 31.56 7.41 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.74 83.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -124.19 136.09 27.2 Favored Pre-proline 0 C--N 1.323 -0.562 0 O-C-N 121.95 -0.735 . . . . 0.0 111.576 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.16 146.16 45.61 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.948 2.432 . . . . 0.0 111.944 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.42 136.03 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 111.714 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.97 157.69 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.613 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 4.3 pt-20 -62.87 -18.45 62.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.263 0.554 . . . . 0.0 112.198 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.7 p -80.86 -11.4 59.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.082 0.468 . . . . 0.0 111.266 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -87.52 160.02 18.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.88 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 p -117.35 155.21 50.24 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.575 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 78' ' ' MET . 43.7 Cg_endo -67.13 -12.86 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.31 2.007 . . . . 0.0 112.163 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.85 -16.99 21.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.188 0.518 . . . . 0.0 110.861 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.28 -34.55 76.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.405 0.621 . . . . 0.0 110.666 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.19 0.96 21.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.336 0.589 . . . . 0.0 110.413 177.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 50.67 59.52 4.53 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.367 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.534 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.84 170.37 15.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.08 0.467 . . . . 0.0 110.043 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -95.13 162.77 13.57 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.027 0.442 . . . . 0.0 110.532 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.27 137.37 41.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.153 0.502 . . . . 0.0 110.491 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 75.19 16.25 2.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.65 177.25 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.8 m -135.18 151.68 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.15 0.5 . . . . 0.0 111.216 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.9 142.69 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.9 t70 -93.06 132.95 36.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.027 0.442 . . . . 0.0 110.838 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.9 t -116.15 132.55 65.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.84 0.828 . . . . 0.0 111.49 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -135.33 143.29 46.07 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.634 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -110.38 111.87 23.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.143 0.497 . . . . 0.0 110.616 -176.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -107.17 82.3 1.66 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -168.81 103.02 0.4 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.349 0.595 . . . . 0.0 112.294 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -60.21 107.73 0.69 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.111 0.481 . . . . 0.0 110.971 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.96 56.42 0.48 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.733 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.622 -179.132 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.112 0.482 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.16 106.36 6.02 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.088 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -118.62 11.99 12.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.225 0.536 . . . . 0.0 110.286 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.71 -71.41 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.078 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 54.73 74.08 0.79 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.159 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.31 164.71 29.49 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.692 2.261 . . . . 0.0 112.876 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -83.32 -39.8 20.31 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.453 0.644 . . . . 0.0 109.786 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.24 159.42 12.76 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.78 57.97 4.07 Favored Glycine 0 C--N 1.316 -0.538 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.004 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.06 135.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.322 0.582 . . . . 0.0 110.397 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -97.81 136.06 38.68 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -44.75 133.79 5.89 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.575 0.702 . . . . 0.0 111.336 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -88.19 177.82 6.79 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.236 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.41 140.31 58.86 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.868 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -94.56 79.47 3.82 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.522 0.677 . . . . 0.0 111.002 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -100.89 -169.41 1.7 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.023 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 41.2 p-80 -139.27 161.17 38.09 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.629 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 pt -110.74 169.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.542 0.686 . . . . 0.0 112.655 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.446 ' O ' HD22 ' A' ' 20' ' ' LEU . 25.1 m-80 -94.66 140.91 29.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.589 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.593 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -129.8 159.66 35.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.7 mtpt -134.52 147.17 50.27 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 32' ' ' PHE . 77.4 t -127.74 116.94 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.118 0.485 . . . . 0.0 110.372 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.62 31.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.591 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.03 162.25 32.36 Favored Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.201 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -16.42 63.87 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.734 0.778 . . . . 0.0 110.571 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.25 -19.45 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.98 7.87 54.72 Favored Glycine 0 C--N 1.323 -0.166 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.263 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -108.39 165.03 11.82 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.269 0.557 . . . . 0.0 110.674 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG21 ' HG3' ' A' ' 50' ' ' ARG . 10.0 p -106.32 139.62 27.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.19 124.83 53.45 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.0 p90 -147.75 167.78 23.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 -174.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -114.7 138.49 50.64 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -144.18 148.65 18.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 110.586 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.1 mtmp? -81.07 154.88 26.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.969 0.414 . . . . 0.0 110.627 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 24.3 mmm-85 -66.14 -37.47 85.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.223 0.535 . . . . 0.0 110.562 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -90.24 6.79 41.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.584 0.707 . . . . 0.0 110.49 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.536 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.7 m -94.71 131.52 30.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.79 149.94 86.4 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.804 2.336 . . . . 0.0 113.009 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.0 mt -64.56 -12.02 40.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.452 0.701 . . . . 0.0 112.132 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.0 t -52.07 -46.54 65.21 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.467 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 40' ' ' LEU . 2.9 tt -61.95 -49.06 77.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.306 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.686 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -58.81 -49.47 77.56 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.101 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.677 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.2 tppt? -60.03 -43.0 95.61 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.33 -49.92 72.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.042 0.449 . . . . 0.0 110.95 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -64.17 -41.11 97.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.4 m -63.72 -33.94 76.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.515 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.8 mm-40 -71.6 -40.86 69.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.23 0.538 . . . . 0.0 110.177 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.498 ' HG3' HG21 ' A' ' 30' ' ' VAL . 10.2 mmm180 -66.21 -46.69 76.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -80.19 -22.11 42.25 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.009 0.433 . . . . 0.0 111.436 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.35 58.47 3.61 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.144 -1.026 . . . . 0.0 111.773 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.41 176.06 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.57 -0.37 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -95.4 130.31 42.24 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.821 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.571 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 4.2 ptp -64.5 -21.41 66.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.085 0.469 . . . . 0.0 111.84 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -83.19 -6.72 59.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 0.0 111.274 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.345 0.593 . . . . 0.0 110.725 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.582 HD11 ' SG ' ' A' ' 48' ' ' CYS . 28.8 pt -136.56 170.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 18.0 mmm180 -141.22 143.01 33.93 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.6 m-85 -110.1 134.39 52.22 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.57 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.58 ' CG ' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.295 0.569 . . . . 0.0 110.599 178.005 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -140.78 139.27 34.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.6 31.09 16.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.07 -4.09 72.99 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.943 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -119.65 140.15 28.98 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 121.955 -0.733 . . . . 0.0 111.358 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.16 146.15 45.62 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.486 2.124 . . . . 0.0 111.641 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.18 135.84 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 121.605 0.716 . . . . 0.0 111.049 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.06 155.93 18.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.335 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -61.9 -19.93 63.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.268 0.556 . . . . 0.0 111.965 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.1 p -80.2 -10.43 59.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.82 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.39 161.11 17.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 p -118.09 153.7 51.38 Favored Pre-proline 0 C--N 1.32 -0.682 0 O-C-N 122.371 -0.206 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 25.6 Cg_endo -63.99 -10.67 23.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.653 2.235 . . . . 0.0 112.328 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.24 -17.87 21.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.071 0.462 . . . . 0.0 110.962 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -69.14 -35.55 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 110.855 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.03 1.96 24.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 110.77 179.146 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 52.39 61.71 3.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.697 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.593 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.7 ptp -80.29 174.33 11.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.134 -0.354 . . . . 0.0 110.331 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -99.76 169.68 9.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.238 0.542 . . . . 0.0 111.091 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.57 138.56 36.48 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 74.32 12.37 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.056 0.942 . . . . 0.0 111.426 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.63 174.89 3.18 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.5 m -135.33 150.19 49.92 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.363 0.601 . . . . 0.0 111.536 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 61' ' ' ARG . 3.1 mp -121.32 144.33 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.58 ' HB3' ' CG ' ' A' ' 61' ' ' ARG . 25.4 t0 -92.63 138.56 31.39 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.49 137.78 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.571 0.701 . . . . 0.0 110.706 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.434 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 1.7 p90 -134.94 143.3 46.82 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.561 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.454 ' HG2' HG22 ' A' ' 58' ' ' ILE . 6.4 mt-30 -97.13 111.09 23.48 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.872 -178.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -56.25 156.18 6.0 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.673 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -78.23 161.89 26.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.36 0.6 . . . . 0.0 111.306 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 p -83.83 -10.93 57.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.525 0.679 . . . . 0.0 110.494 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.17 -178.34 19.32 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.447 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.387 0 CA-C-O 118.72 -1.044 . . . . 0.0 111.377 179.362 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.989 0.423 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.54 97.09 5.62 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.269 0.557 . . . . 0.0 110.976 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.95 -12.04 42.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.599 0.714 . . . . 0.0 110.627 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -98.68 31.53 2.88 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.701 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -66.48 -47.65 57.62 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.797 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.54 141.4 34.6 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 121.471 1.447 . . . . 0.0 111.846 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -102.87 22.79 13.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.825 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.64 129.16 39.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.202 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.75 57.98 5.03 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.113 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 13' ' ' GLU . 14.3 t -104.18 150.86 7.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -126.95 -34.49 2.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.179 0.514 . . . . 0.0 111.076 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 t -85.09 22.16 1.49 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.855 0.836 . . . . 0.0 111.497 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.425 ' HG2' ' CG1' ' A' ' 10' ' ' VAL . 34.5 mm-40 -58.94 -71.63 0.11 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.173 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.82 25.1 15.01 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.165 0.507 . . . . 0.0 112.02 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -69.56 120.72 15.77 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.372 0.605 . . . . 0.0 109.652 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -161.35 -174.28 4.22 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.0 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.551 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 17.1 p80 -132.75 153.93 50.72 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.6 pt -111.9 169.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.407 0.622 . . . . 0.0 111.666 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.2 m-80 -97.47 143.4 28.23 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.39 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -132.05 162.11 31.58 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.081 0.467 . . . . 0.0 110.054 177.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.4 mtpt -133.94 147.42 51.06 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.071 0.462 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 32' ' ' PHE . 81.1 t -127.99 117.85 47.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.87 122.15 34.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.1 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.04 157.84 28.66 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -66.42 -11.97 54.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.281 0.562 . . . . 0.0 111.242 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.61 -16.56 57.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.289 0.566 . . . . 0.0 110.51 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.73 11.28 30.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.435 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.7 t -111.34 159.07 18.32 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 122.2 -0.588 . . . . 0.0 109.516 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.33 136.17 46.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.269 0.557 . . . . 0.0 110.541 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 90.5 t -103.19 137.58 30.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.225 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -111.41 123.19 49.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CE1' HG23 ' A' ' 22' ' ' VAL . 10.5 p90 -146.5 168.58 20.86 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.181 0.515 . . . . 0.0 111.275 -174.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -112.96 140.36 47.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.081 0.467 . . . . 0.0 111.07 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.85 146.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 110.435 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.6 mtmt -81.72 157.67 24.49 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 24.5 mmm-85 -65.18 -38.93 92.07 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.813 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -90.62 6.21 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.585 0.707 . . . . 0.0 110.348 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 21.3 m -94.32 129.94 35.46 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.8 152.18 82.26 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.869 2.379 . . . . 0.0 113.036 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.474 HD22 HD13 ' A' ' 43' ' ' LEU . 84.0 mt -64.84 -12.03 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.444 0.698 . . . . 0.0 111.884 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.1 p -51.16 -46.9 62.2 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.082 0.467 . . . . 0.0 111.076 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.498 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD13 HD22 ' A' ' 40' ' ' LEU . 2.1 tt -59.78 -49.43 77.74 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.302 0.573 . . . . 0.0 110.137 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.588 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.4 mtt -61.23 -46.29 91.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -64.15 -38.65 91.81 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.75 -49.92 74.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.096 0.474 . . . . 0.0 110.464 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -63.22 -42.85 99.32 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.171 0.51 . . . . 0.0 110.68 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 79.1 m -64.57 -34.47 78.32 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.19 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.72 -42.12 91.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.3 mmm180 -65.33 -44.03 89.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.384 0.611 . . . . 0.0 111.472 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -85.93 -21.53 27.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.895 0.379 . . . . 0.0 111.653 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.1 5.67 88.91 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.014 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -90.48 177.89 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.397 -0.473 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -99.93 134.94 42.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.446 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.9 ptp -66.74 -21.85 66.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.956 0.408 . . . . 0.0 111.935 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.453 ' HG3' HE21 ' A' ' 57' ' ' GLN . 9.7 ptp85 -82.24 -9.56 59.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.117 0.484 . . . . 0.0 110.863 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.453 HE21 ' HG3' ' A' ' 56' ' ' ARG . 17.9 mm-40 -103.88 5.83 36.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.72 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.51 HG22 ' HG2' ' A' ' 88' ' ' GLN . 24.9 pt -137.48 172.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.809 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 26.2 mmm180 -140.82 145.36 36.18 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.071 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.9 m-85 -111.9 128.79 56.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.8 ppt_? -129.98 139.83 51.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.532 0.682 . . . . 0.0 111.395 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -141.94 137.33 31.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.175 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.95 27.91 14.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 110.861 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 -2.31 76.16 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.545 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -126.32 145.81 54.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.914 -0.756 . . . . 0.0 111.244 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.93 150.3 54.82 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.373 2.049 . . . . 0.0 111.899 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.26 138.3 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-O 121.502 0.668 . . . . 0.0 111.055 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.31 150.78 21.16 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.787 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.521 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -60.83 -18.56 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.404 0.621 . . . . 0.0 111.784 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -79.68 -10.89 59.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.473 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 162.12 14.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.856 0.36 . . . . 0.0 111.32 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.8 p -118.69 154.28 52.58 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.813 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.95 -9.08 21.87 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.483 2.122 . . . . 0.0 111.932 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.53 -22.31 17.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -63.76 -43.69 95.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.55 0.691 . . . . 0.0 110.222 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -101.18 0.92 38.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.853 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 53.75 56.66 6.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.822 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.97 168.99 18.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.823 0.344 . . . . 0.0 110.258 177.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.23 164.83 13.4 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.233 0.54 . . . . 0.0 111.663 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -78.85 133.34 37.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.223 0.535 . . . . 0.0 109.764 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 75.51 15.98 2.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.268 1.027 . . . . 0.0 110.819 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.34 176.05 2.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.76 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.9 m -134.21 150.84 51.08 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.649 -0.657 . . . . 0.0 111.559 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.425 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -122.7 139.75 48.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -90.51 134.66 34.21 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.101 0.477 . . . . 0.0 110.718 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.14 135.53 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.847 0.832 . . . . 0.0 111.163 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.3 146.52 46.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.515 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.51 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -110.0 111.3 22.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.141 0.496 . . . . 0.0 109.823 -177.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.43 ' OE1' ' HG2' ' A' ' 90' ' ' GLN . 3.5 pp0? -144.26 144.77 31.65 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.118 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.43 ' HG2' ' OE1' ' A' ' 89' ' ' GLN . 85.7 mm-40 72.67 98.57 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.725 0.774 . . . . 0.0 111.097 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -120.77 17.67 11.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.029 0.918 . . . . 0.0 109.291 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.41 -52.56 2.42 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.89 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.332 0 CA-C-O 118.253 -1.304 . . . . 0.0 111.253 179.115 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.594 0.235 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -53.32 115.86 2.13 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.455 0.645 . . . . 0.0 111.814 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -133.74 39.72 3.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.854 0.835 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.29 103.86 13.01 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.871 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -134.01 77.53 61.86 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.68 -35.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.775 2.317 . . . . 0.0 113.372 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 39.63 37.76 0.35 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.615 1.166 . . . . 0.0 113.834 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -92.45 -80.36 0.37 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.188 0.518 . . . . 0.0 111.09 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.16 53.69 0.17 Allowed Glycine 0 C--N 1.306 -1.095 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.863 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.63 151.2 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.49 -65.72 0.64 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.037 0.446 . . . . 0.0 110.815 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 13' ' ' GLU . 7.3 m -104.85 171.02 7.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 1.9 mp0 -116.59 -65.97 1.13 Allowed 'General case' 0 CA--C 1.517 -0.308 0 O-C-N 121.421 -0.799 . . . . 0.0 110.642 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 50.9 m-80 74.4 8.81 4.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.013 0.925 . . . . 0.0 110.492 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -78.99 74.66 5.51 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 17' ' ' HIS . 42.5 t0 -112.74 -179.13 3.57 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.361 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 11.0 p-80 -134.43 167.28 21.04 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.325 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.67 168.88 10.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.451 0.643 . . . . 0.0 111.473 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.7 m-80 -98.36 141.32 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.687 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.544 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.44 160.96 35.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.156 0.503 . . . . 0.0 110.365 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.6 mtpt -136.52 147.75 47.26 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.885 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.2 t -127.75 117.87 47.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.031 0.443 . . . . 0.0 110.804 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.22 121.24 31.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.1 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.85 159.88 28.27 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.57 -13.77 44.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.279 0.561 . . . . 0.0 111.615 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.42 -10.4 59.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.61 10.41 57.96 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.609 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -106.96 156.73 18.41 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.71 135.55 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.315 0.579 . . . . 0.0 110.943 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG21 ' HG3' ' A' ' 50' ' ' ARG . 7.6 p -100.28 138.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.263 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.63 127.81 54.8 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE1' HG23 ' A' ' 22' ' ' VAL . 14.2 p90 -151.87 168.51 24.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.743 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -119.08 134.73 55.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -138.0 145.77 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 26.8 mtmm -79.33 153.3 29.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.206 0.527 . . . . 0.0 111.29 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -59.58 -40.02 86.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -93.18 9.35 36.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.186 0.517 . . . . 0.0 111.488 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 11.8 m -94.53 128.84 38.54 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.68 150.26 79.36 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.939 2.426 . . . . 0.0 113.625 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.2 mp -60.94 -12.63 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.168 0.987 . . . . 0.0 112.776 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.3 p -54.29 -41.14 68.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.787 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.468 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.8 tt -62.3 -50.66 70.76 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.295 0.569 . . . . 0.0 109.804 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.695 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.6 mtt -60.34 -37.44 80.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.18 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 14.8 tppt? -68.01 -46.2 71.93 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.042 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.07 -49.17 74.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.227 0.537 . . . . 0.0 110.766 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.81 -37.77 88.75 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.105 0.479 . . . . 0.0 110.924 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -39.28 93.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.215 0.531 . . . . 0.0 110.718 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.5 mm-40 -68.41 -40.01 81.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.099 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG3' HG21 ' A' ' 30' ' ' VAL . 17.3 mmt180 -65.52 -51.45 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.333 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.69 -18.96 53.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 111.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.74 89.48 Favored Glycine 0 C--O 1.235 0.17 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.721 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.56 177.6 7.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.705 0.288 . . . . 0.0 111.059 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -96.03 123.85 39.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -23.88 66.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.141 0.496 . . . . 0.0 111.752 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.0 ptt180 -77.16 -16.05 59.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.354 0.597 . . . . 0.0 110.696 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -99.73 6.48 45.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.183 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.52 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.7 pt -132.86 168.28 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.264 0.554 . . . . 0.0 111.104 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 18.1 mmt180 -137.42 147.83 45.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.98 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.3 m-85 -115.68 132.03 56.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.649 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.7 ppt_? -132.56 135.98 46.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.487 0.66 . . . . 0.0 111.283 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -139.62 139.78 36.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.932 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.64 28.14 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.381 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.05 -6.6 78.61 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.54 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -121.48 145.59 43.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.126 -0.632 . . . . 0.0 111.306 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.33 147.18 46.75 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.354 2.036 . . . . 0.0 110.949 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.97 136.16 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 121.514 0.674 . . . . 0.0 110.78 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.87 153.29 20.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -58.82 -20.54 51.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.285 0.564 . . . . 0.0 111.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 p -83.48 -0.63 51.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.968 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -95.53 159.57 14.93 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 121.883 -0.511 . . . . 0.0 110.354 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 p -117.15 149.99 45.36 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.57 -12.97 36.12 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.511 2.14 . . . . 0.0 112.462 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.57 -10.8 28.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.305 0.574 . . . . 0.0 110.748 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -78.15 -33.11 50.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.194 0.521 . . . . 0.0 110.517 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.39 2.1 22.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.161 0.505 . . . . 0.0 110.902 178.557 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 49.42 60.77 3.53 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.544 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.2 ptp -74.44 170.49 15.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.125 0.488 . . . . 0.0 110.588 176.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 41.8 tt0 -94.64 156.92 16.2 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.46 137.65 42.71 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.342 0.592 . . . . 0.0 110.538 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 73.77 19.04 3.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.572 1.149 . . . . 0.0 111.076 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -71.4 176.57 4.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.204 177.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.87 151.61 52.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.188 0.518 . . . . 0.0 111.565 -177.286 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.07 144.57 30.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.9 t0 -93.55 134.65 35.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.49 138.66 51.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.667 0.746 . . . . 0.0 111.151 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -138.21 148.37 44.73 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.67 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' A' ' 58' ' ' ILE . 6.6 mt-30 -109.08 111.13 22.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -108.99 89.86 3.12 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.425 0.631 . . . . 0.0 111.917 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.422 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 4.8 pm0 -96.6 108.22 20.78 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.885 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.9 p 56.96 47.72 17.14 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.67 0.788 . . . . 0.0 111.336 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.98 -152.37 20.56 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.091 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.242 0 CA-C-O 118.403 -1.221 . . . . 0.0 111.491 179.934 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.978 0.418 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.32 85.49 2.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.458 0.647 . . . . 0.0 110.947 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -103.81 19.16 20.45 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.898 0.856 . . . . 0.0 109.882 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -121.77 -53.42 1.98 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.843 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? 51.31 71.23 1.58 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.553 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.41 128.29 15.23 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.08 1.853 . . . . 0.0 111.619 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -88.7 -0.66 57.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.143 0.497 . . . . 0.0 111.017 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -81.14 110.38 16.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.404 0.621 . . . . 0.0 109.878 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.64 58.74 0.18 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.23 116.75 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.441 0.639 . . . . 0.0 111.397 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -131.41 122.12 25.76 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m 68.2 112.01 0.04 OUTLIER 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.829 0.823 . . . . 0.0 112.329 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -108.74 151.7 25.84 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -94.37 -9.09 36.88 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 71.67 43.97 0.54 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.349 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -75.35 111.74 10.94 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.462 ' CD2' ' HD2' ' A' ' 33' ' ' LYS . 46.0 p-80 -161.83 162.06 29.26 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.76 167.93 11.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.516 0.674 . . . . 0.0 112.351 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.55 ' O ' HD22 ' A' ' 20' ' ' LEU . 8.5 m-80 -94.65 142.83 26.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.561 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -133.87 159.76 39.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.045 0.45 . . . . 0.0 110.199 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.9 mtpt -134.83 149.04 50.3 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 0.0 110.218 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 32' ' ' PHE . 97.2 t -128.07 117.65 46.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.085 0.469 . . . . 0.0 110.124 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.95 124.19 37.8 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.876 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.89 159.9 28.24 Favored Glycine 0 N--CA 1.425 -2.072 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.158 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -65.71 -11.96 49.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.439 0.638 . . . . 0.0 111.012 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.03 -16.95 54.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.12 12.0 40.86 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.937 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -106.06 155.4 19.45 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 139.1 41.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.211 0.529 . . . . 0.0 111.126 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.564 HG21 ' HG3' ' A' ' 50' ' ' ARG . 9.7 p -108.89 140.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.167 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.22 123.3 49.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB2' HH31 ' A' ' 42' ' ' ALY . 19.7 p90 -145.03 167.71 22.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.344 0.592 . . . . 0.0 111.459 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HD2' ' CD2' ' A' ' 17' ' ' HIS . 27.8 mmtt -106.32 144.01 33.61 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.553 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.459 ' CG2' HD23 ' A' ' 20' ' ' LEU . 17.9 tt -148.91 144.04 18.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.056 0.455 . . . . 0.0 109.901 176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 5.6 mtmp? -84.46 158.01 21.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.865 -0.522 . . . . 0.0 110.512 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -64.47 -36.73 85.12 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.044 0.449 . . . . 0.0 111.091 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -92.01 5.98 48.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.215 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 18.0 m -93.64 128.65 41.15 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.18 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.69 149.08 73.11 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.944 2.43 . . . . 0.0 113.576 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.7 mp -59.87 -12.59 7.92 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.191 0.997 . . . . 0.0 112.683 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.3 t -54.24 -40.77 68.03 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.145 0.498 . . . . 0.0 110.742 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALY . . . . . 0.525 HH31 ' HB2' ' A' ' 32' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.7 tt -60.81 -51.64 68.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.193 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.69 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 32.6 mtt -58.17 -50.33 73.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.037 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.608 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 2.9 tppp? -64.57 -38.97 92.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.55 -48.57 81.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -63.04 -40.26 97.18 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.15 0.5 . . . . 0.0 110.991 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 58' ' ' ILE . 75.2 m -62.96 -36.01 82.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.394 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 28.4 mm-40 -73.18 -35.84 66.46 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.259 0.552 . . . . 0.0 110.763 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.564 ' HG3' HG21 ' A' ' 30' ' ' VAL . 44.1 mmm-85 -70.0 -48.92 56.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.433 0.635 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.95 -18.3 50.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.073 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.68 57.8 4.39 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.828 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.17 172.79 13.25 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.491 -0.417 . . . . 0.0 111.165 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.2 m -97.03 130.34 44.36 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.264 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.496 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.4 ptp -64.67 -25.45 67.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.429 . . . . 0.0 111.414 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -76.69 -10.51 59.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.4 0.619 . . . . 0.0 110.328 179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -105.01 3.9 31.06 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.403 -179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.536 HG22 ' HG2' ' A' ' 88' ' ' GLN . 20.9 pt -136.71 172.28 15.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.043 0.449 . . . . 0.0 110.87 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 25.6 mmm180 -143.76 148.21 35.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 11.1 m-85 -113.39 129.66 56.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.657 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.3 ppt_? -131.58 140.79 49.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.411 0.624 . . . . 0.0 111.541 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.415 ' HB2' HG13 ' A' ' 84' ' ' ILE . 80.6 t80 -145.44 139.32 26.8 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 63.93 26.41 14.18 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.168 0.509 . . . . 0.0 110.815 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 -0.99 80.78 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.896 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -125.16 144.63 47.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 O-C-N 122.11 -0.641 . . . . 0.0 111.528 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.74 147.84 45.59 Favored 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 122.628 2.218 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.14 137.65 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-O 121.468 0.651 . . . . 0.0 111.0 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 155.53 18.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.485 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.622 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -64.41 -16.96 63.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.0 p -81.2 -5.98 58.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.442 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.74 161.54 14.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.405 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 p -117.6 153.04 50.4 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.743 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 -8.56 21.48 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.353 2.036 . . . . 0.0 112.054 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.03 -18.21 20.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.093 0.473 . . . . 0.0 111.068 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -68.92 -36.9 78.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.239 0.542 . . . . 0.0 110.848 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.34 1.15 25.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.346 0.593 . . . . 0.0 110.756 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 51.18 58.66 5.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.962 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.6 ptp -73.92 164.63 26.38 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.664 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 36.2 tt0 -100.55 134.4 43.57 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.19 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -41.69 135.85 2.09 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 26.2 mt-10 74.12 16.47 3.53 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.777 1.231 . . . . 0.0 111.801 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.664 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -71.84 178.45 3.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 110.463 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.423 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.8 m -135.23 151.58 50.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.21 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.423 HD12 ' C ' ' A' ' 83' ' ' THR . 2.8 mp -123.12 140.28 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.563 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 33.6 t70 -90.03 135.64 33.53 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.008 0.432 . . . . 0.0 110.651 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -119.64 135.34 60.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.777 0.799 . . . . 0.0 110.911 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.7 p90 -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.582 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.1 mt-30 -104.11 112.41 25.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.999 0.428 . . . . 0.0 110.432 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -69.43 78.52 0.39 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.403 0.621 . . . . 0.0 111.302 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.28 179.35 3.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.904 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 t -147.02 135.29 21.69 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.067 0.46 . . . . 0.0 110.224 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.94 -169.23 42.39 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.886 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.167 0 CA-C-O 118.321 -1.266 . . . . 0.0 111.322 -179.703 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 53.0 p-80 . . . . . 0 N--CA 1.44 -0.955 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -114.82 169.5 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.7 m-80 -97.76 141.37 30.85 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.67 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.499 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -132.38 162.42 31.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.111 0.481 . . . . 0.0 110.421 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.97 148.24 48.39 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.065 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' CE1' ' A' ' 32' ' ' PHE . 80.8 t -126.97 115.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.377 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.82 126.7 37.01 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.86 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.38 164.87 29.68 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.405 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -68.41 -14.24 62.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.444 0.64 . . . . 0.0 110.916 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.8 -12.43 58.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.346 0.593 . . . . 0.0 110.525 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.39 48.79 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.83 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -105.43 152.3 23.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.0 p -136.41 137.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 15.0 p -105.41 141.59 20.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.855 0.359 . . . . 0.0 110.262 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -110.23 127.33 54.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.508 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -149.35 168.36 23.58 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.419 0.628 . . . . 0.0 111.883 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -116.52 134.97 54.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -140.48 147.08 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.044 0.45 . . . . 0.0 110.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 24.9 mtmt -82.47 157.93 23.42 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.754 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 15.4 mmm-85 -63.66 -39.74 95.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.995 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -92.76 8.27 40.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.704 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.4 m -91.6 128.3 47.02 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.702 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.47 145.62 77.47 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.822 2.348 . . . . 0.0 113.085 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.607 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.9 mp -60.09 -14.05 14.84 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.611 0.765 . . . . 0.0 112.087 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.6 m . . . . . 0 C--O 1.242 0.692 0 CA-C-O 121.246 0.545 . . . . 0.0 110.569 179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.3 tt . . . . . 0 C--O 1.238 0.461 0 CA-C-O 120.959 0.409 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 1.9 mpt? -58.02 -42.39 85.2 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.01 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -68.66 -42.2 78.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.299 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.68 -52.86 62.41 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.19 -40.44 93.95 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.171 0.51 . . . . 0.0 110.887 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -40.82 91.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.92 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.02 -39.5 75.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.897 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 32.2 mmt180 -68.54 -52.85 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -22.14 59.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.981 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.13 57.35 3.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 0.0 111.96 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.6 175.6 10.47 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.691 -0.3 . . . . 0.0 110.332 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 71.2 m -96.78 128.38 43.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.825 0.345 . . . . 0.0 111.416 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.8 ptp -63.46 -26.24 68.63 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.233 0.539 . . . . 0.0 111.071 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 5.4 ptm180 -75.81 -11.43 59.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.203 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -105.23 7.04 33.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.332 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.477 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.0 pt -136.15 170.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.342 0.591 . . . . 0.0 111.629 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -140.8 148.78 41.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.147 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.495 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.3 m-85 -116.49 130.9 57.01 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.201 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.645 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.3 OUTLIER -132.36 142.67 49.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 0.0 110.045 177.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' A' ' 84' ' ' ILE . 87.2 t80 -136.74 134.3 36.99 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.255 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.32 31.7 21.19 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.044 0.449 . . . . 0.0 111.874 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.93 -14.85 59.34 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.356 -1.402 . . . . 0.0 113.251 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -117.33 148.16 42.05 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 121.974 -0.721 . . . . 0.0 112.165 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.04 147.96 21.42 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 123.392 2.728 . . . . 0.0 112.863 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.06 138.01 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.266 0.555 . . . . 0.0 111.284 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.81 158.14 15.68 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.61 -21.14 37.49 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.236 0.614 . . . . 0.0 111.956 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.3 p -79.29 -3.15 44.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.136 0.493 . . . . 0.0 111.539 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.6 m-20 -98.47 162.81 12.96 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.0 -0.437 . . . . 0.0 110.978 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.5 p -117.03 156.88 47.81 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.74 -11.05 30.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.278 1.985 . . . . 0.0 111.773 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.61 -19.29 20.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 110.454 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -63.61 -35.95 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 0.0 110.294 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.07 1.14 17.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.921 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 51.53 62.38 2.74 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.52 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.499 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.7 ptp -77.69 165.81 23.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 110.42 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.03 161.97 16.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.348 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.26 136.9 42.68 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.022 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 72.03 16.7 5.32 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.979 0.911 . . . . 0.0 111.484 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.72 175.85 5.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.468 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.439 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.6 m -132.44 150.51 52.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.321 0.582 . . . . 0.0 111.721 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -120.96 139.04 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.645 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 11.3 m-20 -88.99 134.03 34.12 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.011 0.434 . . . . 0.0 110.596 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.07 137.84 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 121.63 0.729 . . . . 0.0 111.019 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -137.8 146.35 43.43 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.377 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.314 -0.937 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 50.6 p-80 . . . . . 0 N--CA 1.429 -1.494 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -122.09 169.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.383 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD22 ' A' ' 20' ' ' LEU . 28.1 m-80 -99.65 144.35 28.83 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -132.4 160.53 36.1 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.102 0.477 . . . . 0.0 110.172 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.5 mtpt -132.5 147.86 52.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.911 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.491 HG23 ' CE1' ' A' ' 32' ' ' PHE . 75.5 t -125.78 118.28 51.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.092 0.472 . . . . 0.0 110.177 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.09 118.28 30.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.056 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.26 155.47 34.44 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -63.06 -13.78 40.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.29 0.567 . . . . 0.0 111.371 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.05 -11.69 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.76 41.41 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.947 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 t -110.2 162.18 14.85 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.18 141.12 28.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.194 0.521 . . . . 0.0 111.126 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG21 ' HG3' ' A' ' 50' ' ' ARG . 12.1 p -109.65 142.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.999 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -113.12 124.14 51.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.274 0.559 . . . . 0.0 109.775 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 22' ' ' VAL . 16.8 p90 -145.29 167.97 21.56 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 29.2 mtmt -114.95 136.79 52.72 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.59 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.413 ' CG2' HD23 ' A' ' 20' ' ' LEU . 15.9 tt -143.81 148.96 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.032 0.444 . . . . 0.0 110.368 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.4 mtmt -83.97 158.69 21.44 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.793 -0.567 . . . . 0.0 110.973 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.496 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 27.6 mmm-85 -64.24 -40.75 96.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -91.17 8.84 33.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.294 0.569 . . . . 0.0 110.995 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 14.7 m -94.31 130.97 32.3 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.0 149.93 77.55 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.974 2.449 . . . . 0.0 113.586 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 71' ' ' ASP . 7.0 mp -61.44 -12.17 13.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.096 0.958 . . . . 0.0 112.873 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 p . . . . . 0 C--N 1.326 -0.456 0 CA-C-O 120.962 0.411 . . . . 0.0 111.049 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.4 tt . . . . . 0 C--O 1.236 0.358 0 CA-C-O 121.394 0.616 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.655 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.9 mtt -60.41 -48.0 83.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -61.53 -42.28 98.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.8 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.38 -52.89 62.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.757 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.28 -41.0 96.21 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.135 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 75.5 m -65.39 -34.89 79.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.079 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -70.31 -34.89 73.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.2 mmp_? -73.77 -46.68 44.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.353 0.596 . . . . 0.0 111.084 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.5 -21.35 42.03 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.056 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.56 57.74 3.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.579 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.58 175.29 10.98 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 122.552 -0.381 . . . . 0.0 110.878 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 26.4 m -97.23 131.37 44.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.012 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 6.5 ptp -66.28 -26.84 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.217 0.532 . . . . 0.0 110.988 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -76.04 -13.75 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 22.2 mm-40 -101.26 2.38 39.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.504 0.669 . . . . 0.0 110.443 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 48' ' ' CYS . 35.0 pt -135.09 176.24 9.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 15.9 mmm180 -146.95 154.43 41.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.834 0.35 . . . . 0.0 111.008 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.5 m-85 -119.03 132.44 56.05 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.092 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.1 ppt_? -134.63 141.5 46.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 111.098 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -141.39 139.83 33.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.575 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t70 57.99 27.97 15.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 111.305 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.12 -3.54 70.94 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.192 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -118.43 140.98 28.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 122.182 -0.599 . . . . 0.0 111.347 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.08 147.33 38.09 Favored 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 122.67 2.247 . . . . 0.0 112.261 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.22 139.0 51.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 110.594 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.8 165.82 11.6 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.979 0.419 . . . . 0.0 111.202 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.2 pt-20 -61.87 -17.13 55.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.194 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.4 p -82.98 -4.28 58.12 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.933 0.397 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.522 ' O ' HD13 ' A' ' 40' ' ' LEU . 46.5 m-20 -88.75 156.71 18.82 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -117.66 150.74 47.42 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 122.427 0.291 . . . . 0.0 110.222 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.413 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 36.9 Cg_endo -65.24 -13.04 37.67 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.366 2.044 . . . . 0.0 112.234 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.76 -13.74 25.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 110.817 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -72.2 -35.86 69.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.332 0.587 . . . . 0.0 110.176 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.89 1.0 22.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.69 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 53.01 61.34 3.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.321 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.481 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.1 ptp -80.24 166.45 21.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.415 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -91.94 167.62 11.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.065 0.459 . . . . 0.0 110.983 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.98 139.67 36.92 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.328 0.585 . . . . 0.0 110.091 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 71.6 15.27 6.06 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.487 1.115 . . . . 0.0 111.341 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.74 176.7 2.87 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.2 m -134.84 150.32 50.47 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.546 -0.721 . . . . 0.0 111.731 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 142.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.587 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 29.5 t70 -90.88 136.53 33.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.11 0.481 . . . . 0.0 110.869 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 134.06 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.948 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.1 p90 -130.76 137.47 49.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.813 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.2 mt-30 . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 0.0 111.1 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.684 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 . . . . . 0 N--CA 1.429 -1.479 0 CA-C-O 121.077 0.465 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 pt -123.2 170.17 13.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.987 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.507 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . 19.3 m-80 -93.89 142.09 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.653 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.53 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.6 mm? -133.24 163.47 29.23 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.288 0.566 . . . . 0.0 110.87 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.4 mtpt -134.82 146.07 48.95 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.905 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' CE1' ' A' ' 32' ' ' PHE . 91.2 t -127.29 114.06 34.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.19 0.519 . . . . 0.0 110.132 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.84 130.32 37.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.414 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.93 161.82 22.82 Favored Glycine 0 N--CA 1.42 -2.417 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.959 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.45 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -65.02 -11.76 42.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.562 0.696 . . . . 0.0 110.897 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.87 -15.0 58.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.254 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.17 6.51 56.77 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.0 t -101.24 153.9 19.22 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.57 136.43 46.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.309 0.576 . . . . 0.0 111.507 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.593 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.6 p -105.19 140.07 24.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.391 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -110.97 124.95 53.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.526 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.4 p90 -149.56 169.85 19.99 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.135 0.493 . . . . 0.0 111.452 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -113.61 143.27 44.85 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.985 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 14.7 tt -148.75 143.34 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.119 0.485 . . . . 0.0 110.359 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 25.7 mtmt -79.45 155.36 28.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.374 0.607 . . . . 0.0 111.772 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 29.0 mmm-85 -64.95 -36.49 84.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.641 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.19 4.91 53.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.337 0.589 . . . . 0.0 110.753 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 20.6 m -93.57 129.49 38.32 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.23 151.46 85.35 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.891 2.394 . . . . 0.0 112.856 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.474 ' CD2' HD13 ' A' ' 43' ' ' LEU . 81.2 mt -65.38 -11.87 46.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.55 0.74 . . . . 0.0 111.919 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.238 0.466 0 CA-C-O 121.117 0.484 . . . . 0.0 111.098 178.546 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD13 ' CD2' ' A' ' 40' ' ' LEU . 4.0 tt . . . . . 0 C--O 1.235 0.341 0 CA-C-O 121.011 0.434 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.71 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 37.8 mtt -61.75 -39.69 92.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.168 0.508 . . . . 0.0 110.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.9 tppp? -70.16 -40.91 74.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.694 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.52 68.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 110.912 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -63.69 -37.05 85.91 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.061 0.458 . . . . 0.0 110.822 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -34.55 78.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.138 0.494 . . . . 0.0 110.812 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.0 mm-40 -72.59 -42.14 64.87 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.272 0.558 . . . . 0.0 110.62 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.593 ' HG3' HG21 ' A' ' 30' ' ' VAL . 22.9 mmm-85 -62.99 -52.6 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.452 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -21.41 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.884 0.373 . . . . 0.0 111.927 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.02 2.82 90.65 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.925 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.54 175.95 8.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 0.0 111.208 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 54.7 m -97.42 127.02 43.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.698 0.285 . . . . 0.0 110.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.6 ptp -60.81 -25.24 66.43 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.093 0.473 . . . . 0.0 111.985 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -78.78 -11.36 59.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.242 0.544 . . . . 0.0 111.129 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.405 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 23.3 mm-40 -101.22 5.67 42.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.0 110.63 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.566 HG22 ' HG2' ' A' ' 88' ' ' GLN . 31.2 pt -135.22 177.23 7.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.118 0.485 . . . . 0.0 111.065 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -147.42 147.18 29.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.71 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 14.0 m-85 -113.87 128.06 56.25 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.21 0.529 . . . . 0.0 111.237 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 1.1 ppt_? -132.04 136.64 47.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.395 0.617 . . . . 0.0 110.735 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -135.79 134.77 39.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.538 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.39 28.5 18.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.216 0.531 . . . . 0.0 110.654 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.76 -4.52 64.86 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 119.645 -1.264 . . . . 0.0 113.198 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -115.99 136.81 23.01 Favored Pre-proline 0 C--N 1.322 -0.607 0 O-C-N 121.905 -0.762 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.27 142.91 30.96 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.704 2.269 . . . . 0.0 112.104 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 133.3 68.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.564 0.697 . . . . 0.0 111.365 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 149.47 21.44 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.335 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.541 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.0 pp20? -58.27 -20.0 38.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.453 HG23 ' OE2' ' A' ' 69' ' ' GLU . 40.9 p -76.26 -13.11 60.17 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.376 0.608 . . . . 0.0 111.164 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.79 166.79 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -118.13 158.4 46.38 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.07 -5.64 14.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.578 2.186 . . . . 0.0 112.074 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.04 -13.73 24.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.16 0.505 . . . . 0.0 110.525 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -68.6 -35.93 78.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.429 0.633 . . . . 0.0 110.549 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.456 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.16 1.47 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.482 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 52.6 60.05 4.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.53 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.6 ptp -74.97 163.02 28.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -87.89 159.97 18.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.47 131.48 44.81 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 14.3 mt-10 72.88 20.67 3.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 124.288 1.035 . . . . 0.0 111.593 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.75 179.42 3.13 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.4 m -135.13 150.43 50.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.509 -0.745 . . . . 0.0 111.887 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.63 148.81 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 6.8 t70 -97.97 128.59 44.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.788 0.328 . . . . 0.0 110.334 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.11 135.0 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.576 0.703 . . . . 0.0 110.846 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.484 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -136.85 145.08 44.0 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.64 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.7 OUTLIER . . . . . 0 C--N 1.313 -1.002 0 CA-C-O 121.126 0.488 . . . . 0.0 110.06 -177.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 41.7 p-80 . . . . . 0 N--CA 1.43 -1.452 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.79 169.61 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.349 0.595 . . . . 0.0 111.095 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' O ' HD22 ' A' ' 20' ' ' LEU . 22.2 m-80 -99.95 145.81 27.41 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -132.63 162.39 31.46 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.323 0.582 . . . . 0.0 110.823 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 57.5 mtpt -133.55 147.98 51.61 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.989 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.7 t -128.74 117.96 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.09 0.472 . . . . 0.0 110.265 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.94 124.93 35.15 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.889 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.31 159.52 27.44 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.7 pp0? -63.32 -14.68 52.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.496 0.665 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.23 -19.25 62.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.55 6.19 50.6 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -107.39 163.66 12.86 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.0 143.39 31.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.576 HG21 ' HG3' ' A' ' 50' ' ' ARG . 6.1 p -112.36 145.28 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.172 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -112.77 131.05 55.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.299 0.571 . . . . 0.0 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 22' ' ' VAL . 10.8 p90 -152.08 169.12 23.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.219 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -111.95 143.72 42.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.036 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.441 ' CG2' HD23 ' A' ' 20' ' ' LEU . 16.5 tt -150.54 149.23 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.063 0.459 . . . . 0.0 110.333 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.3 mtmt -87.23 158.03 19.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.73 -0.606 . . . . 0.0 110.74 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.9 mmm-85 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -90.48 7.75 37.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.119 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.3 m -93.7 129.98 36.48 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.37 150.22 87.35 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.904 2.402 . . . . 0.0 112.984 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.463 ' CD2' HD13 ' A' ' 43' ' ' LEU . 87.4 mt -65.26 -11.97 46.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.862 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p . . . . . 0 C--O 1.235 0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 111.142 178.817 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt . . . . . 0 C--O 1.238 0.487 0 CA-C-O 121.186 0.517 . . . . 0.0 110.096 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.666 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 29.9 mtt -61.31 -40.88 95.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 17.8 tppt? -70.37 -38.33 74.72 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.967 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.09 -50.99 71.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.957 0.408 . . . . 0.0 110.566 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.41 -33.61 76.25 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.985 0.421 . . . . 0.0 110.532 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -38.13 89.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.247 0.546 . . . . 0.0 110.547 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 68.2 mm-40 -73.12 -34.64 66.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.071 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HG3' HG21 ' A' ' 30' ' ' VAL . 11.5 mmt180 -68.1 -49.54 60.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.011 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -22.38 28.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.81 58.31 3.06 Favored Glycine 0 C--N 1.321 -0.301 0 C-N-CA 119.673 -1.251 . . . . 0.0 111.696 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.52 174.07 11.74 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 122.564 -0.374 . . . . 0.0 110.286 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.9 m -100.05 129.23 46.08 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.86 0.362 . . . . 0.0 110.897 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.1 ptp -64.85 -25.52 67.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HG3' ' HG2' ' A' ' 57' ' ' GLN . 12.7 ptt180 -75.81 -11.62 60.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.199 0.523 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.431 ' HG2' ' HG3' ' A' ' 56' ' ' ARG . 19.3 mm-40 -104.53 2.62 31.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HG2' ' A' ' 88' ' ' GLN . 37.7 pt -134.0 172.97 15.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.043 0.449 . . . . 0.0 110.636 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 19.6 mmt180 -142.24 149.89 40.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.778 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.666 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.3 m-85 -114.53 132.8 56.19 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.318 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.6 ppt_? -135.82 140.03 43.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.328 0.585 . . . . 0.0 111.076 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -138.2 137.7 37.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.822 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.85 34.06 21.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.78 -4.55 74.03 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.735 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -120.95 141.49 32.76 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.992 -0.711 . . . . 0.0 111.684 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.51 148.08 32.9 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 111.711 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.82 136.19 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.063 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.25 157.65 16.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -59.74 -22.07 61.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.4 p -74.5 -15.17 60.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.998 0.428 . . . . 0.0 111.229 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.36 165.45 13.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.6 p -117.33 158.76 43.93 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -67.35 -7.46 19.13 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.432 2.088 . . . . 0.0 111.83 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.91 -19.49 20.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.534 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -60.91 -40.01 91.54 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.63 0.729 . . . . 0.0 110.39 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.45 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.81 0.35 25.98 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.767 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.5 62.21 2.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.535 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.0 ptp -79.8 167.12 21.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.007 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -92.85 167.02 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.286 0.565 . . . . 0.0 110.914 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -75.92 139.74 41.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.134 0.492 . . . . 0.0 110.119 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 68.21 19.56 9.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.755 0.822 . . . . 0.0 111.137 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -72.06 179.76 3.14 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.798 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.432 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.6 m -135.04 150.07 50.23 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 121.602 -0.687 . . . . 0.0 111.618 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.432 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.98 144.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 28.8 t70 -92.2 139.69 30.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 120.812 0.339 . . . . 0.0 110.685 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -123.73 139.34 50.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.677 0.751 . . . . 0.0 110.956 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -137.43 146.04 43.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.946 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 1.3 mt-30 . . . . . 0 C--N 1.319 -0.761 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 38.4 p-80 . . . . . 0 N--CA 1.443 -0.811 0 CA-C-O 120.84 0.352 . . . . 0.0 111.763 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.34 170.81 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.577 0.704 . . . . 0.0 112.466 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.45 ' O ' HD22 ' A' ' 20' ' ' LEU . 25.4 m-80 -96.42 139.64 32.23 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.632 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -128.87 161.38 29.96 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 83' ' ' THR . 60.1 mtpt -136.73 146.91 46.38 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.169 0.509 . . . . 0.0 110.247 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.42 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.7 t -128.22 117.25 45.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.201 0.524 . . . . 0.0 110.639 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.58 118.23 28.09 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.46 160.84 33.4 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.169 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -9.14 38.74 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.681 0.753 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -74.72 -15.73 60.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.62 6.94 57.12 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.472 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 t -110.01 167.33 10.26 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.61 140.14 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.611 HG21 ' HG3' ' A' ' 50' ' ' ARG . 9.5 p -103.98 140.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.003 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -113.84 123.51 49.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.43 0.633 . . . . 0.0 109.651 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.425 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 8.8 p90 -147.12 169.04 20.12 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.231 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 33.5 mtmm -115.28 144.6 43.49 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 111.462 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.7 tt -148.25 146.07 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.023 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 29.4 mtmt -81.05 155.31 26.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 18.6 mmm-85 -60.79 -40.19 91.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.094 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -92.91 10.15 32.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.6 m -95.6 130.21 32.54 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.396 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 150.24 83.48 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.765 2.31 . . . . 0.0 112.97 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.535 HD22 HD13 ' A' ' 43' ' ' LEU . 88.5 mt -62.11 -12.18 18.09 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 123.456 0.702 . . . . 0.0 111.799 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.5 t . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.956 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.535 HD13 HD22 ' A' ' 40' ' ' LEU . 2.3 tt . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.23 0.538 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.568 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 25.8 mtt -63.27 -39.29 94.17 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.651 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.678 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 4.1 tppp? -67.96 -44.51 76.56 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.246 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.663 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -53.97 -53.15 56.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.386 . . . . 0.0 111.016 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CE2' HG11 ' A' ' 86' ' ' VAL . 46.9 t80 -60.55 -41.58 94.82 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -41.55 81.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.288 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.678 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 22.6 mt-10 -71.7 -42.52 67.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.307 0.575 . . . . 0.0 111.211 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.1 mmt85 -65.09 -50.66 65.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.247 0.546 . . . . 0.0 111.321 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.6 -14.7 59.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.431 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.18 57.19 8.78 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.519 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -146.68 176.13 10.08 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -99.57 128.3 45.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.424 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 ptp -63.12 -19.95 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.111 0.481 . . . . 0.0 111.789 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -83.07 -15.11 52.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.244 0.545 . . . . 0.0 111.011 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -100.04 5.13 45.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.454 0.645 . . . . 0.0 110.47 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.509 HG22 ' HG2' ' A' ' 88' ' ' GLN . 34.2 pt -135.32 171.9 16.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.733 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 21.5 mmm180 -141.99 148.45 38.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.775 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.7 m-85 -113.68 130.33 56.43 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.726 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.48 131.86 38.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.092 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' HG13 ' A' ' 84' ' ' ILE . 82.5 t80 -126.56 136.48 52.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.287 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.88 32.56 22.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.285 0.564 . . . . 0.0 111.013 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.35 -3.4 58.88 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.565 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -119.33 135.05 23.77 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 121.847 -0.796 . . . . 0.0 111.215 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.37 150.6 76.13 Favored 'Trans proline' 0 C--N 1.326 -0.619 0 C-N-CA 122.702 2.268 . . . . 0.0 111.831 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.32 142.93 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.805 0.812 . . . . 0.0 111.34 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.22 153.81 17.6 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.105 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.8 pt-20 -63.95 -17.28 63.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.164 0.507 . . . . 0.0 111.731 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.6 p -81.56 -5.97 58.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -93.26 158.7 15.61 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.154 -0.341 . . . . 0.0 110.365 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.55 ' OG1' ' HB2' ' A' ' 75' ' ' GLN . 20.0 p -118.16 151.41 49.14 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.54 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 78' ' ' MET . 27.6 Cg_endo -63.07 -13.76 37.37 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.428 2.085 . . . . 0.0 112.55 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.07 -21.31 18.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.106 0.479 . . . . 0.0 110.964 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.55 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 6.1 tt0 -66.0 -33.74 76.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.866 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.32 -1.72 24.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.343 0.592 . . . . 0.0 110.5 177.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.47 58.41 4.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.426 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.632 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.2 ptp -77.49 172.29 13.58 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.878 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.9 tp10 -92.18 156.54 17.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.17 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.88 141.6 49.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.234 0.54 . . . . 0.0 110.839 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 69.08 18.88 8.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.111 0.965 . . . . 0.0 111.04 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -70.47 175.78 4.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.19 150.5 52.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.46 0.647 . . . . 0.0 111.923 -176.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 62' ' ' PHE . 3.3 mp -122.69 145.52 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -92.43 135.88 33.67 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.975 0.417 . . . . 0.0 110.607 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.427 HG11 ' CE2' ' A' ' 47' ' ' TYR . 2.8 t -120.62 135.58 60.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.781 0.801 . . . . 0.0 111.132 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 1.5 p90 -135.79 145.2 46.27 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.509 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.2 mt-30 . . . . . 0 C--N 1.318 -0.784 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.824 -177.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.52 HG21 ' OD1' ' A' ' 80' ' ' ASP . 32.4 pt -130.08 169.1 21.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.34 0.591 . . . . 0.0 111.414 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.2 140.49 32.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.48 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.474 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.2 mm? -128.97 164.34 23.38 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.087 0.47 . . . . 0.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 83' ' ' THR . 62.6 mtpt -133.57 147.19 51.52 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.027 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.534 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.5 t -125.0 116.39 47.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 120.968 0.413 . . . . 0.0 109.892 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.39 122.62 35.02 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.753 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.3 160.06 34.37 Favored Glycine 0 N--CA 1.424 -2.158 0 C-N-CA 120.439 -0.886 . . . . 0.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -15.16 60.51 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.128 0.49 . . . . 0.0 111.832 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.559 0.695 . . . . 0.0 110.025 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.86 5.52 50.57 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.67 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -95.76 162.75 13.47 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.24 136.74 22.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.479 0.657 . . . . 0.0 111.297 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.428 HG11 ' HG3' ' A' ' 50' ' ' ARG . 89.3 t -107.65 138.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.933 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.84 128.18 55.16 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 22' ' ' VAL . 13.7 p90 -147.91 168.35 22.46 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.274 0.559 . . . . 0.0 111.538 -174.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 37.5 mtmt -112.19 135.54 52.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.619 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -144.43 144.15 22.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.19 0.519 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 24.3 mtmm -82.18 156.79 24.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 12.4 mmm-85 -64.14 -34.64 78.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.371 0.605 . . . . 0.0 110.547 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -95.21 6.65 48.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.288 0.566 . . . . 0.0 110.914 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 8.3 m -92.2 129.76 40.27 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.048 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.0 147.16 73.35 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 123.141 2.561 . . . . 0.0 113.595 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.8 mp -61.55 -12.27 14.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.285 1.034 . . . . 0.0 112.99 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.2 p . . . . . 0 C--N 1.321 -0.672 0 CA-C-O 121.046 0.45 . . . . 0.0 110.805 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 7.2 tt . . . . . 0 C--O 1.236 0.347 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 mtt -58.85 -42.61 89.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -67.94 -43.35 79.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.009 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.44 -49.89 73.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.128 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.66 -39.22 93.31 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.194 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -39.17 93.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 110.502 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -68.37 -36.73 79.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.187 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 50' ' ' ARG . 10.7 mmp_? -70.12 -45.55 66.64 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.404 HE22 HG21 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -81.36 -21.56 39.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.864 -178.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.22 4.5 89.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.368 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.64 177.21 6.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.934 0.397 . . . . 0.0 110.99 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 37.7 m -93.97 126.45 39.19 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.263 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -62.51 -28.7 70.02 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -76.55 -9.84 58.95 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.457 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.48 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 25.0 mm-40 -101.09 4.54 42.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.157 0.503 . . . . 0.0 111.373 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.77 HG22 ' HG2' ' A' ' 88' ' ' GLN . 23.0 pt -133.17 168.5 24.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.246 0.546 . . . . 0.0 110.786 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 54.8 mmt-85 -133.78 153.09 51.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.339 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.706 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 13.5 m-85 -119.17 131.03 55.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.315 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.617 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.1 ppt_? -136.56 143.94 43.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.251 0.548 . . . . 0.0 111.316 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.721 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 74.8 t80 -139.39 130.98 27.2 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER 53.87 32.22 14.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.52 -33.08 1.38 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.623 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.721 ' HG2' ' O ' ' A' ' 62' ' ' PHE . 7.5 pt20 -70.06 119.82 74.13 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.688 0.756 . . . . 0.0 111.736 -177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.08 144.51 57.88 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.658 2.238 . . . . 0.0 110.724 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.403 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -124.8 133.01 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.354 0.597 . . . . 0.0 110.668 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.94 159.11 15.91 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.456 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.4 pt-20 -58.8 -21.84 57.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.322 0.582 . . . . 0.0 111.79 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.9 p -84.97 0.26 51.96 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.575 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.525 ' O ' HD13 ' A' ' 40' ' ' LEU . 66.9 m-20 -96.07 161.76 13.83 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.885 -0.51 . . . . 0.0 110.325 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.3 p -119.38 153.53 53.71 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.954 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 37.3 Cg_endo -66.24 -12.0 33.71 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.722 2.281 . . . . 0.0 112.863 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.05 -17.08 22.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.37 0.605 . . . . 0.0 110.937 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -67.94 -32.88 73.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.561 . . . . 0.0 110.771 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.2 3.09 19.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.045 0.45 . . . . 0.0 110.957 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 50.22 57.85 6.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.721 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -72.81 168.98 17.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.432 . . . . 0.0 110.88 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.5 tp10 -87.97 143.84 26.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.042 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.52 ' OD1' HG21 ' A' ' 18' ' ' ILE . 3.4 m-20 -59.02 138.68 57.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.86 0.362 . . . . 0.0 110.352 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.65 25.55 8.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 112.042 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -77.73 -174.28 3.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 110.964 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.447 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 m -136.23 150.97 49.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.447 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.66 140.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.8 t70 -89.01 138.03 31.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.256 0.55 . . . . 0.0 110.9 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 136.21 57.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.314 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.463 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 3.8 p90 -146.77 158.95 44.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.095 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.77 ' HG2' HG22 ' A' ' 58' ' ' ILE . 87.6 mt-30 . . . . . 0 C--N 1.317 -0.828 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.464 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.9 p-80 . . . . . 0 N--CA 1.417 -2.085 0 CA-C-O 121.225 0.536 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.43 HG23 ' HD3' ' A' ' 36' ' ' ARG . 33.9 pt -106.08 169.73 2.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.674 0.749 . . . . 0.0 111.621 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.526 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.4 m-80 -99.71 148.68 24.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.055 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.3 mm? -136.94 162.77 32.37 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.393 0.616 . . . . 0.0 111.087 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.2 mtpt -136.73 148.18 47.14 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.183 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.466 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.0 t -129.25 117.97 44.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.434 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.02 122.1 33.4 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.694 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.07 162.91 30.15 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.4 pp0? -69.18 -12.09 61.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.743 0.782 . . . . 0.0 109.851 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.33 -21.43 60.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.801 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.12 10.82 41.27 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 t -109.77 158.47 18.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 7.6 p -135.19 134.22 52.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.383 0.611 . . . . 0.0 111.211 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 7.5 p -100.67 139.66 21.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.528 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE1' HG23 ' A' ' 22' ' ' VAL . 7.3 p90 -154.97 169.57 23.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.074 0.464 . . . . 0.0 111.377 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -118.22 138.3 52.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.652 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.481 ' CG2' HD23 ' A' ' 20' ' ' LEU . 14.0 tt -143.35 148.0 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 26.8 mtmt -84.44 157.7 21.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.247 0.546 . . . . 0.0 110.994 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 28.1 mmm-85 -68.55 -34.46 75.87 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.323 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -95.2 6.49 48.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.587 0.708 . . . . 0.0 110.668 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.7 m -94.54 131.98 29.77 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.205 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.1 151.1 86.78 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.571 2.181 . . . . 0.0 112.265 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 43' ' ' LEU . 67.2 mt -65.57 -13.7 59.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.746 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 2.4 p . . . . . 0 C--O 1.235 0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.239 0.506 0 CA-C-O 120.839 0.352 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.403 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.0 mpt? -60.15 -37.89 81.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.341 0.591 . . . . 0.0 110.502 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.4 tppp? -69.41 -42.25 75.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.45 -50.24 70.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.29 0.567 . . . . 0.0 110.723 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.31 -39.65 94.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.15 0.5 . . . . 0.0 110.902 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -34.15 77.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm-40 -71.64 -40.84 69.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.675 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG3' HG21 ' A' ' 30' ' ' VAL . 10.5 mmm180 -68.97 -43.75 74.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.099 0.476 . . . . 0.0 111.657 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.95 -16.65 40.28 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.979 0.418 . . . . 0.0 111.714 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.03 2.93 80.01 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.919 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -83.46 176.46 9.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.075 0.465 . . . . 0.0 111.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.0 m -94.21 130.57 40.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.4 ptp -66.54 -22.01 66.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.063 0.459 . . . . 0.0 111.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HG3' HE21 ' A' ' 57' ' ' GLN . 19.4 ptp180 -80.05 -8.25 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.269 0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.411 HE21 ' HG3' ' A' ' 56' ' ' ARG . 28.6 mm-40 -104.66 7.96 35.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.969 0.414 . . . . 0.0 111.711 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' HG2' ' A' ' 88' ' ' GLN . 22.2 pt -136.53 171.82 16.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.394 0.616 . . . . 0.0 111.364 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.436 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 16.6 mmm180 -140.64 145.79 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.573 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.66 130.47 56.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.593 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.6 ppt_? -133.1 138.24 46.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.351 0.596 . . . . 0.0 110.986 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -138.48 140.36 39.17 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.551 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.12 26.05 16.0 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.09 0.472 . . . . 0.0 111.297 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.31 -6.8 70.47 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.856 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.56 142.61 31.82 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.073 -0.663 . . . . 0.0 111.411 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.94 148.9 36.2 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 122.431 2.087 . . . . 0.0 111.435 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.96 135.29 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.428 0.633 . . . . 0.0 111.545 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.48 154.65 17.32 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.46 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.4 pt-20 -60.67 -21.28 62.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.054 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -76.46 -12.49 60.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 111.271 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.2 166.43 11.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 p -115.9 158.57 41.95 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.99 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' MET . 39.1 Cg_endo -67.79 -3.23 10.0 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.71 2.273 . . . . 0.0 112.124 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.43 -21.3 19.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.0 110.547 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -62.29 -39.49 93.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.378 0.609 . . . . 0.0 110.92 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.449 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.12 1.42 28.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.174 0.511 . . . . 0.0 111.221 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 3.5 mm-40 51.88 62.62 2.61 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.496 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.7 ptp -76.33 165.22 25.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.05 0.452 . . . . 0.0 110.366 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.82 165.83 11.92 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.1 131.56 44.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 21.8 mt-10 69.67 21.13 6.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.555 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -67.89 176.63 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 1.3 m -132.81 148.67 52.31 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.577 -0.702 . . . . 0.0 111.427 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.05 142.14 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.593 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 36.1 t70 -89.52 134.08 34.28 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.101 0.477 . . . . 0.0 110.531 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.17 137.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.789 0.804 . . . . 0.0 110.75 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.8 p90 -135.07 144.59 47.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.37 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.572 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.4 mt-30 . . . . . 0 CA--C 1.499 -1.0 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 46.9 p-80 . . . . . 0 N--CA 1.443 -0.803 0 CA-C-O 120.759 0.314 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 pt -108.05 169.87 2.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.502 0.668 . . . . 0.0 112.232 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' O ' HD22 ' A' ' 20' ' ' LEU . 15.6 m-80 -97.34 142.47 29.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.464 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -133.17 163.9 28.24 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.382 0.611 . . . . 0.0 110.887 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.8 mtpt -138.64 148.6 44.26 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.628 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG23 ' CE1' ' A' ' 32' ' ' PHE . 92.7 t -127.88 117.25 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.094 0.473 . . . . 0.0 110.497 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.36 123.19 35.5 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.292 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.88 163.01 26.69 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -19.42 63.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.706 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.1 -6.14 49.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.261 0.553 . . . . 0.0 110.98 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.17 64.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.838 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 t -103.88 158.4 16.43 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.94 136.04 45.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.253 0.549 . . . . 0.0 111.191 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.57 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.4 p -106.54 141.79 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 122.188 -0.32 . . . . 0.0 110.217 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -111.88 129.87 56.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.229 0.538 . . . . 0.0 109.968 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.7 p90 -154.09 169.95 22.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.585 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -115.56 143.27 45.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.651 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.436 ' CG2' HD23 ' A' ' 20' ' ' LEU . 13.6 tt -148.9 148.53 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.231 0.539 . . . . 0.0 110.398 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.459 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.0 mtmt -84.15 158.05 21.48 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.01 0.433 . . . . 0.0 110.782 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 23.8 mmm-85 -69.13 -34.04 74.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.517 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.45 5.13 52.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.58 . . . . 0.0 110.913 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.1 m -93.46 131.26 32.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.778 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.69 149.57 90.53 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.923 2.415 . . . . 0.0 112.784 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.7 mt -65.13 -12.14 47.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.906 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 177.42 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.392 0.615 . . . . 0.0 109.79 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.751 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 38.5 mtt -61.57 -49.65 75.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.353 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.0 tppp? -59.66 -44.31 93.6 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.18 -50.79 68.46 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.773 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -62.78 -41.01 99.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.186 0.517 . . . . 0.0 110.813 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.562 ' SG ' HD11 ' A' ' 58' ' ' ILE . 79.2 m -65.52 -34.64 78.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.399 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 18.9 mm-40 -68.89 -37.13 78.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.22 0.533 . . . . 0.0 110.99 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 mmt180 -69.63 -44.33 70.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.34 -21.74 33.06 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.295 0.569 . . . . 0.0 110.67 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.71 88.79 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.532 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.69 176.0 7.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.288 0.566 . . . . 0.0 111.815 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.403 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 70.7 m -96.9 134.62 40.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.548 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.6 ptp -68.18 -19.74 64.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.096 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -83.42 -8.05 59.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.167 0.508 . . . . 0.0 111.059 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 18.0 mm-40 -106.65 9.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.001 0.429 . . . . 0.0 110.811 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.676 HG22 ' HG2' ' A' ' 88' ' ' GLN . 19.6 pt -137.29 173.41 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.614 0.721 . . . . 0.0 111.856 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 21.3 mmm180 -140.27 146.9 39.18 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.071 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.751 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.6 m-85 -113.75 128.15 56.3 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.386 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.618 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.5 OUTLIER -128.63 145.41 51.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.003 0.43 . . . . 0.0 110.211 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -140.96 131.44 25.32 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.039 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 t0 58.33 29.38 18.05 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.893 0.378 . . . . 0.0 111.684 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.9 69.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.089 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -114.03 134.79 22.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.054 -0.674 . . . . 0.0 111.116 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.65 149.33 33.98 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.848 2.365 . . . . 0.0 112.376 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.87 137.52 52.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -97.9 161.28 13.82 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.216 177.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.597 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.4 pt-20 -62.22 -20.91 64.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.093 0.473 . . . . 0.0 112.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -76.33 -6.89 53.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.251 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' OD1' ' HG2' ' A' ' 75' ' ' GLN . 1.7 m-20 -103.22 166.85 10.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.136 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -116.84 159.89 38.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 78' ' ' MET . 35.3 Cg_endo -66.52 -8.71 21.72 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.506 2.137 . . . . 0.0 111.912 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.99 -13.09 25.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.303 0.573 . . . . 0.0 110.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.412 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 2.3 tp-100 -68.26 -35.49 77.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.511 0.672 . . . . 0.0 110.16 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.472 HD21 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -110.52 1.19 18.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.366 -179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 54.16 61.73 2.91 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.382 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.8 ptp -77.18 164.39 25.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 110.734 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 38.1 tt0 -95.09 161.58 14.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.128 -175.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.54 134.56 53.62 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.061 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 70.05 19.67 6.74 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.836 0.855 . . . . 0.0 111.555 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t0 -71.49 176.14 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.429 . . . . 0.0 110.111 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.46 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.5 m -131.32 150.26 52.22 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.22 0.534 . . . . 0.0 111.246 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.46 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.19 136.69 58.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.618 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 19.4 m-20 -89.83 138.07 31.8 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.041 0.448 . . . . 0.0 110.833 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -122.7 139.56 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.98 151.28 45.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.676 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.4 mt-30 . . . . . 0 CA--C 1.512 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.998 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 45.8 p-80 . . . . . 0 N--CA 1.437 -1.119 0 CA-C-O 120.886 0.374 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.44 170.51 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.369 0.604 . . . . 0.0 111.332 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.437 ' O ' HD22 ' A' ' 20' ' ' LEU . 23.6 m-80 -96.77 142.32 28.93 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.56 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -130.49 162.31 29.49 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.987 0.422 . . . . 0.0 109.889 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.2 mtpt -136.3 145.52 45.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.102 0.477 . . . . 0.0 110.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.6 t -125.56 116.67 47.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.156 0.503 . . . . 0.0 109.961 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.9 122.55 35.38 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.53 159.61 32.18 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -64.13 -11.9 34.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.166 0.508 . . . . 0.0 111.775 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -80.36 -15.51 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.356 0.598 . . . . 0.0 110.072 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 4.99 48.29 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.072 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 t -99.61 160.05 14.58 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.25 136.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.468 0.651 . . . . 0.0 111.496 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.74 HG21 ' HG3' ' A' ' 50' ' ' ARG . 7.4 p -102.28 142.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -113.64 125.04 53.71 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 22' ' ' VAL . 12.2 p90 -146.42 167.98 22.28 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.533 -174.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 40.8 mtmt -114.99 134.16 55.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 111.255 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.0 tt -144.71 150.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.106 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.8 mtmt -81.03 163.89 22.89 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.863 -0.523 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 22.4 mmm-85 -70.74 -40.24 72.84 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 110.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -91.8 5.97 47.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.568 0.699 . . . . 0.0 110.517 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.8 m -90.98 130.4 40.6 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.14 149.01 92.68 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.049 2.499 . . . . 0.0 113.233 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 43' ' ' LEU . 83.7 mt -64.05 -12.59 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.406 0.683 . . . . 0.0 111.994 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 13.5 t . . . . . 0 C--O 1.239 0.519 0 CA-C-O 120.86 0.362 . . . . 0.0 110.991 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 44' ' ' MET . 2.4 tt . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.32 0.581 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.614 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 28.1 mtt -60.04 -47.28 86.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.369 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.0 tppt? -63.08 -41.87 99.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.752 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.73 74.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.958 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.67 -39.8 95.06 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.157 0.503 . . . . 0.0 110.71 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 58' ' ' ILE . 70.7 m -67.68 -34.87 77.77 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 16.2 mm-40 -70.72 -33.99 71.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.2 0.524 . . . . 0.0 110.505 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.74 ' HG3' HG21 ' A' ' 30' ' ' VAL . 15.9 mmt180 -65.45 -49.01 70.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.302 0.572 . . . . 0.0 110.511 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.63 -20.76 35.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.674 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.83 14.25 79.95 Favored Glycine 0 C--N 1.321 -0.269 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.371 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.99 178.54 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.451 0.643 . . . . 0.0 112.25 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.0 m -100.36 129.57 46.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.759 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.505 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.7 ptp -63.13 -24.04 67.71 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.119 0.485 . . . . 0.0 112.087 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -78.91 -12.48 60.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.351 0.596 . . . . 0.0 111.142 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -99.33 -0.29 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.146 0.498 . . . . 0.0 110.999 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.523 HD11 ' SG ' ' A' ' 48' ' ' CYS . 29.2 pt -132.77 169.9 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.229 0.537 . . . . 0.0 111.567 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 17.7 mmm180 -138.83 146.88 41.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.988 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.614 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.1 m-85 -112.72 130.73 55.96 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.825 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.625 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -130.71 145.22 51.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 0.0 110.66 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -146.51 135.79 22.77 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 60.88 28.04 17.83 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.427 0.632 . . . . 0.0 110.743 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.18 -1.2 70.94 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.445 -1.359 . . . . 0.0 113.51 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -118.53 139.84 27.5 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 117.527 0.664 . . . . 0.0 110.853 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.81 145.66 36.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.341 2.028 . . . . 0.0 111.577 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.7 137.58 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-O 121.543 0.687 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.53 154.25 17.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.544 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.584 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.2 pt-20 -61.7 -18.04 58.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.522 . . . . 0.0 112.325 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -79.51 -15.65 57.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.021 0.439 . . . . 0.0 111.278 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.39 164.07 15.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.942 0.401 . . . . 0.0 111.345 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -118.04 155.18 51.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.221 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.45 -11.35 29.97 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.754 2.303 . . . . 0.0 112.243 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.93 -14.81 24.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.896 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -69.31 -38.79 78.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.438 0.637 . . . . 0.0 110.168 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -104.92 1.28 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.432 0.634 . . . . 0.0 110.15 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 50.85 60.83 3.59 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.784 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.56 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -77.0 163.6 26.55 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.5 tp10 -92.96 161.83 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.453 . . . . 0.0 110.814 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.36 138.65 51.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.286 0.565 . . . . 0.0 111.215 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 73.03 19.45 3.69 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.413 1.085 . . . . 0.0 110.9 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -72.82 175.35 6.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.731 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.459 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.2 m -133.33 147.26 51.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.578 0.704 . . . . 0.0 111.506 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.459 HD12 ' C ' ' A' ' 83' ' ' THR . 2.5 mp -121.4 137.87 53.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.625 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 13.4 m-20 -88.73 136.38 33.03 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.1 0.476 . . . . 0.0 111.022 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -120.88 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-O 121.465 0.65 . . . . 0.0 110.609 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.6 p90 -137.94 147.15 44.06 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.305 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.459 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 121.191 0.52 . . . . 0.0 109.9 -175.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 10.6 p-80 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 120.989 0.423 . . . . 0.0 111.852 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 pt -129.66 169.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.353 -0.842 . . . . 0.0 112.125 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.57 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.3 m-80 -103.87 144.49 31.44 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.215 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.3 mm? -135.23 160.69 37.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.336 0.589 . . . . 0.0 110.936 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.2 mtpt -135.93 148.32 48.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.478 HG23 ' CE1' ' A' ' 32' ' ' PHE . 96.9 t -125.38 119.32 55.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.244 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.75 119.9 35.06 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.338 0.59 . . . . 0.0 110.222 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.84 157.98 32.96 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.9 pp0? -64.43 -16.41 62.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.276 0.56 . . . . 0.0 111.369 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.98 -10.95 58.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 0.0 110.916 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.59 30.41 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.31 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -105.43 155.6 18.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.3 p -141.01 134.11 31.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.384 0.611 . . . . 0.0 110.958 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 85.9 t -107.24 138.45 33.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.99 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -110.11 131.75 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 22' ' ' VAL . 7.1 p90 -155.9 170.07 22.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.305 0.574 . . . . 0.0 111.887 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -116.45 138.38 51.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.744 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' CG2' HD23 ' A' ' 20' ' ' LEU . 15.5 tt -143.52 150.52 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.103 0.477 . . . . 0.0 110.069 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 25.8 mtmm -86.47 158.39 19.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.408 ' NH2' ' HA ' ' A' ' 74' ' ' ALA . 24.0 mmm-85 -63.25 -38.29 90.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.647 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -95.47 9.41 40.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.027 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.9 m -93.95 128.34 41.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.378 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.0 149.42 89.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.685 2.256 . . . . 0.0 112.925 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD2' HD13 ' A' ' 43' ' ' LEU . 83.8 mt -63.91 -11.71 30.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.971 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 21.9 p . . . . . 0 C--O 1.236 0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt . . . . . 0 C--O 1.237 0.431 0 CA-C-O 121.135 0.493 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.63 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 34.0 mtt -62.32 -46.57 88.15 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.227 0.537 . . . . 0.0 110.648 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.711 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 17.6 tppt? -64.99 -41.44 95.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.793 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.586 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.39 -50.96 71.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.796 0.332 . . . . 0.0 110.655 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.17 -42.34 99.37 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.362 0.601 . . . . 0.0 110.262 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.711 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.09 -40.17 88.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.958 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 7.8 mt-10 -73.38 -33.51 65.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.866 0.365 . . . . 0.0 111.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 50' ' ' ARG . 7.1 mmp_? -65.44 -47.71 75.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.314 0.578 . . . . 0.0 110.417 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.12 46.16 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.124 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.79 2.6 78.37 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.975 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.86 176.27 7.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.459 0.647 . . . . 0.0 112.47 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.4 m -97.52 136.68 37.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.651 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 6.5 ptp -68.09 -26.64 65.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.158 0.504 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.405 ' HG3' HE21 ' A' ' 57' ' ' GLN . 13.1 ptm180 -75.17 -10.28 59.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.407 0.623 . . . . 0.0 110.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.405 HE21 ' HG3' ' A' ' 56' ' ' ARG . 24.8 mm-40 -102.66 5.67 39.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.231 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 88' ' ' GLN . 28.6 pt -138.8 176.66 6.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.118 0.485 . . . . 0.0 110.983 -177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.419 HH21 ' HB2' ' A' ' 66' ' ' PRO . 22.7 mmm180 -146.94 148.03 31.34 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.631 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.6 m-85 -114.55 132.33 56.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.789 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.625 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -131.0 142.58 50.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.46 0.648 . . . . 0.0 111.028 177.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -146.55 140.1 25.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t70 64.44 25.35 13.32 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.068 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.41 -0.39 64.34 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 119.819 -1.181 . . . . 0.0 113.161 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -120.79 143.3 36.27 Favored Pre-proline 0 N--CA 1.445 -0.695 0 O-C-N 122.134 -0.627 . . . . 0.0 110.808 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HB2' HH21 ' A' ' 59' ' ' ARG . 58.3 Cg_endo -72.62 148.7 47.87 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 122.233 1.956 . . . . 0.0 111.716 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.29 137.09 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-O 121.334 0.588 . . . . 0.0 110.648 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.19 156.24 16.96 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -60.66 -20.15 60.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.183 0.516 . . . . 0.0 112.062 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -79.54 -10.95 59.89 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.22 162.73 14.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.679 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -118.45 158.63 46.43 Favored Pre-proline 0 C--N 1.307 -1.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.16 -6.04 13.77 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.649 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . . . -95.42 -14.07 24.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.557 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -68.06 -37.02 80.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.444 0.64 . . . . 0.0 110.102 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.468 HD21 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -111.75 1.72 16.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.546 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 53.11 60.36 3.82 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.9 ptp -78.72 167.37 21.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.855 0.36 . . . . 0.0 110.534 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 80' ' ' ASP . 43.1 tt0 -93.29 165.64 12.7 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.095 0.474 . . . . 0.0 110.568 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 3.9 p-10 -77.25 137.87 39.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.063 0.459 . . . . 0.0 110.036 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.13 16.72 4.21 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.356 1.062 . . . . 0.0 111.317 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.07 176.43 3.81 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.6 m -136.41 151.04 49.09 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 121.805 -0.56 . . . . 0.0 111.004 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 61' ' ' ARG . 2.8 mp -120.81 144.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.625 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.5 t0 -88.87 130.96 35.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.146 0.498 . . . . 0.0 110.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.48 134.89 60.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.653 0.739 . . . . 0.0 111.046 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.411 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 4.3 p90 -135.65 145.96 47.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.0 OUTLIER . . . . . 0 C--N 1.317 -0.809 0 CA-C-O 121.085 0.469 . . . . 0.0 110.659 -177.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 21.5 p-80 . . . . . 0 N--CA 1.429 -1.518 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.7 pt -104.22 168.8 2.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-O 121.662 0.744 . . . . 0.0 112.217 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.9 m-80 -101.47 144.93 29.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.948 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -132.28 161.78 32.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.233 0.539 . . . . 0.0 110.459 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.0 mtpt -135.76 147.64 48.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.759 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 32' ' ' PHE . 79.3 t -127.48 113.91 33.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 121.082 0.468 . . . . 0.0 110.294 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.07 123.02 34.21 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.778 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.01 163.75 29.47 Favored Glycine 0 N--CA 1.418 -2.545 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -12.08 59.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.574 0.702 . . . . 0.0 111.28 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.41 -13.15 58.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.734 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.73 9.3 56.5 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.764 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -103.28 155.39 18.49 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.32 130.71 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.635 0.731 . . . . 0.0 111.377 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 94.2 t -101.81 135.85 36.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.325 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -108.44 128.82 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.2 p90 -151.42 169.7 21.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.216 0.531 . . . . 0.0 111.528 -174.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -115.46 138.21 51.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.842 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tt -145.54 149.31 16.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 30.5 mtmt -83.62 159.86 21.5 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.504 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 25.3 mmm-85 -69.46 -36.03 76.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.165 0.507 . . . . 0.0 110.594 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.99 5.95 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.272 0.558 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.2 m -91.29 131.57 36.23 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.321 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.45 147.89 93.0 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 70.9 mt -64.54 -13.44 52.67 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.408 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p . . . . . 0 C--O 1.238 0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 111.7 179.733 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.476 HD13 HD22 ' A' ' 40' ' ' LEU . 3.9 tt . . . . . 0 C--O 1.238 0.496 0 CA-C-O 120.822 0.344 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -60.56 -39.45 87.99 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.513 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 tppp? -68.72 -43.11 76.66 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.2 -51.15 65.33 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.78 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -64.68 -39.9 94.47 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.18 83.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 5.9 mm-40 -72.23 -35.36 68.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.273 0.558 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 27.6 mmm180 -69.43 -45.55 68.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.392 0.615 . . . . 0.0 111.402 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -21.74 33.54 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.676 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.09 89.78 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.908 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.79 178.04 7.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.912 0.386 . . . . 0.0 111.502 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.8 m -96.87 124.67 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.17 -27.77 64.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -79.05 -9.47 59.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.218 0.532 . . . . 0.0 111.622 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.48 2.11 35.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.556 0.693 . . . . 0.0 110.617 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.529 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.9 pt -130.78 170.68 19.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.235 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 16.2 mmm180 -140.51 147.27 39.29 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.252 0.549 . . . . 0.0 111.253 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.2 m-85 -113.26 129.16 56.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.112 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.598 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.2 ppt_? -132.86 136.38 46.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 111.468 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -136.23 137.31 40.68 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 60.89 29.8 19.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.324 0.583 . . . . 0.0 111.134 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.51 67.99 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.197 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.03 139.78 31.02 Favored Pre-proline 0 C--N 1.323 -0.576 0 O-C-N 122.175 -0.603 . . . . 0.0 111.251 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 151.28 44.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.413 2.075 . . . . 0.0 111.851 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.88 136.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.353 0.597 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.71 154.51 17.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.508 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -59.11 -20.6 54.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.395 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.5 p -80.29 -10.37 59.75 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.304 0.573 . . . . 0.0 111.399 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.78 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 p -113.31 155.15 44.98 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.004 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -66.47 -7.77 18.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.56 2.173 . . . . 0.0 111.879 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.98 -16.61 22.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.929 0.395 . . . . 0.0 110.618 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -68.97 -40.65 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.628 . . . . 0.0 110.49 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.488 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.83 -1.14 38.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.487 0.66 . . . . 0.0 110.205 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 60.07 3.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.929 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.1 ptp -79.83 165.17 22.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 175.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.608 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 13.0 pt-20 -100.73 169.51 8.97 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.146 0.498 . . . . 0.0 112.203 -175.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.64 133.3 50.84 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.894 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 69.24 18.63 8.07 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.508 0.723 . . . . 0.0 111.61 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.608 ' OD2' ' HG2' ' A' ' 79' ' ' GLU . 4.0 t0 -67.92 174.77 3.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.1 m -133.11 150.51 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.687 -0.633 . . . . 0.0 110.899 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.57 145.98 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.0 t70 -92.71 133.63 35.82 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.028 0.442 . . . . 0.0 110.521 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.61 137.13 54.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.7 0.762 . . . . 0.0 110.644 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -137.54 148.15 45.72 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.582 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.313 -1.009 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 50.1 p-80 . . . . . 0 N--CA 1.443 -0.793 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.56 169.37 20.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.326 0.584 . . . . 0.0 111.56 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.453 ' O ' HD22 ' A' ' 20' ' ' LEU . 19.3 m-80 -98.94 143.2 29.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.634 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.8 mm? -129.96 163.86 25.52 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.084 0.468 . . . . 0.0 110.026 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 55.6 mtpt -135.73 147.61 48.51 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 32' ' ' PHE . 69.6 t -126.53 117.23 47.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.169 0.509 . . . . 0.0 110.264 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.72 121.42 32.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.758 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.85 159.13 30.06 Favored Glycine 0 N--CA 1.42 -2.398 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.17 58.74 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.358 0.599 . . . . 0.0 111.679 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.76 -12.38 60.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.429 0.633 . . . . 0.0 110.499 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 8.46 57.67 Favored Glycine 0 C--N 1.321 -0.28 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.807 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -99.28 159.57 14.9 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.66 135.46 30.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-O 121.483 0.658 . . . . 0.0 111.274 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 14.6 p -104.98 138.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.063 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -108.78 125.62 52.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CE1' HG23 ' A' ' 22' ' ' VAL . 15.7 p90 -147.29 168.82 20.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.228 0.537 . . . . 0.0 111.446 -174.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -112.26 141.18 46.28 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.056 0.455 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.402 ' CG2' HD23 ' A' ' 20' ' ' LEU . 14.9 tt -148.2 148.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.088 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.5 mtmm -85.05 157.79 20.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.762 -0.586 . . . . 0.0 110.418 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.53 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 17.3 mmm-85 -64.28 -41.18 97.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.501 . . . . 0.0 110.803 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -89.92 7.42 37.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.421 0.629 . . . . 0.0 110.461 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 19.1 m -93.94 130.27 35.12 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 148.57 91.13 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.818 2.345 . . . . 0.0 113.123 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 43' ' ' LEU . 82.6 mt -62.76 -12.28 23.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.513 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 12.8 t . . . . . 0 C--N 1.327 -0.4 0 C-N-CA 122.609 0.364 . . . . 0.0 111.065 178.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 44' ' ' MET . 2.6 tt . . . . . 0 C--O 1.236 0.349 0 CA-C-O 121.249 0.547 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.589 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 36.4 mtt -61.86 -40.17 94.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.377 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.3 tppp? -66.71 -44.32 81.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.54 -51.58 66.58 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.11 -40.42 95.85 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.003 0.43 . . . . 0.0 111.111 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -42.01 96.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.2 mm-40 -65.21 -39.65 93.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.852 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.8 mmp_? -65.61 -54.2 31.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.188 0.518 . . . . 0.0 111.51 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -21.41 59.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.184 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.08 87.74 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -86.99 177.45 7.23 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.404 -0.468 . . . . 0.0 110.734 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 m -100.25 128.05 46.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.641 0.258 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -64.35 -24.25 67.58 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.547 . . . . 0.0 111.247 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.444 ' HG3' HE21 ' A' ' 57' ' ' GLN . 10.6 ptp85 -77.67 -14.71 59.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.53 . . . . 0.0 110.778 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.444 HE21 ' HG3' ' A' ' 56' ' ' ARG . 23.9 mm-40 -99.85 1.0 42.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.156 0.503 . . . . 0.0 111.23 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.462 HG22 ' HG2' ' A' ' 88' ' ' GLN . 29.9 pt -130.71 173.03 15.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 22.0 mmm180 -141.12 149.83 42.06 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.741 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-85 -114.34 132.17 56.28 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.544 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.6 ppt_? -134.25 140.5 46.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 0.0 110.993 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -139.51 138.21 36.15 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.707 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.47 33.82 21.77 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.175 0.512 . . . . 0.0 112.107 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.1 -6.32 67.79 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.758 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.23 145.18 37.81 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 122.13 -0.629 . . . . 0.0 111.045 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.05 151.61 35.1 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.386 2.057 . . . . 0.0 111.179 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.44 141.33 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.458 0.647 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 154.2 17.36 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.589 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.4 pt-20 -62.17 -16.34 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.2 p -79.55 -18.63 51.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.203 0.525 . . . . 0.0 110.874 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 75' ' ' GLN . 0.3 OUTLIER -83.08 161.2 21.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.1 p -117.16 158.42 44.45 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.722 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 78' ' ' MET . 38.1 Cg_endo -68.27 -8.66 23.56 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.113 1.875 . . . . 0.0 111.529 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.38 -19.56 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.609 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.446 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 3.0 tp-100 -62.45 -36.31 82.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.42 0.628 . . . . 0.0 110.307 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.461 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.54 -0.3 20.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 51.05 63.09 2.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.507 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.634 ' SD ' HD11 ' A' ' 20' ' ' LEU . 12.1 ptp -77.44 175.47 9.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.825 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -96.19 157.84 15.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.39 143.32 48.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.438 0.637 . . . . 0.0 111.17 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 69.93 20.19 6.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.06 176.92 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.419 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.4 m -133.43 151.58 51.82 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 83' ' ' THR . 3.2 mp -124.19 142.51 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 30.0 t70 -89.42 136.83 32.8 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.2 137.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.631 0.729 . . . . 0.0 110.691 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -138.22 149.11 45.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.703 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--N 1.32 -0.681 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.611 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 23.7 p-80 . . . . . 0 N--CA 1.435 -1.216 0 CA-C-O 120.782 0.325 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.05 169.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.516 0.674 . . . . 0.0 112.756 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD22 ' A' ' 20' ' ' LEU . 9.5 m-80 -99.35 139.91 34.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.43 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.529 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -131.69 159.91 37.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.211 0.529 . . . . 0.0 110.296 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -134.53 148.39 50.5 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.494 HG23 ' CE1' ' A' ' 32' ' ' PHE . 70.2 t -126.64 117.19 47.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.163 0.506 . . . . 0.0 109.986 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.14 119.29 31.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.95 158.33 30.41 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.453 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.2 pp0? -66.24 -10.51 42.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.506 0.67 . . . . 0.0 110.886 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -76.53 -15.5 59.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.329 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 14.23 37.16 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.543 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t -119.59 166.25 13.39 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.23 137.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.171 0.51 . . . . 0.0 111.282 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.516 HG11 ' HG3' ' A' ' 50' ' ' ARG . 96.6 t -102.95 139.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.904 176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -110.24 130.33 55.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CE1' HG23 ' A' ' 22' ' ' VAL . 6.0 p90 -150.86 168.91 23.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.181 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -117.27 133.98 55.34 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 16.9 tt -135.2 150.1 29.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 12.8 mttt -86.92 151.44 23.3 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.082 0.468 . . . . 0.0 110.847 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -61.72 -40.1 93.86 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.241 0.543 . . . . 0.0 110.805 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -87.73 6.17 36.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.289 0.566 . . . . 0.0 111.353 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.6 m -96.81 131.77 27.32 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.84 154.89 71.84 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.931 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 43' ' ' LEU . 95.4 mt -66.76 -11.25 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.771 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.24 0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.948 178.817 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.537 HD13 HD22 ' A' ' 40' ' ' LEU . 3.1 tt . . . . . 0 C--O 1.236 0.377 0 CA-C-O 121.306 0.574 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.656 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -60.81 -50.36 73.76 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.402 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.682 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 18.3 tppt? -60.84 -43.1 98.74 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.84 -52.79 61.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.047 0.451 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -61.03 -43.96 98.11 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.333 0.587 . . . . 0.0 110.503 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.4 m -61.02 -39.79 91.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.545 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.0 mt-10 -66.65 -33.82 76.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.054 0.454 . . . . 0.0 110.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.516 ' HG3' HG11 ' A' ' 30' ' ' VAL . 10.8 mmm180 -67.65 -48.74 65.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.143 0.497 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -22.7 39.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.069 0.461 . . . . 0.0 111.533 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.23 72.6 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.023 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.73 177.01 6.85 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.177 -0.602 . . . . 0.0 112.266 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.8 m -99.89 140.24 34.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.45 -25.9 66.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HG3' HE21 ' A' ' 57' ' ' GLN . 15.2 ptp180 -75.53 -10.7 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.159 0.504 . . . . 0.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.456 HE21 ' HG3' ' A' ' 56' ' ' ARG . 21.9 mm-40 -101.41 4.32 41.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 0.0 110.933 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.524 HD11 ' SG ' ' A' ' 48' ' ' CYS . 31.3 pt -139.92 174.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.289 0.566 . . . . 0.0 111.701 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -141.25 145.02 35.02 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.656 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.7 m-85 -113.43 131.57 55.97 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.673 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.612 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.53 141.78 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.589 . . . . 0.0 111.209 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -145.5 142.76 29.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.353 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 t70 60.64 25.67 15.4 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 120.96 0.409 . . . . 0.0 110.998 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.45 72.28 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.094 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -120.34 145.11 39.68 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.165 -0.609 . . . . 0.0 111.426 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.73 147.9 40.67 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 122.371 2.047 . . . . 0.0 111.181 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.05 136.52 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.255 0.55 . . . . 0.0 111.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.51 152.17 18.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.04 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.739 ' OE2' HG23 ' A' ' 70' ' ' THR . 0.2 OUTLIER -53.46 -21.48 6.24 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.739 HG23 ' OE2' ' A' ' 69' ' ' GLU . 40.6 p -74.16 -15.6 61.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.341 0.591 . . . . 0.0 111.661 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 55.9 m-20 -85.99 159.25 19.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -119.8 155.4 54.96 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.62 -7.64 19.95 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 112.336 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.88 -28.19 15.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.945 0.402 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -60.96 -39.62 90.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.5 . . . . 0.0 111.478 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.7 0.76 33.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 50.98 61.0 3.47 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.153 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.529 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.8 ptp -77.02 168.97 19.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -88.02 164.98 15.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.974 0.416 . . . . 0.0 110.169 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.24 141.37 31.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.626 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 73.67 14.4 4.21 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.074 0.95 . . . . 0.0 110.649 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.96 175.51 3.66 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.421 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.401 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.4 m -133.69 150.62 51.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.272 0.558 . . . . 0.0 111.193 -176.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.94 144.81 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.612 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 38.7 t70 -92.17 134.31 34.98 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.077 0.465 . . . . 0.0 110.775 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.52 135.21 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.809 0.814 . . . . 0.0 111.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -138.61 149.5 45.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.163 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.511 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.741 0 CA-C-O 121.452 0.644 . . . . 0.0 110.63 -177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 36.1 p-80 . . . . . 0 N--CA 1.43 -1.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.39 170.05 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.133 0.492 . . . . 0.0 110.639 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.523 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.9 m-80 -100.22 144.87 28.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -133.43 162.68 31.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.094 0.473 . . . . 0.0 110.483 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 83' ' ' THR . 58.5 mtpt -137.39 147.5 45.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.483 HG23 ' CE1' ' A' ' 32' ' ' PHE . 76.3 t -125.17 120.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.951 0.405 . . . . 0.0 110.411 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.28 122.54 38.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.597 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.0 160.8 30.03 Favored Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -21.1 65.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.428 0.632 . . . . 0.0 111.022 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.44 -16.5 62.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.477 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.04 49.93 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.675 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 t -101.91 157.54 16.78 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 8.2 p -139.99 137.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.561 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.4 p -109.43 142.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.85 127.01 56.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.323 0.582 . . . . 0.0 109.542 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' HG23 ' A' ' 22' ' ' VAL . 13.4 p90 -151.04 168.73 23.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.284 0.564 . . . . 0.0 111.561 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -112.51 142.86 44.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.697 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.426 ' CG2' HD23 ' A' ' 20' ' ' LEU . 16.1 tt -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.078 0.466 . . . . 0.0 110.192 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.4 mtmt -83.97 158.45 21.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.874 -0.516 . . . . 0.0 110.738 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.714 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 26.1 mmm-85 -65.45 -38.98 91.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 110.485 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.4 6.86 43.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.313 0.578 . . . . 0.0 110.538 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.0 m -93.93 130.03 35.9 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.78 151.16 85.13 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.886 2.39 . . . . 0.0 112.89 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.483 HD22 HD13 ' A' ' 43' ' ' LEU . 86.8 mt -64.26 -11.77 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 C--O 1.237 0.413 0 CA-C-O 120.924 0.392 . . . . 0.0 111.364 178.877 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD13 HD22 ' A' ' 40' ' ' LEU . 3.0 tt . . . . . 0 C--O 1.236 0.369 0 CA-C-O 121.158 0.504 . . . . 0.0 110.21 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.625 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.1 mtt -61.54 -41.8 97.88 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.719 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 18.1 tppt? -68.13 -41.59 81.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -47.45 85.82 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.15 0.5 . . . . 0.0 110.957 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -65.01 -40.19 94.52 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.248 0.547 . . . . 0.0 110.693 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.719 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.97 -36.7 80.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.277 -177.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.2 mm-40 -74.46 -39.74 62.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.229 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.561 ' HG3' HG21 ' A' ' 30' ' ' VAL . 17.0 mmt180 -64.04 -46.8 82.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.217 0.532 . . . . 0.0 111.437 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.46 -16.64 51.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.58 57.28 5.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.535 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.44 175.58 10.7 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.749 0.309 . . . . 0.0 110.253 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 58.3 m -99.93 132.2 45.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.762 0.315 . . . . 0.0 110.984 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.9 ptp -63.74 -26.05 68.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 111.088 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 7.6 ptm180 -74.72 -13.38 60.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.999 0.428 . . . . 0.0 111.347 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.422 HE21 ' HG3' ' A' ' 56' ' ' ARG . 21.9 mm-40 -103.25 6.92 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.143 0.497 . . . . 0.0 111.381 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.495 HG22 ' HG2' ' A' ' 88' ' ' GLN . 23.2 pt -133.36 170.31 20.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.122 0.487 . . . . 0.0 111.241 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 6.7 mmm180 -138.1 140.2 39.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.397 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.3 m-85 -108.75 131.36 55.02 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 5.4 ppt_? -131.69 140.93 49.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -141.75 138.8 32.58 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.5 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.94 28.78 18.34 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.45 -3.57 77.4 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.545 -1.312 . . . . 0.0 113.316 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -123.45 144.89 45.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 O-C-N 121.899 -0.765 . . . . 0.0 111.637 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.57 150.44 40.38 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.665 2.244 . . . . 0.0 112.014 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 138.95 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 121.713 0.768 . . . . 0.0 111.267 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.47 154.91 18.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.589 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.602 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.6 pt-20 -62.49 -18.29 61.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.097 0.475 . . . . 0.0 112.227 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -79.63 -14.77 58.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.288 0.566 . . . . 0.0 111.283 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.2 158.61 21.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.001 0.429 . . . . 0.0 110.151 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 p -118.69 151.58 50.16 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.512 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.43 -9.05 18.75 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.47 2.113 . . . . 0.0 112.111 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.68 -20.46 18.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.424 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -69.68 -36.14 75.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.144 0.497 . . . . 0.0 110.814 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.49 -0.34 24.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.344 0.592 . . . . 0.0 110.224 178.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 48.95 62.5 2.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.9 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ptp -74.3 166.62 23.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.09 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 39.1 tt0 -87.75 157.02 19.15 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.114 0.483 . . . . 0.0 110.849 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -72.81 139.4 47.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.118 0.485 . . . . 0.0 110.066 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 71.13 15.93 6.42 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.069 0.948 . . . . 0.0 110.594 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -70.37 176.68 3.82 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.448 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -130.14 147.26 51.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.4 0.619 . . . . 0.0 111.45 -177.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.82 133.97 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 2.5 m-20 -86.31 136.31 33.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.045 0.45 . . . . 0.0 111.088 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -123.87 140.36 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.382 0.611 . . . . 0.0 111.145 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.66 147.01 44.54 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.588 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.495 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.316 -0.867 0 CA-C-O 121.36 0.6 . . . . 0.0 111.107 -176.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 36.5 p-80 . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 120.999 0.428 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.5 pt -128.59 169.08 20.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.332 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.507 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.9 m-80 -97.46 144.61 27.02 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -132.75 160.77 35.86 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.292 0.568 . . . . 0.0 110.779 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.8 mtpt -136.11 148.84 48.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.789 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.46 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.8 t -129.16 116.6 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 120.955 0.407 . . . . 0.0 110.171 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.54 128.03 35.55 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.9 156.87 22.59 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -64.45 -11.55 34.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.493 0.663 . . . . 0.0 110.879 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.55 -19.29 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.211 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 9.36 36.33 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.297 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 t -113.45 157.36 22.05 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 122.296 -0.532 . . . . 0.0 109.899 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.44 135.02 58.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.425 0.631 . . . . 0.0 111.258 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 50' ' ' ARG . 14.4 p -101.78 142.09 16.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 122.118 -0.364 . . . . 0.0 110.263 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -112.03 130.93 55.7 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.107 0.48 . . . . 0.0 109.73 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 22' ' ' VAL . 9.5 p90 -151.37 168.37 25.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.438 -175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 41.8 mtmt -113.87 136.5 52.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.862 0.363 . . . . 0.0 110.818 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tt -142.62 147.09 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.049 0.452 . . . . 0.0 110.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 27.1 mtmm -85.14 157.62 20.62 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 121.083 0.468 . . . . 0.0 111.376 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -63.16 -41.52 99.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.704 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -88.73 6.86 36.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.322 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 13.6 m -93.99 130.12 35.51 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.87 151.32 84.49 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.696 2.264 . . . . 0.0 112.655 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 43' ' ' LEU . 87.3 mt -66.64 -13.19 60.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.296 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 14.4 m . . . . . 0 C--O 1.241 0.624 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 HD22 ' A' ' 40' ' ' LEU . 4.0 tt . . . . . 0 C--O 1.237 0.408 0 CA-C-O 120.755 0.312 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -58.51 -50.24 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.963 0.411 . . . . 0.0 110.601 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.7 tppp? -62.82 -37.92 88.69 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.402 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.25 -49.8 76.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.451 . . . . 0.0 110.531 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.05 -40.5 96.43 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.025 0.441 . . . . 0.0 111.036 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.1 m -63.15 -34.98 78.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 110.997 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.5 mm-40 -71.55 -41.79 68.68 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.789 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.6 mmp_? -66.48 -47.15 73.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.353 0.597 . . . . 0.0 111.303 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.16 -16.61 52.42 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.895 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.78 57.77 5.2 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.606 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.92 173.6 12.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.666 -0.314 . . . . 0.0 110.425 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -98.87 133.73 42.74 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.756 0.312 . . . . 0.0 111.698 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.483 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 9.5 ptp -65.06 -26.36 68.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.078 0.466 . . . . 0.0 111.269 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HG3' HE21 ' A' ' 57' ' ' GLN . 19.1 ptp180 -74.66 -6.24 47.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.238 0.542 . . . . 0.0 110.836 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.4 HE21 ' HG3' ' A' ' 56' ' ' ARG . 23.8 mm-40 -109.35 5.17 23.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.932 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.724 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.7 pt -137.19 171.99 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.188 0.518 . . . . 0.0 111.177 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 24.2 mmt180 -142.6 147.91 36.61 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.265 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.423 ' HB3' HG21 ' A' ' 84' ' ' ILE . 9.0 m-85 -114.28 128.22 56.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.121 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.8 ppt_? -130.26 136.8 49.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 84' ' ' ILE . 81.9 t80 -138.69 133.14 31.92 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.548 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 65.06 26.3 12.58 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.064 0.459 . . . . 0.0 110.57 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.85 -5.13 76.94 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.242 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.05 142.91 34.31 Favored Pre-proline 0 C--N 1.322 -0.603 0 O-C-N 122.054 -0.674 . . . . 0.0 111.381 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 144.55 29.76 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.538 2.159 . . . . 0.0 111.955 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.62 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.589 0.709 . . . . 0.0 110.674 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.21 156.84 18.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.96 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.37 -26.49 61.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.134 0.492 . . . . 0.0 112.176 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.2 p -74.29 -17.2 60.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.072 0.463 . . . . 0.0 111.223 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -78.87 158.4 28.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.195 0.521 . . . . 0.0 111.005 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -117.33 153.11 49.97 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.69 -7.35 19.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.449 2.099 . . . . 0.0 112.018 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.23 -23.06 17.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.095 0.474 . . . . 0.0 110.608 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -62.54 -39.46 93.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.391 0.615 . . . . 0.0 110.561 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.71 1.48 23.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.863 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 49.16 62.65 2.5 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.658 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -76.23 170.44 16.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -88.06 163.91 16.01 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.394 0.616 . . . . 0.0 111.237 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.46 138.83 34.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 72.36 13.46 5.55 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.963 0.905 . . . . 0.0 110.246 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.08 172.8 5.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.92 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.1 m -132.1 151.56 51.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.281 0.562 . . . . 0.0 111.355 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -123.85 141.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.62 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 31.8 t70 -90.82 132.32 35.95 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.907 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -116.19 134.58 59.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.555 0.693 . . . . 0.0 110.917 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -141.93 153.24 44.21 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.724 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.0 mt-30 . . . . . 0 CA--C 1.507 -0.71 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 51.7 p-80 . . . . . 0 N--CA 1.435 -1.219 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.5 pt -121.07 168.94 12.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.451 0.643 . . . . 0.0 111.657 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.505 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.7 m-80 -100.47 141.7 32.97 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.751 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.534 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.56 162.78 30.98 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.042 0.449 . . . . 0.0 110.446 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.66 149.04 49.18 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.24 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.517 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.5 t -127.36 115.6 40.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.53 118.36 29.93 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.058 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.0 156.96 30.36 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.1 pp0? -63.54 -15.44 58.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.02 -17.49 61.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.763 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.57 36.43 Favored Glycine 0 C--O 1.229 -0.178 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 t -112.41 161.72 16.37 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -138.09 136.84 44.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.452 0.644 . . . . 0.0 110.713 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 87.5 t -102.58 135.03 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -109.59 126.74 53.92 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.517 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -148.18 168.15 23.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.408 0.623 . . . . 0.0 111.755 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 38.2 mtmt -115.53 134.6 54.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.302 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 17.6 tt -139.07 149.82 23.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.6 mtmp? -87.78 155.93 19.66 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.907 -0.496 . . . . 0.0 111.187 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 28.9 mmm-85 -63.72 -34.69 78.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -96.41 6.53 48.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 110.781 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.9 m -93.65 130.79 33.95 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.49 151.65 79.65 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.717 2.278 . . . . 0.0 112.122 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.823 HD22 HD13 ' A' ' 43' ' ' LEU . 33.3 mt -65.61 -11.37 43.81 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.108 -0.497 . . . . 0.0 112.32 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 15.8 p . . . . . 0 C--O 1.239 0.523 0 CA-C-O 121.061 0.457 . . . . 0.0 111.047 178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.823 HD13 HD22 ' A' ' 40' ' ' LEU . 4.3 tt . . . . . 0 C--O 1.237 0.434 0 CA-C-O 120.962 0.41 . . . . 0.0 110.473 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.433 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.0 mpt? -59.72 -39.85 86.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.113 0.482 . . . . 0.0 110.589 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.8 tppp? -70.12 -40.72 74.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.024 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.9 75.66 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 110.336 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -65.44 -39.43 92.05 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.67 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.01 -38.67 86.87 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.792 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 41.8 mm-40 -67.04 -46.21 75.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.346 0.593 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -59.77 -47.68 84.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.755 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.34 -21.38 30.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.971 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.8 90.13 Favored Glycine 0 C--N 1.322 -0.246 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.647 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -87.39 177.22 7.18 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.995 0.426 . . . . 0.0 111.633 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.482 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 43.8 m -95.34 130.38 42.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 ptp -65.17 -24.78 67.48 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.213 0.53 . . . . 0.0 111.341 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -79.37 -12.48 59.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.361 0.6 . . . . 0.0 111.118 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.482 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 26.3 mm-40 -98.72 8.24 45.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.476 0.655 . . . . 0.0 111.013 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.4 pt -137.47 174.78 10.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.803 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 26.8 mmt180 -139.77 146.31 39.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.598 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 16.8 m-85 -115.26 128.09 55.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.32 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.0 ppt_? -132.02 134.22 45.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.498 0.665 . . . . 0.0 110.866 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -128.09 131.99 49.03 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.224 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.4 31.56 7.41 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.74 83.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -124.19 136.09 27.2 Favored Pre-proline 0 C--N 1.323 -0.562 0 O-C-N 121.95 -0.735 . . . . 0.0 111.576 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.16 146.16 45.61 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.948 2.432 . . . . 0.0 111.944 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.42 136.03 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 111.714 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.97 157.69 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.613 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 4.3 pt-20 -62.87 -18.45 62.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.263 0.554 . . . . 0.0 112.198 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.7 p -80.86 -11.4 59.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.082 0.468 . . . . 0.0 111.266 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -87.52 160.02 18.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.88 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 p -117.35 155.21 50.24 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.575 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 78' ' ' MET . 43.7 Cg_endo -67.13 -12.86 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.31 2.007 . . . . 0.0 112.163 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.85 -16.99 21.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.188 0.518 . . . . 0.0 110.861 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.28 -34.55 76.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.405 0.621 . . . . 0.0 110.666 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.19 0.96 21.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.336 0.589 . . . . 0.0 110.413 177.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 50.67 59.52 4.53 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.367 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.534 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.84 170.37 15.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.08 0.467 . . . . 0.0 110.043 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -95.13 162.77 13.57 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.027 0.442 . . . . 0.0 110.532 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.27 137.37 41.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.153 0.502 . . . . 0.0 110.491 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 75.19 16.25 2.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.65 177.25 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.8 m -135.18 151.68 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.15 0.5 . . . . 0.0 111.216 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.9 142.69 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.9 t70 -93.06 132.95 36.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.027 0.442 . . . . 0.0 110.838 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.9 t -116.15 132.55 65.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.84 0.828 . . . . 0.0 111.49 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -135.33 143.29 46.07 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.634 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-O 121.143 0.497 . . . . 0.0 110.616 -176.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 41.2 p-80 . . . . . 0 N--CA 1.442 -0.869 0 CA-C-O 120.839 0.352 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 pt -110.74 169.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.542 0.686 . . . . 0.0 112.655 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.446 ' O ' HD22 ' A' ' 20' ' ' LEU . 25.1 m-80 -94.66 140.91 29.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.589 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.593 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -129.8 159.66 35.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.7 mtpt -134.52 147.17 50.27 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 32' ' ' PHE . 77.4 t -127.74 116.94 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.118 0.485 . . . . 0.0 110.372 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.62 31.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.591 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.03 162.25 32.36 Favored Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.201 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -16.42 63.87 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.734 0.778 . . . . 0.0 110.571 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.25 -19.45 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.98 7.87 54.72 Favored Glycine 0 C--N 1.323 -0.166 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.263 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -108.39 165.03 11.82 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.269 0.557 . . . . 0.0 110.674 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.498 HG21 ' HG3' ' A' ' 50' ' ' ARG . 10.0 p -106.32 139.62 27.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.19 124.83 53.45 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.0 p90 -147.75 167.78 23.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 -174.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -114.7 138.49 50.64 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -144.18 148.65 18.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 110.586 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.1 mtmp? -81.07 154.88 26.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.969 0.414 . . . . 0.0 110.627 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 24.3 mmm-85 -66.14 -37.47 85.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.223 0.535 . . . . 0.0 110.562 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -90.24 6.79 41.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.584 0.707 . . . . 0.0 110.49 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.536 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.7 m -94.71 131.52 30.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.79 149.94 86.4 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.804 2.336 . . . . 0.0 113.009 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.0 mt -64.56 -12.02 40.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.452 0.701 . . . . 0.0 112.132 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.0 t . . . . . 0 C--O 1.239 0.552 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 40' ' ' LEU . 2.9 tt . . . . . 0 C--O 1.235 0.338 0 CA-C-O 121.138 0.494 . . . . 0.0 110.306 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.686 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -58.81 -49.47 77.56 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.101 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.677 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.2 tppt? -60.03 -43.0 95.61 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.33 -49.92 72.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.042 0.449 . . . . 0.0 110.95 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -64.17 -41.11 97.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.4 m -63.72 -33.94 76.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.515 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.8 mm-40 -71.6 -40.86 69.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.23 0.538 . . . . 0.0 110.177 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.498 ' HG3' HG21 ' A' ' 30' ' ' VAL . 10.2 mmm180 -66.21 -46.69 76.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -22.11 42.25 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.009 0.433 . . . . 0.0 111.436 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.35 58.47 3.61 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.144 -1.026 . . . . 0.0 111.773 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.41 176.06 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.57 -0.37 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -95.4 130.31 42.24 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.821 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.571 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 4.2 ptp -64.5 -21.41 66.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.085 0.469 . . . . 0.0 111.84 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -83.19 -6.72 59.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 0.0 111.274 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.345 0.593 . . . . 0.0 110.725 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.582 HD11 ' SG ' ' A' ' 48' ' ' CYS . 28.8 pt -136.56 170.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 18.0 mmm180 -141.22 143.01 33.93 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.6 m-85 -110.1 134.39 52.22 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.57 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.58 ' CG ' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.295 0.569 . . . . 0.0 110.599 178.005 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -140.78 139.27 34.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.6 31.09 16.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.07 -4.09 72.99 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.943 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -119.65 140.15 28.98 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 121.955 -0.733 . . . . 0.0 111.358 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.16 146.15 45.62 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.486 2.124 . . . . 0.0 111.641 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.18 135.84 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 121.605 0.716 . . . . 0.0 111.049 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.06 155.93 18.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.335 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.589 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -61.9 -19.93 63.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.268 0.556 . . . . 0.0 111.965 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.1 p -80.2 -10.43 59.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.82 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.39 161.11 17.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 p -118.09 153.7 51.38 Favored Pre-proline 0 C--N 1.32 -0.682 0 O-C-N 122.371 -0.206 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 25.6 Cg_endo -63.99 -10.67 23.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.653 2.235 . . . . 0.0 112.328 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.24 -17.87 21.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.071 0.462 . . . . 0.0 110.962 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -35.55 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 110.855 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.03 1.96 24.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 110.77 179.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 52.39 61.71 3.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.697 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.593 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.7 ptp -80.29 174.33 11.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.134 -0.354 . . . . 0.0 110.331 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -99.76 169.68 9.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.238 0.542 . . . . 0.0 111.091 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.57 138.56 36.48 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 74.32 12.37 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.056 0.942 . . . . 0.0 111.426 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.63 174.89 3.18 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.5 m -135.33 150.19 49.92 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.363 0.601 . . . . 0.0 111.536 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 61' ' ' ARG . 3.1 mp -121.32 144.33 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.58 ' HB3' ' CG ' ' A' ' 61' ' ' ARG . 25.4 t0 -92.63 138.56 31.39 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.49 137.78 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.571 0.701 . . . . 0.0 110.706 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.434 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 1.7 p90 -134.94 143.3 46.82 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.561 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.454 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.869 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.872 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.551 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 57.2 p-80 . . . . . 0 N--CA 1.438 -1.073 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.6 pt -111.9 169.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.407 0.622 . . . . 0.0 111.666 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.2 m-80 -97.47 143.4 28.23 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.39 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -132.05 162.11 31.58 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.081 0.467 . . . . 0.0 110.054 177.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.4 mtpt -133.94 147.42 51.06 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.071 0.462 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 32' ' ' PHE . 81.1 t -127.99 117.85 47.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.87 122.15 34.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.1 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.04 157.84 28.66 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -66.42 -11.97 54.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.281 0.562 . . . . 0.0 111.242 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.61 -16.56 57.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.289 0.566 . . . . 0.0 110.51 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.73 11.28 30.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.435 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.7 t -111.34 159.07 18.32 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 122.2 -0.588 . . . . 0.0 109.516 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.33 136.17 46.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.269 0.557 . . . . 0.0 110.541 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 90.5 t -103.19 137.58 30.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.225 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -111.41 123.19 49.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CE1' HG23 ' A' ' 22' ' ' VAL . 10.5 p90 -146.5 168.58 20.86 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.181 0.515 . . . . 0.0 111.275 -174.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -112.96 140.36 47.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.081 0.467 . . . . 0.0 111.07 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.85 146.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 110.435 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.6 mtmt -81.72 157.67 24.49 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 24.5 mmm-85 -65.18 -38.93 92.07 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.813 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -90.62 6.21 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.585 0.707 . . . . 0.0 110.348 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 21.3 m -94.32 129.94 35.46 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.8 152.18 82.26 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.869 2.379 . . . . 0.0 113.036 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.474 HD22 HD13 ' A' ' 43' ' ' LEU . 84.0 mt -64.84 -12.03 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.444 0.698 . . . . 0.0 111.884 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.241 0.607 0 CA-C-O 121.082 0.467 . . . . 0.0 111.076 178.738 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD13 HD22 ' A' ' 40' ' ' LEU . 2.1 tt . . . . . 0 C--O 1.237 0.41 0 CA-C-O 121.302 0.573 . . . . 0.0 110.137 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.588 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.4 mtt -61.23 -46.29 91.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -64.15 -38.65 91.81 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.75 -49.92 74.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.096 0.474 . . . . 0.0 110.464 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -63.22 -42.85 99.32 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.171 0.51 . . . . 0.0 110.68 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 79.1 m -64.57 -34.47 78.32 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.19 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.72 -42.12 91.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.3 mmm180 -65.33 -44.03 89.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.384 0.611 . . . . 0.0 111.472 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -21.53 27.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.895 0.379 . . . . 0.0 111.653 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.1 5.67 88.91 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.014 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -90.48 177.89 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.397 -0.473 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -99.93 134.94 42.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.446 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.9 ptp -66.74 -21.85 66.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.956 0.408 . . . . 0.0 111.935 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.453 ' HG3' HE21 ' A' ' 57' ' ' GLN . 9.7 ptp85 -82.24 -9.56 59.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.117 0.484 . . . . 0.0 110.863 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.453 HE21 ' HG3' ' A' ' 56' ' ' ARG . 17.9 mm-40 -103.88 5.83 36.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.72 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.51 HG22 ' HG2' ' A' ' 88' ' ' GLN . 24.9 pt -137.48 172.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.809 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 26.2 mmm180 -140.82 145.36 36.18 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.071 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.9 m-85 -111.9 128.79 56.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.8 ppt_? -129.98 139.83 51.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.532 0.682 . . . . 0.0 111.395 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -141.94 137.33 31.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.175 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.95 27.91 14.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 110.861 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 -2.31 76.16 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.545 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -126.32 145.81 54.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.914 -0.756 . . . . 0.0 111.244 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.93 150.3 54.82 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.373 2.049 . . . . 0.0 111.899 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.26 138.3 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-O 121.502 0.668 . . . . 0.0 111.055 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.31 150.78 21.16 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.787 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.521 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -60.83 -18.56 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.404 0.621 . . . . 0.0 111.784 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -79.68 -10.89 59.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.473 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 162.12 14.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.856 0.36 . . . . 0.0 111.32 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.8 p -118.69 154.28 52.58 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.813 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.95 -9.08 21.87 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.483 2.122 . . . . 0.0 111.932 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.53 -22.31 17.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -63.76 -43.69 95.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.55 0.691 . . . . 0.0 110.222 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -101.18 0.92 38.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.853 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 53.75 56.66 6.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.822 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.97 168.99 18.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.823 0.344 . . . . 0.0 110.258 177.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.23 164.83 13.4 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.233 0.54 . . . . 0.0 111.663 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -78.85 133.34 37.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.223 0.535 . . . . 0.0 109.764 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 75.51 15.98 2.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.268 1.027 . . . . 0.0 110.819 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.34 176.05 2.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.76 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.9 m -134.21 150.84 51.08 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.649 -0.657 . . . . 0.0 111.559 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.425 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -122.7 139.75 48.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -90.51 134.66 34.21 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.101 0.477 . . . . 0.0 110.718 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.14 135.53 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.847 0.832 . . . . 0.0 111.163 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.3 146.52 46.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.515 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.51 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER . . . . . 0 C--N 1.31 -1.132 0 CA-C-O 121.141 0.496 . . . . 0.0 109.823 -177.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 11.0 p-80 . . . . . 0 N--CA 1.43 -1.467 0 CA-C-O 120.752 0.311 . . . . 0.0 110.325 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.67 168.88 10.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.451 0.643 . . . . 0.0 111.473 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.7 m-80 -98.36 141.32 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.687 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.544 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.44 160.96 35.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.156 0.503 . . . . 0.0 110.365 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.6 mtpt -136.52 147.75 47.26 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.885 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.2 t -127.75 117.87 47.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.031 0.443 . . . . 0.0 110.804 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.22 121.24 31.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.1 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.85 159.88 28.27 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.57 -13.77 44.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.279 0.561 . . . . 0.0 111.615 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.42 -10.4 59.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.61 10.41 57.96 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.609 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -106.96 156.73 18.41 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.71 135.55 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.315 0.579 . . . . 0.0 110.943 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.529 HG21 ' HG3' ' A' ' 50' ' ' ARG . 7.6 p -100.28 138.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.263 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.63 127.81 54.8 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE1' HG23 ' A' ' 22' ' ' VAL . 14.2 p90 -151.87 168.51 24.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.743 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -119.08 134.73 55.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -138.0 145.77 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 26.8 mtmm -79.33 153.3 29.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.206 0.527 . . . . 0.0 111.29 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -59.58 -40.02 86.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -93.18 9.35 36.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.186 0.517 . . . . 0.0 111.488 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 11.8 m -94.53 128.84 38.54 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.68 150.26 79.36 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.939 2.426 . . . . 0.0 113.625 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.2 mp -60.94 -12.63 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.168 0.987 . . . . 0.0 112.776 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.3 p . . . . . 0 C--N 1.326 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.787 178.73 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.8 tt . . . . . 0 C--O 1.237 0.398 0 CA-C-O 121.295 0.569 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.695 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.6 mtt -60.34 -37.44 80.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.18 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 14.8 tppt? -68.01 -46.2 71.93 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.042 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.07 -49.17 74.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.227 0.537 . . . . 0.0 110.766 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.81 -37.77 88.75 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.105 0.479 . . . . 0.0 110.924 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -39.28 93.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.215 0.531 . . . . 0.0 110.718 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.5 mm-40 -68.41 -40.01 81.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.099 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG3' HG21 ' A' ' 30' ' ' VAL . 17.3 mmt180 -65.52 -51.45 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.333 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.69 -18.96 53.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 111.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.74 89.48 Favored Glycine 0 C--O 1.235 0.17 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.721 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.56 177.6 7.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.705 0.288 . . . . 0.0 111.059 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -96.03 123.85 39.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -23.88 66.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.141 0.496 . . . . 0.0 111.752 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HG3' HE21 ' A' ' 57' ' ' GLN . 11.0 ptt180 -77.16 -16.05 59.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.354 0.597 . . . . 0.0 110.696 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.463 HE21 ' HG3' ' A' ' 56' ' ' ARG . 19.7 mm-40 -99.73 6.48 45.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.183 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.52 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.7 pt -132.86 168.28 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.264 0.554 . . . . 0.0 111.104 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 18.1 mmt180 -137.42 147.83 45.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.98 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.3 m-85 -115.68 132.03 56.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.649 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.7 ppt_? -132.56 135.98 46.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.487 0.66 . . . . 0.0 111.283 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -139.62 139.78 36.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.932 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.64 28.14 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.381 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.05 -6.6 78.61 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.54 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -121.48 145.59 43.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.126 -0.632 . . . . 0.0 111.306 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.33 147.18 46.75 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.354 2.036 . . . . 0.0 110.949 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.97 136.16 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 121.514 0.674 . . . . 0.0 110.78 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.87 153.29 20.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -58.82 -20.54 51.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.285 0.564 . . . . 0.0 111.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 p -83.48 -0.63 51.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.968 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -95.53 159.57 14.93 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 121.883 -0.511 . . . . 0.0 110.354 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 p -117.15 149.99 45.36 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.57 -12.97 36.12 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.511 2.14 . . . . 0.0 112.462 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.57 -10.8 28.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.305 0.574 . . . . 0.0 110.748 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -78.15 -33.11 50.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.194 0.521 . . . . 0.0 110.517 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.39 2.1 22.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.161 0.505 . . . . 0.0 110.902 178.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 49.42 60.77 3.53 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.544 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.2 ptp -74.44 170.49 15.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.125 0.488 . . . . 0.0 110.588 176.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 41.8 tt0 -94.64 156.92 16.2 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.46 137.65 42.71 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.342 0.592 . . . . 0.0 110.538 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 73.77 19.04 3.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.572 1.149 . . . . 0.0 111.076 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -71.4 176.57 4.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.204 177.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.87 151.61 52.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.188 0.518 . . . . 0.0 111.565 -177.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.07 144.57 30.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.9 t0 -93.55 134.65 35.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.49 138.66 51.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.667 0.746 . . . . 0.0 111.151 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -138.21 148.37 44.73 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.67 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.745 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.462 ' CD2' ' HD2' ' A' ' 33' ' ' LYS . 46.0 p-80 . . . . . 0 N--CA 1.427 -1.615 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.76 167.93 11.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.516 0.674 . . . . 0.0 112.351 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.55 ' O ' HD22 ' A' ' 20' ' ' LEU . 8.5 m-80 -94.65 142.83 26.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.561 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -133.87 159.76 39.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.045 0.45 . . . . 0.0 110.199 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.9 mtpt -134.83 149.04 50.3 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 0.0 110.218 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 32' ' ' PHE . 97.2 t -128.07 117.65 46.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.085 0.469 . . . . 0.0 110.124 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.95 124.19 37.8 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.876 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.89 159.9 28.24 Favored Glycine 0 N--CA 1.425 -2.072 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.158 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -65.71 -11.96 49.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.439 0.638 . . . . 0.0 111.012 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.03 -16.95 54.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.12 12.0 40.86 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.937 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -106.06 155.4 19.45 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 139.1 41.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.211 0.529 . . . . 0.0 111.126 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.564 HG21 ' HG3' ' A' ' 50' ' ' ARG . 9.7 p -108.89 140.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.167 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.22 123.3 49.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.51 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 19.7 p90 -145.03 167.71 22.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.344 0.592 . . . . 0.0 111.459 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HD2' ' CD2' ' A' ' 17' ' ' HIS . 27.8 mmtt -106.32 144.01 33.61 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.553 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.459 ' CG2' HD23 ' A' ' 20' ' ' LEU . 17.9 tt -148.91 144.04 18.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.056 0.455 . . . . 0.0 109.901 176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 5.6 mtmp? -84.46 158.01 21.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.865 -0.522 . . . . 0.0 110.512 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -64.47 -36.73 85.12 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.044 0.449 . . . . 0.0 111.091 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -92.01 5.98 48.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.215 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 18.0 m -93.64 128.65 41.15 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.18 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.69 149.08 73.11 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.944 2.43 . . . . 0.0 113.576 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.7 mp -59.87 -12.59 7.92 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.191 0.997 . . . . 0.0 112.683 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.3 t . . . . . 0 C--O 1.24 0.599 0 CA-C-O 121.145 0.498 . . . . 0.0 110.742 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.7 tt . . . . . 0 C--O 1.236 0.378 0 CA-C-O 121.278 0.561 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.69 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 32.6 mtt -58.17 -50.33 73.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.037 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.608 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 2.9 tppp? -64.57 -38.97 92.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.55 -48.57 81.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -63.04 -40.26 97.18 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.15 0.5 . . . . 0.0 110.991 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 58' ' ' ILE . 75.2 m -62.96 -36.01 82.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.394 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 28.4 mm-40 -73.18 -35.84 66.46 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.259 0.552 . . . . 0.0 110.763 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.564 ' HG3' HG21 ' A' ' 30' ' ' VAL . 44.1 mmm-85 -70.0 -48.92 56.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.433 0.635 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.95 -18.3 50.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.073 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.68 57.8 4.39 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.828 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.17 172.79 13.25 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.491 -0.417 . . . . 0.0 111.165 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.2 m -97.03 130.34 44.36 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.264 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.496 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.4 ptp -64.67 -25.45 67.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.429 . . . . 0.0 111.414 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HG3' HE21 ' A' ' 57' ' ' GLN . 11.5 ptp180 -76.69 -10.51 59.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.4 0.619 . . . . 0.0 110.328 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.476 HE21 ' HG3' ' A' ' 56' ' ' ARG . 26.6 mm-40 -105.01 3.9 31.06 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.536 HG22 ' HG2' ' A' ' 88' ' ' GLN . 20.9 pt -136.71 172.28 15.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.043 0.449 . . . . 0.0 110.87 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 25.6 mmm180 -143.76 148.21 35.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 11.1 m-85 -113.39 129.66 56.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.657 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.3 ppt_? -131.58 140.79 49.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.411 0.624 . . . . 0.0 111.541 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.415 ' HB2' HG13 ' A' ' 84' ' ' ILE . 80.6 t80 -145.44 139.32 26.8 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 63.93 26.41 14.18 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.168 0.509 . . . . 0.0 110.815 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 -0.99 80.78 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.896 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -125.16 144.63 47.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 O-C-N 122.11 -0.641 . . . . 0.0 111.528 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.74 147.84 45.59 Favored 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 122.628 2.218 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.14 137.65 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-O 121.468 0.651 . . . . 0.0 111.0 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 155.53 18.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.485 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.622 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -64.41 -16.96 63.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.0 p -81.2 -5.98 58.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.442 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.74 161.54 14.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.405 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 p -117.6 153.04 50.4 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.743 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 -8.56 21.48 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.353 2.036 . . . . 0.0 112.054 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.03 -18.21 20.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.093 0.473 . . . . 0.0 111.068 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -68.92 -36.9 78.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.239 0.542 . . . . 0.0 110.848 -177.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.34 1.15 25.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.346 0.593 . . . . 0.0 110.756 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 51.18 58.66 5.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.962 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.6 ptp -73.92 164.63 26.38 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.664 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 36.2 tt0 -100.55 134.4 43.57 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.19 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -41.69 135.85 2.09 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 26.2 mt-10 74.12 16.47 3.53 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.777 1.231 . . . . 0.0 111.801 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.664 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -71.84 178.45 3.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 110.463 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.423 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.8 m -135.23 151.58 50.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.21 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.423 HD12 ' C ' ' A' ' 83' ' ' THR . 2.8 mp -123.12 140.28 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.563 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 33.6 t70 -90.03 135.64 33.53 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.008 0.432 . . . . 0.0 110.651 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -119.64 135.34 60.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.777 0.799 . . . . 0.0 110.911 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.7 p90 -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.582 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.1 mt-30 . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 120.999 0.428 . . . . 0.0 110.432 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 120.948 0.404 . . . . 0.0 111.909 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.8 45.99 1.33 Allowed 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.822 0.82 . . . . 0.0 110.206 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.79 14.93 2.9 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.759 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -90.62 111.95 23.47 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -147.28 93.38 4.69 Favored Pre-proline 0 C--N 1.315 -0.926 0 CA-C-O 120.972 0.415 . . . . 0.0 111.21 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -88.98 137.68 3.28 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 122.922 2.415 . . . . 0.0 112.493 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -88.93 19.52 4.07 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.503 0.668 . . . . 0.0 110.126 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.13 171.96 1.17 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.409 0.623 . . . . 0.0 112.123 -178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -113.25 43.45 1.71 Allowed Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.442 HG21 ' HA ' ' A' ' 14' ' ' ASN . 5.9 p -59.6 124.38 13.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 121.235 0.54 . . . . 0.0 111.384 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -128.76 -58.95 1.15 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.2 t -67.82 -60.31 2.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.96 96.09 5.65 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.552 0.691 . . . . 0.0 111.707 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' HA ' HG21 ' A' ' 10' ' ' VAL . 1.8 p30 -87.94 90.83 8.54 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-O 122.261 1.029 . . . . 0.0 111.47 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -137.84 164.12 29.72 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.526 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -155.49 -63.42 0.12 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.567 0.699 . . . . 0.0 110.253 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 53.0 p-80 -135.0 158.9 43.15 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.317 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -114.82 169.5 5.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.7 m-80 -97.76 141.37 30.85 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.67 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.499 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -132.38 162.42 31.14 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.111 0.481 . . . . 0.0 110.421 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.97 148.24 48.39 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.065 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.508 HG23 ' CE1' ' A' ' 32' ' ' PHE . 80.8 t -126.97 115.36 41.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.377 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.82 126.7 37.01 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.86 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.38 164.87 29.68 Favored Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.405 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -68.41 -14.24 62.86 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.444 0.64 . . . . 0.0 110.916 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.8 -12.43 58.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.346 0.593 . . . . 0.0 110.525 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.39 48.79 Favored Glycine 0 C--O 1.227 -0.298 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.83 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.6 t -105.43 152.3 23.16 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.0 p -136.41 137.02 48.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.003 0.43 . . . . 0.0 110.595 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 15.0 p -105.41 141.59 20.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 120.855 0.359 . . . . 0.0 110.262 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -110.23 127.33 54.91 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.508 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.9 p90 -149.35 168.36 23.58 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.419 0.628 . . . . 0.0 111.883 -176.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -116.52 134.97 54.22 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.36 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.0 tt -140.48 147.08 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.044 0.45 . . . . 0.0 110.316 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.506 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 24.9 mtmt -82.47 157.93 23.42 Favored 'General case' 0 CA--C 1.507 -0.694 0 CA-C-O 121.093 0.473 . . . . 0.0 110.754 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 15.4 mmm-85 -63.66 -39.74 95.08 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.995 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -92.76 8.27 40.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.536 0.684 . . . . 0.0 110.704 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.4 m -91.6 128.3 47.02 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.702 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.47 145.62 77.47 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.822 2.348 . . . . 0.0 113.085 -178.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.607 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.9 mp -60.09 -14.05 14.84 Favored 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.611 0.765 . . . . 0.0 112.087 177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.6 m -50.51 -42.7 55.19 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-O 121.246 0.545 . . . . 0.0 110.569 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.502 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.3 tt -61.15 -54.2 47.47 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.401 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.607 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 1.9 mpt? -58.02 -42.39 85.2 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.01 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -68.66 -42.2 78.24 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.299 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.68 -52.86 62.41 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.949 0.404 . . . . 0.0 110.919 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -61.19 -40.44 93.95 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 121.171 0.51 . . . . 0.0 110.887 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -40.82 91.38 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.92 -179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -70.02 -39.5 75.77 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.897 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 32.2 mmt180 -68.54 -52.85 27.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.148 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -22.14 59.81 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.981 -177.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.13 57.35 3.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 0.0 111.96 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 pp -146.6 175.6 10.47 Favored 'General case' 0 C--N 1.315 -0.905 0 O-C-N 122.691 -0.3 . . . . 0.0 110.332 -178.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.406 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 71.2 m -96.78 128.38 43.68 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.825 0.345 . . . . 0.0 111.416 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.8 ptp -63.46 -26.24 68.63 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.233 0.539 . . . . 0.0 111.071 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 5.4 ptm180 -75.81 -11.43 59.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.193 0.521 . . . . 0.0 111.203 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -105.23 7.04 33.41 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.954 0.407 . . . . 0.0 111.332 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.477 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.0 pt -136.15 170.03 19.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-O 121.342 0.591 . . . . 0.0 111.629 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -140.8 148.78 41.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.147 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.495 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.3 m-85 -116.49 130.9 57.01 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.201 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.645 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.3 OUTLIER -132.36 142.67 49.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 0.0 110.045 177.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' A' ' 84' ' ' ILE . 87.2 t80 -136.74 134.3 36.99 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.255 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.32 31.7 21.19 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.044 0.449 . . . . 0.0 111.874 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.93 -14.85 59.34 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.356 -1.402 . . . . 0.0 113.251 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -117.33 148.16 42.05 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 121.974 -0.721 . . . . 0.0 112.165 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -79.04 147.96 21.42 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 123.392 2.728 . . . . 0.0 112.863 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.06 138.01 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 121.266 0.555 . . . . 0.0 111.284 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -97.81 158.14 15.68 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.978 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.61 -21.14 37.49 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.236 0.614 . . . . 0.0 111.956 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 65.3 p -79.29 -3.15 44.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.136 0.493 . . . . 0.0 111.539 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' O ' HD13 ' A' ' 40' ' ' LEU . 1.6 m-20 -98.47 162.81 12.96 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.0 -0.437 . . . . 0.0 110.978 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.5 p -117.03 156.88 47.81 Favored Pre-proline 0 C--N 1.319 -0.749 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.74 -11.05 30.4 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.278 1.985 . . . . 0.0 111.773 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.61 -19.29 20.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.197 0.522 . . . . 0.0 110.454 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -63.61 -35.95 82.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.368 0.604 . . . . 0.0 110.294 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.07 1.14 17.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.921 179.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 51.53 62.38 2.74 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.52 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.499 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.7 ptp -77.69 165.81 23.77 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.014 0.435 . . . . 0.0 110.42 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -89.03 161.97 16.27 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.348 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -74.26 136.9 42.68 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.022 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 72.03 16.7 5.32 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.979 0.911 . . . . 0.0 111.484 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.72 175.85 5.36 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.808 0.337 . . . . 0.0 110.468 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.439 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.6 m -132.44 150.51 52.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.321 0.582 . . . . 0.0 111.721 -177.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.439 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -120.96 139.04 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.645 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 11.3 m-20 -88.99 134.03 34.12 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.011 0.434 . . . . 0.0 110.596 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -120.07 137.84 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-O 121.63 0.729 . . . . 0.0 111.019 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -137.8 146.35 43.43 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.377 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -111.77 109.09 18.75 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -177.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -111.63 104.92 13.33 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -98.17 94.93 7.08 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.159 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.1 m -126.68 117.39 22.64 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.219 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.99 -10.06 64.17 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.155 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.137 0 CA-C-O 117.833 -1.537 . . . . 0.0 110.832 -179.877 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.478 0.965 0 CA-C-O 120.87 0.367 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.93 94.24 1.01 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 120.92 0.39 . . . . 0.0 110.021 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.477 ' HB2' ' HA3' ' A' ' 9' ' ' GLY . 7.2 m-20 -70.37 -19.45 63.03 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 121.526 0.679 . . . . 0.0 110.721 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -127.89 -79.45 0.58 Allowed 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.416 178.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.608 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 33.4 mmtp -143.28 -55.19 0.02 OUTLIER Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.647 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 5' ' ' LYS . 70.5 Cg_endo -75.39 -168.76 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.547 1.498 . . . . 0.0 111.101 175.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -79.02 -25.48 43.27 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.318 0.58 . . . . 0.0 110.404 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -90.53 135.95 33.37 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 3' ' ' ASP . . . -109.94 8.47 31.58 Favored Glycine 0 CA--C 1.494 -1.23 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 ' HB2' ' A' ' 13' ' ' GLU . 7.1 p -142.83 122.96 9.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 114.612 -0.794 . . . . 0.0 109.852 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -129.63 -71.0 0.63 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.107 0.48 . . . . 0.0 110.658 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -94.76 68.67 3.34 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.946 0.879 . . . . 0.0 109.955 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' VAL . 10.6 mm-40 -145.11 178.92 7.71 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.198 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 14.7 m120 81.84 13.24 0.6 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.582 0.706 . . . . 0.0 110.843 177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -82.34 -94.81 0.05 Allowed 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.539 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.96 119.68 24.27 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.311 0.577 . . . . 0.0 111.244 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 50.6 p-80 -170.28 167.9 8.32 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.8 pt -122.09 169.62 13.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.307 0.575 . . . . 0.0 111.383 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD22 ' A' ' 20' ' ' LEU . 28.1 m-80 -99.65 144.35 28.83 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -132.4 160.53 36.1 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.102 0.477 . . . . 0.0 110.172 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.5 mtpt -132.5 147.86 52.37 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.911 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.491 HG23 ' CE1' ' A' ' 32' ' ' PHE . 75.5 t -125.78 118.28 51.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.092 0.472 . . . . 0.0 110.177 177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.09 118.28 30.66 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.056 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.26 155.47 34.44 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.462 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -63.06 -13.78 40.12 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.29 0.567 . . . . 0.0 111.371 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -80.05 -11.69 59.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.837 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.17 12.76 41.41 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.947 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 t -110.2 162.18 14.85 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -142.18 141.12 28.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-O 121.194 0.521 . . . . 0.0 111.126 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG21 ' HG3' ' A' ' 50' ' ' ARG . 12.1 p -109.65 142.22 22.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.999 178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -113.12 124.14 51.88 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.274 0.559 . . . . 0.0 109.775 179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 22' ' ' VAL . 16.8 p90 -145.29 167.97 21.56 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.239 -174.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 29.2 mtmt -114.95 136.79 52.72 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.59 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.413 ' CG2' HD23 ' A' ' 20' ' ' LEU . 15.9 tt -143.81 148.96 18.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.032 0.444 . . . . 0.0 110.368 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.4 mtmt -83.97 158.69 21.44 Favored 'General case' 0 CA--C 1.504 -0.791 0 O-C-N 121.793 -0.567 . . . . 0.0 110.973 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.496 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 27.6 mmm-85 -64.24 -40.75 96.66 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -91.17 8.84 33.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.294 0.569 . . . . 0.0 110.995 -178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.507 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 14.7 m -94.31 130.97 32.3 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.0 149.93 77.55 Favored 'Trans proline' 0 C--O 1.241 0.667 0 C-N-CA 122.974 2.449 . . . . 0.0 113.586 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 71' ' ' ASP . 7.0 mp -61.44 -12.17 13.54 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.096 0.958 . . . . 0.0 112.873 177.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 11.4 p -53.92 -44.46 70.61 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.962 0.411 . . . . 0.0 111.049 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.47 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.489 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.4 tt -60.34 -52.99 62.89 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.394 0.616 . . . . 0.0 110.166 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.655 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.9 mtt -60.41 -48.0 83.66 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.515 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -61.53 -42.28 98.58 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.8 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.617 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.38 -52.89 62.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.879 0.371 . . . . 0.0 110.757 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.28 -41.0 96.21 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-O 121.074 0.464 . . . . 0.0 111.135 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 75.5 m -65.39 -34.89 79.38 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.079 -178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -70.31 -34.89 73.25 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.228 0.537 . . . . 0.0 110.902 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.617 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 5.2 mmp_? -73.77 -46.68 44.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.353 0.596 . . . . 0.0 111.084 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.5 -21.35 42.03 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.056 -177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.56 57.74 3.78 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.579 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.58 175.29 10.98 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 122.552 -0.381 . . . . 0.0 110.878 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 26.4 m -97.23 131.37 44.02 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.012 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 6.5 ptp -66.28 -26.84 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.217 0.532 . . . . 0.0 110.988 179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -76.04 -13.75 60.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.135 0.493 . . . . 0.0 111.25 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 22.2 mm-40 -101.26 2.38 39.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.504 0.669 . . . . 0.0 110.443 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.455 HD11 ' SG ' ' A' ' 48' ' ' CYS . 35.0 pt -135.09 176.24 9.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 15.9 mmm180 -146.95 154.43 41.26 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.834 0.35 . . . . 0.0 111.008 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.655 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.5 m-85 -119.03 132.44 56.05 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.092 -177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.1 ppt_? -134.63 141.5 46.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.325 0.583 . . . . 0.0 111.098 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -141.39 139.83 33.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.575 -177.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 2.5 t70 57.99 27.97 15.55 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-O 121.001 0.429 . . . . 0.0 111.305 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.12 -3.54 70.94 Favored Glycine 0 N--CA 1.438 -1.184 0 C-N-CA 119.728 -1.225 . . . . 0.0 113.192 -177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -118.43 140.98 28.94 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 122.182 -0.599 . . . . 0.0 111.347 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.08 147.33 38.09 Favored 'Trans proline' 0 C--N 1.329 -0.498 0 C-N-CA 122.67 2.247 . . . . 0.0 112.261 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.22 139.0 51.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 110.594 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.8 165.82 11.6 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.979 0.419 . . . . 0.0 111.202 177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.2 pt-20 -61.87 -17.13 55.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.194 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.4 p -82.98 -4.28 58.12 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 120.933 0.397 . . . . 0.0 110.848 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.522 ' O ' HD13 ' A' ' 40' ' ' LEU . 46.5 m-20 -88.75 156.71 18.82 Favored 'General case' 0 CA--C 1.52 -0.187 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -117.66 150.74 47.42 Favored Pre-proline 0 C--N 1.319 -0.725 0 C-N-CA 122.427 0.291 . . . . 0.0 110.222 177.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.413 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 36.9 Cg_endo -65.24 -13.04 37.67 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.366 2.044 . . . . 0.0 112.234 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.76 -13.74 25.39 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.013 0.435 . . . . 0.0 110.817 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -72.2 -35.86 69.04 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.332 0.587 . . . . 0.0 110.176 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.47 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.89 1.0 22.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.69 178.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 53.01 61.34 3.22 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.47 -0.787 . . . . 0.0 112.321 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.481 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.1 ptp -80.24 166.45 21.38 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.019 0.438 . . . . 0.0 110.415 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -91.94 167.62 11.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.065 0.459 . . . . 0.0 110.983 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -79.98 139.67 36.92 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.328 0.585 . . . . 0.0 110.091 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 71.6 15.27 6.06 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 124.487 1.115 . . . . 0.0 111.341 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.74 176.7 2.87 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.2 m -134.84 150.32 50.47 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.546 -0.721 . . . . 0.0 111.731 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -121.47 142.49 37.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.587 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 29.5 t70 -90.88 136.53 33.01 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-O 121.11 0.481 . . . . 0.0 110.869 -178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 134.06 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.948 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.404 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.1 p90 -130.76 137.47 49.49 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.813 178.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 2.2 mt-30 -106.78 113.29 26.69 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.025 0.441 . . . . 0.0 111.1 -175.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -59.38 170.8 0.91 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.062 176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -78.14 137.02 37.97 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.352 0.596 . . . . 0.0 111.377 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 p -79.07 133.22 36.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.19 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.85 50.33 19.3 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.722 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.968 0 CA-C-O 118.655 -1.081 . . . . 0.0 111.83 -179.725 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.955 0.407 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.38 34.34 22.74 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.226 0.61 . . . . 0.0 112.483 178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.06 26.29 1.41 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.447 0.641 . . . . 0.0 110.715 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -89.55 -77.39 0.39 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.647 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 57.1 tttp -178.46 -54.11 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.751 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.589 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 47.3 Cg_endo -66.58 173.48 7.78 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.165 1.91 . . . . 0.0 113.249 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -104.94 -33.7 8.27 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.054 -178.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.12 12.2 1.23 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.29 0.567 . . . . 0.0 111.023 -176.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.01 176.55 14.48 Favored Glycine 0 N--CA 1.421 -2.355 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.1 p -121.07 138.22 52.2 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-O 121.404 0.621 . . . . 0.0 110.837 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -128.43 144.74 51.18 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' THR . 5.6 m 64.1 38.54 8.34 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 121.787 0.803 . . . . 0.0 112.936 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -61.53 150.28 36.39 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 172.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -129.61 -61.28 1.02 Allowed 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.778 -0.577 . . . . 0.0 110.971 -177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -154.68 141.06 18.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.194 0.521 . . . . 0.0 110.981 -177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.533 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 10.8 t70 -152.02 -66.77 0.17 Allowed 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.665 0.745 . . . . 0.0 109.786 176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.684 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 -135.29 159.33 41.89 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.159 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.4 pt -123.2 170.17 13.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.987 -177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.507 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . 19.3 m-80 -93.89 142.09 27.77 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.653 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.53 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.6 mm? -133.24 163.47 29.23 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.288 0.566 . . . . 0.0 110.87 177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.4 mtpt -134.82 146.07 48.95 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.905 178.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG23 ' CE1' ' A' ' 32' ' ' PHE . 91.2 t -127.29 114.06 34.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.19 0.519 . . . . 0.0 110.132 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.84 130.32 37.64 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.414 179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -95.93 161.82 22.82 Favored Glycine 0 N--CA 1.42 -2.417 0 C-N-CA 120.438 -0.887 . . . . 0.0 110.959 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.45 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.0 pp0? -65.02 -11.76 42.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.562 0.696 . . . . 0.0 110.897 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -79.87 -15.0 58.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.254 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.17 6.51 56.77 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.82 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.0 t -101.24 153.9 19.22 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p -137.57 136.43 46.15 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-O 121.309 0.576 . . . . 0.0 111.507 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.593 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.6 p -105.19 140.07 24.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.391 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -110.97 124.95 53.16 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.526 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.4 p90 -149.56 169.85 19.99 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 121.135 0.493 . . . . 0.0 111.452 -173.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -113.61 143.27 44.85 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.985 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 14.7 tt -148.75 143.34 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 121.119 0.485 . . . . 0.0 110.359 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.684 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 25.7 mtmt -79.45 155.36 28.35 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 121.374 0.607 . . . . 0.0 111.772 -178.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 16' ' ' ASP . 29.0 mmm-85 -64.95 -36.49 84.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.641 -178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -93.19 4.91 53.2 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.337 0.589 . . . . 0.0 110.753 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 20.6 m -93.57 129.49 38.32 Favored Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.23 151.46 85.35 Favored 'Trans proline' 0 C--O 1.24 0.591 0 C-N-CA 122.891 2.394 . . . . 0.0 112.856 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.474 ' CD2' HD13 ' A' ' 43' ' ' LEU . 81.2 mt -65.38 -11.87 46.56 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 123.55 0.74 . . . . 0.0 111.919 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p -51.28 -46.35 62.44 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.117 0.484 . . . . 0.0 111.098 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.488 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD13 ' CD2' ' A' ' 40' ' ' LEU . 4.0 tt -63.85 -48.29 77.34 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.333 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.71 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 37.8 mtt -61.75 -39.69 92.49 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.168 0.508 . . . . 0.0 110.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.588 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.9 tppp? -70.16 -40.91 74.46 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.694 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.49 -51.52 68.18 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 110.912 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -63.69 -37.05 85.91 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-O 121.061 0.458 . . . . 0.0 110.822 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -34.55 78.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.138 0.494 . . . . 0.0 110.812 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.588 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.0 mm-40 -72.59 -42.14 64.87 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.272 0.558 . . . . 0.0 110.62 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.593 ' HG3' HG21 ' A' ' 30' ' ' VAL . 22.9 mmm-85 -62.99 -52.6 62.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.452 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.73 -21.41 44.57 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.884 0.373 . . . . 0.0 111.927 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.02 2.82 90.65 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.925 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.54 175.95 8.95 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.929 0.395 . . . . 0.0 111.208 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.405 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 54.7 m -97.42 127.02 43.03 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 120.698 0.285 . . . . 0.0 110.574 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.6 ptp -60.81 -25.24 66.43 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.093 0.473 . . . . 0.0 111.985 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -78.78 -11.36 59.98 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.242 0.544 . . . . 0.0 111.129 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.405 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 23.3 mm-40 -101.22 5.67 42.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.213 0.53 . . . . 0.0 110.63 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.566 HG22 ' HG2' ' A' ' 88' ' ' GLN . 31.2 pt -135.22 177.23 7.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.118 0.485 . . . . 0.0 111.065 -177.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.2 mmm180 -147.42 147.18 29.97 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.455 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.71 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 14.0 m-85 -113.87 128.06 56.25 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-O 121.21 0.529 . . . . 0.0 111.237 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 1.1 ppt_? -132.04 136.64 47.38 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.395 0.617 . . . . 0.0 110.735 178.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -135.79 134.77 39.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.538 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 60.39 28.5 18.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.216 0.531 . . . . 0.0 110.654 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.76 -4.52 64.86 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 119.645 -1.264 . . . . 0.0 113.198 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -115.99 136.81 23.01 Favored Pre-proline 0 C--N 1.322 -0.607 0 O-C-N 121.905 -0.762 . . . . 0.0 111.318 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.27 142.91 30.96 Favored 'Trans proline' 0 C--N 1.328 -0.534 0 C-N-CA 122.704 2.269 . . . . 0.0 112.104 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.92 133.3 68.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-O 121.564 0.697 . . . . 0.0 111.365 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.25 149.47 21.44 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.335 178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.541 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.0 pp20? -58.27 -20.0 38.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.453 HG23 ' OE2' ' A' ' 69' ' ' GLU . 40.9 p -76.26 -13.11 60.17 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.376 0.608 . . . . 0.0 111.164 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -95.79 166.79 11.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.017 0.437 . . . . 0.0 111.888 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.2 p -118.13 158.4 46.38 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -67.07 -5.64 14.1 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.578 2.186 . . . . 0.0 112.074 177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.04 -13.73 24.93 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.16 0.505 . . . . 0.0 110.525 178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -68.6 -35.93 78.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.429 0.633 . . . . 0.0 110.549 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.456 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.16 1.47 17.28 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.482 -178.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 52.6 60.05 4.07 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.53 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.6 ptp -74.97 163.02 28.06 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.141 0.496 . . . . 0.0 110.752 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -87.89 159.97 18.16 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.455 -177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.47 131.48 44.81 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 14.3 mt-10 72.88 20.67 3.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 124.288 1.035 . . . . 0.0 111.593 178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -71.75 179.42 3.13 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.4 m -135.13 150.43 50.19 Favored 'General case' 0 C--N 1.315 -0.912 0 O-C-N 121.509 -0.745 . . . . 0.0 111.887 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.63 148.81 21.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 6.8 t70 -97.97 128.59 44.63 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.788 0.328 . . . . 0.0 110.334 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.11 135.0 55.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.576 0.703 . . . . 0.0 110.846 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.484 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -136.85 145.08 44.0 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.64 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -110.19 111.39 22.69 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.126 0.488 . . . . 0.0 110.06 -177.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -77.21 79.9 3.73 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.651 0.738 . . . . 0.0 111.491 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.67 170.87 1.76 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.505 177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -159.43 157.32 29.97 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 122.123 -0.361 . . . . 0.0 110.272 -177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.81 54.92 27.78 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.662 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.164 0 CA-C-O 118.498 -1.168 . . . . 0.0 111.969 -178.568 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.5 mtt . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 121.18 0.514 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.99 102.98 3.97 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -111.41 8.06 21.09 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.631 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 22.9 mt-10 -79.15 173.24 12.78 Favored 'General case' 0 N--CA 1.395 -3.192 0 CA-C-O 122.139 0.971 . . . . 0.0 109.773 177.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -73.17 -49.89 6.84 Favored Pre-proline 0 C--N 1.265 -3.086 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.474 179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 18.0 Cg_endo -61.82 146.45 96.52 Favored 'Trans proline' 0 C--N 1.365 1.4 0 C-N-CA 121.708 1.606 . . . . 0.0 111.264 174.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -56.95 -39.29 74.26 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.835 0.454 . . . . 0.0 111.824 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -103.25 -170.0 1.73 Allowed 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.979 0.419 . . . . 0.0 110.946 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 166.22 -141.71 7.15 Favored Glycine 0 N--CA 1.431 -1.695 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.0 p -159.47 135.77 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.073 0.463 . . . . 0.0 110.669 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 12' ' ' THR . 4.1 tmtm? -130.95 131.79 44.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 120.881 0.372 . . . . 0.0 110.112 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.552 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 62.0 m 67.37 -65.38 0.23 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.731 0.812 . . . . 0.0 112.921 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -48.53 94.52 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -73.61 119.37 17.75 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.88 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -121.47 142.38 50.1 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.302 0.572 . . . . 0.0 111.26 -177.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.58 115.96 24.4 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.786 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 41.7 p-80 -159.61 -177.93 6.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -176.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.79 169.61 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-O 121.349 0.595 . . . . 0.0 111.095 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.47 ' O ' HD22 ' A' ' 20' ' ' LEU . 22.2 m-80 -99.95 145.81 27.41 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.3 mm? -132.63 162.39 31.46 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 121.323 0.582 . . . . 0.0 110.823 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 57.5 mtpt -133.55 147.98 51.61 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.989 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.7 t -128.74 117.96 45.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.09 0.472 . . . . 0.0 110.265 177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.94 124.93 35.15 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.889 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.31 159.52 27.44 Favored Glycine 0 N--CA 1.423 -2.197 0 C-N-CA 120.424 -0.894 . . . . 0.0 111.01 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.477 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.7 pp0? -63.32 -14.68 52.47 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.496 0.665 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -71.23 -19.25 62.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.335 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.55 6.19 50.6 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.503 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -107.39 163.66 12.86 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.4 p -139.0 143.39 31.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 120.996 0.427 . . . . 0.0 110.537 -178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.576 HG21 ' HG3' ' A' ' 50' ' ' ARG . 6.1 p -112.36 145.28 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.172 178.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -112.77 131.05 55.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.299 0.571 . . . . 0.0 110.116 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 22' ' ' VAL . 10.8 p90 -152.08 169.12 23.17 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.219 -175.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -111.95 143.72 42.48 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.036 -177.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.441 ' CG2' HD23 ' A' ' 20' ' ' LEU . 16.5 tt -150.54 149.23 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.063 0.459 . . . . 0.0 110.333 177.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.479 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.3 mtmt -87.23 158.03 19.2 Favored 'General case' 0 CA--C 1.508 -0.658 0 O-C-N 121.73 -0.606 . . . . 0.0 110.74 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.9 mmm-85 -64.11 -40.21 95.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -178.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -90.48 7.75 37.29 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.119 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.3 m -93.7 129.98 36.48 Favored Pre-proline 0 N--CA 1.433 -1.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.828 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.37 150.22 87.35 Favored 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 122.904 2.402 . . . . 0.0 112.984 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.463 ' CD2' HD13 ' A' ' 43' ' ' LEU . 87.4 mt -65.26 -11.97 46.7 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.862 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 p -52.81 -43.1 65.68 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.159 0.504 . . . . 0.0 111.142 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.437 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.463 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt -62.68 -48.49 79.06 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.186 0.517 . . . . 0.0 110.096 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.666 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 29.9 mtt -61.31 -40.88 95.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.607 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 17.8 tppt? -70.37 -38.33 74.72 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.967 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.09 -50.99 71.95 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.957 0.408 . . . . 0.0 110.566 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -64.41 -33.61 76.25 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 120.985 0.421 . . . . 0.0 110.532 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -38.13 89.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.247 0.546 . . . . 0.0 110.547 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 68.2 mm-40 -73.12 -34.64 66.25 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.071 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HG3' HG21 ' A' ' 30' ' ' VAL . 11.5 mmt180 -68.1 -49.54 60.59 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.011 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.48 -22.38 28.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.81 58.31 3.06 Favored Glycine 0 C--N 1.321 -0.301 0 C-N-CA 119.673 -1.251 . . . . 0.0 111.696 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.52 174.07 11.74 Favored 'General case' 0 C--N 1.314 -0.967 0 O-C-N 122.564 -0.374 . . . . 0.0 110.286 -176.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.9 m -100.05 129.23 46.08 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.86 0.362 . . . . 0.0 110.897 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.1 ptp -64.85 -25.52 67.93 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.188 0.518 . . . . 0.0 111.168 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HG3' ' HG2' ' A' ' 57' ' ' GLN . 12.7 ptt180 -75.81 -11.62 60.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.199 0.523 . . . . 0.0 111.202 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.431 ' HG2' ' HG3' ' A' ' 56' ' ' ARG . 19.3 mm-40 -104.53 2.62 31.06 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' HG2' ' A' ' 88' ' ' GLN . 37.7 pt -134.0 172.97 15.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.043 0.449 . . . . 0.0 110.636 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 19.6 mmt180 -142.24 149.89 40.22 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.778 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.666 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.3 m-85 -114.53 132.8 56.19 Favored 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.318 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.6 ppt_? -135.82 140.03 43.91 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.328 0.585 . . . . 0.0 111.076 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -138.2 137.7 37.83 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.822 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 54.85 34.06 21.22 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.78 -4.55 74.03 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.372 -0.918 . . . . 0.0 113.735 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -120.95 141.49 32.76 Favored Pre-proline 0 C--N 1.318 -0.781 0 O-C-N 121.992 -0.711 . . . . 0.0 111.684 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.51 148.08 32.9 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 111.711 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.82 136.19 61.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.067 0.46 . . . . 0.0 111.063 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.25 157.65 16.15 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -59.74 -22.07 61.57 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.4 p -74.5 -15.17 60.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.998 0.428 . . . . 0.0 111.229 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -92.36 165.45 13.07 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.071 0.462 . . . . 0.0 111.571 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 35.6 p -117.33 158.76 43.93 Favored Pre-proline 0 C--N 1.316 -0.884 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.764 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -67.35 -7.46 19.13 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.432 2.088 . . . . 0.0 111.83 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.91 -19.49 20.22 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.534 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -60.91 -40.01 91.54 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.63 0.729 . . . . 0.0 110.39 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.45 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.81 0.35 25.98 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.767 -179.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 53.5 62.21 2.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.649 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.535 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.0 ptp -79.8 167.12 21.01 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.007 176.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -92.85 167.02 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.286 0.565 . . . . 0.0 110.914 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -75.92 139.74 41.77 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-O 121.134 0.492 . . . . 0.0 110.119 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 68.21 19.56 9.07 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.755 0.822 . . . . 0.0 111.137 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -72.06 179.76 3.14 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.798 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.432 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.6 m -135.04 150.07 50.23 Favored 'General case' 0 C--N 1.316 -0.864 0 O-C-N 121.602 -0.687 . . . . 0.0 111.618 -177.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.432 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.98 144.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 28.8 t70 -92.2 139.69 30.36 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 120.812 0.339 . . . . 0.0 110.685 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -123.73 139.34 50.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.677 0.751 . . . . 0.0 110.956 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -137.43 146.04 43.89 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.946 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.477 ' HG3' ' HG2' ' A' ' 25' ' ' GLN . 1.3 mt-30 -113.08 114.43 26.82 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -67.76 -179.55 1.17 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.251 0.548 . . . . 0.0 111.215 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -112.68 101.51 9.62 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.923 0.392 . . . . 0.0 110.329 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.6 p -98.75 112.22 24.36 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 120.905 0.383 . . . . 0.0 110.477 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -60.02 -61.55 7.04 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.691 179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.352 -1.249 . . . . 0.0 111.471 179.208 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.908 0 CA-C-O 121.26 0.552 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.69 103.52 0.56 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -93.58 37.68 1.06 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.846 0.832 . . . . 0.0 108.999 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -121.77 36.77 4.53 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.008 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -121.63 95.06 48.27 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.137 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.46 -170.17 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.845 2.364 . . . . 0.0 111.152 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -87.88 27.1 1.21 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.439 0.638 . . . . 0.0 110.254 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -82.28 17.17 1.75 Allowed 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.258 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.3 65.04 3.41 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.916 -0.659 . . . . 0.0 111.588 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 13' ' ' GLU . 7.3 p -104.89 136.42 38.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HD3' ' N ' ' A' ' 12' ' ' THR . 0.1 OUTLIER -106.67 -17.43 14.24 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 121.559 0.695 . . . . 0.0 110.525 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 90.0 m -69.55 -32.0 70.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.617 0.723 . . . . 0.0 110.635 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' H ' HG22 ' A' ' 10' ' ' VAL . 19.1 mm-40 -105.06 176.67 5.09 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.313 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -161.43 -29.09 0.05 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.421 0.629 . . . . 0.0 109.872 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -118.03 172.51 7.36 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.438 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -103.18 -176.38 3.07 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.916 0.389 . . . . 0.0 109.983 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 38.4 p-80 -139.41 159.72 41.5 Favored 'General case' 0 C--N 1.312 -1.036 0 O-C-N 121.97 -0.456 . . . . 0.0 111.763 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.5 pt -112.34 170.81 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.577 0.704 . . . . 0.0 112.466 -175.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.45 ' O ' HD22 ' A' ' 20' ' ' LEU . 25.4 m-80 -96.42 139.64 32.23 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.225 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.632 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.0 mm? -128.87 161.38 29.96 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 83' ' ' THR . 60.1 mtpt -136.73 146.91 46.38 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 121.169 0.509 . . . . 0.0 110.247 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.42 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.7 t -128.22 117.25 45.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.201 0.524 . . . . 0.0 110.639 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.58 118.23 28.09 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.94 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.46 160.84 33.4 Favored Glycine 0 N--CA 1.423 -2.175 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.169 -179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -9.14 38.74 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-O 121.681 0.753 . . . . 0.0 111.124 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -74.72 -15.73 60.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.821 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.62 6.94 57.12 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.472 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 t -110.01 167.33 10.26 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -139.61 140.14 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 CA-C-O 121.246 0.546 . . . . 0.0 110.776 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.611 HG21 ' HG3' ' A' ' 50' ' ' ARG . 9.5 p -103.98 140.41 22.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.003 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -113.84 123.51 49.98 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-O 121.43 0.633 . . . . 0.0 109.651 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.425 ' CZ ' ' HG ' ' A' ' 43' ' ' LEU . 8.8 p90 -147.12 169.04 20.12 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.231 -174.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 33.5 mtmm -115.28 144.6 43.49 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.143 0.497 . . . . 0.0 111.462 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.7 tt -148.25 146.07 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.023 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 29.4 mtmt -81.05 155.31 26.4 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 121.192 0.52 . . . . 0.0 111.041 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 18.6 mmm-85 -60.79 -40.19 91.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.094 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -92.91 10.15 32.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.343 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.539 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 17.6 m -95.6 130.21 32.54 Favored Pre-proline 0 N--CA 1.435 -1.18 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.396 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.75 150.24 83.48 Favored 'Trans proline' 0 C--O 1.241 0.672 0 C-N-CA 122.765 2.31 . . . . 0.0 112.97 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.535 HD22 HD13 ' A' ' 43' ' ' LEU . 88.5 mt -62.11 -12.18 18.09 Favored 'General case' 0 C--O 1.222 -0.346 0 C-N-CA 123.456 0.702 . . . . 0.0 111.799 178.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.5 t -51.13 -45.52 61.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.958 0.409 . . . . 0.0 110.956 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.471 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.535 HD13 HD22 ' A' ' 40' ' ' LEU . 2.3 tt -62.34 -48.16 81.02 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.23 0.538 . . . . 0.0 110.252 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.568 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 25.8 mtt -63.27 -39.29 94.17 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.651 178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.678 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 4.1 tppp? -67.96 -44.51 76.56 Favored 'General case' 0 C--O 1.215 -0.714 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.246 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.663 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -53.97 -53.15 56.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.912 0.386 . . . . 0.0 111.016 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.427 ' CE2' HG11 ' A' ' 86' ' ' VAL . 46.9 t80 -60.55 -41.58 94.82 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.207 0.527 . . . . 0.0 110.338 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.64 -41.55 81.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.288 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.678 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 22.6 mt-10 -71.7 -42.52 67.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.307 0.575 . . . . 0.0 111.211 -178.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.663 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 16.1 mmt85 -65.09 -50.66 65.27 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.247 0.546 . . . . 0.0 111.321 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -77.6 -14.7 59.58 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.431 -177.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.18 57.19 8.78 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 119.967 -1.111 . . . . 0.0 111.519 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -146.68 176.13 10.08 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -99.57 128.3 45.68 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.861 0.362 . . . . 0.0 111.424 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.0 ptp -63.12 -19.95 64.92 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.111 0.481 . . . . 0.0 111.789 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -83.07 -15.11 52.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.244 0.545 . . . . 0.0 111.011 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -100.04 5.13 45.04 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.454 0.645 . . . . 0.0 110.47 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.509 HG22 ' HG2' ' A' ' 88' ' ' GLN . 34.2 pt -135.32 171.9 16.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.733 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 21.5 mmm180 -141.99 148.45 38.58 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.775 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.568 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.7 m-85 -113.68 130.33 56.43 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.726 -178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.48 131.86 38.57 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.563 0.697 . . . . 0.0 111.092 177.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.422 ' HB2' HG13 ' A' ' 84' ' ' ILE . 82.5 t80 -126.56 136.48 52.61 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.287 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 t70 57.88 32.56 22.1 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.285 0.564 . . . . 0.0 111.013 178.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.35 -3.4 58.88 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.565 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -119.33 135.05 23.77 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 121.847 -0.796 . . . . 0.0 111.215 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.37 150.6 76.13 Favored 'Trans proline' 0 C--N 1.326 -0.619 0 C-N-CA 122.702 2.268 . . . . 0.0 111.831 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.32 142.93 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 CA-C-O 121.805 0.812 . . . . 0.0 111.34 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -96.22 153.81 17.6 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 114.82 -1.082 . . . . 0.0 110.105 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.8 pt-20 -63.95 -17.28 63.1 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.164 0.507 . . . . 0.0 111.731 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.6 p -81.56 -5.97 58.53 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.242 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -93.26 158.7 15.61 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.154 -0.341 . . . . 0.0 110.365 178.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.55 ' OG1' ' HB2' ' A' ' 75' ' ' GLN . 20.0 p -118.16 151.41 49.14 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.54 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.444 ' O ' ' HG2' ' A' ' 78' ' ' MET . 27.6 Cg_endo -63.07 -13.76 37.37 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.428 2.085 . . . . 0.0 112.55 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.07 -21.31 18.04 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.106 0.479 . . . . 0.0 110.964 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.55 ' HB2' ' OG1' ' A' ' 72' ' ' THR . 6.1 tt0 -66.0 -33.74 76.51 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.078 0.466 . . . . 0.0 110.866 -177.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.32 -1.72 24.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.343 0.592 . . . . 0.0 110.5 177.194 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 56.47 58.41 4.23 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.426 177.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.632 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.2 ptp -77.49 172.29 13.58 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.043 0.449 . . . . 0.0 110.878 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.9 tp10 -92.18 156.54 17.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.17 -178.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.88 141.6 49.54 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.234 0.54 . . . . 0.0 110.839 177.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 69.08 18.88 8.22 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.111 0.965 . . . . 0.0 111.04 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -70.47 175.78 4.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.19 150.5 52.14 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.46 0.647 . . . . 0.0 111.923 -176.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.422 HG13 ' HB2' ' A' ' 62' ' ' PHE . 3.3 mp -122.69 145.52 29.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -92.43 135.88 33.67 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 120.975 0.417 . . . . 0.0 110.607 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.427 HG11 ' CE2' ' A' ' 47' ' ' TYR . 2.8 t -120.62 135.58 60.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-O 121.781 0.801 . . . . 0.0 111.132 178.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 1.5 p90 -135.79 145.2 46.27 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.424 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.509 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.2 mt-30 -103.69 110.98 23.27 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.824 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -79.46 73.09 6.12 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 121.566 0.698 . . . . 0.0 110.855 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.08 -171.97 0.5 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.4 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.0 m -146.31 112.38 5.76 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.044 0.45 . . . . 0.0 110.41 -178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -101.62 143.88 16.22 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.761 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.078 0 CA-C-O 118.532 -1.149 . . . . 0.0 111.531 -179.878 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 mmt . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 121.15 0.5 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.02 156.31 27.73 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 120.915 0.388 . . . . 0.0 110.566 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -90.7 32.99 0.94 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.797 0.808 . . . . 0.0 110.757 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -121.98 -172.55 2.47 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.112 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -175.94 86.47 0.29 Allowed Pre-proline 0 C--N 1.289 -2.023 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.291 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -72.54 163.54 38.26 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 122.695 2.264 . . . . 0.0 111.015 175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -98.58 -11.1 22.48 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.938 0.875 . . . . 0.0 108.871 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 mp0 -84.06 -9.38 58.66 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.01 -0.996 . . . . 0.0 109.876 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.46 -51.29 5.69 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.754 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.78 133.24 63.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 121.053 0.454 . . . . 0.0 110.66 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.38 86.3 4.15 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.473 0.654 . . . . 0.0 109.685 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 t -167.19 -177.89 3.89 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -54.92 152.45 7.41 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.411 0.624 . . . . 0.0 111.883 178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -64.18 -23.83 67.46 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.333 0.587 . . . . 0.0 110.375 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -98.04 81.89 2.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.338 0.59 . . . . 0.0 111.605 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.74 -34.23 76.77 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.904 0.859 . . . . 0.0 109.964 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 56.8 p-80 -135.02 174.84 10.16 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.439 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.52 HG21 ' OD1' ' A' ' 80' ' ' ASP . 32.4 pt -130.08 169.1 21.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.34 0.591 . . . . 0.0 111.414 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -98.2 140.49 32.42 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.48 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.474 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.2 mm? -128.97 164.34 23.38 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.087 0.47 . . . . 0.0 109.974 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 83' ' ' THR . 62.6 mtpt -133.57 147.19 51.52 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.988 0.423 . . . . 0.0 110.027 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.534 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.5 t -125.0 116.39 47.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 120.968 0.413 . . . . 0.0 109.892 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.39 122.62 35.02 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.753 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.3 160.06 34.37 Favored Glycine 0 N--CA 1.424 -2.158 0 C-N-CA 120.439 -0.886 . . . . 0.0 110.93 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.54 -15.16 60.51 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.128 0.49 . . . . 0.0 111.832 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.16 -14.24 59.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.559 0.695 . . . . 0.0 110.025 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.86 5.52 50.57 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.67 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.1 t -95.76 162.75 13.47 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -144.24 136.74 22.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-O 121.479 0.657 . . . . 0.0 111.297 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.428 HG11 ' HG3' ' A' ' 50' ' ' ARG . 89.3 t -107.65 138.16 35.3 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.933 178.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -109.84 128.18 55.16 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.534 ' CE1' HG23 ' A' ' 22' ' ' VAL . 13.7 p90 -147.91 168.35 22.46 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.274 0.559 . . . . 0.0 111.538 -174.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 37.5 mtmt -112.19 135.54 52.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.619 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.5 tt -144.43 144.15 22.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.19 0.519 . . . . 0.0 110.208 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 24.3 mtmm -82.18 156.79 24.26 Favored 'General case' 0 CA--C 1.507 -0.708 0 O-C-N 121.847 -0.533 . . . . 0.0 110.809 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.566 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 12.4 mmm-85 -64.14 -34.64 78.52 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.371 0.605 . . . . 0.0 110.547 -177.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -95.21 6.65 48.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.288 0.566 . . . . 0.0 110.914 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.438 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 8.3 m -92.2 129.76 40.27 Favored Pre-proline 0 C--N 1.313 -1.018 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.048 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.0 147.16 73.35 Favored 'Trans proline' 0 C--O 1.238 0.504 0 C-N-CA 123.141 2.561 . . . . 0.0 113.595 -178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.8 mp -61.55 -12.27 14.66 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.285 1.034 . . . . 0.0 112.99 177.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.435 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 5.2 p -54.16 -41.07 68.08 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.046 0.45 . . . . 0.0 110.805 178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.451 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 7.2 tt -61.72 -51.97 66.21 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 178.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.5 mtt -58.85 -42.61 89.73 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.757 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -67.94 -43.35 79.32 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.009 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.44 -49.89 73.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 111.128 -178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -64.66 -39.22 93.31 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.087 0.47 . . . . 0.0 111.194 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -39.17 93.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.286 0.565 . . . . 0.0 110.502 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -68.37 -36.73 79.62 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.187 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.548 ' HA ' ' NE ' ' A' ' 50' ' ' ARG . 10.7 mmp_? -70.12 -45.55 66.64 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.103 0.478 . . . . 0.0 111.521 -178.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.404 HE22 HG21 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -81.36 -21.56 39.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.864 -178.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.22 4.5 89.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.368 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.64 177.21 6.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.934 0.397 . . . . 0.0 110.99 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 37.7 m -93.97 126.45 39.19 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.263 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -62.51 -28.7 70.02 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.305 0.574 . . . . 0.0 111.397 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -76.55 -9.84 58.95 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.049 0.452 . . . . 0.0 111.457 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.48 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 25.0 mm-40 -101.09 4.54 42.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.157 0.503 . . . . 0.0 111.373 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.77 HG22 ' HG2' ' A' ' 88' ' ' GLN . 23.0 pt -133.17 168.5 24.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.246 0.546 . . . . 0.0 110.786 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 54.8 mmt-85 -133.78 153.09 51.97 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.339 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.706 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 13.5 m-85 -119.17 131.03 55.81 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.315 -178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.617 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.1 ppt_? -136.56 143.94 43.93 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.251 0.548 . . . . 0.0 111.316 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.721 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 74.8 t80 -139.39 130.98 27.2 Favored 'General case' 0 C--O 1.198 -1.634 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 65' ' ' GLN . 0.2 OUTLIER 53.87 32.22 14.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -174.557 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.52 -33.08 1.38 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.738 -0.665 . . . . 0.0 112.623 -173.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.721 ' HG2' ' O ' ' A' ' 62' ' ' PHE . 7.5 pt20 -70.06 119.82 74.13 Favored Pre-proline 0 C--N 1.314 -0.95 0 CA-C-O 121.688 0.756 . . . . 0.0 111.736 -177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.08 144.51 57.88 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 122.658 2.238 . . . . 0.0 110.724 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.403 ' HB ' ' CD2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -124.8 133.01 70.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-O 121.354 0.597 . . . . 0.0 110.668 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.94 159.11 15.91 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.456 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.4 pt-20 -58.8 -21.84 57.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.322 0.582 . . . . 0.0 111.79 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 70.9 p -84.97 0.26 51.96 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.575 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.525 ' O ' HD13 ' A' ' 40' ' ' LEU . 66.9 m-20 -96.07 161.76 13.83 Favored 'General case' 0 CA--C 1.511 -0.55 0 O-C-N 121.885 -0.51 . . . . 0.0 110.325 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.3 p -119.38 153.53 53.71 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.954 178.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.408 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 37.3 Cg_endo -66.24 -12.0 33.71 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.722 2.281 . . . . 0.0 112.863 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.566 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.05 -17.08 22.19 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.37 0.605 . . . . 0.0 110.937 179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -67.94 -32.88 73.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.277 0.561 . . . . 0.0 110.771 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -110.2 3.09 19.75 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.045 0.45 . . . . 0.0 110.957 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 50.22 57.85 6.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.721 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.474 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -72.81 168.98 17.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.432 . . . . 0.0 110.88 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 10.5 tp10 -87.97 143.84 26.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.042 -177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' OD1' HG21 ' A' ' 18' ' ' ILE . 3.4 m-20 -59.02 138.68 57.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.86 0.362 . . . . 0.0 110.352 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 67.65 25.55 8.16 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.423 0.689 . . . . 0.0 112.042 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -77.73 -174.28 3.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.038 0.447 . . . . 0.0 110.964 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.447 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.8 m -136.23 150.97 49.2 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.23 0.538 . . . . 0.0 110.554 -179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.447 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.66 140.57 46.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.617 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.8 t70 -89.01 138.03 31.78 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.256 0.55 . . . . 0.0 110.9 -177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -119.75 136.21 57.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.314 178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.463 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 3.8 p90 -146.77 158.95 44.03 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.095 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.77 ' HG2' HG22 ' A' ' 58' ' ' ILE . 87.6 mt-30 -113.84 109.24 18.22 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.436 ' O ' HG23 ' A' ' 91' ' ' THR . 6.4 pt20 -137.08 136.64 38.53 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 47.61 39.61 10.16 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.719 0.808 . . . . 0.0 112.198 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 89' ' ' GLN . 9.6 p -104.01 -68.74 0.83 Allowed 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.234 0.54 . . . . 0.0 111.962 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.14 -68.64 0.05 OUTLIER Glycine 0 C--N 1.3 -1.446 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.413 -1.215 . . . . 0.0 111.366 176.947 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.41 137.86 4.27 Favored 'General case' 0 CA--C 1.519 -0.246 0 O-C-N 121.96 -0.462 . . . . 0.0 110.937 -178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.9 m-20 -91.56 16.23 10.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.711 0.767 . . . . 0.0 109.842 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -125.63 37.75 4.3 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.84 0.828 . . . . 0.0 108.816 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -166.84 99.21 0.66 Allowed Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.953 -175.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.06 143.16 14.1 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.328 2.019 . . . . 0.0 111.359 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -119.3 37.1 4.25 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.314 0.578 . . . . 0.0 110.409 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -99.76 -10.38 21.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.283 0.563 . . . . 0.0 110.637 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -100.7 -49.16 1.41 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.147 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.7 p -110.08 141.01 26.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.384 0.611 . . . . 0.0 110.759 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -129.29 158.17 39.84 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.0 m -48.67 114.08 0.9 Allowed 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.242 0.544 . . . . 0.0 110.714 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -78.96 106.03 10.7 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.425 0.631 . . . . 0.0 112.343 -177.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.42 -176.67 0.47 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.974 176.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 76.01 10.89 3.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.903 0.881 . . . . 0.0 110.486 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -99.14 -15.2 19.05 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.909 0.861 . . . . 0.0 109.226 177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.464 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 56.9 p-80 -131.91 151.12 51.91 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.023 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.43 HG23 ' HD3' ' A' ' 36' ' ' ARG . 33.9 pt -106.08 169.73 2.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 CA-C-O 121.674 0.749 . . . . 0.0 111.621 -176.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.526 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.4 m-80 -99.71 148.68 24.11 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.055 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.3 mm? -136.94 162.77 32.37 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.393 0.616 . . . . 0.0 111.087 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 62.2 mtpt -136.73 148.18 47.14 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.183 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.466 HG23 ' CE1' ' A' ' 32' ' ' PHE . 71.0 t -129.25 117.97 44.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 120.992 0.425 . . . . 0.0 110.434 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.02 122.1 33.4 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.694 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -90.07 162.91 30.15 Favored Glycine 0 N--CA 1.426 -2.001 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.493 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.4 pp0? -69.18 -12.09 61.37 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.743 0.782 . . . . 0.0 109.851 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -73.33 -21.43 60.55 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.801 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.12 10.82 41.27 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.661 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.2 t -109.77 158.47 18.1 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 7.6 p -135.19 134.22 52.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 121.383 0.611 . . . . 0.0 111.211 -179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 7.5 p -100.67 139.66 21.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.528 177.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -109.93 130.66 55.5 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.466 ' CE1' HG23 ' A' ' 22' ' ' VAL . 7.3 p90 -154.97 169.57 23.77 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.074 0.464 . . . . 0.0 111.377 -175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -118.22 138.3 52.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.652 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.481 ' CG2' HD23 ' A' ' 20' ' ' LEU . 14.0 tt -143.35 148.0 19.69 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 CA-C-O 121.245 0.545 . . . . 0.0 110.667 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 26.8 mtmt -84.44 157.7 21.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.247 0.546 . . . . 0.0 110.994 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 28.1 mmm-85 -68.55 -34.46 75.87 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.323 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -95.2 6.49 48.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.587 0.708 . . . . 0.0 110.668 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.7 m -94.54 131.98 29.77 Favored Pre-proline 0 C--N 1.309 -1.153 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.205 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.1 151.1 86.78 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.571 2.181 . . . . 0.0 112.265 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 43' ' ' LEU . 67.2 mt -65.57 -13.7 59.56 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.746 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 69' ' ' GLU . 2.4 p -49.95 -43.29 49.97 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.896 0.379 . . . . 0.0 111.99 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.49 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt -63.41 -49.35 74.11 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.389 177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.403 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.0 mpt? -60.15 -37.89 81.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-O 121.341 0.591 . . . . 0.0 110.502 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.4 tppp? -69.41 -42.25 75.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.726 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.45 -50.24 70.36 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.29 0.567 . . . . 0.0 110.723 -179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -64.31 -39.65 94.34 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.15 0.5 . . . . 0.0 110.902 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -34.15 77.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 9.5 mm-40 -71.64 -40.84 69.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.675 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.491 ' HG3' HG21 ' A' ' 30' ' ' VAL . 10.5 mmm180 -68.97 -43.75 74.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.099 0.476 . . . . 0.0 111.657 -178.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.95 -16.65 40.28 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 120.979 0.418 . . . . 0.0 111.714 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.03 2.93 80.01 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.991 -0.624 . . . . 0.0 112.919 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -83.46 176.46 9.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.075 0.465 . . . . 0.0 111.606 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.0 m -94.21 130.57 40.39 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.841 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.4 ptp -66.54 -22.01 66.16 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.063 0.459 . . . . 0.0 111.564 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.411 ' HG3' HE21 ' A' ' 57' ' ' GLN . 19.4 ptp180 -80.05 -8.25 59.28 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.269 0.557 . . . . 0.0 111.011 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.411 HE21 ' HG3' ' A' ' 56' ' ' ARG . 28.6 mm-40 -104.66 7.96 35.05 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.969 0.414 . . . . 0.0 111.711 -178.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.572 HG22 ' HG2' ' A' ' 88' ' ' GLN . 22.2 pt -136.53 171.82 16.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 CA-C-O 121.394 0.616 . . . . 0.0 111.364 -176.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.436 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 16.6 mmm180 -140.64 145.79 37.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.573 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -114.66 130.47 56.81 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.583 -178.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.593 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.6 ppt_? -133.1 138.24 46.63 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.351 0.596 . . . . 0.0 110.986 177.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -138.48 140.36 39.17 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.551 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.12 26.05 16.0 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 121.09 0.472 . . . . 0.0 111.297 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.31 -6.8 70.47 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 119.585 -1.293 . . . . 0.0 112.856 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -118.56 142.61 31.82 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 122.073 -0.663 . . . . 0.0 111.411 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.94 148.9 36.2 Favored 'Trans proline' 0 C--N 1.324 -0.727 0 C-N-CA 122.431 2.087 . . . . 0.0 111.435 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.96 135.29 63.29 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 CA-C-O 121.428 0.633 . . . . 0.0 111.545 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.48 154.65 17.32 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.46 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' HB2' ' HB3' ' A' ' 41' ' ' SER . 3.4 pt-20 -60.67 -21.28 62.65 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.054 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -76.46 -12.49 60.05 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.314 0.578 . . . . 0.0 111.271 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.2 166.43 11.74 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.713 179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 p -115.9 158.57 41.95 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.99 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 78' ' ' MET . 39.1 Cg_endo -67.79 -3.23 10.0 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.71 2.273 . . . . 0.0 112.124 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.43 -21.3 19.01 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.07 0.462 . . . . 0.0 110.547 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -62.29 -39.49 93.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.378 0.609 . . . . 0.0 110.92 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.449 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.12 1.42 28.39 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.174 0.511 . . . . 0.0 111.221 -178.095 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 3.5 mm-40 51.88 62.62 2.61 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.496 ' SD ' HD11 ' A' ' 20' ' ' LEU . 7.7 ptp -76.33 165.22 25.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.05 0.452 . . . . 0.0 110.366 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -96.82 165.83 11.92 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.623 -176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.1 131.56 44.5 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.274 0.559 . . . . 0.0 109.955 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 21.8 mt-10 69.67 21.13 6.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.555 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -67.89 176.63 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 1.3 m -132.81 148.67 52.31 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.577 -0.702 . . . . 0.0 111.427 -177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.05 142.14 38.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.593 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 36.1 t70 -89.52 134.08 34.28 Favored 'General case' 0 CA--C 1.499 -1.013 0 CA-C-O 121.101 0.477 . . . . 0.0 110.531 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -121.17 137.01 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.798 0 CA-C-O 121.789 0.804 . . . . 0.0 110.75 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.8 p90 -135.07 144.59 47.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.37 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.572 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.4 mt-30 -110.96 114.11 27.18 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -177.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.41 ' NE2' ' H ' ' A' ' 89' ' ' GLN . 1.4 mp0 -64.76 83.39 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.284 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.588 ' NE2' ' H ' ' A' ' 90' ' ' GLN . 0.7 OUTLIER -81.5 179.1 7.98 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.818 0.342 . . . . 0.0 110.432 177.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 m -92.95 -2.41 55.82 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.694 0.759 . . . . 0.0 110.253 -177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.29 -52.22 2.14 Favored Glycine 0 CA--C 1.509 -0.334 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.314 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.291 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.922 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.6 mtt . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 120.662 0.268 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 177.2 -179.76 0.22 Allowed 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -115.71 10.41 15.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.267 0.556 . . . . 0.0 110.862 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.25 128.14 35.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.878 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.482 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 8.0 tmtm? -177.9 -56.92 0.0 OUTLIER Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.737 -177.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 56.7 Cg_endo -69.97 150.02 66.32 Favored 'Trans proline' 0 C--N 1.365 1.407 0 C-N-CA 121.587 1.525 . . . . 0.0 111.611 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -119.49 21.65 12.03 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.441 0.639 . . . . 0.0 109.725 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -85.53 -31.52 22.67 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.238 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.17 60.61 4.72 Favored Glycine 0 C--N 1.313 -0.707 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.248 -176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 12.9 p -74.71 143.6 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 CA-C-O 121.081 0.467 . . . . 0.0 110.245 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -69.68 -73.81 0.15 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.364 -0.38 . . . . 0.0 112.02 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -135.89 43.14 2.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.416 0.627 . . . . 0.0 111.402 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 65.73 29.82 10.52 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.499 177.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -63.78 135.48 56.67 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.312 -179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 65.07 61.59 0.75 Allowed 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.755 0.788 . . . . 0.0 109.988 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -153.1 -59.6 0.14 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.004 -177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 46.9 p-80 -141.92 156.38 45.49 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.451 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.4 pt -108.05 169.87 2.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-O 121.502 0.668 . . . . 0.0 112.232 -175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' O ' HD22 ' A' ' 20' ' ' LEU . 15.6 m-80 -97.34 142.47 29.18 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.464 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.5 mm? -133.17 163.9 28.24 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.382 0.611 . . . . 0.0 110.887 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.8 mtpt -138.64 148.6 44.26 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.628 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG23 ' CE1' ' A' ' 32' ' ' PHE . 92.7 t -127.88 117.25 45.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.094 0.473 . . . . 0.0 110.497 178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.36 123.19 35.5 Favored 'General case' 0 N--CA 1.434 -1.269 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.292 178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -92.88 163.01 26.69 Favored Glycine 0 N--CA 1.419 -2.456 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -19.42 63.61 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.09 0.472 . . . . 0.0 111.706 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.1 -6.14 49.8 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.261 0.553 . . . . 0.0 110.98 177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.03 12.17 64.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.838 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 t -103.88 158.4 16.43 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.94 136.04 45.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.253 0.549 . . . . 0.0 111.191 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.57 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.4 p -106.54 141.79 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 O-C-N 122.188 -0.32 . . . . 0.0 110.217 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -111.88 129.87 56.02 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.229 0.538 . . . . 0.0 109.968 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.493 ' CE1' HG23 ' A' ' 22' ' ' VAL . 11.7 p90 -154.09 169.95 22.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.585 -174.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -115.56 143.27 45.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.651 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.436 ' CG2' HD23 ' A' ' 20' ' ' LEU . 13.6 tt -148.9 148.53 15.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.231 0.539 . . . . 0.0 110.398 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.459 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.0 mtmt -84.15 158.05 21.48 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 121.01 0.433 . . . . 0.0 110.782 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.455 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 23.8 mmm-85 -69.13 -34.04 74.41 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.234 0.54 . . . . 0.0 110.517 -177.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -93.45 5.13 52.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.58 . . . . 0.0 110.913 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.1 m -93.46 131.26 32.97 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.778 -178.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.69 149.57 90.53 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.923 2.415 . . . . 0.0 112.784 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.46 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.7 mt -65.13 -12.14 47.64 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.906 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 49.3 m -49.63 -45.1 47.97 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.925 0.393 . . . . 0.0 111.062 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.49 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.5 tt -61.48 -48.27 81.88 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.392 0.615 . . . . 0.0 109.79 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.751 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 38.5 mtt -61.57 -49.65 75.79 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.353 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.629 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.0 tppp? -59.66 -44.31 93.6 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.958 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.573 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.18 -50.79 68.46 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.107 0.48 . . . . 0.0 110.773 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -62.78 -41.01 99.07 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.186 0.517 . . . . 0.0 110.813 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.562 ' SG ' HD11 ' A' ' 58' ' ' ILE . 79.2 m -65.52 -34.64 78.74 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.399 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.629 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 18.9 mm-40 -68.89 -37.13 78.81 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.22 0.533 . . . . 0.0 110.99 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.9 mmt180 -69.63 -44.33 70.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.406 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -83.34 -21.74 33.06 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.295 0.569 . . . . 0.0 110.67 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.81 6.71 88.79 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.532 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.69 176.0 7.98 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.288 0.566 . . . . 0.0 111.815 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.403 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 70.7 m -96.9 134.62 40.0 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.939 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.548 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.6 ptp -68.18 -19.74 64.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.181 0.515 . . . . 0.0 111.096 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -83.42 -8.05 59.45 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.167 0.508 . . . . 0.0 111.059 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 18.0 mm-40 -106.65 9.68 31.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.001 0.429 . . . . 0.0 110.811 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.676 HG22 ' HG2' ' A' ' 88' ' ' GLN . 19.6 pt -137.29 173.41 13.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.614 0.721 . . . . 0.0 111.856 -178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.515 ' HG2' ' NE2' ' A' ' 89' ' ' GLN . 21.3 mmm180 -140.27 146.9 39.18 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.071 177.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.751 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.6 m-85 -113.75 128.15 56.3 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.386 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.618 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.5 OUTLIER -128.63 145.41 51.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.003 0.43 . . . . 0.0 110.211 179.169 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -140.96 131.44 25.32 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.039 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.7 t0 58.33 29.38 18.05 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 120.893 0.378 . . . . 0.0 111.684 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.12 -7.9 69.38 Favored Glycine 0 N--CA 1.44 -1.093 0 C-N-CA 119.538 -1.315 . . . . 0.0 113.089 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -114.03 134.79 22.1 Favored Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 122.054 -0.674 . . . . 0.0 111.116 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.65 149.33 33.98 Favored 'Trans proline' 0 C--O 1.241 0.653 0 C-N-CA 122.848 2.365 . . . . 0.0 112.376 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.87 137.52 52.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.234 0.54 . . . . 0.0 110.986 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 68' ' ' ASN . 0.2 OUTLIER -97.9 161.28 13.82 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.216 177.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.597 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.4 pt-20 -62.22 -20.91 64.7 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.093 0.473 . . . . 0.0 112.044 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 57.2 p -76.33 -6.89 53.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.437 0.637 . . . . 0.0 111.251 -178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' OD1' ' HG2' ' A' ' 75' ' ' GLN . 1.7 m-20 -103.22 166.85 10.19 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.136 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 p -116.84 159.89 38.92 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.776 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 78' ' ' MET . 35.3 Cg_endo -66.52 -8.71 21.72 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.506 2.137 . . . . 0.0 111.912 177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.99 -13.09 25.59 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.303 0.573 . . . . 0.0 110.639 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.412 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 2.3 tp-100 -68.26 -35.49 77.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.511 0.672 . . . . 0.0 110.16 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.472 HD21 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -110.52 1.19 18.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.366 -179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 54.16 61.73 2.91 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.382 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.8 ptp -77.18 164.39 25.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 110.734 177.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 38.1 tt0 -95.09 161.58 14.07 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.128 -175.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.54 134.56 53.62 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.85 0.357 . . . . 0.0 110.061 178.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 70.05 19.67 6.74 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 123.836 0.855 . . . . 0.0 111.555 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t0 -71.49 176.14 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.002 0.429 . . . . 0.0 110.111 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.46 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.5 m -131.32 150.26 52.22 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-O 121.22 0.534 . . . . 0.0 111.246 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.46 HD12 ' C ' ' A' ' 83' ' ' THR . 2.7 mp -122.19 136.69 58.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.618 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 19.4 m-20 -89.83 138.07 31.8 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.041 0.448 . . . . 0.0 110.833 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -122.7 139.56 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-O 121.179 0.514 . . . . 0.0 111.037 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -139.98 151.28 45.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.056 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.676 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.4 mt-30 -108.68 112.57 24.96 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.998 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.515 ' NE2' ' HG2' ' A' ' 59' ' ' ARG . 14.0 mp0 -57.55 164.17 2.09 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.734 0.778 . . . . 0.0 111.661 176.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -71.4 158.0 37.07 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.39 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.3 p -87.17 -44.28 11.61 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.685 0.755 . . . . 0.0 110.376 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.77 47.97 13.51 Favored Glycine 0 N--CA 1.442 -0.947 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.236 0 CA-C-O 118.387 -1.23 . . . . 0.0 111.136 -177.318 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 121.055 0.455 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.32 100.49 2.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.29 0.567 . . . . 0.0 109.926 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -128.19 8.46 6.09 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.731 0.777 . . . . 0.0 109.668 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.6 -79.7 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.469 -175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? 57.21 84.03 0.21 Allowed Pre-proline 0 C--N 1.323 -0.582 0 C-N-CA 123.064 0.546 . . . . 0.0 110.627 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.08 -153.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.916 3.077 . . . . 0.0 113.592 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -91.57 -6.61 52.1 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.712 0.768 . . . . 0.0 109.92 -177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -92.17 165.1 13.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.796 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.87 -12.04 72.41 Favored Glycine 0 CA--C 1.503 -0.706 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.141 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.44 ' CG2' ' HB2' ' A' ' 13' ' ' GLU . 3.1 p -92.04 114.38 29.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.373 0.606 . . . . 0.0 111.913 -178.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.563 ' HG3' ' N ' ' A' ' 12' ' ' THR . 19.8 ptpt -76.3 -49.58 16.58 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.262 0.553 . . . . 0.0 111.139 176.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.563 ' N ' ' HG3' ' A' ' 11' ' ' LYS . 91.8 m -160.35 99.3 1.31 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.249 0.547 . . . . 0.0 109.744 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.44 ' HB2' ' CG2' ' A' ' 10' ' ' VAL . 4.7 mm-40 -155.37 -173.49 4.58 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.827 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 19.4 m120 77.76 16.65 1.45 Allowed 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 123.624 0.77 . . . . 0.0 111.604 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -85.09 -83.25 0.17 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.701 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.97 114.24 18.74 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 45.8 p-80 -167.66 174.64 7.56 Favored 'General case' 0 N--CA 1.437 -1.119 0 O-C-N 121.975 -0.453 . . . . 0.0 111.009 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.5 pt -128.44 170.51 17.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.369 0.604 . . . . 0.0 111.332 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.437 ' O ' HD22 ' A' ' 20' ' ' LEU . 23.6 m-80 -96.77 142.32 28.93 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.56 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -130.49 162.31 29.49 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 120.987 0.422 . . . . 0.0 109.889 176.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.2 mtpt -136.3 145.52 45.59 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.102 0.477 . . . . 0.0 110.299 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.6 t -125.56 116.67 47.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-O 121.156 0.503 . . . . 0.0 109.961 178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.9 122.55 35.38 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.955 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.53 159.61 32.18 Favored Glycine 0 N--CA 1.422 -2.268 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -64.13 -11.9 34.61 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.166 0.508 . . . . 0.0 111.775 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -80.36 -15.51 56.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.356 0.598 . . . . 0.0 110.072 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.82 4.99 48.29 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.072 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 t -99.61 160.05 14.58 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.25 136.81 33.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-O 121.468 0.651 . . . . 0.0 111.496 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.74 HG21 ' HG3' ' A' ' 50' ' ' ARG . 7.4 p -102.28 142.22 16.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.303 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -113.64 125.04 53.71 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 22' ' ' VAL . 12.2 p90 -146.42 167.98 22.28 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.533 -174.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 40.8 mtmt -114.99 134.16 55.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.193 0.52 . . . . 0.0 111.255 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.0 tt -144.71 150.47 16.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.106 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.566 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 15.8 mtmt -81.03 163.89 22.89 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 121.863 -0.523 . . . . 0.0 110.724 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.492 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 22.4 mmm-85 -70.74 -40.24 72.84 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.182 0.515 . . . . 0.0 110.356 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -91.8 5.97 47.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.568 0.699 . . . . 0.0 110.517 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.8 m -90.98 130.4 40.6 Favored Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.821 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.14 149.01 92.68 Favored 'Trans proline' 0 C--O 1.24 0.622 0 C-N-CA 123.049 2.499 . . . . 0.0 113.233 -178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.455 HD22 HD13 ' A' ' 43' ' ' LEU . 83.7 mt -64.05 -12.59 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.406 0.683 . . . . 0.0 111.994 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 13.5 t -52.89 -43.54 66.25 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.86 0.362 . . . . 0.0 110.991 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.497 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 44' ' ' MET . 2.4 tt -60.72 -49.77 76.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.32 0.581 . . . . 0.0 110.318 178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.614 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 28.1 mtt -60.04 -47.28 86.52 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.369 179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.0 tppt? -63.08 -41.87 99.51 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.752 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.64 -49.73 74.15 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.887 0.375 . . . . 0.0 110.958 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -62.67 -39.8 95.06 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-O 121.157 0.503 . . . . 0.0 110.71 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 58' ' ' ILE . 70.7 m -67.68 -34.87 77.77 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.211 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 16.2 mm-40 -70.72 -33.99 71.43 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.2 0.524 . . . . 0.0 110.505 179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.74 ' HG3' HG21 ' A' ' 30' ' ' VAL . 15.9 mmt180 -65.45 -49.01 70.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.302 0.572 . . . . 0.0 110.511 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.63 -20.76 35.7 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.674 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.83 14.25 79.95 Favored Glycine 0 C--N 1.321 -0.269 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.371 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -95.99 178.54 5.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.451 0.643 . . . . 0.0 112.25 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.0 m -100.36 129.57 46.36 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.759 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.505 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 5.7 ptp -63.13 -24.04 67.71 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.119 0.485 . . . . 0.0 112.087 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -78.91 -12.48 60.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.351 0.596 . . . . 0.0 111.142 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -99.33 -0.29 41.43 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.146 0.498 . . . . 0.0 110.999 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.523 HD11 ' SG ' ' A' ' 48' ' ' CYS . 29.2 pt -132.77 169.9 21.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.229 0.537 . . . . 0.0 111.567 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 17.7 mmm180 -138.83 146.88 41.78 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.988 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.614 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.1 m-85 -112.72 130.73 55.96 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.825 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.625 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -130.71 145.22 51.88 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.19 0.519 . . . . 0.0 110.66 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -146.51 135.79 22.77 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t70 60.88 28.04 17.83 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.427 0.632 . . . . 0.0 110.743 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.18 -1.2 70.94 Favored Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 119.445 -1.359 . . . . 0.0 113.51 -177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -118.53 139.84 27.5 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 117.527 0.664 . . . . 0.0 110.853 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.81 145.66 36.8 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.341 2.028 . . . . 0.0 111.577 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.7 137.58 56.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-O 121.543 0.687 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.53 154.25 17.99 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.544 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.584 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 4.2 pt-20 -61.7 -18.04 58.05 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.195 0.522 . . . . 0.0 112.325 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.4 p -79.51 -15.65 57.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.021 0.439 . . . . 0.0 111.278 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.39 164.07 15.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.942 0.401 . . . . 0.0 111.345 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.9 p -118.04 155.18 51.52 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.221 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.45 -11.35 29.97 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.754 2.303 . . . . 0.0 112.243 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.93 -14.81 24.12 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.896 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -69.31 -38.79 78.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.438 0.637 . . . . 0.0 110.168 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.464 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -104.92 1.28 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.432 0.634 . . . . 0.0 110.15 179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 50.85 60.83 3.59 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.784 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.56 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -77.0 163.6 26.55 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 6.5 tp10 -92.96 161.83 14.3 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.05 0.453 . . . . 0.0 110.814 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -70.36 138.65 51.58 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.286 0.565 . . . . 0.0 111.215 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 73.03 19.45 3.69 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 124.413 1.085 . . . . 0.0 110.9 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.498 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.2 t70 -72.82 175.35 6.6 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.731 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.459 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.2 m -133.33 147.26 51.84 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 121.578 0.704 . . . . 0.0 111.506 -176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.459 HD12 ' C ' ' A' ' 83' ' ' THR . 2.5 mp -121.4 137.87 53.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.625 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 13.4 m-20 -88.73 136.38 33.03 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.1 0.476 . . . . 0.0 111.022 -178.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.4 t -120.88 139.27 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-O 121.465 0.65 . . . . 0.0 110.609 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.6 p90 -137.94 147.15 44.06 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.305 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.459 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -109.55 111.65 23.29 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 121.191 0.52 . . . . 0.0 109.9 -175.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -132.85 135.27 45.53 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.496 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -115.57 117.78 31.28 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.29 0.567 . . . . 0.0 110.293 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.8 t -64.93 -24.69 67.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.266 0.555 . . . . 0.0 111.749 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -133.1 143.37 15.05 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.094 0 CA-C-O 118.837 -0.979 . . . . 0.0 112.138 -177.607 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 121.084 0.469 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.66 108.71 4.57 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.04 0.448 . . . . 0.0 110.899 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -85.13 32.38 0.55 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.628 0.728 . . . . 0.0 110.452 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -122.47 17.41 10.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.433 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -122.85 92.17 49.28 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.949 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -80.3 146.74 17.79 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.503 2.135 . . . . 0.0 112.261 -178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 7' ' ' LYS . 9.6 mmpt? -96.07 -10.14 29.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.564 0.697 . . . . 0.0 109.382 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -78.19 -3.02 40.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.008 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.38 -77.29 0.29 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 121.217 -0.516 . . . . 0.0 113.304 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -135.6 139.08 47.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 O-C-N 122.471 -0.429 . . . . 0.0 110.458 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -82.79 -53.26 6.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.834 0.349 . . . . 0.0 111.705 179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 t -61.94 -19.13 62.41 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -100.7 125.66 47.17 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 177.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -155.7 144.56 20.52 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.222 0.534 . . . . 0.0 110.584 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 16' ' ' ASP . 55.9 m-80 -129.18 140.74 51.39 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.488 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 15' ' ' ASN . 13.6 p-10 168.84 168.31 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.535 0 C-N-CA 124.621 1.168 . . . . 0.0 108.655 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.538 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 10.6 p-80 40.97 -159.31 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.681 0.792 . . . . 0.0 111.852 -172.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.2 pt -129.66 169.1 21.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.353 -0.842 . . . . 0.0 112.125 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.57 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.3 m-80 -103.87 144.49 31.44 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.215 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.3 mm? -135.23 160.69 37.59 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.336 0.589 . . . . 0.0 110.936 176.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 61.2 mtpt -135.93 148.32 48.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.601 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.478 HG23 ' CE1' ' A' ' 32' ' ' PHE . 96.9 t -125.38 119.32 55.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.244 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.75 119.9 35.06 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 121.338 0.59 . . . . 0.0 110.222 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.84 157.98 32.96 Favored Glycine 0 N--CA 1.425 -2.083 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.427 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 4.9 pp0? -64.43 -16.41 62.35 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.276 0.56 . . . . 0.0 111.369 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -82.98 -10.95 58.52 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 0.0 110.916 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.16 14.59 30.41 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.31 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.4 t -105.43 155.6 18.99 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 9.3 p -141.01 134.11 31.16 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-O 121.384 0.611 . . . . 0.0 110.958 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 85.9 t -107.24 138.45 33.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.99 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -110.11 131.75 54.77 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.478 ' CE1' HG23 ' A' ' 22' ' ' VAL . 7.1 p90 -155.9 170.07 22.97 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.305 0.574 . . . . 0.0 111.887 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -116.45 138.38 51.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.744 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' CG2' HD23 ' A' ' 20' ' ' LEU . 15.5 tt -143.52 150.52 17.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.103 0.477 . . . . 0.0 110.069 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.538 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 25.8 mtmm -86.47 158.39 19.58 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.115 0.483 . . . . 0.0 111.291 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.408 ' NH2' ' HA ' ' A' ' 74' ' ' ALA . 24.0 mmm-85 -63.25 -38.29 90.59 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.647 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -95.47 9.41 40.14 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.027 -178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.474 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.9 m -93.95 128.34 41.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.378 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -65.0 149.42 89.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 122.685 2.256 . . . . 0.0 112.925 -178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD2' HD13 ' A' ' 43' ' ' LEU . 83.8 mt -63.91 -11.71 30.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.971 178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 21.9 p -51.67 -46.0 63.63 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.961 0.41 . . . . 0.0 111.156 178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.493 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD13 ' CD2' ' A' ' 40' ' ' LEU . 3.7 tt -63.37 -49.33 74.29 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.397 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.63 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 34.0 mtt -62.32 -46.57 88.15 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.227 0.537 . . . . 0.0 110.648 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.711 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 17.6 tppt? -64.99 -41.44 95.41 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.793 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.586 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -58.39 -50.96 71.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.796 0.332 . . . . 0.0 110.655 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -63.17 -42.34 99.37 Favored 'General case' 0 C--O 1.246 0.87 0 CA-C-O 121.362 0.601 . . . . 0.0 110.262 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.711 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.09 -40.17 88.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.958 -178.185 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 7.8 mt-10 -73.38 -33.51 65.07 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.866 0.365 . . . . 0.0 111.335 -177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.593 ' HE ' ' HA ' ' A' ' 50' ' ' ARG . 7.1 mmp_? -65.44 -47.71 75.24 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.314 0.578 . . . . 0.0 110.417 178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.96 -22.12 46.16 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.124 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.79 2.6 78.37 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.975 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -88.86 176.27 7.11 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.459 0.647 . . . . 0.0 112.47 -179.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.4 m -97.52 136.68 37.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.651 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 6.5 ptp -68.09 -26.64 65.92 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.158 0.504 . . . . 0.0 111.325 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.405 ' HG3' HE21 ' A' ' 57' ' ' GLN . 13.1 ptm180 -75.17 -10.28 59.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.407 0.623 . . . . 0.0 110.665 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.405 HE21 ' HG3' ' A' ' 56' ' ' ARG . 24.8 mm-40 -102.66 5.67 39.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.231 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.497 HG22 ' HG2' ' A' ' 88' ' ' GLN . 28.6 pt -138.8 176.66 6.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-O 121.118 0.485 . . . . 0.0 110.983 -177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.419 HH21 ' HB2' ' A' ' 66' ' ' PRO . 22.7 mmm180 -146.94 148.03 31.34 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.631 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.63 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.6 m-85 -114.55 132.33 56.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.789 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.625 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -131.0 142.58 50.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.46 0.648 . . . . 0.0 111.028 177.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -146.55 140.1 25.88 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.9 t70 64.44 25.35 13.32 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.068 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 76.41 -0.39 64.34 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 119.819 -1.181 . . . . 0.0 113.161 -177.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -120.79 143.3 36.27 Favored Pre-proline 0 N--CA 1.445 -0.695 0 O-C-N 122.134 -0.627 . . . . 0.0 110.808 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HB2' HH21 ' A' ' 59' ' ' ARG . 58.3 Cg_endo -72.62 148.7 47.87 Favored 'Trans proline' 0 C--N 1.322 -0.824 0 C-N-CA 122.233 1.956 . . . . 0.0 111.716 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.29 137.09 57.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.824 0 CA-C-O 121.334 0.588 . . . . 0.0 110.648 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.19 156.24 16.96 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.812 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -60.66 -20.15 60.13 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.183 0.516 . . . . 0.0 112.062 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.1 p -79.54 -10.95 59.89 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 121.496 0.665 . . . . 0.0 110.941 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -91.22 162.73 14.52 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.679 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -118.45 158.63 46.43 Favored Pre-proline 0 C--N 1.307 -1.25 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.16 -6.04 13.77 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.196 1.931 . . . . 0.0 111.649 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.408 ' HA ' ' NH2' ' A' ' 36' ' ' ARG . . . -95.42 -14.07 24.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.557 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -68.06 -37.02 80.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.444 0.64 . . . . 0.0 110.102 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.468 HD21 ' HE3' ' A' ' 78' ' ' MET . 0.0 OUTLIER -111.75 1.72 16.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.546 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 53.11 60.36 3.82 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.9 ptp -78.72 167.37 21.32 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.855 0.36 . . . . 0.0 110.534 177.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' N ' ' A' ' 80' ' ' ASP . 43.1 tt0 -93.29 165.64 12.7 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.095 0.474 . . . . 0.0 110.568 -178.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 3.9 p-10 -77.25 137.87 39.07 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-O 121.063 0.459 . . . . 0.0 110.036 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 73.13 16.72 4.21 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 124.356 1.062 . . . . 0.0 111.317 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -70.07 176.43 3.81 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.153 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.6 m -136.41 151.04 49.09 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 121.805 -0.56 . . . . 0.0 111.004 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 61' ' ' ARG . 2.8 mp -120.81 144.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.625 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.5 t0 -88.87 130.96 35.31 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.146 0.498 . . . . 0.0 110.314 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 t -118.48 134.89 60.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.653 0.739 . . . . 0.0 111.046 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.411 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 4.3 p90 -135.65 145.96 47.35 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.643 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.497 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.0 OUTLIER -110.32 112.14 23.89 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.085 0.469 . . . . 0.0 110.659 -177.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -69.51 -178.9 1.53 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.423 0.63 . . . . 0.0 111.575 177.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.476 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 0.5 OUTLIER -84.51 -171.41 3.61 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.222 -177.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.9 t -166.54 162.01 16.43 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.069 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -90.01 -179.13 44.48 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.845 0 CA-C-O 118.725 -1.042 . . . . 0.0 112.329 -178.599 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.836 0.35 . . . . 0.0 111.025 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.67 ' HB1' ' OE2' ' A' ' 4' ' ' GLU . . . -63.61 159.91 17.9 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.908 0.385 . . . . 0.0 111.47 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -106.23 28.16 7.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.475 0.655 . . . . 0.0 111.126 -176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.67 ' OE2' ' HB1' ' A' ' 2' ' ' ALA . 0.3 OUTLIER -155.34 88.3 1.15 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 122.11 0.957 . . . . 0.0 112.552 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -141.95 105.64 5.74 Favored Pre-proline 0 C--N 1.313 -0.999 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.93 128.31 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.548 2.166 . . . . 0.0 113.602 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.32 29.23 3.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.927 0.87 . . . . 0.0 109.747 177.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -77.91 103.38 7.82 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.998 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.59 -121.95 2.94 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.2 p -159.82 147.91 6.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -84.06 -54.46 4.83 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.794 0.331 . . . . 0.0 111.75 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.6 m -139.59 119.77 13.71 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.914 0.388 . . . . 0.0 110.726 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.23 124.61 42.91 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 176.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -36.92 113.03 0.22 Allowed 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 122.096 0.951 . . . . 0.0 113.205 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -140.67 3.9 1.9 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.475 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -52.86 -39.04 62.25 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.959 0.885 . . . . 0.0 110.801 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 21.5 p-80 -141.94 164.78 29.26 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 43.7 pt -104.22 168.8 2.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.543 0 CA-C-O 121.662 0.744 . . . . 0.0 112.217 -174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 20' ' ' LEU . 16.9 m-80 -101.47 144.93 29.65 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.948 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -132.28 161.78 32.64 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.233 0.539 . . . . 0.0 110.459 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.0 mtpt -135.76 147.64 48.48 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.759 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 32' ' ' PHE . 79.3 t -127.48 113.91 33.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 CA-C-O 121.082 0.468 . . . . 0.0 110.294 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.07 123.02 34.21 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.778 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -91.01 163.75 29.47 Favored Glycine 0 N--CA 1.418 -2.545 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -12.08 59.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.574 0.702 . . . . 0.0 111.28 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -81.41 -13.15 58.59 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.734 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.73 9.3 56.5 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.764 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -103.28 155.39 18.49 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.32 130.71 44.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.635 0.731 . . . . 0.0 111.377 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 94.2 t -101.81 135.85 36.58 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.325 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -108.44 128.82 55.12 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.2 p90 -151.42 169.7 21.39 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 121.216 0.531 . . . . 0.0 111.528 -174.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -115.46 138.21 51.25 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.842 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.8 tt -145.54 149.31 16.68 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 30.5 mtmt -83.62 159.86 21.5 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.009 0.433 . . . . 0.0 110.368 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.504 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 25.3 mmm-85 -69.46 -36.03 76.2 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.165 0.507 . . . . 0.0 110.594 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -93.99 5.95 50.07 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.272 0.558 . . . . 0.0 110.888 -178.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.466 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.2 m -91.29 131.57 36.23 Favored Pre-proline 0 C--N 1.313 -1.02 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.321 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.45 147.89 93.0 Favored 'Trans proline' 0 C--O 1.239 0.561 0 C-N-CA 122.552 2.168 . . . . 0.0 112.374 -178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.494 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 70.9 mt -64.54 -13.44 52.67 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.408 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.1 p -49.96 -40.85 45.27 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 120.976 0.417 . . . . 0.0 111.7 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.48 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.476 HD13 HD22 ' A' ' 40' ' ' LEU . 3.9 tt -63.08 -51.69 65.66 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.521 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.494 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -60.56 -39.45 87.99 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 121.111 0.482 . . . . 0.0 110.513 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.514 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.3 tppp? -68.72 -43.11 76.66 Favored 'General case' 0 C--O 1.214 -0.816 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.615 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.2 -51.15 65.33 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 110.78 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -64.68 -39.9 94.47 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.89 -36.18 83.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.277 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 5.9 mm-40 -72.23 -35.36 68.83 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.273 0.558 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 27.6 mmm180 -69.43 -45.55 68.89 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.392 0.615 . . . . 0.0 111.402 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -83.12 -21.74 33.54 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.676 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.65 5.09 89.78 Favored Glycine 0 CA--C 1.518 0.225 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.908 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.79 178.04 7.12 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.912 0.386 . . . . 0.0 111.502 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.8 m -96.87 124.67 40.91 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.822 0.344 . . . . 0.0 110.384 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.2 ptp -58.17 -27.77 64.14 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -79.05 -9.47 59.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.218 0.532 . . . . 0.0 111.622 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -102.48 2.11 35.98 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.556 0.693 . . . . 0.0 110.617 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.529 HG22 ' HG2' ' A' ' 88' ' ' GLN . 27.9 pt -130.78 170.68 19.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.235 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 16.2 mmm180 -140.51 147.27 39.29 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.252 0.549 . . . . 0.0 111.253 179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.4 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 12.2 m-85 -113.26 129.16 56.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.112 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.598 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.2 ppt_? -132.86 136.38 46.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.502 0.667 . . . . 0.0 111.468 178.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -136.23 137.31 40.68 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.2 t70 60.89 29.8 19.24 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 121.324 0.583 . . . . 0.0 111.134 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.27 -0.51 67.99 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 119.539 -1.315 . . . . 0.0 113.197 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -122.03 139.78 31.02 Favored Pre-proline 0 C--N 1.323 -0.576 0 O-C-N 122.175 -0.603 . . . . 0.0 111.251 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 151.28 44.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.413 2.075 . . . . 0.0 111.851 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.88 136.46 58.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.353 0.597 . . . . 0.0 110.893 179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.71 154.51 17.18 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.508 179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -59.11 -20.6 54.99 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.395 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 64.5 p -80.29 -10.37 59.75 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.304 0.573 . . . . 0.0 111.399 -178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.78 164.54 13.09 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.748 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.0 p -113.31 155.15 44.98 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.004 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' A' ' 78' ' ' MET . 36.8 Cg_endo -66.47 -7.77 18.8 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.56 2.173 . . . . 0.0 111.879 178.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.98 -16.61 22.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.929 0.395 . . . . 0.0 110.618 178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -68.97 -40.65 78.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.42 0.628 . . . . 0.0 110.49 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.488 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -99.83 -1.14 38.28 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.487 0.66 . . . . 0.0 110.205 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 60.07 3.41 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.986 -1.006 . . . . 0.0 112.929 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.1 ptp -79.83 165.17 22.99 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 175.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.608 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 13.0 pt-20 -100.73 169.51 8.97 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.146 0.498 . . . . 0.0 112.203 -175.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.64 133.3 50.84 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.894 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 69.24 18.63 8.07 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.508 0.723 . . . . 0.0 111.61 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.608 ' OD2' ' HG2' ' A' ' 79' ' ' GLU . 4.0 t0 -67.92 174.77 3.47 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 177.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.418 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.1 m -133.11 150.51 52.05 Favored 'General case' 0 C--N 1.313 -1.019 0 O-C-N 121.687 -0.633 . . . . 0.0 110.899 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.418 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -122.57 145.98 28.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.598 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.0 t70 -92.71 133.63 35.82 Favored 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 121.028 0.442 . . . . 0.0 110.521 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.61 137.13 54.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-O 121.7 0.762 . . . . 0.0 110.644 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -137.54 148.15 45.72 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.582 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -107.21 111.84 24.44 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 -59.98 167.55 2.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.78 0.8 . . . . 0.0 111.766 177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -106.3 87.0 2.45 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.495 -0.775 . . . . 0.0 108.991 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 m -148.56 139.97 23.42 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.073 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -129.5 159.16 22.39 Favored Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.054 0 CA-C-O 118.515 -1.158 . . . . 0.0 111.678 179.653 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.959 0.409 . . . . 0.0 111.449 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.22 97.95 9.93 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -81.16 36.58 0.42 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.325 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -60.77 107.87 0.76 Allowed 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.125 0.488 . . . . 0.0 109.999 178.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 37.3 ttpt -174.28 -48.7 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.078 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.104 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 2.8 Cg_exo -77.48 170.82 18.67 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 121.938 1.758 . . . . 0.0 111.959 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -114.24 31.97 6.23 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.632 0.73 . . . . 0.0 109.746 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -68.41 -179.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.992 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.21 -27.96 16.42 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.2 p -113.16 121.22 64.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-O 121.345 0.593 . . . . 0.0 110.529 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.611 ' HD3' ' N ' ' A' ' 12' ' ' THR . 0.0 OUTLIER -74.14 -37.11 64.15 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 120.958 0.409 . . . . 0.0 111.941 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.611 ' N ' ' HD3' ' A' ' 11' ' ' LYS . 35.9 m -158.43 145.91 17.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 1.7 mp0 -63.63 103.41 0.54 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -83.5 -31.65 26.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.084 0.468 . . . . 0.0 109.932 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -64.98 154.52 37.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.83 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 17' ' ' HIS . 12.5 t70 -140.16 -161.55 1.21 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.45 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 50.1 p-80 -155.06 177.04 11.78 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -176.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 41.8 pt -128.56 169.37 20.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.326 0.584 . . . . 0.0 111.56 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.453 ' O ' HD22 ' A' ' 20' ' ' LEU . 19.3 m-80 -98.94 143.2 29.5 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.634 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.8 mm? -129.96 163.86 25.52 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.084 0.468 . . . . 0.0 110.026 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 55.6 mtpt -135.73 147.61 48.51 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' A' ' 32' ' ' PHE . 69.6 t -126.53 117.23 47.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.169 0.509 . . . . 0.0 110.264 177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.72 121.42 32.6 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.758 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.85 159.13 30.06 Favored Glycine 0 N--CA 1.42 -2.398 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -18.17 58.74 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.358 0.599 . . . . 0.0 111.679 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.76 -12.38 60.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.429 0.633 . . . . 0.0 110.499 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.24 8.46 57.67 Favored Glycine 0 C--N 1.321 -0.28 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.807 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.0 t -99.28 159.57 14.9 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.66 135.46 30.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-O 121.483 0.658 . . . . 0.0 111.274 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 14.6 p -104.98 138.49 29.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.063 177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -108.78 125.62 52.14 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.499 ' CE1' HG23 ' A' ' 22' ' ' VAL . 15.7 p90 -147.29 168.82 20.8 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.228 0.537 . . . . 0.0 111.446 -174.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -112.26 141.18 46.28 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.056 0.455 . . . . 0.0 111.157 -178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.402 ' CG2' HD23 ' A' ' 20' ' ' LEU . 14.9 tt -148.2 148.83 15.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.088 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 22.5 mtmm -85.05 157.79 20.63 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.762 -0.586 . . . . 0.0 110.418 -179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.53 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 17.3 mmm-85 -64.28 -41.18 97.02 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.151 0.501 . . . . 0.0 110.803 -177.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -89.92 7.42 37.4 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.421 0.629 . . . . 0.0 110.461 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 19.1 m -93.94 130.27 35.12 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.23 148.57 91.13 Favored 'Trans proline' 0 C--O 1.243 0.75 0 C-N-CA 122.818 2.345 . . . . 0.0 113.123 -178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.44 HD22 HD13 ' A' ' 43' ' ' LEU . 82.6 mt -62.76 -12.28 23.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.513 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 12.8 t -52.03 -43.79 63.88 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.609 0.364 . . . . 0.0 111.065 178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.538 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 44' ' ' MET . 2.6 tt -62.28 -51.33 68.14 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.35 178.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.589 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 36.4 mtt -61.86 -40.17 94.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.377 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 4.3 tppp? -66.71 -44.32 81.94 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.481 179.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.526 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -55.54 -51.58 66.58 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.868 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.11 -40.42 95.85 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-O 121.003 0.43 . . . . 0.0 111.111 178.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -42.01 96.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.041 0.448 . . . . 0.0 110.942 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 7.2 mm-40 -65.21 -39.65 93.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.852 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.8 mmp_? -65.61 -54.2 31.08 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.188 0.518 . . . . 0.0 111.51 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -21.41 59.36 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.184 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.67 4.08 87.74 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.694 178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -86.99 177.45 7.23 Favored 'General case' 0 C--N 1.318 -0.79 0 O-C-N 122.404 -0.468 . . . . 0.0 110.734 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 m -100.25 128.05 46.41 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 120.641 0.258 . . . . 0.0 110.603 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 3.1 ptp -64.35 -24.25 67.58 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.248 0.547 . . . . 0.0 111.247 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.444 ' HG3' HE21 ' A' ' 57' ' ' GLN . 10.6 ptp85 -77.67 -14.71 59.55 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.214 0.53 . . . . 0.0 110.778 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.444 HE21 ' HG3' ' A' ' 56' ' ' ARG . 23.9 mm-40 -99.85 1.0 42.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.156 0.503 . . . . 0.0 111.23 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.462 HG22 ' HG2' ' A' ' 88' ' ' GLN . 29.9 pt -130.71 173.03 15.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.135 0.493 . . . . 0.0 110.889 -178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.426 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 22.0 mmm180 -141.12 149.83 42.06 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.741 178.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.589 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 4.0 m-85 -114.34 132.17 56.28 Favored 'General case' 0 C--O 1.245 0.819 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.544 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 7.6 ppt_? -134.25 140.5 46.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.388 0.613 . . . . 0.0 110.993 178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -139.51 138.21 36.15 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.707 -178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.47 33.82 21.77 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.175 0.512 . . . . 0.0 112.107 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.1 -6.32 67.79 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.758 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -119.23 145.18 37.81 Favored Pre-proline 0 C--N 1.316 -0.886 0 O-C-N 122.13 -0.629 . . . . 0.0 111.045 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.05 151.61 35.1 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.386 2.057 . . . . 0.0 111.179 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.44 141.33 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 CA-C-O 121.458 0.647 . . . . 0.0 110.989 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 154.2 17.36 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.237 178.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.4 pt-20 -62.17 -16.34 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.2 p -79.55 -18.63 51.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.203 0.525 . . . . 0.0 110.874 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.446 ' OD2' ' HG2' ' A' ' 75' ' ' GLN . 0.3 OUTLIER -83.08 161.2 21.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.204 -179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 37.1 p -117.16 158.42 44.45 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.722 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.41 ' O ' ' HG2' ' A' ' 78' ' ' MET . 38.1 Cg_endo -68.27 -8.66 23.56 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.113 1.875 . . . . 0.0 111.529 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.38 -19.56 19.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.609 178.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.446 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 3.0 tp-100 -62.45 -36.31 82.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.42 0.628 . . . . 0.0 110.307 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.461 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.54 -0.3 20.44 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.783 179.222 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 51.05 63.09 2.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.507 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.634 ' SD ' HD11 ' A' ' 20' ' ' LEU . 12.1 ptp -77.44 175.47 9.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.825 178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -96.19 157.84 15.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.992 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -72.39 143.32 48.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 121.438 0.637 . . . . 0.0 111.17 177.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 69.93 20.19 6.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.27 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -73.06 176.92 5.35 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.419 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.4 m -133.43 151.58 51.82 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.163 0.506 . . . . 0.0 111.398 -176.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 83' ' ' THR . 3.2 mp -124.19 142.51 40.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.596 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 30.0 t70 -89.42 136.83 32.8 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 120.997 0.427 . . . . 0.0 110.601 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.6 t -121.2 137.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-O 121.631 0.729 . . . . 0.0 110.691 178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -138.22 149.11 45.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.703 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -107.49 110.26 22.14 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -121.54 116.12 24.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.571 0.7 . . . . 0.0 112.29 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.07 -83.25 0.31 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.129 174.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 17.0 p -147.27 136.86 22.84 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.23 106.31 0.2 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.917 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.288 0 CA-C-O 118.56 -1.134 . . . . 0.0 111.766 -179.13 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 121.045 0.45 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.04 139.8 31.49 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.131 0.491 . . . . 0.0 110.822 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -94.07 11.53 29.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.449 0.642 . . . . 0.0 110.461 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -110.66 99.1 8.12 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.237 0.542 . . . . 0.0 110.785 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -148.83 89.85 4.91 Favored Pre-proline 0 C--N 1.322 -0.595 0 O-C-N 121.871 -0.518 . . . . 0.0 110.396 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -91.39 135.7 1.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.783 2.322 . . . . 0.0 111.094 176.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -99.87 20.08 14.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.447 0.641 . . . . 0.0 110.649 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.58 171.6 14.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.158 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.44 -65.84 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.569 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.535 HG21 ' OD1' ' A' ' 14' ' ' ASN . 11.3 p -110.77 140.51 29.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.155 0.503 . . . . 0.0 111.475 -177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -63.62 -69.96 0.24 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.624 178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -85.84 150.97 24.17 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.158 0.504 . . . . 0.0 111.167 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -63.76 114.72 4.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.535 ' OD1' HG21 ' A' ' 10' ' ' VAL . 0.4 OUTLIER -126.83 119.16 26.16 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.257 0.551 . . . . 0.0 110.646 172.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -175.26 164.14 3.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.843 -177.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -22.55 124.93 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 124.439 1.087 . . . . 0.0 112.032 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.611 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 23.7 p-80 -141.81 179.2 6.99 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.28 -173.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.5 pt -109.05 169.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.516 0.674 . . . . 0.0 112.756 -175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.493 ' O ' HD22 ' A' ' 20' ' ' LEU . 9.5 m-80 -99.35 139.91 34.3 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.43 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.529 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -131.69 159.91 37.0 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.211 0.529 . . . . 0.0 110.296 176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -134.53 148.39 50.5 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.046 179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.494 HG23 ' CE1' ' A' ' 32' ' ' PHE . 70.2 t -126.64 117.19 47.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.163 0.506 . . . . 0.0 109.986 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.14 119.29 31.13 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.881 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.95 158.33 30.41 Favored Glycine 0 N--CA 1.426 -1.989 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.453 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.2 pp0? -66.24 -10.51 42.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.506 0.67 . . . . 0.0 110.886 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -76.53 -15.5 59.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.329 179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 99.01 14.23 37.16 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.543 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.9 t -119.59 166.25 13.39 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.7 p -139.23 137.79 41.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.171 0.51 . . . . 0.0 111.282 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.516 HG11 ' HG3' ' A' ' 50' ' ' ARG . 96.6 t -102.95 139.48 23.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.904 176.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -110.24 130.33 55.56 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.494 ' CE1' HG23 ' A' ' 22' ' ' VAL . 6.0 p90 -150.86 168.91 23.05 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.181 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -117.27 133.98 55.34 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 120.893 0.378 . . . . 0.0 111.018 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.611 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 16.9 tt -135.2 150.1 29.3 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 CA-C-O 121.225 0.536 . . . . 0.0 110.654 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.59 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 12.8 mttt -86.92 151.44 23.3 Favored 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 121.082 0.468 . . . . 0.0 110.847 -177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.51 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -61.72 -40.1 93.86 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.241 0.543 . . . . 0.0 110.805 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -87.73 6.17 36.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.289 0.566 . . . . 0.0 111.353 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.6 m -96.81 131.77 27.32 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.459 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.84 154.89 71.84 Favored 'Trans proline' 0 C--O 1.238 0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.931 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD22 HD13 ' A' ' 43' ' ' LEU . 95.4 mt -66.76 -11.25 54.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.771 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.4 p -50.74 -47.43 59.34 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.948 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.476 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.537 HD13 HD22 ' A' ' 40' ' ' LEU . 3.1 tt -61.01 -47.95 84.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.306 0.574 . . . . 0.0 110.331 178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.656 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -60.81 -50.36 73.76 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.402 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.682 ' O ' ' HG3' ' A' ' 49' ' ' GLU . 18.3 tppt? -60.84 -43.1 98.74 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.997 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.444 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -54.84 -52.79 61.63 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.047 0.451 . . . . 0.0 110.984 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -61.03 -43.96 98.11 Favored 'General case' 0 C--O 1.246 0.869 0 CA-C-O 121.333 0.587 . . . . 0.0 110.503 178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.524 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.4 m -61.02 -39.79 91.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.545 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.682 ' HG3' ' O ' ' A' ' 45' ' ' LYS . 36.0 mt-10 -66.65 -33.82 76.49 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.054 0.454 . . . . 0.0 110.927 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.516 ' HG3' HG11 ' A' ' 30' ' ' VAL . 10.8 mmm180 -67.65 -48.74 65.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.143 0.497 . . . . 0.0 111.139 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -80.76 -22.7 39.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.069 0.461 . . . . 0.0 111.533 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.23 72.6 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.43 -0.414 . . . . 0.0 113.023 178.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pp -88.73 177.01 6.85 Favored 'General case' 0 C--N 1.32 -0.697 0 O-C-N 122.177 -0.602 . . . . 0.0 112.266 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.8 m -99.89 140.24 34.39 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.073 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 8.0 ptp -66.45 -25.9 66.95 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.994 0.426 . . . . 0.0 111.321 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.456 ' HG3' HE21 ' A' ' 57' ' ' GLN . 15.2 ptp180 -75.53 -10.7 59.68 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.159 0.504 . . . . 0.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.456 HE21 ' HG3' ' A' ' 56' ' ' ARG . 21.9 mm-40 -101.41 4.32 41.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.003 0.43 . . . . 0.0 110.933 -177.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.524 HD11 ' SG ' ' A' ' 48' ' ' CYS . 31.3 pt -139.92 174.65 8.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.289 0.566 . . . . 0.0 111.701 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 -141.25 145.02 35.02 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.602 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.656 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 7.7 m-85 -113.43 131.57 55.97 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.673 -178.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.612 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -134.53 141.78 46.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.336 0.589 . . . . 0.0 111.209 178.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -145.5 142.76 29.51 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.353 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.0 t70 60.64 25.67 15.4 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 120.96 0.409 . . . . 0.0 110.998 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.24 -5.45 72.28 Favored Glycine 0 N--CA 1.435 -1.412 0 C-N-CA 119.367 -1.397 . . . . 0.0 113.094 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -120.34 145.11 39.68 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 122.165 -0.609 . . . . 0.0 111.426 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.73 147.9 40.67 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 122.371 2.047 . . . . 0.0 111.181 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.05 136.52 60.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.588 0 CA-C-O 121.255 0.55 . . . . 0.0 111.117 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.51 152.17 18.66 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.04 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.739 ' OE2' HG23 ' A' ' 70' ' ' THR . 0.2 OUTLIER -53.46 -21.48 6.24 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.739 HG23 ' OE2' ' A' ' 69' ' ' GLU . 40.6 p -74.16 -15.6 61.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.341 0.591 . . . . 0.0 111.661 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 55.9 m-20 -85.99 159.25 19.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.206 -178.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.8 p -119.8 155.4 54.96 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.62 -7.64 19.95 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.538 2.159 . . . . 0.0 112.336 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -94.88 -28.19 15.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.945 0.402 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -60.96 -39.62 90.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.151 0.5 . . . . 0.0 111.478 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.7 0.76 33.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 50.98 61.0 3.47 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.153 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.529 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.8 ptp -77.02 168.97 19.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.428 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -88.02 164.98 15.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.974 0.416 . . . . 0.0 110.169 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.24 141.37 31.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 120.349 -0.541 . . . . 0.0 109.626 177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 73.67 14.4 4.21 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 124.074 0.95 . . . . 0.0 110.649 -179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.96 175.51 3.66 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.421 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.401 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.4 m -133.69 150.62 51.53 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.272 0.558 . . . . 0.0 111.193 -176.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.401 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.94 144.81 28.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.612 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 38.7 t70 -92.17 134.31 34.98 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.077 0.465 . . . . 0.0 110.775 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.52 135.21 61.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-O 121.809 0.814 . . . . 0.0 111.178 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -138.61 149.5 45.3 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.163 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.511 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -110.71 110.48 21.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.452 0.644 . . . . 0.0 110.63 -177.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -82.94 75.7 9.81 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.271 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 13.1 mm100 -127.09 104.82 8.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.737 178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.3 t -164.82 165.82 20.23 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.67 -46.44 61.55 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.752 178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.548 -1.14 . . . . 0.0 112.172 178.024 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 111.582 0.216 . . . . 0.0 111.582 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -43.11 107.12 0.08 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.368 0.604 . . . . 0.0 111.901 178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -115.64 30.97 7.0 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.846 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -68.83 -26.56 65.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.329 0.585 . . . . 0.0 110.369 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -138.62 92.37 11.58 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.79 170.56 16.32 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.597 2.198 . . . . 0.0 112.237 -177.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -104.02 7.18 36.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.986 0.898 . . . . 0.0 108.95 179.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -143.91 166.17 25.68 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.147 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.04 60.37 0.36 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.489 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.8 p -127.31 104.09 11.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.879 0.847 . . . . 0.0 111.293 179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -104.82 -35.67 7.66 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.631 0.729 . . . . 0.0 109.873 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.0 161.94 37.46 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.185 -177.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 44.4 mt-10 -126.18 174.4 8.53 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.976 -0.452 . . . . 0.0 111.365 -178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 62.3 m-80 80.25 10.49 1.19 Allowed 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 124.272 1.029 . . . . 0.0 111.556 177.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.32 -73.56 0.25 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.041 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -105.63 124.62 49.85 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.46 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 36.1 p-80 -173.4 -178.82 1.76 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.7 pt -132.39 170.05 20.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.133 0.492 . . . . 0.0 110.639 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.523 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.9 m-80 -100.22 144.87 28.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.523 HD22 ' O ' ' A' ' 19' ' ' ASN . 1.8 mm? -133.43 162.68 31.2 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.094 0.473 . . . . 0.0 110.483 177.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 83' ' ' THR . 58.5 mtpt -137.39 147.5 45.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.816 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.483 HG23 ' CE1' ' A' ' 32' ' ' PHE . 76.3 t -125.17 120.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 120.951 0.405 . . . . 0.0 110.411 179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -95.28 122.54 38.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.597 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.0 160.8 30.03 Favored Glycine 0 N--CA 1.419 -2.453 0 C-N-CA 120.547 -0.835 . . . . 0.0 111.136 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -21.1 65.57 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.428 0.632 . . . . 0.0 111.022 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -71.44 -16.5 62.38 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.477 178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.27 11.04 49.93 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.675 -179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 t -101.91 157.54 16.78 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 8.2 p -139.99 137.6 38.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.128 0.489 . . . . 0.0 110.794 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.561 HG21 ' HG3' ' A' ' 50' ' ' ARG . 11.4 p -109.43 142.52 21.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 178.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -112.85 127.01 56.06 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.323 0.582 . . . . 0.0 109.542 178.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.483 ' CE1' HG23 ' A' ' 22' ' ' VAL . 13.4 p90 -151.04 168.73 23.7 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-O 121.284 0.564 . . . . 0.0 111.561 -174.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mtmm -112.51 142.86 44.57 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.697 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.426 ' CG2' HD23 ' A' ' 20' ' ' LEU . 16.1 tt -148.15 146.5 17.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.078 0.466 . . . . 0.0 110.192 178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 33.4 mtmt -83.97 158.45 21.52 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.874 -0.516 . . . . 0.0 110.738 -178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.714 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 26.1 mmm-85 -65.45 -38.98 91.43 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.164 0.507 . . . . 0.0 110.485 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -91.4 6.86 43.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.313 0.578 . . . . 0.0 110.538 -178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 16.0 m -93.93 130.03 35.9 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.78 151.16 85.13 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.886 2.39 . . . . 0.0 112.89 -178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.483 HD22 HD13 ' A' ' 43' ' ' LEU . 86.8 mt -64.26 -11.77 34.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.282 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.5 p -51.51 -45.11 62.76 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.924 0.392 . . . . 0.0 111.364 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.482 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD13 HD22 ' A' ' 40' ' ' LEU . 3.0 tt -62.5 -48.64 78.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.21 178.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.625 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 30.1 mtt -61.54 -41.8 97.88 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.539 178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.719 ' HD3' ' SG ' ' A' ' 48' ' ' CYS . 18.1 tppt? -68.13 -41.59 81.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.266 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -60.05 -47.45 85.82 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-O 121.15 0.5 . . . . 0.0 110.957 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -65.01 -40.19 94.52 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-O 121.248 0.547 . . . . 0.0 110.693 178.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.719 ' SG ' ' HD3' ' A' ' 45' ' ' LYS . 0.5 OUTLIER -60.97 -36.7 80.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.277 -177.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.2 mm-40 -74.46 -39.74 62.33 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.229 -178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.561 ' HG3' HG21 ' A' ' 30' ' ' VAL . 17.0 mmt180 -64.04 -46.8 82.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.217 0.532 . . . . 0.0 111.437 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -81.46 -16.64 51.34 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.58 57.28 5.08 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.919 -1.134 . . . . 0.0 111.535 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.44 175.58 10.7 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.749 0.309 . . . . 0.0 110.253 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.485 ' HB3' ' HG2' ' A' ' 56' ' ' ARG . 58.3 m -99.93 132.2 45.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.762 0.315 . . . . 0.0 110.984 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.9 ptp -63.74 -26.05 68.47 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.215 0.531 . . . . 0.0 111.088 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 54' ' ' SER . 7.6 ptm180 -74.72 -13.38 60.6 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.999 0.428 . . . . 0.0 111.347 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.422 HE21 ' HG3' ' A' ' 56' ' ' ARG . 21.9 mm-40 -103.25 6.92 38.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.143 0.497 . . . . 0.0 111.381 -178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.495 HG22 ' HG2' ' A' ' 88' ' ' GLN . 23.2 pt -133.36 170.31 20.19 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-O 121.122 0.487 . . . . 0.0 111.241 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 6.7 mmm180 -138.1 140.2 39.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.397 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.625 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 8.3 m-85 -108.75 131.36 55.02 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.55 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.499 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 5.4 ppt_? -131.69 140.93 49.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -141.75 138.8 32.58 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.5 -179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 t70 59.94 28.78 18.34 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 120.953 0.406 . . . . 0.0 111.274 177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.45 -3.57 77.4 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 119.545 -1.312 . . . . 0.0 113.316 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -123.45 144.89 45.24 Favored Pre-proline 0 C--N 1.321 -0.67 0 O-C-N 121.899 -0.765 . . . . 0.0 111.637 -179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -74.57 150.44 40.38 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 122.665 2.244 . . . . 0.0 112.014 178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 138.95 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 121.713 0.768 . . . . 0.0 111.267 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -92.47 154.91 18.19 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.589 178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.602 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.6 pt-20 -62.49 -18.29 61.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.097 0.475 . . . . 0.0 112.227 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 61.8 p -79.63 -14.77 58.57 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.288 0.566 . . . . 0.0 111.283 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.2 158.61 21.24 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.001 0.429 . . . . 0.0 110.151 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 p -118.69 151.58 50.16 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.512 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.43 -9.05 18.75 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.47 2.113 . . . . 0.0 112.111 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.68 -20.46 18.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.424 178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -69.68 -36.14 75.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.144 0.497 . . . . 0.0 110.814 -178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.49 -0.34 24.08 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.344 0.592 . . . . 0.0 110.224 178.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 48.95 62.5 2.56 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.9 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.6 ptp -74.3 166.62 23.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.09 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 39.1 tt0 -87.75 157.02 19.15 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.114 0.483 . . . . 0.0 110.849 -176.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -72.81 139.4 47.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.118 0.485 . . . . 0.0 110.066 177.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 71.13 15.93 6.42 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 124.069 0.948 . . . . 0.0 110.594 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.0 OUTLIER -70.37 176.68 3.82 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.448 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -130.14 147.26 51.85 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.4 0.619 . . . . 0.0 111.45 -177.207 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.41 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -120.82 133.97 65.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 61' ' ' ARG . 2.5 m-20 -86.31 136.31 33.2 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.045 0.45 . . . . 0.0 111.088 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -123.87 140.36 47.57 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 CA-C-O 121.382 0.611 . . . . 0.0 111.145 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.66 147.01 44.54 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.588 178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.495 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -105.15 111.48 24.26 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.36 0.6 . . . . 0.0 111.107 -176.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -130.43 121.32 25.67 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.868 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -85.41 -59.66 2.26 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 120.962 0.411 . . . . 0.0 110.543 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.1 m 59.74 67.97 0.83 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.615 0.721 . . . . 0.0 110.168 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.3 -47.95 3.84 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.289 -178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.155 0 CA-C-O 118.305 -1.275 . . . . 0.0 111.863 -179.931 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 mmt . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.75 0.309 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.4 133.99 43.1 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.956 0.408 . . . . 0.0 111.141 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -112.34 38.78 2.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.087 0.946 . . . . 0.0 109.694 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.414 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 48.3 mt-10 -139.79 150.06 44.27 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.5 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 19.9 ttmm -48.01 -53.61 31.26 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.448 176.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 5' ' ' LYS . 72.7 Cg_endo -74.17 163.0 37.6 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 121.88 1.72 . . . . 0.0 111.33 174.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.6 ptmt -93.83 -16.45 24.09 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.39 0.614 . . . . 0.0 110.321 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.35 22.57 1.23 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.333 0.587 . . . . 0.0 111.29 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -85.43 -22.79 49.98 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 177.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.08 141.4 20.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.201 -0.499 . . . . 0.0 110.202 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -117.17 -69.7 0.84 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.299 0.571 . . . . 0.0 110.551 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -143.68 137.26 28.1 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.651 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -141.76 91.69 2.38 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.582 0.706 . . . . 0.0 111.498 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -124.15 16.4 9.16 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 122.003 0.906 . . . . 0.0 108.84 176.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -108.2 15.83 23.8 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.058 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.5 89.37 0.23 Allowed 'General case' 0 CA--C 1.511 -0.531 0 CA-C-O 121.454 0.645 . . . . 0.0 110.741 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.536 ' HB2' ' HA ' ' A' ' 35' ' ' LYS . 36.5 p-80 -137.92 174.65 10.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 120.999 0.428 . . . . 0.0 110.312 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 35.5 pt -128.59 169.08 20.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.332 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.507 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.9 m-80 -97.46 144.61 27.02 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -132.75 160.77 35.86 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.292 0.568 . . . . 0.0 110.779 177.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.8 mtpt -136.11 148.84 48.44 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.789 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.46 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.8 t -129.16 116.6 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-O 120.955 0.407 . . . . 0.0 110.171 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -88.54 128.03 35.55 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.9 156.87 22.59 Favored Glycine 0 N--CA 1.417 -2.616 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -64.45 -11.55 34.62 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.493 0.663 . . . . 0.0 110.879 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.55 -19.29 55.96 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.211 178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.34 9.36 36.33 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.913 -0.66 . . . . 0.0 113.297 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 t -113.45 157.36 22.05 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 122.296 -0.532 . . . . 0.0 109.899 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.44 135.02 58.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.425 0.631 . . . . 0.0 111.258 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 50' ' ' ARG . 14.4 p -101.78 142.09 16.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 O-C-N 122.118 -0.364 . . . . 0.0 110.263 177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -112.03 130.93 55.7 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.107 0.48 . . . . 0.0 109.73 178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.46 ' CE1' HG23 ' A' ' 22' ' ' VAL . 9.5 p90 -151.37 168.37 25.02 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.438 -175.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.496 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 41.8 mtmt -113.87 136.5 52.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.862 0.363 . . . . 0.0 110.818 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 15.9 tt -142.62 147.09 21.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.049 0.452 . . . . 0.0 110.227 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HA ' ' HB2' ' A' ' 17' ' ' HIS . 27.1 mtmm -85.14 157.62 20.62 Favored 'General case' 0 CA--C 1.501 -0.929 0 CA-C-O 121.083 0.468 . . . . 0.0 111.376 -177.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -63.16 -41.52 99.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.704 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -88.73 6.86 36.65 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.322 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 13.6 m -93.99 130.12 35.51 Favored Pre-proline 0 C--N 1.309 -1.156 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.873 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.87 151.32 84.49 Favored 'Trans proline' 0 C--O 1.241 0.669 0 C-N-CA 122.696 2.264 . . . . 0.0 112.655 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 43' ' ' LEU . 87.3 mt -66.64 -13.19 60.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.296 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 14.4 m -47.92 -44.34 29.76 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.189 0.518 . . . . 0.0 110.904 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.502 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD13 HD22 ' A' ' 40' ' ' LEU . 4.0 tt -61.73 -51.67 67.39 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.789 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 40' ' ' LEU . 2.0 mpt? -58.51 -50.24 74.47 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 120.963 0.411 . . . . 0.0 110.601 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.7 tppp? -62.82 -37.92 88.69 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.402 -178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.623 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -60.25 -49.8 76.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.046 0.451 . . . . 0.0 110.531 -178.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -64.05 -40.5 96.43 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.025 0.441 . . . . 0.0 111.036 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.588 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.1 m -63.15 -34.98 78.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.299 0.571 . . . . 0.0 110.997 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.5 mm-40 -71.55 -41.79 68.68 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.789 178.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.623 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 3.6 mmp_? -66.48 -47.15 73.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.353 0.597 . . . . 0.0 111.303 -178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.16 -16.61 52.42 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.895 -177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.78 57.77 5.2 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.606 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.5 pp -147.92 173.6 12.71 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 122.666 -0.314 . . . . 0.0 110.425 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.2 m -98.87 133.73 42.74 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.756 0.312 . . . . 0.0 111.698 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.483 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 9.5 ptp -65.06 -26.36 68.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.078 0.466 . . . . 0.0 111.269 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.4 ' HG3' HE21 ' A' ' 57' ' ' GLN . 19.1 ptp180 -74.66 -6.24 47.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.238 0.542 . . . . 0.0 110.836 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.4 HE21 ' HG3' ' A' ' 56' ' ' ARG . 23.8 mm-40 -109.35 5.17 23.31 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.932 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.724 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.7 pt -137.19 171.99 15.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.188 0.518 . . . . 0.0 111.177 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 24.2 mmt180 -142.6 147.91 36.61 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.265 177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.423 ' HB3' HG21 ' A' ' 84' ' ' ILE . 9.0 m-85 -114.28 128.22 56.25 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.121 -178.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.62 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 5.8 ppt_? -130.26 136.8 49.57 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.552 0.692 . . . . 0.0 111.534 178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.421 ' HB2' HG13 ' A' ' 84' ' ' ILE . 81.9 t80 -138.69 133.14 31.92 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.548 -178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.5 t70 65.06 26.3 12.58 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.064 0.459 . . . . 0.0 110.57 178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 82.85 -5.13 76.94 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 119.851 -1.166 . . . . 0.0 113.242 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -120.05 142.91 34.31 Favored Pre-proline 0 C--N 1.322 -0.603 0 O-C-N 122.054 -0.674 . . . . 0.0 111.381 -179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.19 144.55 29.76 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.538 2.159 . . . . 0.0 111.955 179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.62 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 121.589 0.709 . . . . 0.0 110.674 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.21 156.84 18.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.96 179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 5.1 pt-20 -57.37 -26.49 61.1 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.134 0.492 . . . . 0.0 112.176 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.2 p -74.29 -17.2 60.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.072 0.463 . . . . 0.0 111.223 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -78.87 158.4 28.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.195 0.521 . . . . 0.0 111.005 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.0 p -117.33 153.11 49.97 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.572 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.69 -7.35 19.17 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.449 2.099 . . . . 0.0 112.018 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.23 -23.06 17.42 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.095 0.474 . . . . 0.0 110.608 178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -62.54 -39.46 93.68 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.391 0.615 . . . . 0.0 110.561 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.71 1.48 23.08 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.863 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 49.16 62.65 2.5 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.658 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.526 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.3 ptp -76.23 170.44 16.31 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.28 177.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -88.06 163.91 16.01 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.394 0.616 . . . . 0.0 111.237 -177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -82.46 138.83 34.26 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 72.36 13.46 5.55 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 123.963 0.905 . . . . 0.0 110.246 -177.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -68.08 172.8 5.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.92 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.424 ' C ' HD12 ' A' ' 84' ' ' ILE . 2.1 m -132.1 151.56 51.71 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.281 0.562 . . . . 0.0 111.355 -177.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 83' ' ' THR . 3.0 mp -123.85 141.59 43.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.62 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 31.8 t70 -90.82 132.32 35.95 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.14 0.495 . . . . 0.0 110.907 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.6 t -116.19 134.58 59.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 121.555 0.693 . . . . 0.0 110.917 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -141.93 153.24 44.21 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.179 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.724 ' HG2' HG22 ' A' ' 58' ' ' ILE . 91.0 mt-30 -107.79 108.64 19.93 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -126.79 15.0 7.5 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.17 135.93 53.65 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 121.658 -0.651 . . . . 0.0 110.026 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.1 t -106.71 -22.75 12.63 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 121.757 0.789 . . . . 0.0 109.725 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -82.57 -136.27 2.46 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.544 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.108 0 CA-C-O 118.363 -1.243 . . . . 0.0 111.394 -178.41 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 1' ' ' MET . 25.0 ttt . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 121.769 0.795 . . . . 0.0 110.351 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.1 107.23 17.46 Favored 'General case' 0 C--N 1.317 -0.813 0 O-C-N 121.964 -0.46 . . . . 0.0 110.079 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -84.98 -29.18 25.27 Favored 'General case' 0 CA--C 1.5 -0.946 0 CA-C-O 121.748 0.785 . . . . 0.0 109.509 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 62.65 54.55 2.35 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.365 -1.289 . . . . 0.0 112.063 176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 62.9 mttm -73.1 -50.71 6.47 Favored Pre-proline 0 CA--C 1.539 0.537 0 O-C-N 122.203 -0.31 . . . . 0.0 111.081 176.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 5' ' ' LYS . 6.3 Cg_exo -80.32 142.76 15.16 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 121.823 1.682 . . . . 0.0 110.828 176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -85.17 61.16 6.7 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.554 0.692 . . . . 0.0 110.337 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.3 98.69 0.11 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.263 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.9 28.38 0.04 OUTLIER Glycine 0 C--N 1.309 -0.943 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.511 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.0 m -132.68 -177.73 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -57.5 -67.15 0.36 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.298 0.571 . . . . 0.0 111.172 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -124.06 87.69 2.78 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.301 0.572 . . . . 0.0 109.907 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -63.09 152.01 38.36 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.999 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -95.51 122.43 38.23 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -126.49 -170.63 2.23 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.672 0.749 . . . . 0.0 111.975 -175.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.36 118.76 13.58 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 33' ' ' LYS . 51.7 p-80 -157.69 167.57 29.71 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 109.047 -0.724 . . . . 0.0 109.047 -175.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.5 pt -121.07 168.94 12.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.451 0.643 . . . . 0.0 111.657 -179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.505 ' O ' HD22 ' A' ' 20' ' ' LEU . 21.7 m-80 -100.47 141.7 32.97 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.751 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.534 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.56 162.78 30.98 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.042 0.449 . . . . 0.0 110.446 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.7 mtpt -135.66 149.04 49.18 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.24 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.517 HG23 ' CE1' ' A' ' 32' ' ' PHE . 72.5 t -127.36 115.6 40.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.12 0.486 . . . . 0.0 110.308 177.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -90.53 118.36 29.93 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.058 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -86.0 156.96 30.36 Favored Glycine 0 N--CA 1.425 -2.051 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HG2' ' HG3' ' A' ' 88' ' ' GLN . 5.1 pp0? -63.54 -15.44 58.0 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.362 0.601 . . . . 0.0 111.094 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.02 -17.49 61.44 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.763 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.1 10.57 36.43 Favored Glycine 0 C--O 1.229 -0.178 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.601 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 t -112.41 161.72 16.37 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.2 p -138.09 136.84 44.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 121.452 0.644 . . . . 0.0 110.713 -179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 87.5 t -102.58 135.03 41.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -109.59 126.74 53.92 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.605 ' HB2' HH31 ' A' ' 42' ' ' ALY . 11.9 p90 -148.18 168.15 23.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.408 0.623 . . . . 0.0 111.755 -174.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 38.2 mtmt -115.53 134.6 54.91 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.302 -178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.419 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 17.6 tt -139.07 149.82 23.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.976 0.417 . . . . 0.0 110.206 -179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.6 mtmp? -87.78 155.93 19.66 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 121.907 -0.496 . . . . 0.0 111.187 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 28.9 mmm-85 -63.72 -34.69 78.44 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.784 -177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -96.41 6.53 48.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 110.781 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.534 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 15.9 m -93.65 130.79 33.95 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -67.49 151.65 79.65 Favored 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 122.717 2.278 . . . . 0.0 112.122 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.823 HD22 HD13 ' A' ' 43' ' ' LEU . 33.3 mt -65.61 -11.37 43.81 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 116.108 -0.497 . . . . 0.0 112.32 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 15.8 p -48.91 -42.34 36.67 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.061 0.457 . . . . 0.0 111.047 178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.605 HH31 ' HB2' ' A' ' 32' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.823 HD13 HD22 ' A' ' 40' ' ' LEU . 4.3 tt -61.72 -53.35 57.26 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.473 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.433 ' N ' HD23 ' A' ' 43' ' ' LEU . 2.0 mpt? -59.72 -39.85 86.01 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.113 0.482 . . . . 0.0 110.589 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 3.8 tppp? -70.12 -40.72 74.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.024 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.27 -48.9 75.66 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.379 0.609 . . . . 0.0 110.336 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -65.44 -39.43 92.05 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.67 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.01 -38.67 86.87 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.792 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 41.8 mm-40 -67.04 -46.21 75.12 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.346 0.593 . . . . 0.0 110.92 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -59.77 -47.68 84.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.755 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.34 -21.38 30.95 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.971 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.09 4.8 90.13 Favored Glycine 0 C--N 1.322 -0.246 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.647 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 pp -87.39 177.22 7.18 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.995 0.426 . . . . 0.0 111.633 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.482 ' HB2' ' CG ' ' A' ' 57' ' ' GLN . 43.8 m -95.34 130.38 42.15 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 4.7 ptp -65.17 -24.78 67.48 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.213 0.53 . . . . 0.0 111.341 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -79.37 -12.48 59.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.361 0.6 . . . . 0.0 111.118 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.482 ' CG ' ' HB2' ' A' ' 54' ' ' SER . 26.3 mm-40 -98.72 8.24 45.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.476 0.655 . . . . 0.0 111.013 -178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.546 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.4 pt -137.47 174.78 10.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 CA-C-O 120.996 0.427 . . . . 0.0 110.803 -178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 26.8 mmt180 -139.77 146.31 39.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.598 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 44' ' ' MET . 16.8 m-85 -115.26 128.09 55.9 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.32 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.581 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.0 ppt_? -132.02 134.22 45.31 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.498 0.665 . . . . 0.0 110.866 178.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -128.09 131.99 49.03 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.224 -177.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.4 31.56 7.41 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.78 -1.74 83.8 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.66 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -124.19 136.09 27.2 Favored Pre-proline 0 C--N 1.323 -0.562 0 O-C-N 121.95 -0.735 . . . . 0.0 111.576 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.16 146.16 45.61 Favored 'Trans proline' 0 C--O 1.24 0.599 0 C-N-CA 122.948 2.432 . . . . 0.0 111.944 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.42 136.03 61.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.614 0.721 . . . . 0.0 111.714 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.97 157.69 16.19 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.613 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 41' ' ' SER . 4.3 pt-20 -62.87 -18.45 62.96 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.263 0.554 . . . . 0.0 112.198 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.7 p -80.86 -11.4 59.6 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 121.082 0.468 . . . . 0.0 111.266 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.489 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.2 OUTLIER -87.52 160.02 18.4 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.88 -179.56 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.5 p -117.35 155.21 50.24 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.575 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' A' ' 78' ' ' MET . 43.7 Cg_endo -67.13 -12.86 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.31 2.007 . . . . 0.0 112.163 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.85 -16.99 21.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.188 0.518 . . . . 0.0 110.861 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -68.28 -34.55 76.38 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.405 0.621 . . . . 0.0 110.666 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.462 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.19 0.96 21.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.336 0.589 . . . . 0.0 110.413 177.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 50.67 59.52 4.53 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.21 -0.905 . . . . 0.0 113.367 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.534 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.84 170.37 15.48 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.08 0.467 . . . . 0.0 110.043 176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -95.13 162.77 13.57 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.027 0.442 . . . . 0.0 110.532 -178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -75.27 137.37 41.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.153 0.502 . . . . 0.0 110.491 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 75.19 16.25 2.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.171 0.989 . . . . 0.0 110.995 177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -69.65 177.25 3.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.146 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.8 m -135.18 151.68 50.87 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.15 0.5 . . . . 0.0 111.216 -178.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.9 142.69 35.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.581 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 35.9 t70 -93.06 132.95 36.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.027 0.442 . . . . 0.0 110.838 -178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.9 t -116.15 132.55 65.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.84 0.828 . . . . 0.0 111.49 178.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE1' ' HG2' ' A' ' 61' ' ' ARG . 2.1 p90 -135.33 143.29 46.07 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.634 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -110.38 111.87 23.44 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.143 0.497 . . . . 0.0 110.616 -176.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -107.17 82.3 1.66 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.101 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -168.81 103.02 0.4 Allowed 'General case' 0 C--O 1.226 -0.146 0 CA-C-O 121.349 0.595 . . . . 0.0 112.294 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.4 m -60.21 107.73 0.69 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.111 0.481 . . . . 0.0 110.971 177.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -112.96 56.42 0.48 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.134 -0.555 . . . . 0.0 111.733 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.6 -1.111 . . . . 0.0 111.622 -179.132 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.471 0.601 0 CA-C-O 121.112 0.482 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.16 106.36 6.02 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.088 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -118.62 11.99 12.99 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.225 0.536 . . . . 0.0 110.286 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -58.71 -71.41 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.078 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 54.73 74.08 0.79 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.159 -177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.31 164.71 29.49 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.692 2.261 . . . . 0.0 112.876 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -83.32 -39.8 20.31 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.453 0.644 . . . . 0.0 109.786 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -167.24 159.42 12.76 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -88.78 57.97 4.07 Favored Glycine 0 C--N 1.316 -0.538 0 C-N-CA 120.292 -0.956 . . . . 0.0 113.004 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.06 135.07 26.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.322 0.582 . . . . 0.0 110.397 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -97.81 136.06 38.68 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.5 t -44.75 133.79 5.89 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.575 0.702 . . . . 0.0 111.336 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -88.19 177.82 6.79 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.236 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -64.41 140.31 58.86 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.868 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -94.56 79.47 3.82 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.522 0.677 . . . . 0.0 111.002 -178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -100.89 -169.41 1.7 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.023 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 34' ' ' ILE . 41.2 p-80 -139.27 161.17 38.09 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.839 0.352 . . . . 0.0 110.629 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.6 pt -110.74 169.86 3.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 121.542 0.686 . . . . 0.0 112.655 -174.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.446 ' O ' HD22 ' A' ' 20' ' ' LEU . 25.1 m-80 -94.66 140.91 29.24 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.589 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.593 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.7 mm? -129.8 159.66 35.87 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.7 mtpt -134.52 147.17 50.27 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-O 121.093 0.473 . . . . 0.0 110.178 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 32' ' ' PHE . 77.4 t -127.74 116.94 44.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.118 0.485 . . . . 0.0 110.372 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -91.08 119.62 31.38 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.591 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.03 162.25 32.36 Favored Glycine 0 N--CA 1.421 -2.337 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.201 -178.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -16.42 63.87 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.734 0.778 . . . . 0.0 110.571 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.25 -19.45 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.17 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.98 7.87 54.72 Favored Glycine 0 C--N 1.323 -0.166 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.263 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.8 t -108.39 165.03 11.82 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -139.41 139.51 38.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-O 121.269 0.557 . . . . 0.0 110.674 -178.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG21 ' HG3' ' A' ' 50' ' ' ARG . 10.0 p -106.32 139.62 27.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -113.19 124.83 53.45 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.433 ' CE1' HG23 ' A' ' 22' ' ' VAL . 8.0 p90 -147.75 167.78 23.8 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.143 -174.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -114.7 138.49 50.64 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.018 0.437 . . . . 0.0 111.146 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -144.18 148.65 18.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.986 0.422 . . . . 0.0 110.586 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 6.1 mtmp? -81.07 154.88 26.59 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 120.969 0.414 . . . . 0.0 110.627 -179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.488 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 24.3 mmm-85 -66.14 -37.47 85.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.223 0.535 . . . . 0.0 110.562 -178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -90.24 6.79 41.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.584 0.707 . . . . 0.0 110.49 -178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.536 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 12.7 m -94.71 131.52 30.48 Favored Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.924 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.79 149.94 86.4 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.804 2.336 . . . . 0.0 113.009 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.445 ' CD2' HD13 ' A' ' 43' ' ' LEU . 78.0 mt -64.56 -12.02 40.61 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.452 0.701 . . . . 0.0 112.132 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.0 t -52.07 -46.54 65.21 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.891 0.377 . . . . 0.0 110.867 179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.467 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD13 ' CD2' ' A' ' 40' ' ' LEU . 2.9 tt -61.95 -49.06 77.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.306 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.686 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 31.6 mtt -58.81 -49.47 77.56 Favored 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.101 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.677 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 18.2 tppt? -60.03 -43.0 95.61 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -56.33 -49.92 72.97 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.042 0.449 . . . . 0.0 110.95 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -64.17 -41.11 97.27 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 58' ' ' ILE . 73.4 m -63.72 -33.94 76.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.515 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.677 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 14.8 mm-40 -71.6 -40.86 69.57 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.23 0.538 . . . . 0.0 110.177 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.498 ' HG3' HG21 ' A' ' 30' ' ' VAL . 10.2 mmm180 -66.21 -46.69 76.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.649 -179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.19 -22.11 42.25 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.009 0.433 . . . . 0.0 111.436 -177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.35 58.47 3.61 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.144 -1.026 . . . . 0.0 111.773 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.41 176.06 10.32 Favored 'General case' 0 C--N 1.316 -0.873 0 O-C-N 122.57 -0.37 . . . . 0.0 110.992 -177.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -95.4 130.31 42.24 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.821 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.571 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 4.2 ptp -64.5 -21.41 66.67 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.085 0.469 . . . . 0.0 111.84 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -83.19 -6.72 59.58 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 0.0 111.274 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.345 0.593 . . . . 0.0 110.725 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.582 HD11 ' SG ' ' A' ' 48' ' ' CYS . 28.8 pt -136.56 170.58 18.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.064 0.459 . . . . 0.0 110.642 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 18.0 mmm180 -141.22 143.01 33.93 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.6 m-85 -110.1 134.39 52.22 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.57 -179.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.58 ' CG ' ' HB3' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.295 0.569 . . . . 0.0 110.599 178.005 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -140.78 139.27 34.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 55.6 31.09 16.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.98 0.419 . . . . 0.0 111.103 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.07 -4.09 72.99 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.943 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -119.65 140.15 28.98 Favored Pre-proline 0 C--N 1.322 -0.61 0 O-C-N 121.955 -0.733 . . . . 0.0 111.358 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.16 146.15 45.62 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.486 2.124 . . . . 0.0 111.641 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.18 135.84 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.845 0 CA-C-O 121.605 0.716 . . . . 0.0 111.049 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.06 155.93 18.73 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.111 -0.949 . . . . 0.0 110.335 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.589 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -61.9 -19.93 63.21 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.268 0.556 . . . . 0.0 111.965 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 49.1 p -80.2 -10.43 59.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.82 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.39 161.11 17.26 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.722 0.296 . . . . 0.0 110.471 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.0 p -118.09 153.7 51.38 Favored Pre-proline 0 C--N 1.32 -0.682 0 O-C-N 122.371 -0.206 . . . . 0.0 111.049 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.42 ' HG2' ' HA ' ' A' ' 36' ' ' ARG . 25.6 Cg_endo -63.99 -10.67 23.88 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.653 2.235 . . . . 0.0 112.328 178.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.24 -17.87 21.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.071 0.462 . . . . 0.0 110.962 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -35.55 76.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.386 0.612 . . . . 0.0 110.855 -178.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.03 1.96 24.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.444 0.64 . . . . 0.0 110.77 179.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 52.39 61.71 3.06 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.697 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.593 ' SD ' HD11 ' A' ' 20' ' ' LEU . 11.7 ptp -80.29 174.33 11.71 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.134 -0.354 . . . . 0.0 110.331 176.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -99.76 169.68 9.08 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.238 0.542 . . . . 0.0 111.091 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -80.57 138.56 36.48 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 74.32 12.37 4.02 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 124.056 0.942 . . . . 0.0 111.426 -179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -67.63 174.89 3.18 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 2.5 m -135.33 150.19 49.92 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.363 0.601 . . . . 0.0 111.536 -176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 61' ' ' ARG . 3.1 mp -121.32 144.33 30.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.58 ' HB3' ' CG ' ' A' ' 61' ' ' ARG . 25.4 t0 -92.63 138.56 31.39 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.352 -179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -123.49 137.78 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 CA-C-O 121.571 0.701 . . . . 0.0 110.706 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.434 ' HE1' ' HG2' ' A' ' 61' ' ' ARG . 1.7 p90 -134.94 143.3 46.82 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.561 177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.454 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.3 OUTLIER -97.13 111.09 23.48 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.872 -178.127 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -56.25 156.18 6.0 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.673 176.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -78.23 161.89 26.96 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.36 0.6 . . . . 0.0 111.306 -177.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.1 p -83.83 -10.93 57.69 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.525 0.679 . . . . 0.0 110.494 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 138.17 -178.34 19.32 Favored Glycine 0 N--CA 1.437 -1.294 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.447 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.387 0 CA-C-O 118.72 -1.044 . . . . 0.0 111.377 179.362 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 120.989 0.423 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.54 97.09 5.62 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.269 0.557 . . . . 0.0 110.976 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -88.95 -12.04 42.69 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.599 0.714 . . . . 0.0 110.627 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -98.68 31.53 2.88 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.701 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.6 tttp -66.48 -47.65 57.62 Favored Pre-proline 0 CA--C 1.546 0.803 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.797 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -72.54 141.4 34.6 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 121.471 1.447 . . . . 0.0 111.846 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -102.87 22.79 13.22 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.825 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.64 129.16 39.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.202 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -83.75 57.98 5.03 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 121.17 -0.538 . . . . 0.0 112.113 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 13' ' ' GLU . 14.3 t -104.18 150.86 7.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -126.95 -34.49 2.36 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.179 0.514 . . . . 0.0 111.076 -177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.4 t -85.09 22.16 1.49 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.855 0.836 . . . . 0.0 111.497 -176.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.457 ' HB3' HD22 ' A' ' 15' ' ' ASN . 34.5 mm-40 -58.94 -71.63 0.11 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.173 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.82 25.1 15.01 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.165 0.507 . . . . 0.0 112.02 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.457 HD22 ' HB3' ' A' ' 13' ' ' GLU . 10.3 p30 -69.56 120.72 15.77 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.372 0.605 . . . . 0.0 109.652 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -161.35 -174.28 4.22 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.0 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.551 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 57.2 p-80 -132.75 153.93 50.72 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.089 0.471 . . . . 0.0 110.982 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.6 pt -111.9 169.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-O 121.407 0.622 . . . . 0.0 111.666 -176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.2 m-80 -97.47 143.4 28.23 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.39 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.9 mm? -132.05 162.11 31.58 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.081 0.467 . . . . 0.0 110.054 177.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 60.4 mtpt -133.94 147.42 51.06 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.071 0.462 . . . . 0.0 110.134 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 32' ' ' PHE . 81.1 t -127.99 117.85 47.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.108 0.48 . . . . 0.0 110.165 177.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -92.87 122.15 34.95 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.1 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -88.04 157.84 28.66 Favored Glycine 0 N--CA 1.425 -2.046 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -66.42 -11.97 54.6 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.281 0.562 . . . . 0.0 111.242 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.61 -16.56 57.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.289 0.566 . . . . 0.0 110.51 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.73 11.28 30.98 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.435 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.7 t -111.34 159.07 18.32 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 122.2 -0.588 . . . . 0.0 109.516 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.2 p -137.33 136.17 46.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.269 0.557 . . . . 0.0 110.541 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 90.5 t -103.19 137.58 30.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.225 178.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -111.41 123.19 49.71 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.507 ' CE1' HG23 ' A' ' 22' ' ' VAL . 10.5 p90 -146.5 168.58 20.86 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.181 0.515 . . . . 0.0 111.275 -174.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -112.96 140.36 47.84 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 121.081 0.467 . . . . 0.0 111.07 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.2 tt -145.85 146.4 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.959 0.409 . . . . 0.0 110.435 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HA ' ' CB ' ' A' ' 17' ' ' HIS . 30.6 mtmt -81.72 157.67 24.49 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.323 0.582 . . . . 0.0 111.238 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.517 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 24.5 mmm-85 -65.18 -38.93 92.07 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.813 -179.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -90.62 6.21 44.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.585 0.707 . . . . 0.0 110.348 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.532 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 21.3 m -94.32 129.94 35.46 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.067 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.8 152.18 82.26 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.869 2.379 . . . . 0.0 113.036 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.474 HD22 HD13 ' A' ' 43' ' ' LEU . 84.0 mt -64.84 -12.03 43.93 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.444 0.698 . . . . 0.0 111.884 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.1 p -51.16 -46.9 62.2 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.082 0.467 . . . . 0.0 111.076 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.498 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD13 HD22 ' A' ' 40' ' ' LEU . 2.1 tt -59.78 -49.43 77.74 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-O 121.302 0.573 . . . . 0.0 110.137 177.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.588 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.4 mtt -61.23 -46.29 91.04 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.301 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -64.15 -38.65 91.81 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.887 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -57.75 -49.92 74.96 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.096 0.474 . . . . 0.0 110.464 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -63.22 -42.85 99.32 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-O 121.171 0.51 . . . . 0.0 110.68 178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 55' ' ' MET . 79.1 m -64.57 -34.47 78.32 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.19 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -65.72 -42.12 91.44 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 46' ' ' ALA . 10.3 mmm180 -65.33 -44.03 89.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.384 0.611 . . . . 0.0 111.472 -179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.93 -21.53 27.88 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.895 0.379 . . . . 0.0 111.653 -178.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.1 5.67 88.91 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 121.124 -0.56 . . . . 0.0 113.014 179.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -90.48 177.89 6.25 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.397 -0.473 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.2 m -99.93 134.94 42.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.01 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.446 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.9 ptp -66.74 -21.85 66.06 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.956 0.408 . . . . 0.0 111.935 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.453 ' HG3' HE21 ' A' ' 57' ' ' GLN . 9.7 ptp85 -82.24 -9.56 59.45 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.117 0.484 . . . . 0.0 110.863 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.453 HE21 ' HG3' ' A' ' 56' ' ' ARG . 17.9 mm-40 -103.88 5.83 36.03 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.412 0.625 . . . . 0.0 110.72 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.51 HG22 ' HG2' ' A' ' 88' ' ' GLN . 24.9 pt -137.48 172.9 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.809 -179.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' A' ' 59' ' ' ARG . 26.2 mmm180 -140.82 145.36 36.18 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.071 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 5.9 m-85 -111.9 128.79 56.25 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.189 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.6 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.8 ppt_? -129.98 139.83 51.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.532 0.682 . . . . 0.0 111.395 178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -141.94 137.33 31.18 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.175 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 t70 63.95 27.91 14.41 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.082 0.468 . . . . 0.0 110.861 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 80.07 -2.31 76.16 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.545 -176.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -126.32 145.81 54.0 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 121.914 -0.756 . . . . 0.0 111.244 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.93 150.3 54.82 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.373 2.049 . . . . 0.0 111.899 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.26 138.3 54.81 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.954 0 CA-C-O 121.502 0.668 . . . . 0.0 111.055 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -91.31 150.78 21.16 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.787 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.521 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 2.3 pt-20 -60.83 -18.56 56.36 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.404 0.621 . . . . 0.0 111.784 -179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -79.68 -10.89 59.86 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.473 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.04 162.12 14.84 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.856 0.36 . . . . 0.0 111.32 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.8 p -118.69 154.28 52.58 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.813 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -65.95 -9.08 21.87 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.483 2.122 . . . . 0.0 111.932 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.53 -22.31 17.73 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.919 0.39 . . . . 0.0 110.973 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -63.76 -43.69 95.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.55 0.691 . . . . 0.0 110.222 -178.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' H ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -101.18 0.92 38.49 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.853 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 53.75 56.66 6.91 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.834 . . . . 0.0 112.822 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.489 ' SD ' HD11 ' A' ' 20' ' ' LEU . 10.4 ptp -73.97 168.99 18.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.823 0.344 . . . . 0.0 110.258 177.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -92.23 164.83 13.4 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.233 0.54 . . . . 0.0 111.663 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -78.85 133.34 37.01 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-O 121.223 0.535 . . . . 0.0 109.764 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 75.51 15.98 2.65 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 124.268 1.027 . . . . 0.0 110.819 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -67.34 176.05 2.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.76 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.425 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.9 m -134.21 150.84 51.08 Favored 'General case' 0 C--N 1.313 -1.007 0 O-C-N 121.649 -0.657 . . . . 0.0 111.559 -177.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.425 HD12 ' C ' ' A' ' 83' ' ' THR . 2.9 mp -122.7 139.75 48.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.6 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 25.7 t0 -90.51 134.66 34.21 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-O 121.101 0.477 . . . . 0.0 110.718 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 3.0 t -119.14 135.53 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-O 121.847 0.832 . . . . 0.0 111.163 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -136.3 146.52 46.72 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.515 178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.51 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -110.0 111.3 22.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.141 0.496 . . . . 0.0 109.823 -177.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.43 ' OE1' ' HG2' ' A' ' 90' ' ' GLN . 3.5 pp0? -144.26 144.77 31.65 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.118 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.43 ' HG2' ' OE1' ' A' ' 89' ' ' GLN . 85.7 mm-40 72.67 98.57 0.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.725 0.774 . . . . 0.0 111.097 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 15.2 t -120.77 17.67 11.89 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 122.029 0.918 . . . . 0.0 109.291 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.41 -52.56 2.42 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.89 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.332 0 CA-C-O 118.253 -1.304 . . . . 0.0 111.253 179.115 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.939 0 CA-C-O 120.594 0.235 . . . . 0.0 111.562 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -53.32 115.86 2.13 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.455 0.645 . . . . 0.0 111.814 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -133.74 39.72 3.15 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.854 0.835 . . . . 0.0 109.482 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -83.29 103.86 13.01 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.871 -177.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.8 tmmm? -134.01 77.53 61.86 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -88.68 -35.79 0.08 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.775 2.317 . . . . 0.0 113.372 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt 39.63 37.76 0.35 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.615 1.166 . . . . 0.0 113.834 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -92.45 -80.36 0.37 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.188 0.518 . . . . 0.0 111.09 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.16 53.69 0.17 Allowed Glycine 0 C--N 1.306 -1.095 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.863 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.8 t -126.63 151.2 33.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -66.49 -65.72 0.64 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.037 0.446 . . . . 0.0 110.815 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 13' ' ' GLU . 7.3 m -104.85 171.02 7.54 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 1.9 mp0 -116.59 -65.97 1.13 Allowed 'General case' 0 CA--C 1.517 -0.308 0 O-C-N 121.421 -0.799 . . . . 0.0 110.642 -177.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 13' ' ' GLU . 50.9 m-80 74.4 8.81 4.47 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.013 0.925 . . . . 0.0 110.492 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -78.99 74.66 5.51 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.454 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 17' ' ' HIS . 42.5 t0 -112.74 -179.13 3.57 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.361 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.507 ' CB ' ' HA ' ' A' ' 35' ' ' LYS . 11.0 p-80 -134.43 167.28 21.04 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.325 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.1 pt -118.67 168.88 10.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.451 0.643 . . . . 0.0 111.473 -178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' HD22 ' A' ' 20' ' ' LEU . 20.7 m-80 -98.36 141.32 31.39 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.687 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.544 HD11 ' SD ' ' A' ' 78' ' ' MET . 2.1 mm? -133.44 160.96 35.86 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.156 0.503 . . . . 0.0 110.365 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 59.6 mtpt -136.52 147.75 47.26 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.885 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG23 ' CE1' ' A' ' 32' ' ' PHE . 73.2 t -127.75 117.87 47.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-O 121.031 0.443 . . . . 0.0 110.804 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -89.22 121.24 31.32 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.1 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.85 159.88 28.27 Favored Glycine 0 N--CA 1.425 -2.042 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -63.57 -13.77 44.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.279 0.561 . . . . 0.0 111.615 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.42 -10.4 59.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.068 0.461 . . . . 0.0 111.054 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.61 10.41 57.96 Favored Glycine 0 C--O 1.225 -0.443 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.609 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -106.96 156.73 18.41 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.71 135.55 50.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.315 0.579 . . . . 0.0 110.943 -178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.529 HG21 ' HG3' ' A' ' 50' ' ' ARG . 7.6 p -100.28 138.22 25.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.263 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -109.63 127.81 54.8 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.467 ' CE1' HG23 ' A' ' 22' ' ' VAL . 14.2 p90 -151.87 168.51 24.91 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.381 0.61 . . . . 0.0 111.743 -174.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -119.08 134.73 55.02 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.479 ' O ' ' HB2' ' A' ' 17' ' ' HIS . 13.8 tt -138.0 145.77 28.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 CA-C-O 120.887 0.375 . . . . 0.0 110.639 -178.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 26.8 mtmm -79.33 153.3 29.91 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 121.206 0.527 . . . . 0.0 111.29 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.508 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 34.8 mmm-85 -59.58 -40.02 86.01 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.067 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 76.2 m-70 -93.18 9.35 36.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.186 0.517 . . . . 0.0 111.488 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 11.8 m -94.53 128.84 38.54 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.711 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.68 150.26 79.36 Favored 'Trans proline' 0 C--O 1.241 0.632 0 C-N-CA 122.939 2.426 . . . . 0.0 113.625 -178.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.2 mp -60.94 -12.63 11.91 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.168 0.987 . . . . 0.0 112.776 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.3 p -54.29 -41.14 68.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.787 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.468 ' C ' ' HD2' ' A' ' 42' ' ' ALY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.8 tt -62.3 -50.66 70.76 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.295 0.569 . . . . 0.0 109.804 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.695 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 33.6 mtt -60.34 -37.44 80.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.18 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 14.8 tppt? -68.01 -46.2 71.93 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.042 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.07 -49.17 74.51 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.227 0.537 . . . . 0.0 110.766 -178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -64.81 -37.77 88.75 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-O 121.105 0.479 . . . . 0.0 110.924 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -39.28 93.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.215 0.531 . . . . 0.0 110.718 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 10.5 mm-40 -68.41 -40.01 81.44 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.099 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.529 ' HG3' HG21 ' A' ' 30' ' ' VAL . 17.3 mmt180 -65.52 -51.45 59.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.156 0.503 . . . . 0.0 111.333 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.69 -18.96 53.54 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.927 0.394 . . . . 0.0 111.62 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.08 5.74 89.48 Favored Glycine 0 C--O 1.235 0.17 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.721 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 pp -86.56 177.6 7.34 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.705 0.288 . . . . 0.0 111.059 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -96.03 123.85 39.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.763 0.316 . . . . 0.0 110.382 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -61.62 -23.88 66.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.141 0.496 . . . . 0.0 111.752 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.463 ' HG3' HE21 ' A' ' 57' ' ' GLN . 11.0 ptt180 -77.16 -16.05 59.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.354 0.597 . . . . 0.0 110.696 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.463 HE21 ' HG3' ' A' ' 56' ' ' ARG . 19.7 mm-40 -99.73 6.48 45.52 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.207 0.527 . . . . 0.0 111.183 -176.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.52 HG22 ' HG2' ' A' ' 88' ' ' GLN . 25.7 pt -132.86 168.28 24.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-O 121.264 0.554 . . . . 0.0 111.104 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.491 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 18.1 mmt180 -137.42 147.83 45.7 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.98 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.695 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 10.3 m-85 -115.68 132.03 56.76 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.649 -177.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.599 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 4.7 ppt_? -132.56 135.98 46.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.487 0.66 . . . . 0.0 111.283 177.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -139.62 139.78 36.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.932 -177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.64 28.14 16.76 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.072 0.463 . . . . 0.0 111.381 178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.05 -6.6 78.61 Favored Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.54 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -121.48 145.59 43.03 Favored Pre-proline 0 C--N 1.319 -0.733 0 O-C-N 122.126 -0.632 . . . . 0.0 111.306 -178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -72.33 147.18 46.75 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.354 2.036 . . . . 0.0 110.949 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.97 136.16 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.997 0 CA-C-O 121.514 0.674 . . . . 0.0 110.78 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.87 153.29 20.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.562 179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.564 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 3.7 pt-20 -58.82 -20.54 51.36 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.285 0.564 . . . . 0.0 111.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 76.4 p -83.48 -0.63 51.02 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.968 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.546 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -95.53 159.57 14.93 Favored 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 121.883 -0.511 . . . . 0.0 110.354 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.9 p -117.15 149.99 45.36 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 116.79 -0.186 . . . . 0.0 110.918 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -64.57 -12.97 36.12 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.511 2.14 . . . . 0.0 112.462 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -95.57 -10.8 28.61 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.305 0.574 . . . . 0.0 110.748 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -78.15 -33.11 50.49 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.194 0.521 . . . . 0.0 110.517 -178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.39 2.1 22.21 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.161 0.505 . . . . 0.0 110.902 178.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 49.42 60.77 3.53 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 178.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.544 ' SD ' HD11 ' A' ' 20' ' ' LEU . 9.2 ptp -74.44 170.49 15.57 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.125 0.488 . . . . 0.0 110.588 176.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 41.8 tt0 -94.64 156.92 16.2 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -74.46 137.65 42.71 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 121.342 0.592 . . . . 0.0 110.538 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 73.77 19.04 3.28 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.572 1.149 . . . . 0.0 111.076 -178.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -71.4 176.57 4.54 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.204 177.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -132.87 151.61 52.0 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.188 0.518 . . . . 0.0 111.565 -177.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 3.4 mp -122.07 144.57 30.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.599 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 26.9 t0 -93.55 134.65 35.61 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 t -121.49 138.66 51.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-O 121.667 0.746 . . . . 0.0 111.151 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -138.21 148.37 44.73 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.67 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -109.08 111.13 22.6 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -108.99 89.86 3.12 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.425 0.631 . . . . 0.0 111.917 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.422 ' H ' ' CD ' ' A' ' 90' ' ' GLN . 4.8 pm0 -96.6 108.22 20.78 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.885 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 57.9 p 56.96 47.72 17.14 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.67 0.788 . . . . 0.0 111.336 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 167.98 -152.37 20.56 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.091 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.242 0 CA-C-O 118.403 -1.221 . . . . 0.0 111.491 179.934 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.978 0.418 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.32 85.49 2.12 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.458 0.647 . . . . 0.0 110.947 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -103.81 19.16 20.45 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.898 0.856 . . . . 0.0 109.882 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -121.77 -53.42 1.98 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.843 179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? 51.31 71.23 1.58 Allowed Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 115.487 -0.778 . . . . 0.0 111.553 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.41 128.29 15.23 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.08 1.853 . . . . 0.0 111.619 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -88.7 -0.66 57.51 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.143 0.497 . . . . 0.0 111.017 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -81.14 110.38 16.59 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.404 0.621 . . . . 0.0 109.878 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.64 58.74 0.18 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.23 116.75 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-O 121.441 0.639 . . . . 0.0 111.397 -177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.0 tmmm? -131.41 122.12 25.76 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.1 m 68.2 112.01 0.04 OUTLIER 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.829 0.823 . . . . 0.0 112.329 -176.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -108.74 151.7 25.84 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -94.37 -9.09 36.88 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 71.67 43.97 0.54 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.349 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -75.35 111.74 10.94 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.462 ' CD2' ' HD2' ' A' ' 33' ' ' LYS . 46.0 p-80 -161.83 162.06 29.26 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 42.2 pt -118.76 167.93 11.51 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-O 121.516 0.674 . . . . 0.0 112.351 -178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.55 ' O ' HD22 ' A' ' 20' ' ' LEU . 8.5 m-80 -94.65 142.83 26.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.561 HD11 ' SD ' ' A' ' 78' ' ' MET . 1.4 mm? -133.87 159.76 39.69 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.045 0.45 . . . . 0.0 110.199 176.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 58.9 mtpt -134.83 149.04 50.3 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 0.0 110.218 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' A' ' 32' ' ' PHE . 97.2 t -128.07 117.65 46.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.085 0.469 . . . . 0.0 110.124 177.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -93.95 124.19 37.8 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.876 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -89.89 159.9 28.24 Favored Glycine 0 N--CA 1.425 -2.072 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.158 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -65.71 -11.96 49.65 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.439 0.638 . . . . 0.0 111.012 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -80.03 -16.95 54.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.322 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.12 12.0 40.86 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.937 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.3 t -106.06 155.4 19.45 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.95 139.1 41.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.211 0.529 . . . . 0.0 111.126 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.564 HG21 ' HG3' ' A' ' 50' ' ' ARG . 9.7 p -108.89 140.17 28.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.167 178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -112.22 123.3 49.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.525 ' HB2' HH31 ' A' ' 42' ' ' ALY . 19.7 p90 -145.03 167.71 22.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 121.344 0.592 . . . . 0.0 111.459 -173.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.462 ' HD2' ' CD2' ' A' ' 17' ' ' HIS . 27.8 mmtt -106.32 144.01 33.61 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.553 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.459 ' CG2' HD23 ' A' ' 20' ' ' LEU . 17.9 tt -148.91 144.04 18.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.056 0.455 . . . . 0.0 109.901 176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 5.6 mtmp? -84.46 158.01 21.17 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.865 -0.522 . . . . 0.0 110.512 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB3' ' HB2' ' A' ' 74' ' ' ALA . 21.4 mmm-85 -64.47 -36.73 85.12 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.044 0.449 . . . . 0.0 111.091 -177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -92.01 5.98 48.11 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.561 0.696 . . . . 0.0 110.215 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 35' ' ' LYS . 18.0 m -93.64 128.65 41.15 Favored Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.18 -178.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.69 149.08 73.11 Favored 'Trans proline' 0 C--O 1.239 0.564 0 C-N-CA 122.944 2.43 . . . . 0.0 113.576 -178.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.541 HD13 ' O ' ' A' ' 71' ' ' ASP . 5.7 mp -59.87 -12.59 7.92 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.191 0.997 . . . . 0.0 112.683 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . 8.3 t -54.24 -40.77 68.03 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-O 121.145 0.498 . . . . 0.0 110.742 178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALY . . . . . 0.525 HH31 ' HB2' ' A' ' 32' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 32' ' ' PHE . 6.7 tt -60.81 -51.64 68.45 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.193 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.69 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 32.6 mtt -58.17 -50.33 73.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.037 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.608 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 2.9 tppp? -64.57 -38.97 92.86 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.725 0.268 . . . . 0.0 111.725 -178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' A' ' 50' ' ' ARG . . . -59.55 -48.57 81.15 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.117 0.484 . . . . 0.0 110.816 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -63.04 -40.26 97.18 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.15 0.5 . . . . 0.0 110.991 178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 58' ' ' ILE . 75.2 m -62.96 -36.01 82.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.394 -177.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.608 ' HG2' ' O ' ' A' ' 45' ' ' LYS . 28.4 mm-40 -73.18 -35.84 66.46 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.259 0.552 . . . . 0.0 110.763 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.564 ' HG3' HG21 ' A' ' 30' ' ' VAL . 44.1 mmm-85 -70.0 -48.92 56.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.433 0.635 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.95 -18.3 50.78 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.073 -177.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.68 57.8 4.39 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.317 -0.944 . . . . 0.0 111.828 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pp -147.17 172.79 13.25 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 122.491 -0.417 . . . . 0.0 111.165 -177.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.2 m -97.03 130.34 44.36 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.264 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.496 ' HB3' ' SG ' ' A' ' 48' ' ' CYS . 8.4 ptp -64.67 -25.45 67.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.0 0.429 . . . . 0.0 111.414 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.476 ' HG3' HE21 ' A' ' 57' ' ' GLN . 11.5 ptp180 -76.69 -10.51 59.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.4 0.619 . . . . 0.0 110.328 179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.476 HE21 ' HG3' ' A' ' 56' ' ' ARG . 26.6 mm-40 -105.01 3.9 31.06 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.403 -179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.536 HG22 ' HG2' ' A' ' 88' ' ' GLN . 20.9 pt -136.71 172.28 15.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 121.043 0.449 . . . . 0.0 110.87 -177.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HB2' ' CE2' ' A' ' 87' ' ' PHE . 25.6 mmm180 -143.76 148.21 35.3 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.781 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.69 ' CE1' ' HG2' ' A' ' 44' ' ' MET . 11.1 m-85 -113.39 129.66 56.48 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.657 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.563 ' HG3' ' HB3' ' A' ' 85' ' ' ASP . 6.3 ppt_? -131.58 140.79 49.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.411 0.624 . . . . 0.0 111.541 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.415 ' HB2' HG13 ' A' ' 84' ' ' ILE . 80.6 t80 -145.44 139.32 26.8 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.4 t70 63.93 26.41 14.18 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.168 0.509 . . . . 0.0 110.815 177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 79.83 -0.99 80.78 Favored Glycine 0 N--CA 1.435 -1.408 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.896 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -125.16 144.63 47.95 Favored Pre-proline 0 C--N 1.327 -0.406 0 O-C-N 122.11 -0.641 . . . . 0.0 111.528 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.74 147.84 45.59 Favored 'Trans proline' 0 C--N 1.328 -0.513 0 C-N-CA 122.628 2.218 . . . . 0.0 111.36 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.14 137.65 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-O 121.468 0.651 . . . . 0.0 111.0 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.83 155.53 18.71 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.485 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.622 ' HB3' ' SD ' ' A' ' 44' ' ' MET . 5.1 pt-20 -64.41 -16.96 63.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.372 0.606 . . . . 0.0 111.594 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 42.0 p -81.2 -5.98 58.34 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.442 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' O ' HD13 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.74 161.54 14.49 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.405 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 p -117.6 153.04 50.4 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 116.786 -0.188 . . . . 0.0 110.743 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.64 -8.56 21.48 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.353 2.036 . . . . 0.0 112.054 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 36' ' ' ARG . . . -96.03 -18.21 20.39 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.093 0.473 . . . . 0.0 111.068 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -68.92 -36.9 78.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.239 0.542 . . . . 0.0 110.848 -177.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -106.34 1.15 25.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.346 0.593 . . . . 0.0 110.756 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 51.18 58.66 5.3 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.962 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' HD11 ' A' ' 20' ' ' LEU . 8.6 ptp -73.92 164.63 26.38 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.664 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 36.2 tt0 -100.55 134.4 43.57 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 120.993 -0.283 . . . . 0.0 111.19 -176.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -41.69 135.85 2.09 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 177.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 26.2 mt-10 74.12 16.47 3.53 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 124.777 1.231 . . . . 0.0 111.801 178.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.664 ' HB2' ' O ' ' A' ' 79' ' ' GLU . 1.1 t70 -71.84 178.45 3.67 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.903 0.382 . . . . 0.0 110.463 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.423 ' C ' HD12 ' A' ' 84' ' ' ILE . 1.8 m -135.23 151.58 50.74 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.313 0.578 . . . . 0.0 111.21 -177.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.423 HD12 ' C ' ' A' ' 83' ' ' THR . 2.8 mp -123.12 140.28 47.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.563 ' HB3' ' HG3' ' A' ' 61' ' ' ARG . 33.6 t70 -90.03 135.64 33.53 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 121.008 0.432 . . . . 0.0 110.651 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ARG . 2.7 t -119.64 135.34 60.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-O 121.777 0.799 . . . . 0.0 110.911 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 59' ' ' ARG . 1.7 p90 -133.8 142.07 47.72 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.582 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG2' HG22 ' A' ' 58' ' ' ILE . 1.1 mt-30 -104.11 112.41 25.4 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.999 0.428 . . . . 0.0 110.432 -176.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -69.43 78.52 0.39 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.403 0.621 . . . . 0.0 111.302 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -72.28 179.35 3.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.904 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.7 t -147.02 135.29 21.69 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.067 0.46 . . . . 0.0 110.224 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 172.94 -169.23 42.39 Favored Glycine 0 N--CA 1.438 -1.203 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.886 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.167 0 CA-C-O 118.321 -1.266 . . . . 0.0 111.322 -179.703 . . . . . . . . 0 0 . 1 stop_ save_